gse	gsm	text	bern_text	pmid	cell line	organism	cell type	method	source name	tissue	treatment	disease	library_strategy	lstrategy_add	library_source	molecule	Sample_type	Last_Update_Date	Release_Date	Supplementary_Data	s_platform_ref	bern_disease_str	bern_disease_id_str	normolize_disease_id_name	normolize_disease_name	bern_drug_str	bern_drug_id_str	normolize_drug_id_name	normolize_drug_name	bern_gene_str	bern_gene_id_str	normolize_gene_id_name	normolize_gene_name	knock_out/knock_down	knock_in	knock	over_expression	cell_line_text_regex	cell_line_bern_text_regex	gsm_rrid_cell_line	gsm_rrid_disease
GSE117702	GSM3307398	{'tissue':'Lung ','organism':'Homo sapiens','source name':'Untreated PC9 cells', 'title':'PC9 Untreated rep1', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'in situ oligonucleotide'}	GSM3307398*#*#*#PC9 Untreated rep1*#*#*#1*#*#*#Untreated PC9 cells*#*#*#Homo sapiens*#*#*#24hours post plating medium was changed to one containng 2µM HCI-2509. After 48hours, cells were harvested to isolate total RNA *#*#*#total RNA*#*#*#None*#*#*#The data were analyzed with Affymetrix ® Transcriptome Analysis Console using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100. *#*#*#null*#*#*#Gene expression data from PC9 NSCLC cells *#*#*#GPL16686*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Lung 	null	null	Homo sapiens	null	in situ oligonucleotide	Untreated PC9 cells	Lung	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307398/suppl/GSM3307398_ODE4_1_HuGene-2_0-st_.CEL.gz 	GPL16686	NSCLC	MESH:D002289;BERN:107402101	MESH:D002289=>Carcinoma, Non-Small-Cell Lung	Carcinoma, Non-Small-Cell Lung	null	null	null	null	rep1	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM	CHM	null	null	null	null	PC9	PC9	null	null
GSE117702	GSM3307399	{'tissue':'Lung ','organism':'Homo sapiens','source name':'Untreated PC9 cells', 'title':'PC9 Untreated rep2', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'in situ oligonucleotide'}	GSM3307399*#*#*#PC9 Untreated rep2*#*#*#1*#*#*#Untreated PC9 cells*#*#*#Homo sapiens*#*#*#24hours post plating medium was changed to one containng 2µM HCI-2509. After 48hours, cells were harvested to isolate total RNA *#*#*#total RNA*#*#*#None*#*#*#The data were analyzed with Affymetrix ® Transcriptome Analysis Console using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100. *#*#*#null*#*#*#Gene expression data from PC9 NSCLC cells *#*#*#GPL16686*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Lung 	null	null	Homo sapiens	null	in situ oligonucleotide	Untreated PC9 cells	Lung	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307399/suppl/GSM3307399_ODE4_2_HuGene-2_0-st_.CEL.gz 	GPL16686	NSCLC	MESH:D002289;BERN:107402101	MESH:D002289=>Carcinoma, Non-Small-Cell Lung	Carcinoma, Non-Small-Cell Lung	null	null	null	null	null	null	null	null	null	null	null	null	PC9	PC9	null	null
GSE117702	GSM3307400	{'tissue':'Lung ','organism':'Homo sapiens','source name':'Untreated PC9 cells', 'title':'PC9 Untreated rep3', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'in situ oligonucleotide'}	GSM3307400*#*#*#PC9 Untreated rep3*#*#*#1*#*#*#Untreated PC9 cells*#*#*#Homo sapiens*#*#*#24hours post plating medium was changed to one containng 2µM HCI-2509. After 48hours, cells were harvested to isolate total RNA *#*#*#total RNA*#*#*#None*#*#*#The data were analyzed with Affymetrix ® Transcriptome Analysis Console using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100. *#*#*#null*#*#*#Gene expression data from PC9 NSCLC cells *#*#*#GPL16686*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Lung 	null	null	Homo sapiens	null	in situ oligonucleotide	Untreated PC9 cells	Lung	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307400/suppl/GSM3307400_ODE4_3_HuGene-2_0-st_.CEL.gz 	GPL16686	NSCLC	MESH:D002289;BERN:107402101	MESH:D002289=>Carcinoma, Non-Small-Cell Lung	Carcinoma, Non-Small-Cell Lung	null	null	null	null	null	null	null	null	null	null	null	null	PC9	PC9	null	null
GSE117702	GSM3307401	{'tissue':'Lung ','organism':'Homo sapiens','source name':'PC9 cells treated with 2µM HCI-2509', 'title':'PC9 HCI-2509 rep1', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'in situ oligonucleotide'}	GSM3307401*#*#*#PC9 HCI-2509 rep1*#*#*#1*#*#*#PC9 cells treated with 2µM HCI-2509*#*#*#Homo sapiens*#*#*#24hours post plating medium was changed to one containng 2µM HCI-2509. After 48hours, cells were harvested to isolate total RNA *#*#*#total RNA*#*#*#None*#*#*#The data were analyzed with Affymetrix ® Transcriptome Analysis Console using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100. *#*#*#null*#*#*#Gene expression data from PC9 NSCLC cells treated with 2µM HCI-2509 *#*#*#GPL16686*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Lung 	null	null	Homo sapiens	null	in situ oligonucleotide	PC9 cells treated with 2µM HCI-2509	Lung	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307401/suppl/GSM3307401_ODE4_4_HuGene-2_0-st_.CEL.gz 	GPL16686	NSCLC	MESH:D002289;BERN:107402101	MESH:D002289=>Carcinoma, Non-Small-Cell Lung	Carcinoma, Non-Small-Cell Lung	null	null	null	null	rep1	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM	CHM	null	null	null	null	PC9	PC9	null	null
GSE117702	GSM3307402	{'tissue':'Lung ','organism':'Homo sapiens','source name':'PC9 cells treated with 2µM HCI-2509', 'title':'PC9 HCI-2509 rep2', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'in situ oligonucleotide'}	GSM3307402*#*#*#PC9 HCI-2509 rep2*#*#*#1*#*#*#PC9 cells treated with 2µM HCI-2509*#*#*#Homo sapiens*#*#*#24hours post plating medium was changed to one containng 2µM HCI-2509. After 48hours, cells were harvested to isolate total RNA *#*#*#total RNA*#*#*#None*#*#*#The data were analyzed with Affymetrix ® Transcriptome Analysis Console using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100. *#*#*#null*#*#*#Gene expression data from PC9 NSCLC cells treated with 2µM HCI-2509 *#*#*#GPL16686*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Lung 	null	null	Homo sapiens	null	in situ oligonucleotide	PC9 cells treated with 2µM HCI-2509	Lung	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307402/suppl/GSM3307402_ODE4_5_HuGene-2_0-st_.CEL.gz 	GPL16686	NSCLC	MESH:D002289;BERN:107402101	MESH:D002289=>Carcinoma, Non-Small-Cell Lung	Carcinoma, Non-Small-Cell Lung	null	null	null	null	null	null	null	null	null	null	null	null	PC9	PC9	null	null
GSE117702	GSM3307403	{'tissue':'Lung ','organism':'Homo sapiens','source name':'PC9 cells treated with 2µM HCI-2509', 'title':'PC9 HCI-2509 rep3', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'in situ oligonucleotide'}	GSM3307403*#*#*#PC9 HCI-2509 rep3*#*#*#1*#*#*#PC9 cells treated with 2µM HCI-2509*#*#*#Homo sapiens*#*#*#24hours post plating medium was changed to one containng 2µM HCI-2509. After 48hours, cells were harvested to isolate total RNA *#*#*#total RNA*#*#*#None*#*#*#The data were analyzed with Affymetrix ® Transcriptome Analysis Console using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100. *#*#*#null*#*#*#Gene expression data from PC9 NSCLC cells treated with 2µM HCI-2509 *#*#*#GPL16686*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Lung 	null	null	Homo sapiens	null	in situ oligonucleotide	PC9 cells treated with 2µM HCI-2509	Lung	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307403/suppl/GSM3307403_ODE4_6_HuGene-2_0-st_.CEL.gz 	GPL16686	NSCLC	MESH:D002289;BERN:107402101	MESH:D002289=>Carcinoma, Non-Small-Cell Lung	Carcinoma, Non-Small-Cell Lung	null	null	null	null	null	null	null	null	null	null	null	null	PC9	PC9	null	null
GSE117720	GSM3307692	{'cell type':'smNPC ','donor':'R_107b ','passage':'P18 ','organism':'Homo sapiens','source name':'R705: smNPC 107b P18', 'title':'R705:_smNPC_107b_P18', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307692*#*#*#R705:_smNPC_107b_P18*#*#*#1*#*#*#R705: smNPC 107b P18*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)smNPC *#*#*#[char](donor)R_107b *#*#*#[char](passage)P18 	30279449	null	Homo sapiens	smNPC	high-throughput sequencing	R705	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307693	{'cell type':'iNSC ','donor':'MJD33b ','passage':'P5 ','organism':'Homo sapiens','source name':'R885: iNSC-SC MJD33b-2-V-8 day11 P5', 'title':'R885:_iNSC-SC_MJD33b-2-V-8_day11_P5', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307693*#*#*#R885:_iNSC-SC_MJD33b-2-V-8_day11_P5*#*#*#1*#*#*#R885: iNSC-SC MJD33b-2-V-8 day11 P5*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)MJD33b *#*#*#[char](passage)P5 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R885	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307694	{'cell type':'iNSC ','donor':'R_107b ','passage':'P19 ','organism':'Homo sapiens','source name':'R699: iNSC-PC 107b-PC (JK80bm-1-II-PC) day16 P19', 'title':'R699:_iNSC-PC_107b-PC_(JK80bm-1-II-PC)_day16_P19', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307694*#*#*#R699:_iNSC-PC_107b-PC_(JK80bm-1-II-PC)_day16_P19*#*#*#1*#*#*#R699: iNSC-PC 107b-PC (JK80bm-1-II-PC) day16 P19*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)R_107b *#*#*#[char](passage)P19 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R699	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307695	{'cell type':'iNSC ','donor':'MJD33b ','passage':'P5 ','organism':'Homo sapiens','source name':'R886: iNSC-SC MJD33b-1-II-10 day18 P5', 'title':'R886:_iNSC-SC_MJD33b-1-II-10_day18_P5', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307695*#*#*#R886:_iNSC-SC_MJD33b-1-II-10_day18_P5*#*#*#1*#*#*#R886: iNSC-SC MJD33b-1-II-10 day18 P5*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)MJD33b *#*#*#[char](passage)P5 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R886	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307696	{'cell type':'iNSC ','donor':'R_107b ','passage':'P6 ','organism':'Homo sapiens','source name':'R892: iNSC-SC 107b-2-II-3 day11 P6', 'title':'R892:_iNSC-SC_107b-2-II-3_day11_P6', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307696*#*#*#R892:_iNSC-SC_107b-2-II-3_day11_P6*#*#*#1*#*#*#R892: iNSC-SC 107b-2-II-3 day11 P6*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)R_107b *#*#*#[char](passage)P6 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R892	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307697	{'cell type':'smNPC ','donor':'R_107b ','passage':'P6 ','organism':'Homo sapiens','source name':'R911: smNPC 107b P6', 'title':'R911:_smNPC_107b_P6', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307697*#*#*#R911:_smNPC_107b_P6*#*#*#1*#*#*#R911: smNPC 107b P6*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)smNPC *#*#*#[char](donor)R_107b *#*#*#[char](passage)P6 	30279449	null	Homo sapiens	smNPC	high-throughput sequencing	R911	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307698	{'cell type':'iNSC ','donor':'MJD33b ','passage':'P21 ','organism':'Homo sapiens','source name':'R877: iNSC-SC MJD33b-2-II-3 day11 P21', 'title':'R877:_iNSC-SC_MJD33b-2-II-3_day11_P21', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307698*#*#*#R877:_iNSC-SC_MJD33b-2-II-3_day11_P21*#*#*#1*#*#*#R877: iNSC-SC MJD33b-2-II-3 day11 P21*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)MJD33b *#*#*#[char](passage)P21 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R877	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307699	{'cell type':'iNSC ','donor':'R_107b ','passage':'P3 ','organism':'Homo sapiens','source name':'R908: iNSC-PC 107b-PC (JK80bm-1-II-PC) day16 P3', 'title':'R908:_iNSC-PC_107b-PC_(JK80bm-1-II-PC)_day16_P3', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307699*#*#*#R908:_iNSC-PC_107b-PC_(JK80bm-1-II-PC)_day16_P3*#*#*#1*#*#*#R908: iNSC-PC 107b-PC (JK80bm-1-II-PC) day16 P3*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)R_107b *#*#*#[char](passage)P3 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R908	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307700	{'cell type':'EPC ','donor':'R_107b ','passage':'P0 ','organism':'Homo sapiens','source name':'R760: EPC iLB-C-107b', 'title':'R760:_EPC_iLB-C-107b', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307700*#*#*#R760:_EPC_iLB-C-107b*#*#*#1*#*#*#R760: EPC iLB-C-107b*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)EPC *#*#*#[char](donor)R_107b *#*#*#[char](passage)P0 	30279449	null	Homo sapiens	EPC	high-throughput sequencing	R760	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307702	{'cell type':'iNSC ','donor':'R_82b ','passage':'P21 ','organism':'Homo sapiens','source name':'R910: iNSC-SC 82b-1-SC (EPC-1-II-1) day11 P21', 'title':'R910:_iNSC-SC_82b-1-SC_(EPC-1-II-1)_day11_P21', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307702*#*#*#R910:_iNSC-SC_82b-1-SC_(EPC-1-II-1)_day11_P21*#*#*#1*#*#*#R910: iNSC-SC 82b-1-SC (EPC-1-II-1) day11 P21*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)R_82b *#*#*#[char](passage)P21 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R910	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307703	{'cell type':'smNPC ','donor':'MJD33b ','passage':'P18 ','organism':'Homo sapiens','source name':'R713: smNPC MJD33b P18', 'title':'R713:_smNPC_MJD33b_P18', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307703*#*#*#R713:_smNPC_MJD33b_P18*#*#*#1*#*#*#R713: smNPC MJD33b P18*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)smNPC *#*#*#[char](donor)MJD33b *#*#*#[char](passage)P18 	30279449	null	Homo sapiens	smNPC	high-throughput sequencing	R713	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307704	{'cell type':'iNSC ','donor':'MJD33b ','passage':'P6 ','organism':'Homo sapiens','source name':'R891: iNSC-SC MJD33b-2-II-3 day11 P6', 'title':'R891:_iNSC-SC_MJD33b-2-II-3_day11_P6', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307704*#*#*#R891:_iNSC-SC_MJD33b-2-II-3_day11_P6*#*#*#1*#*#*#R891: iNSC-SC MJD33b-2-II-3 day11 P6*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)MJD33b *#*#*#[char](passage)P6 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R891	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307705	{'cell type':'iNSC ','donor':'R_107b ','passage':'P21 ','organism':'Homo sapiens','source name':'R867: iNSC-SC 107b-2-II-3 day11 P21', 'title':'R867:_iNSC-SC_107b-2-II-3_day11_P21', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307705*#*#*#R867:_iNSC-SC_107b-2-II-3_day11_P21*#*#*#1*#*#*#R867: iNSC-SC 107b-2-II-3 day11 P21*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)R_107b *#*#*#[char](passage)P21 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R867	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307706	{'cell type':'iNSC ','donor':'R_82b ','passage':'P21 ','organism':'Homo sapiens','source name':'R677: iNSC-SC 82b-3-SC (EPC-2-II-3) day14 P21', 'title':'R677:_iNSC-SC_82b-3-SC_(EPC-2-II-3)_day14_P21', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307706*#*#*#R677:_iNSC-SC_82b-3-SC_(EPC-2-II-3)_day14_P21*#*#*#1*#*#*#R677: iNSC-SC 82b-3-SC (EPC-2-II-3) day14 P21*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)R_82b *#*#*#[char](passage)P21 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R677	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307707	{'cell type':'EPC ','donor':'MJD33b ','passage':'P0 ','organism':'Homo sapiens','source name':'R729: EPC iLB-MJD3-33bf', 'title':'R729:_EPC_iLB-MJD3-33bf', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307707*#*#*#R729:_EPC_iLB-MJD3-33bf*#*#*#1*#*#*#R729: EPC iLB-MJD3-33bf*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)EPC *#*#*#[char](donor)MJD33b *#*#*#[char](passage)P0 	30279449	null	Homo sapiens	EPC	high-throughput sequencing	R729	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307708	{'cell type':'iNSC ','donor':'R_82b ','passage':'P5 ','organism':'Homo sapiens','source name':'R909: iNSC-SC 82b-1-SC (EPC-1-II-1) day11 P5', 'title':'R909:_iNSC-SC_82b-1-SC_(EPC-1-II-1)_day11_P5', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307708*#*#*#R909:_iNSC-SC_82b-1-SC_(EPC-1-II-1)_day11_P5*#*#*#1*#*#*#R909: iNSC-SC 82b-1-SC (EPC-1-II-1) day11 P5*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)R_82b *#*#*#[char](passage)P5 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R909	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307709	{'cell type':'smNPC ','donor':'MJD33b ','passage':'P6 ','organism':'Homo sapiens','source name':'R913: smNPC MJD33b P6', 'title':'R913:_smNPC_MJD33b_P6', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307709*#*#*#R913:_smNPC_MJD33b_P6*#*#*#1*#*#*#R913: smNPC MJD33b P6*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)smNPC *#*#*#[char](donor)MJD33b *#*#*#[char](passage)P6 	30279449	null	Homo sapiens	smNPC	high-throughput sequencing	R913	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117720	GSM3307710	{'cell type':'iNSC ','donor':'MJD33b ','passage':'P21 ','organism':'Homo sapiens','source name':'R720: iNSC-SC MJD33b-1-II-10 day18 P21', 'title':'R720:_iNSC-SC_MJD33b-1-II-10_day18_P21', 'last update date':'2018-11-01', 'release date': '2018-11-01', 'method': 'high-throughput sequencing'}	GSM3307710*#*#*#R720:_iNSC-SC_MJD33b-1-II-10_day18_P21*#*#*#1*#*#*#R720: iNSC-SC MJD33b-1-II-10 day18 P21*#*#*#Homo sapiens*#*#*#no differential treatment *#*#*#total RNA*#*#*#null*#*#*#Transcript and gene level quantification was performed using Salmon55 in combination with the human cDNA file for genome GRCh37 version 89 obtained from ENSEMBL. Gene level read counts were then further analysed in R using tximport and DESeq2. Prior to further analysis, mitochondrial genes, as well as genes with less than a total read count of 4 across all samples (40th percentile) and more than 17,488 reads (95th percentile) were removed. All data was normalized based on standard size factor estimates and variance stabilization transformation was performed on filtered data, giving rise to the normalized gene expression matrix.Genome_build: GRCh37Supplementary_files_format_and_content: ENSEMBL gnee ID and gene symbol ENSEMBL verison 89, variance stabilzation transformed gene level counts. *#*#*#RNA-Seq*#*#*#RNA-Seq *#*#*#GPL16791*#*#*#2018-11-01*#*#*#2018-11-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)iNSC *#*#*#[char](donor)MJD33b *#*#*#[char](passage)P21 	30279449	null	Homo sapiens	iNSC	high-throughput sequencing	R720	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-11-01	2018-11-01	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117727	GSM3307741	{'cell line':'MDA-MB231 ','cell type':'breast cancer cell ','genome-wide binding targets of':'FECR1 ','organism':'Homo sapiens','source name':'MDA-MB231', 'title':'MDA-MB231 RAT-seq', 'last update date':'2018-11-16', 'release date': '2018-11-15', 'method': 'high-throughput sequencing'}	GSM3307741*#*#*#MDA-MB231 RAT-seq*#*#*#1*#*#*#MDA-MB231*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Library strategy: RAT-SeqRaw data were filtered with Fastx (version: 0.0.13) and approximately 12 million single-end clean reads of 50bp length from RAT-seq were mapped to hg38 reference genome using Bowtie (version 0.12.8) with default parameters [44]. Only reads with at most one mismatch and a Phred quality score greater than or equal to 30 were kept for further analysis. Multiple reads that map to exact same coordinates were further filtered out as PCR duplicates. The remaining high quality mapping reads were extended to 500bp fragments, which were then used to compute genome-wide coverage at 5kb resolution with "bedtools genomecov" function [45]. The resulting coverage tracks (bedgraph file) were visualized in the UCSC genome browser.Genome_build: hg38Supplementary_files_format_and_content: bedgraph *#*#*#OTHER*#*#*#FECR1-interacting DNA identified by RAT-Seq *#*#*#GPL16791*#*#*#2018-11-16*#*#*#2018-11-15*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)MDA-MB231 *#*#*#[char](cell type)breast cancer cell *#*#*#[char](genome-wide binding targets of)FECR1 	30537986	MDA-MB231	Homo sapiens	breast cancer cell	high-throughput sequencing	MDA-MB231	null	null	null	OTHER	RAT-Seq	genomic	genomic DNA	SRA	2018-11-16	2018-11-15	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307741/suppl/GSM3307741_FECR1_RAT-seq.bedGraph.gz 	GPL16791	breast cancer	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	MDA	CHEBI:32506;BERN:111040703	CHEBI:32506=>4,4'-diaminodiphenylmethane	4,4'-diaminodiphenylmethane	null	null	null	null	null	null	null	null	null	null	null	null
GSE117734	GSM3307881	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_Control_ChIP-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307881*#*#*#BIN-67_BRG1_Control_ChIP-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+Control_ChIP-Seq_Rep1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307881/suppl/GSM3307881_BIN-67_BRG1_Control_ChIP-Seq_Rep1.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep1|BRG1|SMARCA4	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	CHM|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307882	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'none ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_Input_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307882*#*#*#BIN-67_Input_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_Input_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)none 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307882/suppl/GSM3307882_BIN-67_Input_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307883	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307883*#*#*#BIN-67_BRG1_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307883/suppl/GSM3307883_BIN-67_BRG1_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	BRG1|SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307884	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307884*#*#*#BIN-67_BAF155_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307884/suppl/GSM3307884_BIN-67_BAF155_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307885	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'ARID2 (CST, D8D8U) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_ARID2_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307885*#*#*#BIN-67_ARID2_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_ARID2_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)ARID2 (CST, D8D8U) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307885/suppl/GSM3307885_BIN-67_ARID2_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	CST|ARID2|SMARCA4	MIM:609539;HGNC:18037;Ensembl:ENSG00000189079;BERN:323064702|HGNC:31920;BERN:322312302|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:18037=>ARID2;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:31920=>CST12P;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	ARID2|CST12P|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307886	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'SS18 (Cell Signaling Technologies, D6I4Z) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_SS18_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307886*#*#*#BIN-67_SS18_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_SS18_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)SS18 (Cell Signaling Technologies, D6I4Z) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307886/suppl/GSM3307886_BIN-67_SS18_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SS18|SMARCA4	MIM:600192;HGNC:11340;Ensembl:ENSG00000141380;BERN:324892402|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11340=>SS18;Ensembl:ENSG00000141380=>SS18;MIM:600192=>SS18|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SS18|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307887	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'none ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_Input_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307887*#*#*#BIN-67_Input_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_Input_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)none 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307887/suppl/GSM3307887_BIN-67_Input_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307888	{'cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_Null_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307888*#*#*#BIN-67_BAF155_Null_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_Null_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307888/suppl/GSM3307888_BIN-67_BAF155_Null_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1	SMARCC1	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307889	{'cell line':'BIN-67 ','chip antibody':'45D (Abcam, ab134942, GR3185597-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_45D_Null_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307889*#*#*#BIN-67_45D_Null_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_45D_Null_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)45D (Abcam, ab134942, GR3185597-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307889/suppl/GSM3307889_BIN-67_45D_Null_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307890	{'cell line':'SCCOHT-1 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'SCCOHT-1 (SCCOHT)', 'title':'SCCOHT-1_BAF155_Null_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307890*#*#*#SCCOHT-1_BAF155_Null_ChIP-Seq*#*#*#1*#*#*#SCCOHT-1 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#SCCOHT-1_BAF155_Null_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)SCCOHT-1 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	SCCOHT-1	Homo sapiens	null	high-throughput sequencing	SCCOHT-1 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307890/suppl/GSM3307890_SCCOHT-1_BAF155_Null_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	SCCOHT-1	SCCOHT-1|BIN-67	null	null
GSE117734	GSM3307891	{'cell line':'SCCOHT-1 ','chip antibody':'45D (Abcam, ab134942, GR3185597-1) ','organism':'Homo sapiens','source name':'SCCOHT-1 (SCCOHT)', 'title':'SCCOHT-1_45D_Null_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307891*#*#*#SCCOHT-1_45D_Null_ChIP-Seq*#*#*#1*#*#*#SCCOHT-1 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#SCCOHT-1_45D_Null_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)SCCOHT-1 *#*#*#[char](chip antibody)45D (Abcam, ab134942, GR3185597-1) 	30858614	SCCOHT-1	Homo sapiens	null	high-throughput sequencing	SCCOHT-1 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307891/suppl/GSM3307891_SCCOHT-1_45D_Null_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	null	null	null	null	null	null	null	null	SCCOHT-1	SCCOHT-1|BIN-67	null	null
GSE117734	GSM3307892	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_Control_ChIP-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307892*#*#*#BIN-67_BRG1_Control_ChIP-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+Control_ChIP-Seq_Rep2 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307892/suppl/GSM3307892_BIN-67_BRG1_Control_ChIP-Seq_Rep2.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BRG1|Rep2	MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	CHML|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307893	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'SS18 (Cell Signaling Technologies, D6I4Z) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_SS18_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307893*#*#*#BIN-67_SS18_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_SS18_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)SS18 (Cell Signaling Technologies, D6I4Z) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307893/suppl/GSM3307893_BIN-67_SS18_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SS18|SMARCA4	MIM:600192;HGNC:11340;Ensembl:ENSG00000141380;BERN:324892402|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11340=>SS18;Ensembl:ENSG00000141380=>SS18;MIM:600192=>SS18|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SS18|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307894	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307894*#*#*#BIN-67_BAF155_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307894/suppl/GSM3307894_BIN-67_BAF155_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307895	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'ARID2 (CST, D8D8U) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_ARID2_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307895*#*#*#BIN-67_ARID2_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_ARID2_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)ARID2 (CST, D8D8U) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307895/suppl/GSM3307895_BIN-67_ARID2_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	CST|ARID2|SMARCA4	MIM:609539;HGNC:18037;Ensembl:ENSG00000189079;BERN:323064702|HGNC:31920;BERN:322312302|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:18037=>ARID2;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:31920=>CST12P;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	ARID2|CST12P|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307896	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'45D (Abcam, ab134942, GR3185597-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_45D_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307896*#*#*#BIN-67_45D_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_45D_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)45D (Abcam, ab134942, GR3185597-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307896/suppl/GSM3307896_BIN-67_45D_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	null	null	null	null	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307897	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307897*#*#*#BIN-67_BRG1_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307897/suppl/GSM3307897_BIN-67_BRG1_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	BRG1|SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307898	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'ARID2 (CST, D8D8U) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_ARID2_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307898*#*#*#BIN-67_ARID2_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_ARID2_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)ARID2 (CST, D8D8U) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307898/suppl/GSM3307898_BIN-67_ARID2_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	CST|ARID2|SMARCA4	MIM:609539;HGNC:18037;Ensembl:ENSG00000189079;BERN:323064702|HGNC:31920;BERN:322312302|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:18037=>ARID2;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:31920=>CST12P;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	ARID2|CST12P|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307899	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307899*#*#*#BIN-67_BAF155_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307899/suppl/GSM3307899_BIN-67_BAF155_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307900	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'SS18 (Cell Signaling Technologies, D6I4Z) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_SS18_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307900*#*#*#BIN-67_SS18_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_SS18_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)SS18 (Cell Signaling Technologies, D6I4Z) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307900/suppl/GSM3307900_BIN-67_SS18_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SS18|SMARCA4	MIM:600192;HGNC:11340;Ensembl:ENSG00000141380;BERN:324892402|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11340=>SS18;Ensembl:ENSG00000141380=>SS18;MIM:600192=>SS18|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SS18|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307901	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'45D (Abcam, ab134942, GR3185597-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_45D_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307901*#*#*#BIN-67_45D_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_45D_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)45D (Abcam, ab134942, GR3185597-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307901/suppl/GSM3307901_BIN-67_45D_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307902	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'none ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_Input_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307902*#*#*#BIN-67_Input_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_Input_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)none 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307902/suppl/GSM3307902_BIN-67_Input_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307903	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307903*#*#*#BIN-67_BRG1_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307903/suppl/GSM3307903_BIN-67_BRG1_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	BRG1|SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307904	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307904*#*#*#BIN-67_BAF155_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307904/suppl/GSM3307904_BIN-67_BAF155_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307905	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'ARID2 (CST, D8D8U) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_ARID2_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307905*#*#*#BIN-67_ARID2_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_ARID2_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)ARID2 (CST, D8D8U) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307905/suppl/GSM3307905_BIN-67_ARID2_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	CST|ARID2|SMARCA4	MIM:609539;HGNC:18037;Ensembl:ENSG00000189079;BERN:323064702|HGNC:31920;BERN:322312302|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:18037=>ARID2;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:31920=>CST12P;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	ARID2|CST12P|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307906	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'45D (Abcam, ab134942, GR3185597-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_45D_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307906*#*#*#BIN-67_45D_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_45D_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)45D (Abcam, ab134942, GR3185597-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307906/suppl/GSM3307906_BIN-67_45D_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307907	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'SS18 (Cell Signaling Technologies, D6I4Z) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_SS18_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307907*#*#*#BIN-67_SS18_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_SS18_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)SS18 (Cell Signaling Technologies, D6I4Z) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307907/suppl/GSM3307907_BIN-67_SS18_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SS18|SMARCA4	MIM:600192;HGNC:11340;Ensembl:ENSG00000141380;BERN:324892402|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11340=>SS18;Ensembl:ENSG00000141380=>SS18;MIM:600192=>SS18|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SS18|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307909	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'H3K4me1 (Abcam, ab176877, GR208955-5) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K4me1_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307909*#*#*#BIN-67_H3K4me1_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K4me1_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K4me1 (Abcam, ab176877, GR208955-5) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307909/suppl/GSM3307909_BIN-67_H3K4me1_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307910	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'H3K27ac (Abcam, ab4729, GR288071-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K27ac_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307910*#*#*#BIN-67_H3K27ac_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K27ac_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K27ac (Abcam, ab4729, GR288071-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307910/suppl/GSM3307910_BIN-67_H3K27ac_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307911	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'H3K27me3 (Cell Signaling Technologies, 9733S, 8) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K27me3_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307911*#*#*#BIN-67_H3K27me3_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K27me3_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K27me3 (Cell Signaling Technologies, 9733S, 8) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307911/suppl/GSM3307911_BIN-67_H3K27me3_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307912	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'H3K9me3 (Abcam, ab8898, GR3176466-6) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K9me3_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307912*#*#*#BIN-67_H3K9me3_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K9me3_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K9me3 (Abcam, ab8898, GR3176466-6) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307912/suppl/GSM3307912_BIN-67_H3K9me3_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307913	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'H3K4me1 (Abcam, ab176877, GR208955-5) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K4me1_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307913*#*#*#BIN-67_H3K4me1_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K4me1_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K4me1 (Abcam, ab176877, GR208955-5) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307913/suppl/GSM3307913_BIN-67_H3K4me1_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307914	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'H3K27ac (Abcam, ab4729, GR288071-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K27ac_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307914*#*#*#BIN-67_H3K27ac_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K27ac_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K27ac (Abcam, ab4729, GR288071-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307914/suppl/GSM3307914_BIN-67_H3K27ac_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307915	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'H3K4me1 (Abcam, ab176877, GR208955-5) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K4me1_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307915*#*#*#BIN-67_H3K4me1_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K4me1_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K4me1 (Abcam, ab176877, GR208955-5) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307915/suppl/GSM3307915_BIN-67_H3K4me1_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3307916	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'H3K27ac (Abcam, ab4729, GR288071-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K27ac_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307916*#*#*#BIN-67_H3K27ac_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K27ac_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K27ac (Abcam, ab4729, GR288071-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307916/suppl/GSM3307916_BIN-67_H3K27ac_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3494152	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'BAF155, homemade (PMID: 28945250) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_Control_ChIP-Seq_Rep2', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494152*#*#*#BIN-67_BAF155_Control_ChIP-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+Control_ChIP-Seq_Rep2 *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155, homemade (PMID: 28945250) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494152/suppl/GSM3494152_BIN-67_BAF155_Control_ChIP-Seq_Rep2.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3494153	{'lentivirus':'SMARACA4 ','cell line':'BIN-67 ','chip antibody':'DPF2, Abcam, ab134942 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_DPF2_SMARCA4_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494153*#*#*#BIN-67_DPF2_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_DPF2_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)DPF2, Abcam, ab134942 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494153/suppl/GSM3494153_BIN-67_DPF2_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	DPF2|SMARCA4	MIM:601671;HGNC:9964;Ensembl:ENSG00000133884;BERN:324594202|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:9964=>DPF2;Ensembl:ENSG00000133884=>DPF2;MIM:601671=>DPF2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	DPF2|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3494154	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'MLL3, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL3_Control_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494154*#*#*#BIN-67_MLL3_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL3_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL3, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494154/suppl/GSM3494154_BIN-67_MLL3_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL3|SMARCA4	MIM:606833;HGNC:13726;Ensembl:ENSG00000055609;BERN:324575502|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:13726=>KMT2C;Ensembl:ENSG00000055609=>KMT2C;MIM:606833=>KMT2C|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2C|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3494155	{'lentivirus':'SMARACA4 ','cell line':'BIN-67 ','chip antibody':'MLL3, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL3_SMARCA4_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494155*#*#*#BIN-67_MLL3_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL3_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL3, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494155/suppl/GSM3494155_BIN-67_MLL3_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL3|SMARCA4	MIM:606833;HGNC:13726;Ensembl:ENSG00000055609;BERN:324575502|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:13726=>KMT2C;Ensembl:ENSG00000055609=>KMT2C;MIM:606833=>KMT2C|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2C|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3494156	{'lentivirus':'SMARACA4.T910M ','cell line':'BIN-67 ','chip antibody':'MLL3, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL3_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494156*#*#*#BIN-67_MLL3_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL3_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL3, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494156/suppl/GSM3494156_BIN-67_MLL3_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL3|SMARCA4	MIM:606833;HGNC:13726;Ensembl:ENSG00000055609;BERN:324575502|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:13726=>KMT2C;Ensembl:ENSG00000055609=>KMT2C;MIM:606833=>KMT2C|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2C|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3494157	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'MLL4, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL4_Control_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494157*#*#*#BIN-67_MLL4_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL4_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL4, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494157/suppl/GSM3494157_BIN-67_MLL4_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL4|SMARCA4	MIM:606834;HGNC:15840;Ensembl:ENSG00000272333;BERN:325529802|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:15840=>KMT2B;Ensembl:ENSG00000272333=>KMT2B;MIM:606834=>KMT2B|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2B|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3494158	{'lentivirus':'SMARACA4 ','cell line':'BIN-67 ','chip antibody':'MLL4, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL4_SMARCA4_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494158*#*#*#BIN-67_MLL4_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL4_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL4, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494158/suppl/GSM3494158_BIN-67_MLL4_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL4|SMARCA4	MIM:606834;HGNC:15840;Ensembl:ENSG00000272333;BERN:325529802|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:15840=>KMT2B;Ensembl:ENSG00000272333=>KMT2B;MIM:606834=>KMT2B|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2B|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117734	GSM3494159	{'lentivirus':'SMARACA4.T910M ','cell line':'BIN-67 ','chip antibody':'MLL4, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL4_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494159*#*#*#BIN-67_MLL4_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL4_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL4, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494159/suppl/GSM3494159_BIN-67_MLL4_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL4|SMARCA4	MIM:606834;HGNC:15840;Ensembl:ENSG00000272333;BERN:325529802|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:15840=>KMT2B;Ensembl:ENSG00000272333=>KMT2B;MIM:606834=>KMT2B|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2B|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290735	{'lentivirus':'Control (GFP) ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN67_Control_ATAC-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290735*#*#*#BIN67_Control_ATAC-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control (GFP) in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for ATAC-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.Quality read trimming was performed by Trimmmomatic v0.36ATAC-seq reads were aligned to UCSC hg19 using Bowtie2 v2.29Duplicate reads were removed using Picard v2.8Reads were filtered for quality using SAMtools v1.19Reads in regions considered 'excludable' were removed using BEDtools v2.26To create ChIP-seq coverage plots, bedGraph plots were created using BEDtools genomeCoverageBed, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ATAC-seq*#*#*#BIN67_+Control_ATAC-Seq_Rep1_R1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control (GFP) *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ATAC-seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290735/suppl/GSM3290735_BIN67_Control_ATAC-Seq_Rep1.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep1|GFP|SMARCA4	BERN:326405102|MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	CHM|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290736	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN67_SMARCA4_ATAC-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290736*#*#*#BIN67_SMARCA4_ATAC-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for ATAC-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.Quality read trimming was performed by Trimmmomatic v0.36ATAC-seq reads were aligned to UCSC hg19 using Bowtie2 v2.29Duplicate reads were removed using Picard v2.8Reads were filtered for quality using SAMtools v1.19Reads in regions considered 'excludable' were removed using BEDtools v2.26To create ChIP-seq coverage plots, bedGraph plots were created using BEDtools genomeCoverageBed, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ATAC-seq*#*#*#BIN67_+SMARCA4_ATAC-Seq_Rep1_R1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ATAC-seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290736/suppl/GSM3290736_BIN67_SMARCA4_ATAC-Seq_Rep1.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep1|SMARCA4	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	CHM|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290737	{'lentivirus':'SMARCA2 ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN67_SMARCA2_ATAC-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290737*#*#*#BIN67_SMARCA2_ATAC-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for ATAC-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.Quality read trimming was performed by Trimmmomatic v0.36ATAC-seq reads were aligned to UCSC hg19 using Bowtie2 v2.29Duplicate reads were removed using Picard v2.8Reads were filtered for quality using SAMtools v1.19Reads in regions considered 'excludable' were removed using BEDtools v2.26To create ChIP-seq coverage plots, bedGraph plots were created using BEDtools genomeCoverageBed, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ATAC-seq*#*#*#BIN67_+SMARCA2_ATAC-Seq_Rep1_R1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA2 *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ATAC-seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290737/suppl/GSM3290737_BIN67_SMARCA2_ATAC-Seq_Rep1.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep1|SMARCA2|ATAC|SMARCA4	MIM:600250;HGNC:10645;Ensembl:ENSG00000143184;BERN:324647002|MIM:600014;HGNC:11098;Ensembl:ENSG00000080503;BERN:324871002|MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:10645=>XCL1;Ensembl:ENSG00000143184=>XCL1;MIM:600250=>XCL1|HGNC:11098=>SMARCA2;Ensembl:ENSG00000080503=>SMARCA2;MIM:600014=>SMARCA2|HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	XCL1|SMARCA2|CHM|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290738	{'lentivirus':'T910M ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN67_T910M_ATAC-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290738*#*#*#BIN67_T910M_ATAC-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for ATAC-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.Quality read trimming was performed by Trimmmomatic v0.36ATAC-seq reads were aligned to UCSC hg19 using Bowtie2 v2.29Duplicate reads were removed using Picard v2.8Reads were filtered for quality using SAMtools v1.19Reads in regions considered 'excludable' were removed using BEDtools v2.26To create ChIP-seq coverage plots, bedGraph plots were created using BEDtools genomeCoverageBed, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ATAC-seq*#*#*#BIN67_+T910M_ATAC-Seq_Rep1_R1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)T910M *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ATAC-seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290738/suppl/GSM3290738_BIN67_T910M_ATAC-Seq_Rep1.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep1	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM	CHM	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290739	{'lentivirus':'Control (GFP) ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN67_Control_ATAC-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290739*#*#*#BIN67_Control_ATAC-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for ATAC-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.Quality read trimming was performed by Trimmmomatic v0.36ATAC-seq reads were aligned to UCSC hg19 using Bowtie2 v2.29Duplicate reads were removed using Picard v2.8Reads were filtered for quality using SAMtools v1.19Reads in regions considered 'excludable' were removed using BEDtools v2.26To create ChIP-seq coverage plots, bedGraph plots were created using BEDtools genomeCoverageBed, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ATAC-seq*#*#*#BIN67_+Control_ATAC-Seq_Rep2_R1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control (GFP) *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ATAC-seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290739/suppl/GSM3290739_BIN67_Control_ATAC-Seq_Rep2.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep2|SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202|MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4|HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML	CHML|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290740	{'lentivirus':'SMARCA2 ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN67_SMARCA2_ATAC-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290740*#*#*#BIN67_SMARCA2_ATAC-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for ATAC-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.Quality read trimming was performed by Trimmmomatic v0.36ATAC-seq reads were aligned to UCSC hg19 using Bowtie2 v2.29Duplicate reads were removed using Picard v2.8Reads were filtered for quality using SAMtools v1.19Reads in regions considered 'excludable' were removed using BEDtools v2.26To create ChIP-seq coverage plots, bedGraph plots were created using BEDtools genomeCoverageBed, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ATAC-seq*#*#*#BIN67_+SMARCA2_ATAC-Seq_Rep2_R1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA2 *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ATAC-seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290740/suppl/GSM3290740_BIN67_SMARCA2_ATAC-Seq_Rep2.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA2|Rep2|SMARCA4	MIM:600014;HGNC:11098;Ensembl:ENSG00000080503;BERN:324871002|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202|MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602	HGNC:11098=>SMARCA2;Ensembl:ENSG00000080503=>SMARCA2;MIM:600014=>SMARCA2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4|HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML	SMARCA2|CHML|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290741	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN67_SMARCA4_ATAC-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290741*#*#*#BIN67_SMARCA4_ATAC-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for ATAC-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.Quality read trimming was performed by Trimmmomatic v0.36ATAC-seq reads were aligned to UCSC hg19 using Bowtie2 v2.29Duplicate reads were removed using Picard v2.8Reads were filtered for quality using SAMtools v1.19Reads in regions considered 'excludable' were removed using BEDtools v2.26To create ChIP-seq coverage plots, bedGraph plots were created using BEDtools genomeCoverageBed, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ATAC-seq*#*#*#BIN67_+SMARCA4_ATAC-Seq_Rep2_R1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ATAC-seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290741/suppl/GSM3290741_BIN67_SMARCA4_ATAC-Seq_Rep2.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep2|SMARCA4	MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	CHML|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290742	{'lentivirus':'K785R ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN67_K785R_ATAC-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290742*#*#*#BIN67_K785R_ATAC-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for ATAC-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.Quality read trimming was performed by Trimmmomatic v0.36ATAC-seq reads were aligned to UCSC hg19 using Bowtie2 v2.29Duplicate reads were removed using Picard v2.8Reads were filtered for quality using SAMtools v1.19Reads in regions considered 'excludable' were removed using BEDtools v2.26To create ChIP-seq coverage plots, bedGraph plots were created using BEDtools genomeCoverageBed, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ATAC-seq*#*#*#BIN67_+K785R_ATAC-Seq_Rep1_R1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)K785R *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ATAC-seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290742/suppl/GSM3290742_BIN67_K785R_ATAC-Seq_Rep1.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep1	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM	CHM	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290900	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_SMARCA4_RNA-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290900*#*#*#Bin67_SMARCA4_RNA-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_SMARCA4_RNA-Seq_Rep1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290900/suppl/GSM3290900_Bin67_SMARCA4_RNA-Seq_Rep1.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290901	{'lentivirus':'T910M ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_T910M_RNA-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290901*#*#*#Bin67_T910M_RNA-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_T910M_RNA-Seq_Rep1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)T910M *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290901/suppl/GSM3290901_Bin67_T910M_RNA-Seq_Rep1.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	null	null	null	null	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290902	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_SMARCA4_RNA-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290902*#*#*#Bin67_SMARCA4_RNA-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_SMARCA4_RNA-Seq_Rep2 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290902/suppl/GSM3290902_Bin67_SMARCA4_RNA-Seq_Rep2.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep2|SMARCA4	MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	CHML|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290903	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_SMARCA4_RNA-Seq_Rep3', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290903*#*#*#Bin67_SMARCA4_RNA-Seq_Rep3*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_SMARCA4_RNA-Seq_Rep3 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290903/suppl/GSM3290903_Bin67_SMARCA4_RNA-Seq_Rep3.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290904	{'lentivirus':'T910M ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_T910M_RNA-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290904*#*#*#Bin67_T910M_RNA-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_T910M_RNA-Seq_Rep2 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)T910M *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290904/suppl/GSM3290904_Bin67_T910M_RNA-Seq_Rep2.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	null	null	null	null	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290905	{'lentivirus':'SMARCA2 ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_SMARCA2_RNA-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290905*#*#*#Bin67_SMARCA2_RNA-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_SMARCA2_RNA-Seq_Rep1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA2 *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290905/suppl/GSM3290905_Bin67_SMARCA2_RNA-Seq_Rep1.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA2|SMARCA4	MIM:600014;HGNC:11098;Ensembl:ENSG00000080503;BERN:324871002|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11098=>SMARCA2;Ensembl:ENSG00000080503=>SMARCA2;MIM:600014=>SMARCA2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA2|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290906	{'lentivirus':'Control (GFP) ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_Control_RNA-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290906*#*#*#Bin67_Control_RNA-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_Control_RNA-Seq_Rep1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control (GFP) *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290906/suppl/GSM3290906_Bin67_Control_RNA-Seq_Rep1.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep1|SMARCA4	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	CHM|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290907	{'lentivirus':'Control (GFP) ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_Control_RNA-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290907*#*#*#Bin67_Control_RNA-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_Control_RNA-Seq_Rep2 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control (GFP) *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290907/suppl/GSM3290907_Bin67_Control_RNA-Seq_Rep2.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep2|SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202|MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4|HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML	CHML|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290908	{'lentivirus':'SMARCA2 ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_SMARCA2_RNA-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290908*#*#*#Bin67_SMARCA2_RNA-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_SMARCA2_RNA-Seq_Rep2 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA2 *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290908/suppl/GSM3290908_Bin67_SMARCA2_RNA-Seq_Rep2.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA2|Rep2|SMARCA4	MIM:600014;HGNC:11098;Ensembl:ENSG00000080503;BERN:324871002|MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11098=>SMARCA2;Ensembl:ENSG00000080503=>SMARCA2;MIM:600014=>SMARCA2|HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA2|CHML|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290909	{'lentivirus':'K785R ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_K785R_RNA-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290909*#*#*#Bin67_K785R_RNA-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_K785R_RNA-Seq_Rep1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)K785R *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290909/suppl/GSM3290909_Bin67_K785R_RNA-Seq_Rep1.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	null	null	null	null	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3290910	{'lentivirus':'K785R ','cell line':'BIN-67 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'Bin67_K785R_RNA-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3290910*#*#*#Bin67_K785R_RNA-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Two days later, cells were harvested for RNA-seq. *#*#*#polyA RNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.RNA-seq reads were aligned to UCSC hg19 using STAR version 2.5.2a Only uniquely mapping reads with at most two mismatches were retained.RNA read counts were calculated using GFOLDGenome_build: hg19Supplementary_files_format_and_content: read count files for gene expression created using GFOLD *#*#*#RNA-Seq*#*#*#Bin67_K785R_RNA-Seq_Rep2 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)K785R *#*#*#[char](cell line)BIN-67 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3290nnn/GSM3290910/suppl/GSM3290910_Bin67_K785R_RNA-Seq_Rep2.read_cnt.txt.gz 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	null	null	null	null	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307881	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_Control_ChIP-Seq_Rep1', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307881*#*#*#BIN-67_BRG1_Control_ChIP-Seq_Rep1*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+Control_ChIP-Seq_Rep1 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307881/suppl/GSM3307881_BIN-67_BRG1_Control_ChIP-Seq_Rep1.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	Rep1|BRG1|SMARCA4	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	CHM|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307882	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'none ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_Input_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307882*#*#*#BIN-67_Input_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_Input_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)none 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307882/suppl/GSM3307882_BIN-67_Input_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307883	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307883*#*#*#BIN-67_BRG1_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307883/suppl/GSM3307883_BIN-67_BRG1_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	BRG1|SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307884	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307884*#*#*#BIN-67_BAF155_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307884/suppl/GSM3307884_BIN-67_BAF155_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307885	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'ARID2 (CST, D8D8U) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_ARID2_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307885*#*#*#BIN-67_ARID2_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_ARID2_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)ARID2 (CST, D8D8U) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307885/suppl/GSM3307885_BIN-67_ARID2_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	CST|ARID2|SMARCA4	MIM:609539;HGNC:18037;Ensembl:ENSG00000189079;BERN:323064702|HGNC:31920;BERN:322312302|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:18037=>ARID2;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:31920=>CST12P;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	ARID2|CST12P|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307886	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'SS18 (Cell Signaling Technologies, D6I4Z) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_SS18_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307886*#*#*#BIN-67_SS18_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_SS18_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)SS18 (Cell Signaling Technologies, D6I4Z) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307886/suppl/GSM3307886_BIN-67_SS18_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SS18|SMARCA4	MIM:600192;HGNC:11340;Ensembl:ENSG00000141380;BERN:324892402|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11340=>SS18;Ensembl:ENSG00000141380=>SS18;MIM:600192=>SS18|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SS18|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307887	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'none ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_Input_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307887*#*#*#BIN-67_Input_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_Input_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)none 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307887/suppl/GSM3307887_BIN-67_Input_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307888	{'cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_Null_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307888*#*#*#BIN-67_BAF155_Null_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_Null_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307888/suppl/GSM3307888_BIN-67_BAF155_Null_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1	SMARCC1	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307890	{'cell line':'SCCOHT-1 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'SCCOHT-1 (SCCOHT)', 'title':'SCCOHT-1_BAF155_Null_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307890*#*#*#SCCOHT-1_BAF155_Null_ChIP-Seq*#*#*#1*#*#*#SCCOHT-1 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#SCCOHT-1_BAF155_Null_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)SCCOHT-1 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	SCCOHT-1	Homo sapiens	null	high-throughput sequencing	SCCOHT-1 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307890/suppl/GSM3307890_SCCOHT-1_BAF155_Null_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	SCCOHT-1	SCCOHT-1|BIN-67	null	null
GSE117735	GSM3307891	{'cell line':'SCCOHT-1 ','chip antibody':'45D (Abcam, ab134942, GR3185597-1) ','organism':'Homo sapiens','source name':'SCCOHT-1 (SCCOHT)', 'title':'SCCOHT-1_45D_Null_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307891*#*#*#SCCOHT-1_45D_Null_ChIP-Seq*#*#*#1*#*#*#SCCOHT-1 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#SCCOHT-1_45D_Null_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)SCCOHT-1 *#*#*#[char](chip antibody)45D (Abcam, ab134942, GR3185597-1) 	30858614	SCCOHT-1	Homo sapiens	null	high-throughput sequencing	SCCOHT-1 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307891/suppl/GSM3307891_SCCOHT-1_45D_Null_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	null	null	null	null	null	null	null	null	SCCOHT-1	SCCOHT-1|BIN-67	null	null
GSE117735	GSM3307892	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_Control_ChIP-Seq_Rep2', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307892*#*#*#BIN-67_BRG1_Control_ChIP-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+Control_ChIP-Seq_Rep2 *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307892/suppl/GSM3307892_BIN-67_BRG1_Control_ChIP-Seq_Rep2.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BRG1|Rep2	MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	CHML|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307893	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'SS18 (Cell Signaling Technologies, D6I4Z) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_SS18_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307893*#*#*#BIN-67_SS18_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_SS18_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)SS18 (Cell Signaling Technologies, D6I4Z) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307893/suppl/GSM3307893_BIN-67_SS18_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SS18|SMARCA4	MIM:600192;HGNC:11340;Ensembl:ENSG00000141380;BERN:324892402|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11340=>SS18;Ensembl:ENSG00000141380=>SS18;MIM:600192=>SS18|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SS18|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307894	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307894*#*#*#BIN-67_BAF155_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307894/suppl/GSM3307894_BIN-67_BAF155_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307895	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'ARID2 (CST, D8D8U) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_ARID2_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307895*#*#*#BIN-67_ARID2_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_ARID2_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)ARID2 (CST, D8D8U) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307895/suppl/GSM3307895_BIN-67_ARID2_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	CST|ARID2|SMARCA4	MIM:609539;HGNC:18037;Ensembl:ENSG00000189079;BERN:323064702|HGNC:31920;BERN:322312302|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:18037=>ARID2;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:31920=>CST12P;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	ARID2|CST12P|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307896	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'45D (Abcam, ab134942, GR3185597-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_45D_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307896*#*#*#BIN-67_45D_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_45D_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)45D (Abcam, ab134942, GR3185597-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307896/suppl/GSM3307896_BIN-67_45D_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	null	null	null	null	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307897	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307897*#*#*#BIN-67_BRG1_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307897/suppl/GSM3307897_BIN-67_BRG1_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	BRG1|SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307898	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'ARID2 (CST, D8D8U) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_ARID2_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307898*#*#*#BIN-67_ARID2_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_ARID2_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)ARID2 (CST, D8D8U) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307898/suppl/GSM3307898_BIN-67_ARID2_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	CST|ARID2|SMARCA4	MIM:609539;HGNC:18037;Ensembl:ENSG00000189079;BERN:323064702|HGNC:31920;BERN:322312302|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:18037=>ARID2;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:31920=>CST12P;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	ARID2|CST12P|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307899	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307899*#*#*#BIN-67_BAF155_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307899/suppl/GSM3307899_BIN-67_BAF155_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307900	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'SS18 (Cell Signaling Technologies, D6I4Z) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_SS18_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307900*#*#*#BIN-67_SS18_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_SS18_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)SS18 (Cell Signaling Technologies, D6I4Z) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307900/suppl/GSM3307900_BIN-67_SS18_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SS18|SMARCA4	MIM:600192;HGNC:11340;Ensembl:ENSG00000141380;BERN:324892402|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11340=>SS18;Ensembl:ENSG00000141380=>SS18;MIM:600192=>SS18|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SS18|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307901	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'45D (Abcam, ab134942, GR3185597-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_45D_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307901*#*#*#BIN-67_45D_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_45D_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)45D (Abcam, ab134942, GR3185597-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307901/suppl/GSM3307901_BIN-67_45D_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307902	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'none ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_Input_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307902*#*#*#BIN-67_Input_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_Input_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)none 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307902/suppl/GSM3307902_BIN-67_Input_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307903	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'BRG1 (Abcam, ab110641, GR150844-25) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BRG1_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307903*#*#*#BIN-67_BRG1_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BRG1_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BRG1 (Abcam, ab110641, GR150844-25) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307903/suppl/GSM3307903_BIN-67_BRG1_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	BRG1|SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307904	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'BAF155 (Homemade, Fx3) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307904*#*#*#BIN-67_BAF155_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155 (Homemade, Fx3) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307904/suppl/GSM3307904_BIN-67_BAF155_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307905	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'ARID2 (CST, D8D8U) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_ARID2_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307905*#*#*#BIN-67_ARID2_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_ARID2_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)ARID2 (CST, D8D8U) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307905/suppl/GSM3307905_BIN-67_ARID2_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	CST|ARID2|SMARCA4	MIM:609539;HGNC:18037;Ensembl:ENSG00000189079;BERN:323064702|HGNC:31920;BERN:322312302|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:18037=>ARID2;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:31920=>CST12P;Ensembl:ENSG00000189079=>ARID2;MIM:609539=>ARID2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	ARID2|CST12P|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307906	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'45D (Abcam, ab134942, GR3185597-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_45D_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307906*#*#*#BIN-67_45D_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_45D_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)45D (Abcam, ab134942, GR3185597-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307906/suppl/GSM3307906_BIN-67_45D_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307907	{'lentivirus':'SMARCA4.K785R ','cell line':'BIN-67 ','chip antibody':'SS18 (Cell Signaling Technologies, D6I4Z) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_SS18_SMARCA4.K785R_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307907*#*#*#BIN-67_SS18_SMARCA4.K785R_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_SS18_+SMARCA4.K785R_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.K785R *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)SS18 (Cell Signaling Technologies, D6I4Z) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307907/suppl/GSM3307907_BIN-67_SS18_SMARCA4.K785R_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SS18|SMARCA4	MIM:600192;HGNC:11340;Ensembl:ENSG00000141380;BERN:324892402|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11340=>SS18;Ensembl:ENSG00000141380=>SS18;MIM:600192=>SS18|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SS18|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307908	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'none ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_Input_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307908*#*#*#BIN-67_Input_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_Input_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)none 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307908/suppl/GSM3307908_BIN-67_Input_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307909	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'H3K4me1 (Abcam, ab176877, GR208955-5) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K4me1_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307909*#*#*#BIN-67_H3K4me1_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K4me1_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K4me1 (Abcam, ab176877, GR208955-5) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307909/suppl/GSM3307909_BIN-67_H3K4me1_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307910	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'H3K27ac (Abcam, ab4729, GR288071-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K27ac_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307910*#*#*#BIN-67_H3K27ac_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K27ac_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K27ac (Abcam, ab4729, GR288071-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307910/suppl/GSM3307910_BIN-67_H3K27ac_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307911	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'H3K27me3 (Cell Signaling Technologies, 9733S, 8) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K27me3_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307911*#*#*#BIN-67_H3K27me3_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K27me3_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K27me3 (Cell Signaling Technologies, 9733S, 8) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307911/suppl/GSM3307911_BIN-67_H3K27me3_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307912	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'H3K9me3 (Abcam, ab8898, GR3176466-6) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K9me3_Control_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307912*#*#*#BIN-67_H3K9me3_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K9me3_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K9me3 (Abcam, ab8898, GR3176466-6) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307912/suppl/GSM3307912_BIN-67_H3K9me3_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307913	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'H3K4me1 (Abcam, ab176877, GR208955-5) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K4me1_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307913*#*#*#BIN-67_H3K4me1_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K4me1_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K4me1 (Abcam, ab176877, GR208955-5) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307913/suppl/GSM3307913_BIN-67_H3K4me1_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307914	{'lentivirus':'SMARCA4.T910M ','cell line':'BIN-67 ','chip antibody':'H3K27ac (Abcam, ab4729, GR288071-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K27ac_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307914*#*#*#BIN-67_H3K27ac_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K27ac_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K27ac (Abcam, ab4729, GR288071-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307914/suppl/GSM3307914_BIN-67_H3K27ac_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307915	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'H3K4me1 (Abcam, ab176877, GR208955-5) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K4me1_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307915*#*#*#BIN-67_H3K4me1_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K4me1_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K4me1 (Abcam, ab176877, GR208955-5) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307915/suppl/GSM3307915_BIN-67_H3K4me1_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3307916	{'lentivirus':'SMARCA4 ','cell line':'BIN-67 ','chip antibody':'H3K27ac (Abcam, ab4729, GR288071-1) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_H3K27ac_SMARCA4_ChIP-Seq', 'last update date':'2019-03-11', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3307916*#*#*#BIN-67_H3K27ac_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_H3K27ac_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-11*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARCA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)H3K27ac (Abcam, ab4729, GR288071-1) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-11	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307916/suppl/GSM3307916_BIN-67_H3K27ac_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4	MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3494152	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'BAF155, homemade (PMID: 28945250) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_BAF155_Control_ChIP-Seq_Rep2', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494152*#*#*#BIN-67_BAF155_Control_ChIP-Seq_Rep2*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_BAF155_+Control_ChIP-Seq_Rep2 *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)BAF155, homemade (PMID: 28945250) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494152/suppl/GSM3494152_BIN-67_BAF155_Control_ChIP-Seq_Rep2.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	SMARCA4|BAF155	MIM:601732;HGNC:11104;Ensembl:ENSG00000173473;BERN:324872702|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:11104=>SMARCC1;Ensembl:ENSG00000173473=>SMARCC1;MIM:601732=>SMARCC1|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	SMARCC1|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3494153	{'lentivirus':'SMARACA4 ','cell line':'BIN-67 ','chip antibody':'DPF2, Abcam, ab134942 ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_DPF2_SMARCA4_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494153*#*#*#BIN-67_DPF2_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_DPF2_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)DPF2, Abcam, ab134942 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494153/suppl/GSM3494153_BIN-67_DPF2_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	DPF2|SMARCA4	MIM:601671;HGNC:9964;Ensembl:ENSG00000133884;BERN:324594202|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:9964=>DPF2;Ensembl:ENSG00000133884=>DPF2;MIM:601671=>DPF2|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	DPF2|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3494154	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'MLL3, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL3_Control_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494154*#*#*#BIN-67_MLL3_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL3_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL3, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494154/suppl/GSM3494154_BIN-67_MLL3_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL3|SMARCA4	MIM:606833;HGNC:13726;Ensembl:ENSG00000055609;BERN:324575502|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:13726=>KMT2C;Ensembl:ENSG00000055609=>KMT2C;MIM:606833=>KMT2C|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2C|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3494155	{'lentivirus':'SMARACA4 ','cell line':'BIN-67 ','chip antibody':'MLL3, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL3_SMARCA4_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494155*#*#*#BIN-67_MLL3_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL3_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL3, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494155/suppl/GSM3494155_BIN-67_MLL3_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL3|SMARCA4	MIM:606833;HGNC:13726;Ensembl:ENSG00000055609;BERN:324575502|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:13726=>KMT2C;Ensembl:ENSG00000055609=>KMT2C;MIM:606833=>KMT2C|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2C|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3494156	{'lentivirus':'SMARACA4.T910M ','cell line':'BIN-67 ','chip antibody':'MLL3, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL3_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494156*#*#*#BIN-67_MLL3_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL3_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL3, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494156/suppl/GSM3494156_BIN-67_MLL3_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL3|SMARCA4	MIM:606833;HGNC:13726;Ensembl:ENSG00000055609;BERN:324575502|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:13726=>KMT2C;Ensembl:ENSG00000055609=>KMT2C;MIM:606833=>KMT2C|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2C|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3494157	{'lentivirus':'Control ','cell line':'BIN-67 ','chip antibody':'MLL4, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL4_Control_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494157*#*#*#BIN-67_MLL4_Control_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL4_+Control_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)Control *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL4, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494157/suppl/GSM3494157_BIN-67_MLL4_Control_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL4|SMARCA4	MIM:606834;HGNC:15840;Ensembl:ENSG00000272333;BERN:325529802|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:15840=>KMT2B;Ensembl:ENSG00000272333=>KMT2B;MIM:606834=>KMT2B|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2B|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3494158	{'lentivirus':'SMARACA4 ','cell line':'BIN-67 ','chip antibody':'MLL4, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL4_SMARCA4_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494158*#*#*#BIN-67_MLL4_SMARCA4_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL4_+SMARCA4_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4 *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL4, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494158/suppl/GSM3494158_BIN-67_MLL4_SMARCA4_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL4|SMARCA4	MIM:606834;HGNC:15840;Ensembl:ENSG00000272333;BERN:325529802|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:15840=>KMT2B;Ensembl:ENSG00000272333=>KMT2B;MIM:606834=>KMT2B|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2B|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117735	GSM3494159	{'lentivirus':'SMARACA4.T910M ','cell line':'BIN-67 ','chip antibody':'MLL4, homemade (PMID: 29404406) ','organism':'Homo sapiens','source name':'BIN-67 (SCCOHT)', 'title':'BIN-67_MLL4_SMARCA4.T910M_ChIP-Seq', 'last update date':'2019-03-12', 'release date': '2019-03-11', 'method': 'high-throughput sequencing'}	GSM3494159*#*#*#BIN-67_MLL4_SMARCA4.T910M_ChIP-Seq*#*#*#1*#*#*#BIN-67 (SCCOHT)*#*#*#Homo sapiens*#*#*#Virus was prepared using co-transfection of lentiviral packaging vectors along with SMARCA4 WT, T910M, K785R, and control in a pLEX307 vector backbone. Concentrated virus was added to 15 cm plates of BIN-67 cells at 70% confluency and selected for 2 days using puromycin. Four days later, cells were harvested for ChIP-seq. *#*#*#genomic DNA*#*#*#null*#*#*#Basecalls were performed using bcl2fastq v2.19.1 for NextSeq output.ChIP-seq reads were aligned to UCSC hg19 using Bowtie version 2.1.0, reporting only the highest scoring alignment for each sequence.To create ChIP-seq coverage plots, bedGraph plots were created using MACS2 callpeak, sorted and then converted to bigWig formatGenome_build: hg19Supplementary_files_format_and_content: bigWig files were generated using bedGraphToBigWig script downloaded from UCSC *#*#*#ChIP-Seq*#*#*#BIN-67_MLL4_+SMARCA4.T910M_ChIP-Seq *#*#*#GPL18573*#*#*#2019-03-12*#*#*#2019-03-11*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](lentivirus)SMARACA4.T910M *#*#*#[char](cell line)BIN-67 *#*#*#[char](chip antibody)MLL4, homemade (PMID: 29404406) 	30858614	BIN-67	Homo sapiens	null	high-throughput sequencing	BIN-67 (SCCOHT)	null	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2019-03-12	2019-03-11	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3494nnn/GSM3494159/suppl/GSM3494159_BIN-67_MLL4_SMARCA4.T910M_ChIP-Seq.bw 	GPL18573	null	null	null	null	puromycin	CHEBI:60255;BERN:299059903	CHEBI:60255=>puromycin(1+)	puromycin(1+)	MLL4|SMARCA4	MIM:606834;HGNC:15840;Ensembl:ENSG00000272333;BERN:325529802|MIM:603254;HGNC:11100;Ensembl:ENSG00000127616;BERN:324871202	HGNC:15840=>KMT2B;Ensembl:ENSG00000272333=>KMT2B;MIM:606834=>KMT2B|HGNC:11100=>SMARCA4;Ensembl:ENSG00000127616=>SMARCA4;MIM:603254=>SMARCA4	KMT2B|SMARCA4	null	null	null	null	BIN-67	BIN-67	null	null
GSE117738	GSM3307966	{'cell type':'LCL derived human pluripotent stem cells ','passage number':'20 ','organism':'Homo sapiens','source name':'human induced pluripotent stem cells', 'title':'D149_iPSC', 'last update date':'2018-09-26', 'release date': '2018-09-26', 'method': 'high-throughput sequencing'}	GSM3307966*#*#*#D149_iPSC*#*#*#1*#*#*#human induced pluripotent stem cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#The reads were aligned to the reference genome using tophat v2.0.13Transcript assembly and quantification was performed using cufflinks v2.2.1Genome_build: hg19Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each sample *#*#*#RNA-Seq*#*#*#2x100 paired-end sequence reads *#*#*#GPL16791*#*#*#2018-09-26*#*#*#2018-09-26*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)LCL derived human pluripotent stem cells *#*#*#[char](passage number)20 	null	null	Homo sapiens	LCL derived human pluripotent stem cells	high-throughput sequencing	human induced pluripotent stem cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-26	2018-09-26	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117738	GSM3307967	{'cell type':'LCL derived human pluripotent stem cells ','passage number':'23 ','organism':'Homo sapiens','source name':'human induced pluripotent stem cells', 'title':'D161_iPSC', 'last update date':'2018-09-26', 'release date': '2018-09-26', 'method': 'high-throughput sequencing'}	GSM3307967*#*#*#D161_iPSC*#*#*#1*#*#*#human induced pluripotent stem cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#The reads were aligned to the reference genome using tophat v2.0.13Transcript assembly and quantification was performed using cufflinks v2.2.1Genome_build: hg19Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each sample *#*#*#RNA-Seq*#*#*#2x100 paired-end sequence reads *#*#*#GPL16791*#*#*#2018-09-26*#*#*#2018-09-26*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)LCL derived human pluripotent stem cells *#*#*#[char](passage number)23 	null	null	Homo sapiens	LCL derived human pluripotent stem cells	high-throughput sequencing	human induced pluripotent stem cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-26	2018-09-26	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117738	GSM3307968	{'cell type':'LCL derived human pluripotent stem cells ','passage number':'8 ','organism':'Homo sapiens','source name':'human induced pluripotent stem cells', 'title':'NIH5_iPSC', 'last update date':'2018-09-26', 'release date': '2018-09-26', 'method': 'high-throughput sequencing'}	GSM3307968*#*#*#NIH5_iPSC*#*#*#1*#*#*#human induced pluripotent stem cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#The reads were aligned to the reference genome using tophat v2.0.13Transcript assembly and quantification was performed using cufflinks v2.2.1Genome_build: hg19Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each sample *#*#*#RNA-Seq*#*#*#2x100 paired-end sequence reads *#*#*#GPL16791*#*#*#2018-09-26*#*#*#2018-09-26*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)LCL derived human pluripotent stem cells *#*#*#[char](passage number)8 	null	null	Homo sapiens	LCL derived human pluripotent stem cells	high-throughput sequencing	human induced pluripotent stem cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-26	2018-09-26	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117738	GSM3307969	{'cell type':'human pluripotent stems derived neural stem cells ','passage number':'7 ','organism':'Homo sapiens','source name':'neural stem cells', 'title':'D149_NSC', 'last update date':'2018-09-26', 'release date': '2018-09-26', 'method': 'high-throughput sequencing'}	GSM3307969*#*#*#D149_NSC*#*#*#1*#*#*#neural stem cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#The reads were aligned to the reference genome using tophat v2.0.13Transcript assembly and quantification was performed using cufflinks v2.2.1Genome_build: hg19Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each sample *#*#*#RNA-Seq*#*#*#2x100 paired-end sequence reads *#*#*#GPL16791*#*#*#2018-09-26*#*#*#2018-09-26*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)human pluripotent stems derived neural stem cells *#*#*#[char](passage number)7 	null	null	Homo sapiens	human pluripotent stems derived neural stem cells	high-throughput sequencing	neural stem cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-26	2018-09-26	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117738	GSM3307970	{'cell type':'human pluripotent stems derived neural stem cells ','passage number':'9 ','organism':'Homo sapiens','source name':'neural stem cells', 'title':'D161_NSC', 'last update date':'2018-09-26', 'release date': '2018-09-26', 'method': 'high-throughput sequencing'}	GSM3307970*#*#*#D161_NSC*#*#*#1*#*#*#neural stem cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#The reads were aligned to the reference genome using tophat v2.0.13Transcript assembly and quantification was performed using cufflinks v2.2.1Genome_build: hg19Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each sample *#*#*#RNA-Seq*#*#*#2x100 paired-end sequence reads *#*#*#GPL16791*#*#*#2018-09-26*#*#*#2018-09-26*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)human pluripotent stems derived neural stem cells *#*#*#[char](passage number)9 	null	null	Homo sapiens	human pluripotent stems derived neural stem cells	high-throughput sequencing	neural stem cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-26	2018-09-26	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117738	GSM3307971	{'cell type':'human pluripotent stems derived neural stem cells ','passage number':'17 ','organism':'Homo sapiens','source name':'neural stem cells', 'title':'NIH5_NSC', 'last update date':'2018-09-26', 'release date': '2018-09-26', 'method': 'high-throughput sequencing'}	GSM3307971*#*#*#NIH5_NSC*#*#*#1*#*#*#neural stem cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#The reads were aligned to the reference genome using tophat v2.0.13Transcript assembly and quantification was performed using cufflinks v2.2.1Genome_build: hg19Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each sample *#*#*#RNA-Seq*#*#*#2x100 paired-end sequence reads *#*#*#GPL16791*#*#*#2018-09-26*#*#*#2018-09-26*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)human pluripotent stems derived neural stem cells *#*#*#[char](passage number)17 	null	null	Homo sapiens	human pluripotent stems derived neural stem cells	high-throughput sequencing	neural stem cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-26	2018-09-26	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3307972	{'cell line':'201B7 ','organism':'Homo sapiens','source name':'201B7', 'title':'201B7, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307972*#*#*#201B7, biological rep1*#*#*#1*#*#*#201B7*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)201B7 	30874579	201B7	Homo sapiens	null	in situ oligonucleotide	201B7	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307972/suppl/GSM3307972_201B7_P28_MG4_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	201B7	201B7	null	null
GSE117739	GSM3307973	{'cell line':'201B7 ','organism':'Homo sapiens','source name':'201B7', 'title':'201B7, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307973*#*#*#201B7, biological rep2*#*#*#1*#*#*#201B7*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)201B7 	30874579	201B7	Homo sapiens	null	in situ oligonucleotide	201B7	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307973/suppl/GSM3307973_201B7_P28_MG4_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	201B7	201B7	null	null
GSE117739	GSM3307974	{'cell line':'201B7 ','organism':'Homo sapiens','source name':'201B7', 'title':'201B7, biological rep3', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307974*#*#*#201B7, biological rep3*#*#*#1*#*#*#201B7*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)201B7 	30874579	201B7	Homo sapiens	null	in situ oligonucleotide	201B7	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307974/suppl/GSM3307974_201B7_P28_MG4_miRNA_3_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	201B7	201B7	null	null
GSE117739	GSM3307975	{'cell line':'201B7 ','organism':'Homo sapiens','source name':'201B7', 'title':'201B7, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307975*#*#*#201B7, biological rep4*#*#*#1*#*#*#201B7*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)201B7 	30874579	201B7	Homo sapiens	null	in situ oligonucleotide	201B7	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307975/suppl/GSM3307975_201B7_P28_MG4_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	201B7	201B7	null	null
GSE117739	GSM3307976	{'cell line':'201B7 ','organism':'Homo sapiens','source name':'201B7', 'title':'201B7, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307976*#*#*#201B7, biological rep5*#*#*#1*#*#*#201B7*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)201B7 	30874579	201B7	Homo sapiens	null	in situ oligonucleotide	201B7	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307976/suppl/GSM3307976_201B7_P28_MG4_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	201B7	201B7	null	null
GSE117739	GSM3307977	{'cell line':'201B7 ','organism':'Homo sapiens','source name':'201B7', 'title':'201B7, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307977*#*#*#201B7, biological rep6*#*#*#1*#*#*#201B7*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)201B7 	30874579	201B7	Homo sapiens	null	in situ oligonucleotide	201B7	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307977/suppl/GSM3307977_201B7_P28_MG4_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	201B7	201B7	null	null
GSE117739	GSM3307978	{'cell line':'253G1 ','organism':'Homo sapiens','source name':'253G1', 'title':'253G1, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307978*#*#*#253G1, biological rep1*#*#*#1*#*#*#253G1*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)253G1 	30874579	253G1	Homo sapiens	null	in situ oligonucleotide	253G1	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307978/suppl/GSM3307978_253G1_P33_MG4_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	253G1	253G1	null	null
GSE117739	GSM3307979	{'cell line':'253G1 ','organism':'Homo sapiens','source name':'253G1', 'title':'253G1, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307979*#*#*#253G1, biological rep2*#*#*#1*#*#*#253G1*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)253G1 	30874579	253G1	Homo sapiens	null	in situ oligonucleotide	253G1	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307979/suppl/GSM3307979_253G1_P33_MG4_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	253G1	253G1	null	null
GSE117739	GSM3307980	{'cell line':'253G1 ','organism':'Homo sapiens','source name':'253G1', 'title':'253G1, biological rep3', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307980*#*#*#253G1, biological rep3*#*#*#1*#*#*#253G1*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)253G1 	30874579	253G1	Homo sapiens	null	in situ oligonucleotide	253G1	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307980/suppl/GSM3307980_253G1_P33_MG4_miRNA_3_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	253G1	253G1	null	null
GSE117739	GSM3307981	{'cell line':'253G1 ','organism':'Homo sapiens','source name':'253G1', 'title':'253G1, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307981*#*#*#253G1, biological rep4*#*#*#1*#*#*#253G1*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)253G1 	30874579	253G1	Homo sapiens	null	in situ oligonucleotide	253G1	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307981/suppl/GSM3307981_253G1_P33_MG4_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	253G1	253G1	null	null
GSE117739	GSM3307982	{'cell line':'253G1 ','organism':'Homo sapiens','source name':'253G1', 'title':'253G1, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307982*#*#*#253G1, biological rep5*#*#*#1*#*#*#253G1*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)253G1 	30874579	253G1	Homo sapiens	null	in situ oligonucleotide	253G1	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307982/suppl/GSM3307982_253G1_P33_MG4_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	253G1	253G1	null	null
GSE117739	GSM3307983	{'cell line':'253G1 ','organism':'Homo sapiens','source name':'253G1', 'title':'253G1, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307983*#*#*#253G1, biological rep6*#*#*#1*#*#*#253G1*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)253G1 	30874579	253G1	Homo sapiens	null	in situ oligonucleotide	253G1	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307983/suppl/GSM3307983_253G1_P33_MG4_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	253G1	253G1	null	null
GSE117739	GSM3307984	{'cell line':'498B2 ','organism':'Homo sapiens','source name':'498B2', 'title':'409B2, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307984*#*#*#409B2, biological rep1*#*#*#1*#*#*#498B2*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)498B2 	30874579	498B2	Homo sapiens	null	in situ oligonucleotide	498B2	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307984/suppl/GSM3307984_409B2_P445_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	409B2	409B2	null	null
GSE117739	GSM3307985	{'cell line':'498B2 ','organism':'Homo sapiens','source name':'498B2', 'title':'409B2, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307985*#*#*#409B2, biological rep2*#*#*#1*#*#*#498B2*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)498B2 	30874579	498B2	Homo sapiens	null	in situ oligonucleotide	498B2	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307985/suppl/GSM3307985_409B2_P445_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	409B2	409B2	null	null
GSE117739	GSM3307987	{'cell line':'498B2 ','organism':'Homo sapiens','source name':'498B2', 'title':'409B2, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307987*#*#*#409B2, biological rep4*#*#*#1*#*#*#498B2*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)498B2 	30874579	498B2	Homo sapiens	null	in situ oligonucleotide	498B2	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307987/suppl/GSM3307987_409B2_P456_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	409B2	409B2	null	null
GSE117739	GSM3307988	{'cell line':'498B2 ','organism':'Homo sapiens','source name':'498B2', 'title':'409B2, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307988*#*#*#409B2, biological rep5*#*#*#1*#*#*#498B2*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)498B2 	30874579	498B2	Homo sapiens	null	in situ oligonucleotide	498B2	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307988/suppl/GSM3307988_409B2_P456_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	409B2	409B2	null	null
GSE117739	GSM3307989	{'cell line':'498B2 ','organism':'Homo sapiens','source name':'498B2', 'title':'409B2, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307989*#*#*#409B2, biological rep6*#*#*#1*#*#*#498B2*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)498B2 	30874579	498B2	Homo sapiens	null	in situ oligonucleotide	498B2	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307989/suppl/GSM3307989_409B2_P456_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	409B2	409B2	null	null
GSE117739	GSM3307990	{'cell line':'ATCC-DYR0100hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0100hiPSc', 'title':'ATCC-DYR0100hiPSc, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307990*#*#*#ATCC-DYR0100hiPSc, biological rep1*#*#*#1*#*#*#ATCC-DYR0100hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0100hiPSc 	30874579	ATCC-DYR0100hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0100hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307990/suppl/GSM3307990_Ai-100_P53_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	rep1	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM	CHM	null	null	null	null	null	null	null	null
GSE117739	GSM3307991	{'cell line':'ATCC-DYR0100hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0100hiPSc', 'title':'ATCC-DYR0100hiPSc, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307991*#*#*#ATCC-DYR0100hiPSc, biological rep2*#*#*#1*#*#*#ATCC-DYR0100hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0100hiPSc 	30874579	ATCC-DYR0100hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0100hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307991/suppl/GSM3307991_Ai-100_P53_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3307992	{'cell line':'ATCC-DYR0100hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0100hiPSc', 'title':'ATCC-DYR0100hiPSc, biological rep3', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307992*#*#*#ATCC-DYR0100hiPSc, biological rep3*#*#*#1*#*#*#ATCC-DYR0100hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0100hiPSc 	30874579	ATCC-DYR0100hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0100hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307992/suppl/GSM3307992_Ai-100_P53_miRNA_3_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3307993	{'cell line':'ATCC-DYR0100hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0100hiPSc', 'title':'ATCC-DYR0100hiPSc, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307993*#*#*#ATCC-DYR0100hiPSc, biological rep4*#*#*#1*#*#*#ATCC-DYR0100hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0100hiPSc 	30874579	ATCC-DYR0100hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0100hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307993/suppl/GSM3307993_Ai-100_P53_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3307994	{'cell line':'ATCC-DYR0100hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0100hiPSc', 'title':'ATCC-DYR0100hiPSc, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307994*#*#*#ATCC-DYR0100hiPSc, biological rep5*#*#*#1*#*#*#ATCC-DYR0100hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0100hiPSc 	30874579	ATCC-DYR0100hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0100hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307994/suppl/GSM3307994_Ai-100_P53_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3307995	{'cell line':'ATCC-DYR0100hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0100hiPSc', 'title':'ATCC-DYR0100hiPSc, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307995*#*#*#ATCC-DYR0100hiPSc, biological rep6*#*#*#1*#*#*#ATCC-DYR0100hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0100hiPSc 	30874579	ATCC-DYR0100hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0100hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307995/suppl/GSM3307995_Ai-100_P53_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3307996	{'cell line':'ATCC-DYR0103hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0103hiPSc', 'title':'ATCC-DYR0103hiPSc, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307996*#*#*#ATCC-DYR0103hiPSc, biological rep1*#*#*#1*#*#*#ATCC-DYR0103hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0103hiPSc 	30874579	ATCC-DYR0103hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0103hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307996/suppl/GSM3307996_Ai-103_P53_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	rep1	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM	CHM	null	null	null	null	null	null	null	null
GSE117739	GSM3307997	{'cell line':'ATCC-DYR0103hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0103hiPSc', 'title':'ATCC-DYR0103hiPSc, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307997*#*#*#ATCC-DYR0103hiPSc, biological rep2*#*#*#1*#*#*#ATCC-DYR0103hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0103hiPSc 	30874579	ATCC-DYR0103hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0103hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307997/suppl/GSM3307997_Ai-103_P53_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3307998	{'cell line':'ATCC-DYR0103hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0103hiPSc', 'title':'ATCC-DYR0103hiPSc, biological rep3', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307998*#*#*#ATCC-DYR0103hiPSc, biological rep3*#*#*#1*#*#*#ATCC-DYR0103hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0103hiPSc 	30874579	ATCC-DYR0103hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0103hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307998/suppl/GSM3307998_Ai-103_P53_miRNA_3_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3307999	{'cell line':'ATCC-DYR0103hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0103hiPSc', 'title':'ATCC-DYR0103hiPSc, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3307999*#*#*#ATCC-DYR0103hiPSc, biological rep4*#*#*#1*#*#*#ATCC-DYR0103hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0103hiPSc 	30874579	ATCC-DYR0103hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0103hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3307nnn/GSM3307999/suppl/GSM3307999_Ai-103_P53_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308000	{'cell line':'ATCC-DYR0103hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0103hiPSc', 'title':'ATCC-DYR0103hiPSc, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308000*#*#*#ATCC-DYR0103hiPSc, biological rep5*#*#*#1*#*#*#ATCC-DYR0103hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0103hiPSc 	30874579	ATCC-DYR0103hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0103hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308000/suppl/GSM3308000_Ai-103_P53_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308001	{'cell line':'ATCC-DYR0103hiPSc ','organism':'Homo sapiens','source name':'ATCC-DYR0103hiPSc', 'title':'ATCC-DYR0103hiPSc, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308001*#*#*#ATCC-DYR0103hiPSc, biological rep6*#*#*#1*#*#*#ATCC-DYR0103hiPSc*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)ATCC-DYR0103hiPSc 	30874579	ATCC-DYR0103hiPSc	Homo sapiens	null	in situ oligonucleotide	ATCC-DYR0103hiPSc	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308001/suppl/GSM3308001_Ai-103_P53_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308002	{'cell line':'mc-iPS ','organism':'Homo sapiens','source name':'mc-iPS', 'title':'mc-iPS, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308002*#*#*#mc-iPS, biological rep1*#*#*#1*#*#*#mc-iPS*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)mc-iPS 	30874579	mc-iPS	Homo sapiens	null	in situ oligonucleotide	mc-iPS	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308002/suppl/GSM3308002_mc-iPS_P15_MG4_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308003	{'cell line':'mc-iPS ','organism':'Homo sapiens','source name':'mc-iPS', 'title':'mc-iPS, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308003*#*#*#mc-iPS, biological rep2*#*#*#1*#*#*#mc-iPS*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)mc-iPS 	30874579	mc-iPS	Homo sapiens	null	in situ oligonucleotide	mc-iPS	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308003/suppl/GSM3308003_mc-iPS_P15_MG4_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308004	{'cell line':'mc-iPS ','organism':'Homo sapiens','source name':'mc-iPS', 'title':'mc-iPS, biological rep3', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308004*#*#*#mc-iPS, biological rep3*#*#*#1*#*#*#mc-iPS*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)mc-iPS 	30874579	mc-iPS	Homo sapiens	null	in situ oligonucleotide	mc-iPS	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308004/suppl/GSM3308004_mc-iPS_P15_MG4_miRNA_3_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308005	{'cell line':'mc-iPS ','organism':'Homo sapiens','source name':'mc-iPS', 'title':'mc-iPS, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308005*#*#*#mc-iPS, biological rep4*#*#*#1*#*#*#mc-iPS*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)mc-iPS 	30874579	mc-iPS	Homo sapiens	null	in situ oligonucleotide	mc-iPS	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308005/suppl/GSM3308005_mc-iPS_P15_MG4_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308006	{'cell line':'mc-iPS ','organism':'Homo sapiens','source name':'mc-iPS', 'title':'mc-iPS, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308006*#*#*#mc-iPS, biological rep5*#*#*#1*#*#*#mc-iPS*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)mc-iPS 	30874579	mc-iPS	Homo sapiens	null	in situ oligonucleotide	mc-iPS	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308006/suppl/GSM3308006_mc-iPS_P15_MG4_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308007	{'cell line':'mc-iPS ','organism':'Homo sapiens','source name':'mc-iPS', 'title':'mc-iPS, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308007*#*#*#mc-iPS, biological rep6*#*#*#1*#*#*#mc-iPS*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)mc-iPS 	30874579	mc-iPS	Homo sapiens	null	in situ oligonucleotide	mc-iPS	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308007/suppl/GSM3308007_mc-iPS_P15_MG4_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308008	{'cell line':'HiPS-RIKEN-1A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-1A', 'title':'HiPS-RIKEN-1A, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308008*#*#*#HiPS-RIKEN-1A, biological rep1*#*#*#1*#*#*#HiPS-RIKEN-1A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-1A 	30874579	HiPS-RIKEN-1A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-1A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308008/suppl/GSM3308008_R-1A_P21_MG3_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308009	{'cell line':'HiPS-RIKEN-1A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-1A', 'title':'HiPS-RIKEN-1A, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308009*#*#*#HiPS-RIKEN-1A, biological rep2*#*#*#1*#*#*#HiPS-RIKEN-1A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-1A 	30874579	HiPS-RIKEN-1A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-1A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308009/suppl/GSM3308009_R-1A_P21_MG3_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308010	{'cell line':'HiPS-RIKEN-1A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-1A', 'title':'HiPS-RIKEN-1A, biological rep3', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308010*#*#*#HiPS-RIKEN-1A, biological rep3*#*#*#1*#*#*#HiPS-RIKEN-1A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-1A 	30874579	HiPS-RIKEN-1A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-1A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308010/suppl/GSM3308010_R-1A_P21_MG3_miRNA_3_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308011	{'cell line':'HiPS-RIKEN-1A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-1A', 'title':'HiPS-RIKEN-1A, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308011*#*#*#HiPS-RIKEN-1A, biological rep4*#*#*#1*#*#*#HiPS-RIKEN-1A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-1A 	30874579	HiPS-RIKEN-1A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-1A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308011/suppl/GSM3308011_R-1A_P21_MG3_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308012	{'cell line':'HiPS-RIKEN-1A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-1A', 'title':'HiPS-RIKEN-1A, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308012*#*#*#HiPS-RIKEN-1A, biological rep5*#*#*#1*#*#*#HiPS-RIKEN-1A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-1A 	30874579	HiPS-RIKEN-1A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-1A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308012/suppl/GSM3308012_R-1A_P21_MG3_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308013	{'cell line':'HiPS-RIKEN-1A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-1A', 'title':'HiPS-RIKEN-1A, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308013*#*#*#HiPS-RIKEN-1A, biological rep6*#*#*#1*#*#*#HiPS-RIKEN-1A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-1A 	30874579	HiPS-RIKEN-1A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-1A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308013/suppl/GSM3308013_R-1A_P21_MG3_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308014	{'cell line':'HiPS-RIKEN-2A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-2A', 'title':'HiPS-RIKEN-2A, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308014*#*#*#HiPS-RIKEN-2A, biological rep1*#*#*#1*#*#*#HiPS-RIKEN-2A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-2A 	30874579	HiPS-RIKEN-2A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-2A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308014/suppl/GSM3308014_R-2A_P21_MG3_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308015	{'cell line':'HiPS-RIKEN-2A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-2A', 'title':'HiPS-RIKEN-2A, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308015*#*#*#HiPS-RIKEN-2A, biological rep2*#*#*#1*#*#*#HiPS-RIKEN-2A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-2A 	30874579	HiPS-RIKEN-2A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-2A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308015/suppl/GSM3308015_R-2A_P21_MG3_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308016	{'cell line':'HiPS-RIKEN-2A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-2A', 'title':'HiPS-RIKEN-2A, biological rep3', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308016*#*#*#HiPS-RIKEN-2A, biological rep3*#*#*#1*#*#*#HiPS-RIKEN-2A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-2A 	30874579	HiPS-RIKEN-2A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-2A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308016/suppl/GSM3308016_R-2A_P21_MG3_miRNA_3_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308017	{'cell line':'HiPS-RIKEN-2A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-2A', 'title':'HiPS-RIKEN-2A, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308017*#*#*#HiPS-RIKEN-2A, biological rep4*#*#*#1*#*#*#HiPS-RIKEN-2A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-2A 	30874579	HiPS-RIKEN-2A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-2A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308017/suppl/GSM3308017_R-2A_P21_MG3_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308018	{'cell line':'HiPS-RIKEN-2A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-2A', 'title':'HiPS-RIKEN-2A, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308018*#*#*#HiPS-RIKEN-2A, biological rep5*#*#*#1*#*#*#HiPS-RIKEN-2A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-2A 	30874579	HiPS-RIKEN-2A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-2A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308018/suppl/GSM3308018_R-2A_P21_MG3_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308019	{'cell line':'HiPS-RIKEN-2A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-2A', 'title':'HiPS-RIKEN-2A, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308019*#*#*#HiPS-RIKEN-2A, biological rep6*#*#*#1*#*#*#HiPS-RIKEN-2A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-2A 	30874579	HiPS-RIKEN-2A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-2A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308019/suppl/GSM3308019_R-2A_P21_MG3_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308020	{'cell line':'HiPS-RIKEN-12A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-12A', 'title':'HiPS-RIKEN-12A, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308020*#*#*#HiPS-RIKEN-12A, biological rep1*#*#*#1*#*#*#HiPS-RIKEN-12A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-12A 	30874579	HiPS-RIKEN-12A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-12A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308020/suppl/GSM3308020_R-12A_P18_MG5_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308021	{'cell line':'HiPS-RIKEN-12A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-12A', 'title':'HiPS-RIKEN-12A, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308021*#*#*#HiPS-RIKEN-12A, biological rep2*#*#*#1*#*#*#HiPS-RIKEN-12A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-12A 	30874579	HiPS-RIKEN-12A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-12A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308021/suppl/GSM3308021_R-12A_P18_MG5_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308022	{'cell line':'HiPS-RIKEN-12A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-12A', 'title':'HiPS-RIKEN-12A, biological rep3', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308022*#*#*#HiPS-RIKEN-12A, biological rep3*#*#*#1*#*#*#HiPS-RIKEN-12A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-12A 	30874579	HiPS-RIKEN-12A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-12A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308022/suppl/GSM3308022_R-12A_P18_MG5_miRNA_3_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308023	{'cell line':'HiPS-RIKEN-12A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-12A', 'title':'HiPS-RIKEN-12A, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308023*#*#*#HiPS-RIKEN-12A, biological rep4*#*#*#1*#*#*#HiPS-RIKEN-12A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-12A 	30874579	HiPS-RIKEN-12A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-12A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308023/suppl/GSM3308023_R-12A_P18_MG5_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308024	{'cell line':'HiPS-RIKEN-12A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-12A', 'title':'HiPS-RIKEN-12A, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308024*#*#*#HiPS-RIKEN-12A, biological rep5*#*#*#1*#*#*#HiPS-RIKEN-12A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-12A 	30874579	HiPS-RIKEN-12A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-12A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308024/suppl/GSM3308024_R-12A_P18_MG5_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308025	{'cell line':'HiPS-RIKEN-12A ','organism':'Homo sapiens','source name':'HiPS-RIKEN-12A', 'title':'HiPS-RIKEN-12A, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308025*#*#*#HiPS-RIKEN-12A, biological rep6*#*#*#1*#*#*#HiPS-RIKEN-12A*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)HiPS-RIKEN-12A 	30874579	HiPS-RIKEN-12A	Homo sapiens	null	in situ oligonucleotide	HiPS-RIKEN-12A	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308025/suppl/GSM3308025_R-12A_P18_MG5_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	null	null	null	null	biotin	BERN:326421302			null	null	null	null	null	null	null	null
GSE117739	GSM3308026	{'cell line':'Tic ','organism':'Homo sapiens','source name':'Tic', 'title':'Tic, biological rep1', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308026*#*#*#Tic, biological rep1*#*#*#1*#*#*#Tic*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)Tic 	30874579	Tic	Homo sapiens	null	in situ oligonucleotide	Tic	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308026/suppl/GSM3308026_Tic_P50_MG3_miRNA_1_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308027	{'cell line':'Tic ','organism':'Homo sapiens','source name':'Tic', 'title':'Tic, biological rep2', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308027*#*#*#Tic, biological rep2*#*#*#1*#*#*#Tic*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)Tic 	30874579	Tic	Homo sapiens	null	in situ oligonucleotide	Tic	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308027/suppl/GSM3308027_Tic_P50_MG3_miRNA_2_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308028	{'cell line':'Tic ','organism':'Homo sapiens','source name':'Tic', 'title':'Tic, biological rep3', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308028*#*#*#Tic, biological rep3*#*#*#1*#*#*#Tic*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)Tic 	30874579	Tic	Homo sapiens	null	in situ oligonucleotide	Tic	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308028/suppl/GSM3308028_Tic_P50_MG3_miRNA_3_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308029	{'cell line':'Tic ','organism':'Homo sapiens','source name':'Tic', 'title':'Tic, biological rep4', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308029*#*#*#Tic, biological rep4*#*#*#1*#*#*#Tic*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)Tic 	30874579	Tic	Homo sapiens	null	in situ oligonucleotide	Tic	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308029/suppl/GSM3308029_Tic_P50_MG3_miRNA_4_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308030	{'cell line':'Tic ','organism':'Homo sapiens','source name':'Tic', 'title':'Tic, biological rep5', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308030*#*#*#Tic, biological rep5*#*#*#1*#*#*#Tic*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)Tic 	30874579	Tic	Homo sapiens	null	in situ oligonucleotide	Tic	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308030/suppl/GSM3308030_Tic_P50_MG3_miRNA_5_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117739	GSM3308031	{'cell line':'Tic ','organism':'Homo sapiens','source name':'Tic', 'title':'Tic, biological rep6', 'last update date':'2019-03-28', 'release date': '2019-03-28', 'method': 'in situ oligonucleotide'}	GSM3308031*#*#*#Tic, biological rep6*#*#*#1*#*#*#Tic*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#biotin*#*#*#Scanned images of microarray chips were analyzed using Affymetrix Expression Console with the default RMA settings. Raw data were processed and Nromalized on basis of organism human using RMA algorithm. *#*#*#null*#*#*#null*#*#*#GPL16384*#*#*#2019-03-28*#*#*#2019-03-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)Tic 	30874579	Tic	Homo sapiens	null	in situ oligonucleotide	Tic	null	null	null	null	null	null	total RNA	RNA	2019-03-28	2019-03-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308031/suppl/GSM3308031_Tic_P50_MG3_miRNA_6_miRNA-3_0.CEL.gz 	GPL16384	null	null	null	null	biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	null	null	null	null
GSE117742	GSM3308120	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Parental cell RNA dataset 1 repeat 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308120*#*#*#Parental cell RNA dataset 1 repeat 1*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308120/suppl/GSM3308120_1_-_TP1.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117742	GSM3308121	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Parental cell RNA dataset 1 repeat 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308121*#*#*#Parental cell RNA dataset 1 repeat 2*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308121/suppl/GSM3308121_1_-_TP2.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117742	GSM3308122	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Parental cell RNA dataset 1 repeat 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308122*#*#*#Parental cell RNA dataset 1 repeat 3*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308122/suppl/GSM3308122_1_-_TP3.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117742	GSM3308123	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'pabociclib resistant cell RNA dataset 1 repeat 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308123*#*#*#pabociclib resistant cell RNA dataset 1 repeat 1*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308123/suppl/GSM3308123_2_-_TR1.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117742	GSM3308124	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'pabociclib resistant cell RNA dataset 1 repeat 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308124*#*#*#pabociclib resistant cell RNA dataset 1 repeat 2*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308124/suppl/GSM3308124_2_-_TR2.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117742	GSM3308125	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'pabociclib resistant cell RNA dataset 1 repeat 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308125*#*#*#pabociclib resistant cell RNA dataset 1 repeat 3*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308125/suppl/GSM3308125_2_-_TR3.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117743	GSM3308126	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Parental cell RNA dataset 2 repeat 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308126*#*#*#Parental cell RNA dataset 2 repeat 1*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308126/suppl/GSM3308126_1_-_TP1.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117743	GSM3308127	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Parental cell RNA dataset 2 repeat 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308127*#*#*#Parental cell RNA dataset 2 repeat 2*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308127/suppl/GSM3308127_1_-_TP2.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117743	GSM3308128	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Parental cell RNA dataset 2 repeat 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308128*#*#*#Parental cell RNA dataset 2 repeat 3*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308128/suppl/GSM3308128_1_-_TP3.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117743	GSM3308129	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'pabociclib resistant cell RNA dataset 2 repeat 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308129*#*#*#pabociclib resistant cell RNA dataset 2 repeat 1*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308129/suppl/GSM3308129_2_-_TR1.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117743	GSM3308130	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'pabociclib resistant cell RNA dataset 2 repeat 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308130*#*#*#pabociclib resistant cell RNA dataset 2 repeat 2*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308130/suppl/GSM3308130_2_-_TR2.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117743	GSM3308131	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'pabociclib resistant cell RNA dataset 2 repeat 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308131*#*#*#pabociclib resistant cell RNA dataset 2 repeat 3*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308131/suppl/GSM3308131_2_-_TR3.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117743	GSM3308132	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Ex-Resistant Cell RNA dataset 2 repeat 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308132*#*#*#Ex-Resistant Cell RNA dataset 2 repeat 1*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308132/suppl/GSM3308132_3_-_XR1.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117743	GSM3308133	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Ex-Resistant Cell RNA dataset 2 repeat 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308133*#*#*#Ex-Resistant Cell RNA dataset 2 repeat 2*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308133/suppl/GSM3308133_3_-_XR2.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117743	GSM3308134	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Ex-Resistant Cell RNA dataset 2 repeat 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'in situ oligonucleotide'}	GSM3308134*#*#*#Ex-Resistant Cell RNA dataset 2 repeat 3*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Palbociclib resistant cells were grown with 100 nM palbociclib containing medium. Ex-resistant cells were T47D cells, cutured to resistance then grown in drug free medium for 7 weeks +. *#*#*#total RNA*#*#*#biotin*#*#*#Data was normalised using RMA. *#*#*#null*#*#*#Gene Expression data *#*#*#GPL571*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	in situ oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308134/suppl/GSM3308134_3_-_XR3.CEL.gz 	GPL571	null	null	null	null	palbociclib|Palbociclib|biotin	MESH:C500026;BERN:310900303|CHEBI:57586;BERN:278046903	MESH:C500026=>palbociclib|CHEBI:57586=>biotinate;MESH:C500026=>palbociclib	palbociclib|biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117744	GSM3308135	{'cell line':'PC3 ','cell type':'Prostate Cancer ','cell compartment':'extracellular vesicles ','organism':'Homo sapiens','source name':'PC3 Human Prostate Cancer Cell Line Vesicles', 'title':'VJ-PC3-EX1-smRNA-41326587 REP1', 'last update date':'2018-09-01', 'release date': '2018-09-01', 'method': 'high-throughput sequencing'}	GSM3308135*#*#*#VJ-PC3-EX1-smRNA-41326587 REP1*#*#*#1*#*#*#PC3 Human Prostate Cancer Cell Line Vesicles*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Reads were trimmed with cutadapat (v1.6)microRNAs were mapped using Shrimp and a custom constructed database of mature and hairpin miRNA sequences (Genecode V24) and counts calledmRNAs were mapped using Homo_sapiens.GRCh38.87.gtf (SAM tools) and counts performed using HTSeqGenome_build: Homo sapiens GRCh38.87Supplementary_files_format_and_content: txt files are supplied with the counts per miRNA or gene *#*#*#miRNA-Seq*#*#*#microRNACounts-shrimp.txt *#*#*#GPL18573*#*#*#2018-09-01*#*#*#2018-09-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PC3 *#*#*#[char](cell type)Prostate Cancer *#*#*#[char](cell compartment)extracellular vesicles 	30353168	PC3	Homo sapiens	Prostate Cancer	high-throughput sequencing	PC3 Human Prostate Cancer Cell Line Vesicles	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-01	2018-09-01	NONE 	GPL18573	Prostate Cancer	OMIM:176807;MESH:D011471;BERN:107535701	OMIM:176807=>PROSTATE CANCER;MESH:D011471=>Prostatic Neoplasms	PROSTATE CANCER|Prostatic Neoplasms	null	null	null	null	REP1	MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602	HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM	CHM	null	null	null	null	PC3	PC3	null	null
GSE117744	GSM3308136	{'cell line':'PC3 ','cell type':'Prostate Cancer ','cell compartment':'extracellular vesicles ','organism':'Homo sapiens','source name':'PC3 Human Prostate Cancer Cell Line Vesicles', 'title':'VJ-PC3-EX2-smRNA-41336463 REP2', 'last update date':'2018-09-01', 'release date': '2018-09-01', 'method': 'high-throughput sequencing'}	GSM3308136*#*#*#VJ-PC3-EX2-smRNA-41336463 REP2*#*#*#1*#*#*#PC3 Human Prostate Cancer Cell Line Vesicles*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Reads were trimmed with cutadapat (v1.6)microRNAs were mapped using Shrimp and a custom constructed database of mature and hairpin miRNA sequences (Genecode V24) and counts calledmRNAs were mapped using Homo_sapiens.GRCh38.87.gtf (SAM tools) and counts performed using HTSeqGenome_build: Homo sapiens GRCh38.87Supplementary_files_format_and_content: txt files are supplied with the counts per miRNA or gene *#*#*#miRNA-Seq*#*#*#microRNACounts-shrimp.txt *#*#*#GPL18573*#*#*#2018-09-01*#*#*#2018-09-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PC3 *#*#*#[char](cell type)Prostate Cancer *#*#*#[char](cell compartment)extracellular vesicles 	30353168	PC3	Homo sapiens	Prostate Cancer	high-throughput sequencing	PC3 Human Prostate Cancer Cell Line Vesicles	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-01	2018-09-01	NONE 	GPL18573	Prostate Cancer	OMIM:176807;MESH:D011471;BERN:107535701	OMIM:176807=>PROSTATE CANCER;MESH:D011471=>Prostatic Neoplasms	PROSTATE CANCER|Prostatic Neoplasms	null	null	null	null	REP2	MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602	HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML	CHML	null	null	null	null	PC3	PC3	null	null
GSE117744	GSM3308137	{'cell line':'PC3 ','cell type':'Prostate Cancer ','cell compartment':'extracellular vesicles ','organism':'Homo sapiens','source name':'PC3 Human Prostate Cancer Cell Line Vesicles', 'title':'PC3_EX1_tRNA-41337446 REP1', 'last update date':'2018-09-01', 'release date': '2018-09-01', 'method': 'high-throughput sequencing'}	GSM3308137*#*#*#PC3_EX1_tRNA-41337446 REP1*#*#*#1*#*#*#PC3 Human Prostate Cancer Cell Line Vesicles*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Reads were trimmed with cutadapat (v1.6)microRNAs were mapped using Shrimp and a custom constructed database of mature and hairpin miRNA sequences (Genecode V24) and counts calledmRNAs were mapped using Homo_sapiens.GRCh38.87.gtf (SAM tools) and counts performed using HTSeqGenome_build: Homo sapiens GRCh38.87Supplementary_files_format_and_content: txt files are supplied with the counts per miRNA or gene *#*#*#RNA-Seq*#*#*#total RNAPC3_EX1.htseq.count.txt *#*#*#GPL18573*#*#*#2018-09-01*#*#*#2018-09-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PC3 *#*#*#[char](cell type)Prostate Cancer *#*#*#[char](cell compartment)extracellular vesicles 	30353168	PC3	Homo sapiens	Prostate Cancer	high-throughput sequencing	PC3 Human Prostate Cancer Cell Line Vesicles	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-01	2018-09-01	NONE 	GPL18573	Prostate Cancer	OMIM:176807;MESH:D011471;BERN:107535701	OMIM:176807=>PROSTATE CANCER;MESH:D011471=>Prostatic Neoplasms	PROSTATE CANCER|Prostatic Neoplasms	null	null	null	null	EX1|PC3|REP1	MIM:162150;HGNC:8743;Ensembl:ENSG00000175426;BERN:324244602|MIM:614555;HGNC:19839;Ensembl:ENSG00000139926;BERN:322787902|MIM:300390;HGNC:1940;Ensembl:ENSG00000188419;BERN:322713602	HGNC:8743=>PCSK1;Ensembl:ENSG00000175426=>PCSK1;MIM:162150=>PCSK1|HGNC:19839=>FRMD6;Ensembl:ENSG00000139926=>FRMD6;MIM:614555=>FRMD6|HGNC:1940=>CHM;Ensembl:ENSG00000188419=>CHM;MIM:300390=>CHM	FRMD6|PCSK1|CHM	null	null	null	null	PC3	PC3	null	null
GSE117744	GSM3308138	{'cell line':'PC3 ','cell type':'Prostate Cancer ','cell compartment':'extracellular vesicles ','organism':'Homo sapiens','source name':'PC3 Human Prostate Cancer Cell Line Vesicles', 'title':'PC3_EX1_tRNA-41326582 REP2', 'last update date':'2018-09-01', 'release date': '2018-09-01', 'method': 'high-throughput sequencing'}	GSM3308138*#*#*#PC3_EX1_tRNA-41326582 REP2*#*#*#1*#*#*#PC3 Human Prostate Cancer Cell Line Vesicles*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Reads were trimmed with cutadapat (v1.6)microRNAs were mapped using Shrimp and a custom constructed database of mature and hairpin miRNA sequences (Genecode V24) and counts calledmRNAs were mapped using Homo_sapiens.GRCh38.87.gtf (SAM tools) and counts performed using HTSeqGenome_build: Homo sapiens GRCh38.87Supplementary_files_format_and_content: txt files are supplied with the counts per miRNA or gene *#*#*#RNA-Seq*#*#*#total RNAPC3_EX2.htseq.count.txt *#*#*#GPL18573*#*#*#2018-09-01*#*#*#2018-09-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PC3 *#*#*#[char](cell type)Prostate Cancer *#*#*#[char](cell compartment)extracellular vesicles 	30353168	PC3	Homo sapiens	Prostate Cancer	high-throughput sequencing	PC3 Human Prostate Cancer Cell Line Vesicles	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-09-01	2018-09-01	NONE 	GPL18573	Prostate Cancer	OMIM:176807;MESH:D011471;BERN:107535701	OMIM:176807=>PROSTATE CANCER;MESH:D011471=>Prostatic Neoplasms	PROSTATE CANCER|Prostatic Neoplasms	null	null	null	null	REP2|EX1|PC3	MIM:162150;HGNC:8743;Ensembl:ENSG00000175426;BERN:324244602|MIM:614555;HGNC:19839;Ensembl:ENSG00000139926;BERN:322787902|MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602	HGNC:8743=>PCSK1;Ensembl:ENSG00000175426=>PCSK1;MIM:162150=>PCSK1|HGNC:19839=>FRMD6;Ensembl:ENSG00000139926=>FRMD6;MIM:614555=>FRMD6|HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML	FRMD6|PCSK1|CHML	null	null	null	null	PC3	PC3	null	null
GSE117745	GSM3308139	{'cell type':'Immortalized cell line ','sample type':'reference ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Parental cell RNA repeat 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'spotted oligonucleotide'}	GSM3308139*#*#*#Parental cell RNA repeat 1*#*#*#2*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#"M" samples were parental T47D cells, which had been cultured in conditioned medium for 48 hours. *#*#*#total RNA*#*#*#Hy3*#*#*#The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. Data normalization was performed to minimize differences between the colors in an intensity dependent manner. Normalization was performed using Lowess (Locally Weighted Scatterplot Smoothing) normalization. Lowess uses a locally established regression to smooth the M/A (log ratio/log mean-intensity) scatterplot toward a linear distribution. The Lowess algorithm works under the assumption that the majority of the signals between samples do not differ and it enforces equal overall means on all signal intensities. Therefore, Lowess allows the correction of systematic deviations in the MA plot resulting in an intensity dependent adjustment of MA-data to a straight line. We have found this normalization to produce the best within-slide normalization and thereby minimize the intensity-dependent differences between the dyes. Array slide quality was also assessed using 52 different spole-in controls. *#*#*#null*#*#*#All experiments were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. 750 ng total RNA from both sample and reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ (Exiqon, Denmark) following the procedure described by the manufacturer. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA™ microRNA Array 7th Gen (Exiqon, Denmark), which contains capture probes targeting all microRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization was performed according to the miRCURY LNA™ microRNA Array Instruction manual using a Tecan HS4800™ hybridization station (Tecan, Austria). After hybridization the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene® 9 (miRCURY LNA™ microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm.0_Exiiqon files are the reference files *#*#*#GPL19128*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line *#*#*#[char](sample type)reference 	30840889	null	Homo sapiens	Immortalized cell line	spotted oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308139/suppl/GSM3308139_0_Exiqon_19732327_S01.txt.gz 	GPL19128	null	null	null	null	ozone	CHEBI:25812;BERN:121773403	CHEBI:25812=>ozone	ozone	Hy3	MIM:601822;HGNC:10243;Ensembl:ENSG00000202354;BERN:324611302	HGNC:10243=>RNY3;Ensembl:ENSG00000202354=>RNY3;MIM:601822=>RNY3	RNY3	null	null	null	null	T47D	T47D	null	null
GSE117745	GSM3308140	{'cell type':'Immortalized cell line ','sample type':'reference ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Parental cell RNA repeat 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'spotted oligonucleotide'}	GSM3308140*#*#*#Parental cell RNA repeat 2*#*#*#2*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#"M" samples were parental T47D cells, which had been cultured in conditioned medium for 48 hours. *#*#*#total RNA*#*#*#Hy3*#*#*#The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. Data normalization was performed to minimize differences between the colors in an intensity dependent manner. Normalization was performed using Lowess (Locally Weighted Scatterplot Smoothing) normalization. Lowess uses a locally established regression to smooth the M/A (log ratio/log mean-intensity) scatterplot toward a linear distribution. The Lowess algorithm works under the assumption that the majority of the signals between samples do not differ and it enforces equal overall means on all signal intensities. Therefore, Lowess allows the correction of systematic deviations in the MA plot resulting in an intensity dependent adjustment of MA-data to a straight line. We have found this normalization to produce the best within-slide normalization and thereby minimize the intensity-dependent differences between the dyes. Array slide quality was also assessed using 52 different spole-in controls. *#*#*#null*#*#*#All experiments were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. 750 ng total RNA from both sample and reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ (Exiqon, Denmark) following the procedure described by the manufacturer. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA™ microRNA Array 7th Gen (Exiqon, Denmark), which contains capture probes targeting all microRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization was performed according to the miRCURY LNA™ microRNA Array Instruction manual using a Tecan HS4800™ hybridization station (Tecan, Austria). After hybridization the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene® 9 (miRCURY LNA™ microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm.0_Exiiqon files are the reference files *#*#*#GPL19128*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line *#*#*#[char](sample type)reference 	30840889	null	Homo sapiens	Immortalized cell line	spotted oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308140/suppl/GSM3308140_0_Exiqon_19732324_S01.txt.gz 	GPL19128	null	null	null	null	ozone	CHEBI:25812;BERN:121773403	CHEBI:25812=>ozone	ozone	Hy3	MIM:601822;HGNC:10243;Ensembl:ENSG00000202354;BERN:324611302	HGNC:10243=>RNY3;Ensembl:ENSG00000202354=>RNY3;MIM:601822=>RNY3	RNY3	null	null	null	null	T47D	T47D	null	null
GSE117745	GSM3308141	{'cell type':'Immortalized cell line ','sample type':'reference ','organism':'Homo sapiens','source name':'T47D cells', 'title':'Parental cell RNA repeat 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'spotted oligonucleotide'}	GSM3308141*#*#*#Parental cell RNA repeat 3*#*#*#2*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#"M" samples were parental T47D cells, which had been cultured in conditioned medium for 48 hours. *#*#*#total RNA*#*#*#Hy3*#*#*#The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. Data normalization was performed to minimize differences between the colors in an intensity dependent manner. Normalization was performed using Lowess (Locally Weighted Scatterplot Smoothing) normalization. Lowess uses a locally established regression to smooth the M/A (log ratio/log mean-intensity) scatterplot toward a linear distribution. The Lowess algorithm works under the assumption that the majority of the signals between samples do not differ and it enforces equal overall means on all signal intensities. Therefore, Lowess allows the correction of systematic deviations in the MA plot resulting in an intensity dependent adjustment of MA-data to a straight line. We have found this normalization to produce the best within-slide normalization and thereby minimize the intensity-dependent differences between the dyes. Array slide quality was also assessed using 52 different spole-in controls. *#*#*#null*#*#*#All experiments were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. 750 ng total RNA from both sample and reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ (Exiqon, Denmark) following the procedure described by the manufacturer. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA™ microRNA Array 7th Gen (Exiqon, Denmark), which contains capture probes targeting all microRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization was performed according to the miRCURY LNA™ microRNA Array Instruction manual using a Tecan HS4800™ hybridization station (Tecan, Austria). After hybridization the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene® 9 (miRCURY LNA™ microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm.0_Exiiqon files are the reference files *#*#*#GPL19128*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line *#*#*#[char](sample type)reference 	30840889	null	Homo sapiens	Immortalized cell line	spotted oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308141/suppl/GSM3308141_0_Exiqon_19732305_S01.txt.gz 	GPL19128	null	null	null	null	ozone	CHEBI:25812;BERN:121773403	CHEBI:25812=>ozone	ozone	Hy3	MIM:601822;HGNC:10243;Ensembl:ENSG00000202354;BERN:324611302	HGNC:10243=>RNY3;Ensembl:ENSG00000202354=>RNY3;MIM:601822=>RNY3	RNY3	null	null	null	null	T47D	T47D	null	null
GSE117745	GSM3308142	{'cell type':'Immortalized cell line ','sample type':'reference ','organism':'Homo sapiens','source name':'T47D cells', 'title':'pabociclib resistant cell RNA repeat 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'spotted oligonucleotide'}	GSM3308142*#*#*#pabociclib resistant cell RNA repeat 1*#*#*#2*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#"M" samples were parental T47D cells, which had been cultured in conditioned medium for 48 hours. *#*#*#total RNA*#*#*#Hy3*#*#*#The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. Data normalization was performed to minimize differences between the colors in an intensity dependent manner. Normalization was performed using Lowess (Locally Weighted Scatterplot Smoothing) normalization. Lowess uses a locally established regression to smooth the M/A (log ratio/log mean-intensity) scatterplot toward a linear distribution. The Lowess algorithm works under the assumption that the majority of the signals between samples do not differ and it enforces equal overall means on all signal intensities. Therefore, Lowess allows the correction of systematic deviations in the MA plot resulting in an intensity dependent adjustment of MA-data to a straight line. We have found this normalization to produce the best within-slide normalization and thereby minimize the intensity-dependent differences between the dyes. Array slide quality was also assessed using 52 different spole-in controls. *#*#*#null*#*#*#All experiments were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. 750 ng total RNA from both sample and reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ (Exiqon, Denmark) following the procedure described by the manufacturer. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA™ microRNA Array 7th Gen (Exiqon, Denmark), which contains capture probes targeting all microRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization was performed according to the miRCURY LNA™ microRNA Array Instruction manual using a Tecan HS4800™ hybridization station (Tecan, Austria). After hybridization the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene® 9 (miRCURY LNA™ microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm.0_Exiiqon files are the reference files *#*#*#GPL19128*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line *#*#*#[char](sample type)reference 	30840889	null	Homo sapiens	Immortalized cell line	spotted oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308142/suppl/GSM3308142_0_Exiqon_19732330_S01.txt.gz 	GPL19128	null	null	null	null	ozone	CHEBI:25812;BERN:121773403	CHEBI:25812=>ozone	ozone	Hy3	MIM:601822;HGNC:10243;Ensembl:ENSG00000202354;BERN:324611302	HGNC:10243=>RNY3;Ensembl:ENSG00000202354=>RNY3;MIM:601822=>RNY3	RNY3	null	null	null	null	T47D	T47D	null	null
GSE117745	GSM3308143	{'cell type':'Immortalized cell line ','sample type':'reference ','organism':'Homo sapiens','source name':'T47D cells', 'title':'pabociclib resistant cell RNA repeat 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'spotted oligonucleotide'}	GSM3308143*#*#*#pabociclib resistant cell RNA repeat 2*#*#*#2*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#"M" samples were parental T47D cells, which had been cultured in conditioned medium for 48 hours. *#*#*#total RNA*#*#*#Hy3*#*#*#The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. Data normalization was performed to minimize differences between the colors in an intensity dependent manner. Normalization was performed using Lowess (Locally Weighted Scatterplot Smoothing) normalization. Lowess uses a locally established regression to smooth the M/A (log ratio/log mean-intensity) scatterplot toward a linear distribution. The Lowess algorithm works under the assumption that the majority of the signals between samples do not differ and it enforces equal overall means on all signal intensities. Therefore, Lowess allows the correction of systematic deviations in the MA plot resulting in an intensity dependent adjustment of MA-data to a straight line. We have found this normalization to produce the best within-slide normalization and thereby minimize the intensity-dependent differences between the dyes. Array slide quality was also assessed using 52 different spole-in controls. *#*#*#null*#*#*#All experiments were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. 750 ng total RNA from both sample and reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ (Exiqon, Denmark) following the procedure described by the manufacturer. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA™ microRNA Array 7th Gen (Exiqon, Denmark), which contains capture probes targeting all microRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization was performed according to the miRCURY LNA™ microRNA Array Instruction manual using a Tecan HS4800™ hybridization station (Tecan, Austria). After hybridization the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene® 9 (miRCURY LNA™ microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm.0_Exiiqon files are the reference files *#*#*#GPL19128*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line *#*#*#[char](sample type)reference 	30840889	null	Homo sapiens	Immortalized cell line	spotted oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308143/suppl/GSM3308143_0_Exiqon_19732329_S01.txt.gz 	GPL19128	null	null	null	null	ozone	CHEBI:25812;BERN:121773403	CHEBI:25812=>ozone	ozone	Hy3	MIM:601822;HGNC:10243;Ensembl:ENSG00000202354;BERN:324611302	HGNC:10243=>RNY3;Ensembl:ENSG00000202354=>RNY3;MIM:601822=>RNY3	RNY3	null	null	null	null	T47D	T47D	null	null
GSE117745	GSM3308144	{'cell type':'Immortalized cell line ','sample type':'reference ','organism':'Homo sapiens','source name':'T47D cells', 'title':'pabociclib resistant cell RNA repeat 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'spotted oligonucleotide'}	GSM3308144*#*#*#pabociclib resistant cell RNA repeat 3*#*#*#2*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#"M" samples were parental T47D cells, which had been cultured in conditioned medium for 48 hours. *#*#*#total RNA*#*#*#Hy3*#*#*#The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. Data normalization was performed to minimize differences between the colors in an intensity dependent manner. Normalization was performed using Lowess (Locally Weighted Scatterplot Smoothing) normalization. Lowess uses a locally established regression to smooth the M/A (log ratio/log mean-intensity) scatterplot toward a linear distribution. The Lowess algorithm works under the assumption that the majority of the signals between samples do not differ and it enforces equal overall means on all signal intensities. Therefore, Lowess allows the correction of systematic deviations in the MA plot resulting in an intensity dependent adjustment of MA-data to a straight line. We have found this normalization to produce the best within-slide normalization and thereby minimize the intensity-dependent differences between the dyes. Array slide quality was also assessed using 52 different spole-in controls. *#*#*#null*#*#*#All experiments were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. 750 ng total RNA from both sample and reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ (Exiqon, Denmark) following the procedure described by the manufacturer. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA™ microRNA Array 7th Gen (Exiqon, Denmark), which contains capture probes targeting all microRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization was performed according to the miRCURY LNA™ microRNA Array Instruction manual using a Tecan HS4800™ hybridization station (Tecan, Austria). After hybridization the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene® 9 (miRCURY LNA™ microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm.0_Exiiqon files are the reference files *#*#*#GPL19128*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line *#*#*#[char](sample type)reference 	30840889	null	Homo sapiens	Immortalized cell line	spotted oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308144/suppl/GSM3308144_0_Exiqon_19732334_S01.txt.gz 	GPL19128	null	null	null	null	ozone	CHEBI:25812;BERN:121773403	CHEBI:25812=>ozone	ozone	Hy3	MIM:601822;HGNC:10243;Ensembl:ENSG00000202354;BERN:324611302	HGNC:10243=>RNY3;Ensembl:ENSG00000202354=>RNY3;MIM:601822=>RNY3	RNY3	null	null	null	null	T47D	T47D	null	null
GSE117745	GSM3308145	{'cell type':'Immortalized cell line ','sample type':'reference ','organism':'Homo sapiens','source name':'T47D cells', 'title':'RNA from parental cells gown in resistant cell media repeat 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'spotted oligonucleotide'}	GSM3308145*#*#*#RNA from parental cells gown in resistant cell media repeat 1*#*#*#2*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#"M" samples were parental T47D cells, which had been cultured in conditioned medium for 48 hours. *#*#*#total RNA*#*#*#Hy3*#*#*#The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. Data normalization was performed to minimize differences between the colors in an intensity dependent manner. Normalization was performed using Lowess (Locally Weighted Scatterplot Smoothing) normalization. Lowess uses a locally established regression to smooth the M/A (log ratio/log mean-intensity) scatterplot toward a linear distribution. The Lowess algorithm works under the assumption that the majority of the signals between samples do not differ and it enforces equal overall means on all signal intensities. Therefore, Lowess allows the correction of systematic deviations in the MA plot resulting in an intensity dependent adjustment of MA-data to a straight line. We have found this normalization to produce the best within-slide normalization and thereby minimize the intensity-dependent differences between the dyes. Array slide quality was also assessed using 52 different spole-in controls. *#*#*#null*#*#*#All experiments were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. 750 ng total RNA from both sample and reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ (Exiqon, Denmark) following the procedure described by the manufacturer. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA™ microRNA Array 7th Gen (Exiqon, Denmark), which contains capture probes targeting all microRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization was performed according to the miRCURY LNA™ microRNA Array Instruction manual using a Tecan HS4800™ hybridization station (Tecan, Austria). After hybridization the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene® 9 (miRCURY LNA™ microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm.0_Exiiqon files are the reference files *#*#*#GPL19128*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line *#*#*#[char](sample type)reference 	30840889	null	Homo sapiens	Immortalized cell line	spotted oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308145/suppl/GSM3308145_0_Exiqon_19732328_S01.txt.gz 	GPL19128	null	null	null	null	ozone	CHEBI:25812;BERN:121773403	CHEBI:25812=>ozone	ozone	Hy3	MIM:601822;HGNC:10243;Ensembl:ENSG00000202354;BERN:324611302	HGNC:10243=>RNY3;Ensembl:ENSG00000202354=>RNY3;MIM:601822=>RNY3	RNY3	null	null	null	null	T47D	T47D	null	null
GSE117745	GSM3308146	{'cell type':'Immortalized cell line ','sample type':'reference ','organism':'Homo sapiens','source name':'T47D cells', 'title':'RNA from parental cells gown in resistant cell media repeat 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'spotted oligonucleotide'}	GSM3308146*#*#*#RNA from parental cells gown in resistant cell media repeat 2*#*#*#2*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#"M" samples were parental T47D cells, which had been cultured in conditioned medium for 48 hours. *#*#*#total RNA*#*#*#Hy3*#*#*#The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. Data normalization was performed to minimize differences between the colors in an intensity dependent manner. Normalization was performed using Lowess (Locally Weighted Scatterplot Smoothing) normalization. Lowess uses a locally established regression to smooth the M/A (log ratio/log mean-intensity) scatterplot toward a linear distribution. The Lowess algorithm works under the assumption that the majority of the signals between samples do not differ and it enforces equal overall means on all signal intensities. Therefore, Lowess allows the correction of systematic deviations in the MA plot resulting in an intensity dependent adjustment of MA-data to a straight line. We have found this normalization to produce the best within-slide normalization and thereby minimize the intensity-dependent differences between the dyes. Array slide quality was also assessed using 52 different spole-in controls. *#*#*#null*#*#*#All experiments were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. 750 ng total RNA from both sample and reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ (Exiqon, Denmark) following the procedure described by the manufacturer. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA™ microRNA Array 7th Gen (Exiqon, Denmark), which contains capture probes targeting all microRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization was performed according to the miRCURY LNA™ microRNA Array Instruction manual using a Tecan HS4800™ hybridization station (Tecan, Austria). After hybridization the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene® 9 (miRCURY LNA™ microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm.0_Exiiqon files are the reference files *#*#*#GPL19128*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line *#*#*#[char](sample type)reference 	30840889	null	Homo sapiens	Immortalized cell line	spotted oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308146/suppl/GSM3308146_0_Exiqon_19732336_S01.txt.gz 	GPL19128	null	null	null	null	ozone	CHEBI:25812;BERN:121773403	CHEBI:25812=>ozone	ozone	Hy3	MIM:601822;HGNC:10243;Ensembl:ENSG00000202354;BERN:324611302	HGNC:10243=>RNY3;Ensembl:ENSG00000202354=>RNY3;MIM:601822=>RNY3	RNY3	null	null	null	null	T47D	T47D	null	null
GSE117745	GSM3308147	{'cell type':'Immortalized cell line ','sample type':'reference ','organism':'Homo sapiens','source name':'T47D cells', 'title':'RNA from parental cells gown in resistant cell media repeat 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'spotted oligonucleotide'}	GSM3308147*#*#*#RNA from parental cells gown in resistant cell media repeat 3*#*#*#2*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#"M" samples were parental T47D cells, which had been cultured in conditioned medium for 48 hours. *#*#*#total RNA*#*#*#Hy3*#*#*#The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. Data normalization was performed to minimize differences between the colors in an intensity dependent manner. Normalization was performed using Lowess (Locally Weighted Scatterplot Smoothing) normalization. Lowess uses a locally established regression to smooth the M/A (log ratio/log mean-intensity) scatterplot toward a linear distribution. The Lowess algorithm works under the assumption that the majority of the signals between samples do not differ and it enforces equal overall means on all signal intensities. Therefore, Lowess allows the correction of systematic deviations in the MA plot resulting in an intensity dependent adjustment of MA-data to a straight line. We have found this normalization to produce the best within-slide normalization and thereby minimize the intensity-dependent differences between the dyes. Array slide quality was also assessed using 52 different spole-in controls. *#*#*#null*#*#*#All experiments were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. 750 ng total RNA from both sample and reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ (Exiqon, Denmark) following the procedure described by the manufacturer. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA™ microRNA Array 7th Gen (Exiqon, Denmark), which contains capture probes targeting all microRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization was performed according to the miRCURY LNA™ microRNA Array Instruction manual using a Tecan HS4800™ hybridization station (Tecan, Austria). After hybridization the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene® 9 (miRCURY LNA™ microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background corrected (Normexp with offset value 10, see Ritchie et al. 2007) and normalized using the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm.0_Exiiqon files are the reference files *#*#*#GPL19128*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line *#*#*#[char](sample type)reference 	30840889	null	Homo sapiens	Immortalized cell line	spotted oligonucleotide	T47D cells	null	null	null	null	null	null	total RNA	RNA	2019-03-04	2019-03-04	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308147/suppl/GSM3308147_0_Exiqon_19732331_S01.txt.gz 	GPL19128	null	null	null	null	ozone	CHEBI:25812;BERN:121773403	CHEBI:25812=>ozone	ozone	Hy3	MIM:601822;HGNC:10243;Ensembl:ENSG00000202354;BERN:324611302	HGNC:10243=>RNY3;Ensembl:ENSG00000202354=>RNY3;MIM:601822=>RNY3	RNY3	null	null	null	null	T47D	T47D	null	null
GSE117746	GSM3308148	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'T47D control RNA 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308148*#*#*#T47D control RNA 1*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Biotin labelled miRNA was transfected using lipofectamine 3000 *#*#*#total RNA*#*#*#null*#*#*#FKPM was calculated, data presented in the manuscript is dirived from FKPMFKPM averages for sample repeats which were >0 but <1 was rounded to 1.DESeq2 analysis was also performed and attachedGenome_build: hg19Supplementary_files_format_and_content: Excel spreadsheets of both FKPM and DESeq2 are attached *#*#*#RNA-Seq*#*#*#Control RNA from untreated parental T47D cells *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	high-throughput sequencing	T47D cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	Biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117746	GSM3308149	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'T47D control RNA 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308149*#*#*#T47D control RNA 2*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Biotin labelled miRNA was transfected using lipofectamine 3000 *#*#*#total RNA*#*#*#null*#*#*#FKPM was calculated, data presented in the manuscript is dirived from FKPMFKPM averages for sample repeats which were >0 but <1 was rounded to 1.DESeq2 analysis was also performed and attachedGenome_build: hg19Supplementary_files_format_and_content: Excel spreadsheets of both FKPM and DESeq2 are attached *#*#*#RNA-Seq*#*#*#Control RNA from untreated parental T47D cells *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	high-throughput sequencing	T47D cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	Biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117746	GSM3308150	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'T47D control RNA 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308150*#*#*#T47D control RNA 3*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Biotin labelled miRNA was transfected using lipofectamine 3000 *#*#*#total RNA*#*#*#null*#*#*#FKPM was calculated, data presented in the manuscript is dirived from FKPMFKPM averages for sample repeats which were >0 but <1 was rounded to 1.DESeq2 analysis was also performed and attachedGenome_build: hg19Supplementary_files_format_and_content: Excel spreadsheets of both FKPM and DESeq2 are attached *#*#*#RNA-Seq*#*#*#Control RNA from untreated parental T47D cells *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	high-throughput sequencing	T47D cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	Biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	null	null	null	null	null	null	null	null	T47D	T47D	null	null
GSE117746	GSM3308151	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'T47D mir-432-5p captured RNA 1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308151*#*#*#T47D mir-432-5p captured RNA 1*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Biotin labelled miRNA was transfected using lipofectamine 3000 *#*#*#total RNA*#*#*#null*#*#*#FKPM was calculated, data presented in the manuscript is dirived from FKPMFKPM averages for sample repeats which were >0 but <1 was rounded to 1.DESeq2 analysis was also performed and attachedGenome_build: hg19Supplementary_files_format_and_content: Excel spreadsheets of both FKPM and DESeq2 are attached *#*#*#RNA-Seq*#*#*#RNA captured using a biotin labelled miR-432-5p, performed in parental T47D cells. *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	high-throughput sequencing	T47D cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	Biotin|biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	mir-432-5p|miR-432-5p	HGNC:38304;Ensembl:ENSG00000266666;miRBase:MI0015865;BERN:320342202	HGNC:38304=>MIR4325;Ensembl:ENSG00000266666=>null	MIR4325|null	null	null	null	null	T47D	T47D	null	null
GSE117746	GSM3308152	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'T47D mir-432-5p captured RNA 2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308152*#*#*#T47D mir-432-5p captured RNA 2*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Biotin labelled miRNA was transfected using lipofectamine 3000 *#*#*#total RNA*#*#*#null*#*#*#FKPM was calculated, data presented in the manuscript is dirived from FKPMFKPM averages for sample repeats which were >0 but <1 was rounded to 1.DESeq2 analysis was also performed and attachedGenome_build: hg19Supplementary_files_format_and_content: Excel spreadsheets of both FKPM and DESeq2 are attached *#*#*#RNA-Seq*#*#*#RNA captured using a biotin labelled miR-432-5p, performed in parental T47D cells. *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	high-throughput sequencing	T47D cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	Biotin|biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	mir-432-5p|miR-432-5p	HGNC:38304;Ensembl:ENSG00000266666;miRBase:MI0015865;BERN:320342202	HGNC:38304=>MIR4325;Ensembl:ENSG00000266666=>null	MIR4325|null	null	null	null	null	T47D	T47D	null	null
GSE117746	GSM3308153	{'cell type':'Immortalized cell line ','organism':'Homo sapiens','source name':'T47D cells', 'title':'T47D mir-432-5p captured RNA 3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308153*#*#*#T47D mir-432-5p captured RNA 3*#*#*#1*#*#*#T47D cells*#*#*#Homo sapiens*#*#*#Biotin labelled miRNA was transfected using lipofectamine 3000 *#*#*#total RNA*#*#*#null*#*#*#FKPM was calculated, data presented in the manuscript is dirived from FKPMFKPM averages for sample repeats which were >0 but <1 was rounded to 1.DESeq2 analysis was also performed and attachedGenome_build: hg19Supplementary_files_format_and_content: Excel spreadsheets of both FKPM and DESeq2 are attached *#*#*#RNA-Seq*#*#*#RNA captured using a biotin labelled miR-432-5p, performed in parental T47D cells. *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized cell line 	30840889	null	Homo sapiens	Immortalized cell line	high-throughput sequencing	T47D cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	Biotin|biotin	CHEBI:57586;BERN:278046903	CHEBI:57586=>biotinate	biotinate	mir-432-5p|miR-432-5p	HGNC:38304;Ensembl:ENSG00000266666;miRBase:MI0015865;BERN:320342202	HGNC:38304=>MIR4325;Ensembl:ENSG00000266666=>null	MIR4325|null	null	null	null	null	T47D	T47D	null	null
GSE117747	GSM3308154	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient A1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308154*#*#*#Patient A1*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308156	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient A3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308156*#*#*#Patient A3*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308157	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient A4', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308157*#*#*#Patient A4*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308158	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient A5', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308158*#*#*#Patient A5*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308159	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient A6', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308159*#*#*#Patient A6*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308160	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient B2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308160*#*#*#Patient B2*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308161	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Aquired Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient B3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308161*#*#*#Patient B3*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Aquired Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	B3	B3	null	null
GSE117747	GSM3308162	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'NA ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient B4', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308162*#*#*#Patient B4*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)NA 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308163	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient B5', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308163*#*#*#Patient B5*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308164	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Aquired Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient B6', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308164*#*#*#Patient B6*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Aquired Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308165	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'NA ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient C1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308165*#*#*#Patient C1*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)NA 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308166	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'NA ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient C2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308166*#*#*#Patient C2*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)NA 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308167	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient C3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308167*#*#*#Patient C3*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308168	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Aquired Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient C4', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308168*#*#*#Patient C4*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Aquired Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308169	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient C5', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308169*#*#*#Patient C5*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308170	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient C6', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308170*#*#*#Patient C6*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308171	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient D1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308171*#*#*#Patient D1*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308172	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient D2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308172*#*#*#Patient D2*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308173	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient D3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308173*#*#*#Patient D3*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308174	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient D4', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308174*#*#*#Patient D4*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308175	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'NA ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient D5', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308175*#*#*#Patient D5*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)NA 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308176	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient D6', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308176*#*#*#Patient D6*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308177	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient E1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308177*#*#*#Patient E1*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308178	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'NA ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient E2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308178*#*#*#Patient E2*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)NA 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308179	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient E3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308179*#*#*#Patient E3*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308180	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Aquired Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient E4', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308180*#*#*#Patient E4*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Aquired Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308181	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient E5', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308181*#*#*#Patient E5*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308182	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Aquired Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient E6', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308182*#*#*#Patient E6*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Aquired Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308183	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient F1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308183*#*#*#Patient F1*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308184	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient F2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308184*#*#*#Patient F2*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308185	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient F3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308185*#*#*#Patient F3*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308186	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Aquired Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient F4', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308186*#*#*#Patient F4*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Aquired Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308187	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient F5', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308187*#*#*#Patient F5*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308188	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient F6', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308188*#*#*#Patient F6*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308189	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient G1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308189*#*#*#Patient G1*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308190	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient G2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308190*#*#*#Patient G2*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308191	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient G3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308191*#*#*#Patient G3*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308192	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Aquired Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient G4', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308192*#*#*#Patient G4*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Aquired Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308193	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient G5', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308193*#*#*#Patient G5*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308194	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient H1', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308194*#*#*#Patient H1*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308195	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient H2', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308195*#*#*#Patient H2*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308196	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Sensitive ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient H3', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308196*#*#*#Patient H3*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Sensitive 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117747	GSM3308197	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Intrinsic Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient H4', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308197*#*#*#Patient H4*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Intrinsic Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	H4	H4	null	null
GSE117747	GSM3308198	{'sample type':'Tissue ','cdk4/6 inhibitor phenotype':'Aquired Resistance ','organism':'Homo sapiens','source name':'CDK4/6 inhibitor treated patient biopsy', 'title':'Patient H5', 'last update date':'2019-03-04', 'release date': '2019-03-04', 'method': 'high-throughput sequencing'}	GSM3308198*#*#*#Patient H5*#*#*#1*#*#*#CDK4/6 inhibitor treated patient biopsy*#*#*#Homo sapiens*#*#*#All patients were treated with a CDK4/6 *#*#*#total RNA*#*#*#null*#*#*#Raw counts were normalised to Counts per million. CPM was used for direct comparisons between patient phenotypes. Genome_build: hg19 *#*#*#miRNA-Seq*#*#*#RNA derived from CDK4/6 inhibitor treated patient biopsy *#*#*#GPL18573*#*#*#2019-03-04*#*#*#2019-03-04*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](sample type)Tissue *#*#*#[char](cdk4/6 inhibitor phenotype)Aquired Resistance 	30840889	null	Homo sapiens	null	high-throughput sequencing	CDK4/6 inhibitor treated patient biopsy	null	null	null	miRNA-Seq	null	transcriptomic	total RNA	SRA	2019-03-04	2019-03-04	NONE 	GPL18573	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308226	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'4 ','age (years)':'61 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A001', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308226*#*#*#AIR patient A001*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)4 *#*#*#[char](age (years))61 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308226/suppl/GSM3308226_20160715_5609WV-C.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308227	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'>3 ','age (years)':'71 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A048', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308227*#*#*#AIR patient A048*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)>3 *#*#*#[char](age (years))71 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308227/suppl/GSM3308227_20170504_6090AA-A2.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308228	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'7 ','age (years)':'71 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A052', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308228*#*#*#AIR patient A052*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)7 *#*#*#[char](age (years))71 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308228/suppl/GSM3308228_20170504_6121PF-A2.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308229	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'4 ','age (years)':'66 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A061', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308229*#*#*#AIR patient A061*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)4 *#*#*#[char](age (years))66 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308229/suppl/GSM3308229_20170504_5993KP-A2.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308230	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'9 ','age (years)':'71 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A125', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308230*#*#*#AIR patient A125*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)9 *#*#*#[char](age (years))71 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308230/suppl/GSM3308230_20170504_6536VE-A2.RCC.gz 	GPL25389	Autoimmune retinopathy	MESH:C538273;BERN:254665501	MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308231	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'9 ','age (years)':'59 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A132', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308231*#*#*#AIR patient A132*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)9 *#*#*#[char](age (years))59 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308231/suppl/GSM3308231_20170504_6568NC-A2.RCC.gz 	GPL25389	Autoimmune retinopathy	MESH:C538273;BERN:254665501	MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308232	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'>5 ','age (years)':'54 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A134', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308232*#*#*#AIR patient A134*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)>5 *#*#*#[char](age (years))54 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308232/suppl/GSM3308232_20170504_6612MK-A2.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308233	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'3 ','age (years)':'55 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A135', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308233*#*#*#AIR patient A135*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)3 *#*#*#[char](age (years))55 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308233/suppl/GSM3308233_20170504_6636KS-A2.RCC.gz 	GPL25389	Autoimmune retinopathy	MESH:C538273;BERN:254665501	MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308234	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'3 ','age (years)':'61 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A145', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308234*#*#*#AIR patient A145*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)3 *#*#*#[char](age (years))61 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308234/suppl/GSM3308234_20170504_6204CL-A2.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308235	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'4 ','age (years)':'29 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A166', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308235*#*#*#AIR patient A166*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)4 *#*#*#[char](age (years))29 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308235/suppl/GSM3308235_20161006_6779BL-B.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308236	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'>8 ','age (years)':'41 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A178', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308236*#*#*#AIR patient A178*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)>8 *#*#*#[char](age (years))41 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308236/suppl/GSM3308236_20161006_4988CH-A.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308237	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'5 ','age (years)':'58 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A213', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308237*#*#*#AIR patient A213*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)5 *#*#*#[char](age (years))58 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308237/suppl/GSM3308237_20160329_8017DU-A.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308238	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'>2 ','age (years)':'45 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A277', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308238*#*#*#AIR patient A277*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)>2 *#*#*#[char](age (years))45 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308238/suppl/GSM3308238_20160715_9154ET-A.RCC.gz 	GPL25389	Autoimmune retinopathy	MESH:C538273;BERN:254665501	MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308239	{'tissue':'whole blood ','diagnosis':'Autoimmune retinopathy ','anti-retinal ab bands on wb':'>9 ','age (years)':'40 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'AIR patient A286', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308239*#*#*#AIR patient A286*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Autoimmune retinopathy *#*#*#[char](anti-retinal ab bands on wb)>9 *#*#*#[char](age (years))40 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308239/suppl/GSM3308239_20160715_9164SM-A.RCC.gz 	GPL25389	Autoimmune retinopathy|AIR	MESH:C538273;BERN:254665501|BERN:260618801	MESH:C538273=>Autoimmune enteropathy|MESH:C538273=>Autoimmune enteropathy	Autoimmune enteropathy	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308240	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'2 ','age (years)':'20 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R152', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308240*#*#*#RP patient R152*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)2 *#*#*#[char](age (years))20 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308240/suppl/GSM3308240_20161006_3947MC-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308241	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'2 ','age (years)':'20 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R172', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308241*#*#*#RP patient R172*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)2 *#*#*#[char](age (years))20 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308241/suppl/GSM3308241_20160629_402ER-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308242	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'0 ','age (years)':'58 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R188', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308242*#*#*#RP patient R188*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))58 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308242/suppl/GSM3308242_20160629_991KH-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308243	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'3 ','age (years)':'67 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R201', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308243*#*#*#RP patient R201*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)3 *#*#*#[char](age (years))67 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308243/suppl/GSM3308243_20160715_440JT-B.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308244	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'1 ','age (years)':'39 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R215', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308244*#*#*#RP patient R215*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)1 *#*#*#[char](age (years))39 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308244/suppl/GSM3308244_20160629_5092AD-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308245	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'2 ','age (years)':'56 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R223', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308245*#*#*#RP patient R223*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)2 *#*#*#[char](age (years))56 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308245/suppl/GSM3308245_20170504_8037AM-A3.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308246	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'3 ','age (years)':'61 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R242', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308246*#*#*#RP patient R242*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)3 *#*#*#[char](age (years))61 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308246/suppl/GSM3308246_20170911_3905SW-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308247	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'0 ','age (years)':'33 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R245', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308247*#*#*#RP patient R245*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))33 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308247/suppl/GSM3308247_20160629_4231DK-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308248	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'0 ','age (years)':'47 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R253', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308248*#*#*#RP patient R253*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))47 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308248/suppl/GSM3308248_20160628_6372ML-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308249	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'1 ','age (years)':'75 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R261', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308249*#*#*#RP patient R261*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)1 *#*#*#[char](age (years))75 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308249/suppl/GSM3308249_20170911_5665PB-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308250	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'3 ','age (years)':'35 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R271', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308250*#*#*#RP patient R271*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)3 *#*#*#[char](age (years))35 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308250/suppl/GSM3308250_20170911_9134LH-B.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308251	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'2 ','age (years)':'36 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R281', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308251*#*#*#RP patient R281*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)2 *#*#*#[char](age (years))36 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308251/suppl/GSM3308251_20160715_6034RN-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308252	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'2 ','age (years)':'74 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R294', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308252*#*#*#RP patient R294*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)2 *#*#*#[char](age (years))74 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308252/suppl/GSM3308252_20161006_9219RD-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308253	{'tissue':'whole blood ','diagnosis':'Retinitis pigmentosa ','anti-retinal ab bands on wb':'3 ','age (years)':'37 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'RP patient R300', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308253*#*#*#RP patient R300*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)Retinitis pigmentosa *#*#*#[char](anti-retinal ab bands on wb)3 *#*#*#[char](age (years))37 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308253/suppl/GSM3308253_20161005_2068AP-A.RCC.gz 	GPL25389	Retinitis pigmentosa|RP	MESH:C566579;OMIM:602093;BERN:107001201	OMIM:602093=>CONE DYSTROPHY 3: COD3;MESH:C566579=>Cone Dystrophy 3	CONE DYSTROPHY 3: COD3|Cone Dystrophy 3	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308254	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'1 ','age (years)':'51 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C010', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308254*#*#*#Control C010*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)1 *#*#*#[char](age (years))51 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308254/suppl/GSM3308254_20170504_5885SL-D2.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308255	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'0 ','age (years)':'53 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C230', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308255*#*#*#Control C230*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))53 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308255/suppl/GSM3308255_20170504_9051LS-A3.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308256	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'nd ','age (years)':'39 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C249', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308256*#*#*#Control C249*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)nd *#*#*#[char](age (years))39 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308256/suppl/GSM3308256_20160628_100KB-A2.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308257	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'0 ','age (years)':'50 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C272', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308257*#*#*#Control C272*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))50 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308257/suppl/GSM3308257_20160628_9149DB-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308258	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'2 ','age (years)':'52 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C273', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308258*#*#*#Control C273*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)2 *#*#*#[char](age (years))52 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308258/suppl/GSM3308258_20160628_9147BM-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308259	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'2 ','age (years)':'59 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C275', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308259*#*#*#Control C275*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)2 *#*#*#[char](age (years))59 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308259/suppl/GSM3308259_20160628_9148CW-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308260	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'0 ','age (years)':'65 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C319', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308260*#*#*#Control C319*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))65 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308260/suppl/GSM3308260_20161005_9281JM-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308261	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'0 ','age (years)':'69 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C323', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308261*#*#*#Control C323*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))69 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308261/suppl/GSM3308261_20161005_133BK-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308262	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'1 ','age (years)':'56 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C324', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308262*#*#*#Control C324*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)1 *#*#*#[char](age (years))56 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308262/suppl/GSM3308262_20161005_134CD-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308263	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'0 ','age (years)':'68 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C360', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308263*#*#*#Control C360*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))68 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308263/suppl/GSM3308263_20170911_9653RA-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308264	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'0 ','age (years)':'64 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C361', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308264*#*#*#Control C361*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))64 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308264/suppl/GSM3308264_20170911_9655RK-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308265	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'0 ','age (years)':'59 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C362', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308265*#*#*#Control C362*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)0 *#*#*#[char](age (years))59 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308265/suppl/GSM3308265_20170911_9656CW-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308266	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'1 ','age (years)':'52 ','gender':'Male ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C363', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308266*#*#*#Control C363*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)1 *#*#*#[char](age (years))52 *#*#*#[char](gender)Male 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308266/suppl/GSM3308266_20170911_9654NL-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117751	GSM3308267	{'tissue':'whole blood ','diagnosis':'None ','anti-retinal ab bands on wb':'2 ','age (years)':'55 ','gender':'Female ','organism':'Homo sapiens','source name':'blood RNA', 'title':'Control C364', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'other'}	GSM3308267*#*#*#Control C364*#*#*#1*#*#*#blood RNA*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#None*#*#*#The raw data were filtered to include mRNA expression above 32 copies/100 ng total RNA then linearized and Voom normalized using R statistics package. Batch effects were corrected using the Combat method. *#*#*#null*#*#*#100ng whole blood total RNA was hybridized to NanoString Human Immunology panel and analyzed using nCounter *#*#*#GPL25389*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)whole blood *#*#*#[char](diagnosis)None *#*#*#[char](anti-retinal ab bands on wb)2 *#*#*#[char](age (years))55 *#*#*#[char](gender)Female 	30271775	null	Homo sapiens	null	other	blood RNA	whole blood	null	null	null	null	null	total RNA	RNA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308267/suppl/GSM3308267_20170911_9660TM-A.RCC.gz 	GPL25389	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117752	GSM3308268	{'tissue':'Invasive breast carcinoma ','antibody':'H3K4me3 (Active Motif, 39159, Lot. 01609004) ','organism':'Homo sapiens','source name':'FFPE tissue', 'title':'IBC_H3K4me3_Std_PAT-ChIP', 'last update date':'2018-11-20', 'release date': '2018-11-20', 'method': 'high-throughput sequencing'}	GSM3308268*#*#*#IBC_H3K4me3_Std_PAT-ChIP*#*#*#1*#*#*#FFPE tissue*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Reads were aligned to hg19 using 'bowtie’ (version 0.6.2-r126).Unmapped reads, reads with a MAPQ smaller than 1 and duplicate reads were removed using samtools (version 0.1.18).Mapped sequence reads were extended to 200 bp using deepTools (version 2.5.4).Peaks were called using MACS2 software from Galaxy browser (http://usegalaxy.com - bdgpeakcall function to call narrow peaks from H3K4me3 and H3K27ac tracks and MACS2 bdgbroadcall function for broad peaks from H3K27me3).Genome_build: hg19Supplementary_files_format_and_content: Bedgraph files containing tracks and bedgraph files containing called peaks *#*#*#ChIP-Seq*#*#*#H3K4me3 bedgraph files for BA processed with standard PAT-ChIP *#*#*#GPL11154*#*#*#2018-11-20*#*#*#2018-11-20*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Invasive breast carcinoma *#*#*#[char](antibody)H3K4me3 (Active Motif, 39159, Lot. 01609004) 	30446010	null	Homo sapiens	null	high-throughput sequencing	FFPE tissue	Invasive breast carcinoma	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2018-11-20	2018-11-20	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308268/suppl/GSM3308268_IBC_H3K4me3_Std_PAT-ChIP.bedgraph.gz 	GPL11154	breast carcinoma	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	null	null	null	null	Std	MIM:176947;HGNC:12858;Ensembl:ENSG00000115085;BERN:325085602	HGNC:12858=>ZAP70;Ensembl:ENSG00000115085=>ZAP70;MIM:176947=>ZAP70	ZAP70	null	null	null	null	null	null	null	null
GSE117752	GSM3308269	{'tissue':'Invasive breast carcinoma ','antibody':'H3K4me3 (Active Motif, 39159, Lot. 01609004) ','organism':'Homo sapiens','source name':'FFPE tissue', 'title':'IBC_H3K4me3_ePAT-ChIP', 'last update date':'2018-11-20', 'release date': '2018-11-20', 'method': 'high-throughput sequencing'}	GSM3308269*#*#*#IBC_H3K4me3_ePAT-ChIP*#*#*#1*#*#*#FFPE tissue*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Reads were aligned to hg19 using 'bowtie’ (version 0.6.2-r126).Unmapped reads, reads with a MAPQ smaller than 1 and duplicate reads were removed using samtools (version 0.1.18).Mapped sequence reads were extended to 200 bp using deepTools (version 2.5.4).Peaks were called using MACS2 software from Galaxy browser (http://usegalaxy.com - bdgpeakcall function to call narrow peaks from H3K4me3 and H3K27ac tracks and MACS2 bdgbroadcall function for broad peaks from H3K27me3).Genome_build: hg19Supplementary_files_format_and_content: Bedgraph files containing tracks and bedgraph files containing called peaks *#*#*#ChIP-Seq*#*#*#H3K4me3 bedgraph files for BA processed with ePAT-ChIP *#*#*#GPL11154*#*#*#2018-11-20*#*#*#2018-11-20*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Invasive breast carcinoma *#*#*#[char](antibody)H3K4me3 (Active Motif, 39159, Lot. 01609004) 	30446010	null	Homo sapiens	null	high-throughput sequencing	FFPE tissue	Invasive breast carcinoma	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2018-11-20	2018-11-20	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308269/suppl/GSM3308269_IBC_H3K4me3_ePAT-ChIP.bedgraph.gz 	GPL11154	breast carcinoma	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117752	GSM3308270	{'tissue':'Invasive breast carcinoma ','antibody':'H3K27ac (Abcam, ab4729, Lot. GR254707-1) ','organism':'Homo sapiens','source name':'FFPE tissue', 'title':'IBC_H3K27ac_ePAT-ChIP', 'last update date':'2018-11-20', 'release date': '2018-11-20', 'method': 'high-throughput sequencing'}	GSM3308270*#*#*#IBC_H3K27ac_ePAT-ChIP*#*#*#1*#*#*#FFPE tissue*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Reads were aligned to hg19 using 'bowtie’ (version 0.6.2-r126).Unmapped reads, reads with a MAPQ smaller than 1 and duplicate reads were removed using samtools (version 0.1.18).Mapped sequence reads were extended to 200 bp using deepTools (version 2.5.4).Peaks were called using MACS2 software from Galaxy browser (http://usegalaxy.com - bdgpeakcall function to call narrow peaks from H3K4me3 and H3K27ac tracks and MACS2 bdgbroadcall function for broad peaks from H3K27me3).Genome_build: hg19Supplementary_files_format_and_content: Bedgraph files containing tracks and bedgraph files containing called peaks *#*#*#ChIP-Seq*#*#*#H3K27ac bedgraph files for BA processed with ePAT-ChIP *#*#*#GPL11154*#*#*#2018-11-20*#*#*#2018-11-20*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Invasive breast carcinoma *#*#*#[char](antibody)H3K27ac (Abcam, ab4729, Lot. GR254707-1) 	30446010	null	Homo sapiens	null	high-throughput sequencing	FFPE tissue	Invasive breast carcinoma	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2018-11-20	2018-11-20	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308270/suppl/GSM3308270_IBC_H3K27ac_ePAT-ChIP.bedgraph.gz 	GPL11154	breast carcinoma	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117752	GSM3308271	{'tissue':'Invasive breast carcinoma ','antibody':'H3K27me3 (Millipore, 07-449, Lot. JBC1873477) ','organism':'Homo sapiens','source name':'FFPE tissue', 'title':'IBC_H3K27me3_ePAT-ChIP', 'last update date':'2018-11-20', 'release date': '2018-11-20', 'method': 'high-throughput sequencing'}	GSM3308271*#*#*#IBC_H3K27me3_ePAT-ChIP*#*#*#1*#*#*#FFPE tissue*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Reads were aligned to hg19 using 'bowtie’ (version 0.6.2-r126).Unmapped reads, reads with a MAPQ smaller than 1 and duplicate reads were removed using samtools (version 0.1.18).Mapped sequence reads were extended to 200 bp using deepTools (version 2.5.4).Peaks were called using MACS2 software from Galaxy browser (http://usegalaxy.com - bdgpeakcall function to call narrow peaks from H3K4me3 and H3K27ac tracks and MACS2 bdgbroadcall function for broad peaks from H3K27me3).Genome_build: hg19Supplementary_files_format_and_content: Bedgraph files containing tracks and bedgraph files containing called peaks *#*#*#ChIP-Seq*#*#*#H3K27me3 bedgraph files for BA processed with ePAT-ChIP *#*#*#GPL11154*#*#*#2018-11-20*#*#*#2018-11-20*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Invasive breast carcinoma *#*#*#[char](antibody)H3K27me3 (Millipore, 07-449, Lot. JBC1873477) 	30446010	null	Homo sapiens	null	high-throughput sequencing	FFPE tissue	Invasive breast carcinoma	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2018-11-20	2018-11-20	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308271/suppl/GSM3308271_IBC_H3K27me3_ePAT-ChIP.bedgraph.gz 	GPL11154	breast carcinoma	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117752	GSM3444230	{'tissue':'Invasive breast carcinoma ','antibody':'H3K27ac (Abcam, ab4729, Lot. GR254707-1) ','organism':'Homo sapiens','source name':'FFPE tissue', 'title':'IBC_H3K27ac_Std_PAT-ChIP', 'last update date':'2018-11-20', 'release date': '2018-11-20', 'method': 'high-throughput sequencing'}	GSM3444230*#*#*#IBC_H3K27ac_Std_PAT-ChIP*#*#*#1*#*#*#FFPE tissue*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Reads were aligned to hg19 using 'bowtie’ (version 0.6.2-r126).Unmapped reads, reads with a MAPQ smaller than 1 and duplicate reads were removed using samtools (version 0.1.18).Mapped sequence reads were extended to 200 bp using deepTools (version 2.5.4).Peaks were called using MACS2 software from Galaxy browser (http://usegalaxy.com - bdgpeakcall function to call narrow peaks from H3K4me3 and H3K27ac tracks and MACS2 bdgbroadcall function for broad peaks from H3K27me3).Genome_build: hg19Supplementary_files_format_and_content: Bedgraph files containing tracks and bedgraph files containing called peaks *#*#*#ChIP-Seq*#*#*#H3K4me3 bedgraph files for BA processed with standard PAT-ChIP *#*#*#GPL11154*#*#*#2018-11-20*#*#*#2018-11-20*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Invasive breast carcinoma *#*#*#[char](antibody)H3K27ac (Abcam, ab4729, Lot. GR254707-1) 	30446010	null	Homo sapiens	null	high-throughput sequencing	FFPE tissue	Invasive breast carcinoma	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2018-11-20	2018-11-20	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3444nnn/GSM3444230/suppl/GSM3444230_IBC_H3K27ac_Std_PAT-ChIP.bedGraph.gz 	GPL11154	breast carcinoma	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	null	null	null	null	Std	MIM:176947;HGNC:12858;Ensembl:ENSG00000115085;BERN:325085602	HGNC:12858=>ZAP70;Ensembl:ENSG00000115085=>ZAP70;MIM:176947=>ZAP70	ZAP70	null	null	null	null	null	null	null	null
GSE117752	GSM3444231	{'tissue':'Invasive breast carcinoma ','antibody':'H3K27me3 (Millipore, 07-449, Lot. JBC1873477) ','organism':'Homo sapiens','source name':'FFPE tissue', 'title':'IBC_H3K27me3_Std_PAT-ChIP', 'last update date':'2018-11-20', 'release date': '2018-11-20', 'method': 'high-throughput sequencing'}	GSM3444231*#*#*#IBC_H3K27me3_Std_PAT-ChIP*#*#*#1*#*#*#FFPE tissue*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Reads were aligned to hg19 using 'bowtie’ (version 0.6.2-r126).Unmapped reads, reads with a MAPQ smaller than 1 and duplicate reads were removed using samtools (version 0.1.18).Mapped sequence reads were extended to 200 bp using deepTools (version 2.5.4).Peaks were called using MACS2 software from Galaxy browser (http://usegalaxy.com - bdgpeakcall function to call narrow peaks from H3K4me3 and H3K27ac tracks and MACS2 bdgbroadcall function for broad peaks from H3K27me3).Genome_build: hg19Supplementary_files_format_and_content: Bedgraph files containing tracks and bedgraph files containing called peaks *#*#*#ChIP-Seq*#*#*#H3K4me3 bedgraph files for BA processed with standard PAT-ChIP *#*#*#GPL11154*#*#*#2018-11-20*#*#*#2018-11-20*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Invasive breast carcinoma *#*#*#[char](antibody)H3K27me3 (Millipore, 07-449, Lot. JBC1873477) 	30446010	null	Homo sapiens	null	high-throughput sequencing	FFPE tissue	Invasive breast carcinoma	null	null	ChIP-Seq	null	genomic	genomic DNA	SRA	2018-11-20	2018-11-20	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3444nnn/GSM3444231/suppl/GSM3444231_IBC_H3K27me3_Std_PAT-ChIP.bedGraph.gz 	GPL11154	breast carcinoma	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	null	null	null	null	Std	MIM:176947;HGNC:12858;Ensembl:ENSG00000115085;BERN:325085602	HGNC:12858=>ZAP70;Ensembl:ENSG00000115085=>ZAP70;MIM:176947=>ZAP70	ZAP70	null	null	null	null	null	null	null	null
GSE117753	GSM3308272	{'source tissue':'primary from buchal mucosa ','organism':'Homo sapiens','source name':'HNSCC derived cell line - primary from buchal mucosa', 'title':'54_primary_1', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308272*#*#*#54_primary_1*#*#*#1*#*#*#HNSCC derived cell line - primary from buchal mucosa*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 1 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)primary from buchal mucosa 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line - primary from buchal mucosa	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308272/suppl/GSM3308272_6828271013_B_Grn.idat.gz 	GPL10558	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308273	{'source tissue':'metastatic ','organism':'Homo sapiens','source name':'HNSCC derived cell line -metastatic', 'title':'60_metastasis_1', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308273*#*#*#60_metastasis_1*#*#*#1*#*#*#HNSCC derived cell line -metastatic*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 2 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)metastatic 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line -metastatic	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308273/suppl/GSM3308273_6828271054_D_Grn.idat.gz 	GPL10558	HNSCC	MESH:C535575;OMIM:275355;BERN:262498001	OMIM:275355=>SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC;MESH:C535575=>No items found	No items found|SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308274	{'source tissue':'metastatic ','organism':'Homo sapiens','source name':'HNSCC derived cell line -metastatic', 'title':'54_metastasis_4', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308274*#*#*#54_metastasis_4*#*#*#1*#*#*#HNSCC derived cell line -metastatic*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 3 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)metastatic 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line -metastatic	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308274/suppl/GSM3308274_6828271054_E_Grn.idat.gz 	GPL10558	HNSCC	MESH:C535575;OMIM:275355;BERN:262498001	OMIM:275355=>SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC;MESH:C535575=>No items found	No items found|SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308275	{'source tissue':'metastatic ','organism':'Homo sapiens','source name':'HNSCC derived cell line -metastatic', 'title':'54_metastasis_2', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308275*#*#*#54_metastasis_2*#*#*#1*#*#*#HNSCC derived cell line -metastatic*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 4 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)metastatic 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line -metastatic	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308275/suppl/GSM3308275_6828271054_F_Grn.idat.gz 	GPL10558	HNSCC	MESH:C535575;OMIM:275355;BERN:262498001	OMIM:275355=>SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC;MESH:C535575=>No items found	No items found|SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308276	{'source tissue':'primary from buchal mucosa ','organism':'Homo sapiens','source name':'HNSCC derived cell line - primary from buchal mucosa', 'title':'54_primary_3', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308276*#*#*#54_primary_3*#*#*#1*#*#*#HNSCC derived cell line - primary from buchal mucosa*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 5 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)primary from buchal mucosa 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line - primary from buchal mucosa	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308276/suppl/GSM3308276_6828271054_I_Grn.idat.gz 	GPL10558	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308277	{'source tissue':'primary from left tonsil ','organism':'Homo sapiens','source name':'HNSCC derived cell line - primary from left tonsil', 'title':'60_primary_3', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308277*#*#*#60_primary_3*#*#*#1*#*#*#HNSCC derived cell line - primary from left tonsil*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 6 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)primary from left tonsil 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line - primary from left tonsil	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308277/suppl/GSM3308277_6828271054_K_Grn.idat.gz 	GPL10558	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308278	{'source tissue':'metastatic ','organism':'Homo sapiens','source name':'HNSCC derived cell line -metastatic', 'title':'54_metastasis_1', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308278*#*#*#54_metastasis_1*#*#*#1*#*#*#HNSCC derived cell line -metastatic*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 7 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)metastatic 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line -metastatic	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308278/suppl/GSM3308278_6828271054_L_Grn.idat.gz 	GPL10558	HNSCC	MESH:C535575;OMIM:275355;BERN:262498001	OMIM:275355=>SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC;MESH:C535575=>No items found	No items found|SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308279	{'source tissue':'metastatic ','organism':'Homo sapiens','source name':'HNSCC derived cell line -metastatic', 'title':'60_metastasis_2', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308279*#*#*#60_metastasis_2*#*#*#1*#*#*#HNSCC derived cell line -metastatic*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 8 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)metastatic 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line -metastatic	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308279/suppl/GSM3308279_6828271056_D_Grn.idat.gz 	GPL10558	HNSCC	MESH:C535575;OMIM:275355;BERN:262498001	OMIM:275355=>SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC;MESH:C535575=>No items found	No items found|SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308280	{'source tissue':'primary from left tonsil ','organism':'Homo sapiens','source name':'HNSCC derived cell line - primary from left tonsil', 'title':'60_primary_2', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308280*#*#*#60_primary_2*#*#*#1*#*#*#HNSCC derived cell line - primary from left tonsil*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 9 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)primary from left tonsil 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line - primary from left tonsil	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308280/suppl/GSM3308280_6828271056_E_Grn.idat.gz 	GPL10558	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308281	{'source tissue':'primary from buchal mucosa ','organism':'Homo sapiens','source name':'HNSCC derived cell line - primary from buchal mucosa', 'title':'54_primary_2', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308281*#*#*#54_primary_2*#*#*#1*#*#*#HNSCC derived cell line - primary from buchal mucosa*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 10 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)primary from buchal mucosa 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line - primary from buchal mucosa	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308281/suppl/GSM3308281_6828271056_G_Grn.idat.gz 	GPL10558	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308282	{'source tissue':'primary from left tonsil ','organism':'Homo sapiens','source name':'HNSCC derived cell line - primary from left tonsil', 'title':'60_primary_1', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308282*#*#*#60_primary_1*#*#*#1*#*#*#HNSCC derived cell line - primary from left tonsil*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 11 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)primary from left tonsil 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line - primary from left tonsil	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308282/suppl/GSM3308282_6828271056_J_Grn.idat.gz 	GPL10558	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308283	{'source tissue':'metastatic ','organism':'Homo sapiens','source name':'HNSCC derived cell line -metastatic', 'title':'60_metastasis_3', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308283*#*#*#60_metastasis_3*#*#*#1*#*#*#HNSCC derived cell line -metastatic*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 12 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)metastatic 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line -metastatic	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308283/suppl/GSM3308283_6828271056_K_Grn.idat.gz 	GPL10558	HNSCC	MESH:C535575;OMIM:275355;BERN:262498001	OMIM:275355=>SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC;MESH:C535575=>No items found	No items found|SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308284	{'source tissue':'metastatic ','organism':'Homo sapiens','source name':'HNSCC derived cell line -metastatic', 'title':'74_metastasis_2', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308284*#*#*#74_metastasis_2*#*#*#1*#*#*#HNSCC derived cell line -metastatic*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 13 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)metastatic 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line -metastatic	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308284/suppl/GSM3308284_7649540010_C_Grn.idat.gz 	GPL10558	HNSCC	MESH:C535575;OMIM:275355;BERN:262498001	OMIM:275355=>SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC;MESH:C535575=>No items found	No items found|SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308285	{'source tissue':'primary from tongue ','organism':'Homo sapiens','source name':'HNSCC derived cell line - primary from tongue', 'title':'74_primary_2', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308285*#*#*#74_primary_2*#*#*#1*#*#*#HNSCC derived cell line - primary from tongue*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 14 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)primary from tongue 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line - primary from tongue	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308285/suppl/GSM3308285_7649540017_D_Grn.idat.gz 	GPL10558	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308286	{'source tissue':'metastatic ','organism':'Homo sapiens','source name':'HNSCC derived cell line -metastatic', 'title':'74_metastasis_3', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308286*#*#*#74_metastasis_3*#*#*#1*#*#*#HNSCC derived cell line -metastatic*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 15 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)metastatic 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line -metastatic	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308286/suppl/GSM3308286_7649540017_F_Grn.idat.gz 	GPL10558	HNSCC	MESH:C535575;OMIM:275355;BERN:262498001	OMIM:275355=>SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC;MESH:C535575=>No items found	No items found|SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308287	{'source tissue':'metastatic ','organism':'Homo sapiens','source name':'HNSCC derived cell line -metastatic', 'title':'74_metastasis_1', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308287*#*#*#74_metastasis_1*#*#*#1*#*#*#HNSCC derived cell line -metastatic*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 16 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)metastatic 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line -metastatic	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308287/suppl/GSM3308287_7649540017_L_Grn.idat.gz 	GPL10558	HNSCC	MESH:C535575;OMIM:275355;BERN:262498001	OMIM:275355=>SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC;MESH:C535575=>No items found	No items found|SQUAMOUS CELL CARCINOMA, HEAD AND NECK: HNSCC	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308288	{'source tissue':'primary from tongue ','organism':'Homo sapiens','source name':'HNSCC derived cell line - primary from tongue', 'title':'74_primary_1', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308288*#*#*#74_primary_1*#*#*#1*#*#*#HNSCC derived cell line - primary from tongue*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 17 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)primary from tongue 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line - primary from tongue	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308288/suppl/GSM3308288_7649540053_B_Grn.idat.gz 	GPL10558	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117753	GSM3308289	{'source tissue':'primary from tongue ','organism':'Homo sapiens','source name':'HNSCC derived cell line - primary from tongue', 'title':'74_primary_3', 'last update date':'2018-07-27', 'release date': '2018-07-27', 'method': 'oligonucleotide beads'}	GSM3308289*#*#*#74_primary_3*#*#*#1*#*#*#HNSCC derived cell line - primary from tongue*#*#*#Homo sapiens*#*#*#2M cells are plated in 100 mm dish in triplicates for 48 hours at which point the pellets are collected, washed with PBS and flash frozen at -80. *#*#*#total RNA*#*#*#Cy3*#*#*#Data was checked for overall quality using R (v2.15.1) with the lumi Bioconductor package. The data was imported into GeneSpring (Agilent), log2 transformed and normalized using a quantile normalization. *#*#*#null*#*#*#SAMPLE 18 *#*#*#GPL10558*#*#*#2018-07-27*#*#*#2018-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source tissue)primary from tongue 	null	null	Homo sapiens	null	oligonucleotide beads	HNSCC derived cell line - primary from tongue	null	null	null	null	null	null	total RNA	RNA	2018-07-27	2018-07-27	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308289/suppl/GSM3308289_7649540053_C_Grn.idat.gz 	GPL10558	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117765	GSM3308399	{'cell line':'PEO1 ','phenotype':'parental control ','organism':'Homo sapiens','source name':'parental PEO1 cells', 'title':'PEO1_Adherent_1', 'last update date':'2018-12-03', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308399*#*#*#PEO1_Adherent_1*#*#*#1*#*#*#parental PEO1 cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#[Hisat2 (version 2.1.0)] Used to map reads to human genome GRCh37[bedtools] Used to assemble transcripts[edgeR] Used to identify differenentially expressed genes[filtering] Genes with zero expression in all samples were excludedGenome_build: GRCH37/hg19Supplementary_files_format_and_content: tab-delimited text files include normalized expression values *#*#*#RNA-Seq*#*#*#P1Parental PEO1 cells *#*#*#GPL20301*#*#*#2018-12-03*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PEO1 *#*#*#[char](phenotype)parental control 	31219654	PEO1	Homo sapiens	null	high-throughput sequencing	parental PEO1 cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-12-03	2018-07-28	NONE 	GPL20301	null	null	null	null	null	null	null	null	PEO1	MIM:606075;HGNC:1160;Ensembl:ENSG00000107815;BERN:324484902	HGNC:1160=>TWNK;Ensembl:ENSG00000107815=>TWNK;MIM:606075=>TWNK	TWNK	null	null	null	null	PEO1	PEO1	null	null
GSE117765	GSM3308400	{'cell line':'PEO1 ','phenotype':'parental control ','organism':'Homo sapiens','source name':'parental PEO1 cells', 'title':'PEO1_Adherent_2', 'last update date':'2018-12-03', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308400*#*#*#PEO1_Adherent_2*#*#*#1*#*#*#parental PEO1 cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#[Hisat2 (version 2.1.0)] Used to map reads to human genome GRCh37[bedtools] Used to assemble transcripts[edgeR] Used to identify differenentially expressed genes[filtering] Genes with zero expression in all samples were excludedGenome_build: GRCH37/hg19Supplementary_files_format_and_content: tab-delimited text files include normalized expression values *#*#*#RNA-Seq*#*#*#P2Parental PEO1 cells *#*#*#GPL20301*#*#*#2018-12-03*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PEO1 *#*#*#[char](phenotype)parental control 	31219654	PEO1	Homo sapiens	null	high-throughput sequencing	parental PEO1 cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-12-03	2018-07-28	NONE 	GPL20301	null	null	null	null	null	null	null	null	PEO1	MIM:606075;HGNC:1160;Ensembl:ENSG00000107815;BERN:324484902	HGNC:1160=>TWNK;Ensembl:ENSG00000107815=>TWNK;MIM:606075=>TWNK	TWNK	null	null	null	null	PEO1	PEO1	null	null
GSE117765	GSM3308401	{'cell line':'PEO1 ','phenotype':'Olaparib-resistant ','organism':'Homo sapiens','source name':'PEO1 olaparib-resistant C4 cells', 'title':'PEO1_Clone4', 'last update date':'2019-08-15', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308401*#*#*#PEO1_Clone4*#*#*#1*#*#*#PEO1 olaparib-resistant C4 cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#[Hisat2 (version 2.1.0)] Used to map reads to human genome GRCh37[bedtools] Used to assemble transcripts[edgeR] Used to identify differenentially expressed genes[filtering] Genes with zero expression in all samples were excludedGenome_build: GRCH37/hg19Supplementary_files_format_and_content: tab-delimited text files include normalized expression values *#*#*#RNA-Seq*#*#*#C4Olaparib resistant cells cultured in 2uM olaparib *#*#*#GPL20301*#*#*#2019-08-15*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PEO1 *#*#*#[char](phenotype)Olaparib-resistant 	31219654	PEO1	Homo sapiens	null	high-throughput sequencing	PEO1 olaparib-resistant C4 cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-08-15	2018-07-28	NONE 	GPL20301	null	null	null	null	null	null	null	null	PEO1	MIM:606075;HGNC:1160;Ensembl:ENSG00000107815;BERN:324484902	HGNC:1160=>TWNK;Ensembl:ENSG00000107815=>TWNK;MIM:606075=>TWNK	TWNK	null	null	null	null	PEO1	PEO1	null	null
GSE117765	GSM3308402	{'cell line':'PEO1 ','phenotype':'Olaparib-resistant ','organism':'Homo sapiens','source name':'PEO1 olaparib-resistant C5 cells', 'title':'PEO1_Clone5', 'last update date':'2019-08-15', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308402*#*#*#PEO1_Clone5*#*#*#1*#*#*#PEO1 olaparib-resistant C5 cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#[Hisat2 (version 2.1.0)] Used to map reads to human genome GRCh37[bedtools] Used to assemble transcripts[edgeR] Used to identify differenentially expressed genes[filtering] Genes with zero expression in all samples were excludedGenome_build: GRCH37/hg19Supplementary_files_format_and_content: tab-delimited text files include normalized expression values *#*#*#RNA-Seq*#*#*#C5Olaparib resistant cells cultured in 2uM olaparib *#*#*#GPL20301*#*#*#2019-08-15*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PEO1 *#*#*#[char](phenotype)Olaparib-resistant 	31219654	PEO1	Homo sapiens	null	high-throughput sequencing	PEO1 olaparib-resistant C5 cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-08-15	2018-07-28	NONE 	GPL20301	null	null	null	null	null	null	null	null	PEO1	MIM:606075;HGNC:1160;Ensembl:ENSG00000107815;BERN:324484902	HGNC:1160=>TWNK;Ensembl:ENSG00000107815=>TWNK;MIM:606075=>TWNK	TWNK	null	null	null	null	PEO1	PEO1	null	null
GSE117765	GSM3308403	{'cell line':'PEO1 ','phenotype':'Olaparib-resistant ','organism':'Homo sapiens','source name':'PEO1 olaparib-resistant C10 cells', 'title':'PEO1_Clone10', 'last update date':'2019-08-15', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308403*#*#*#PEO1_Clone10*#*#*#1*#*#*#PEO1 olaparib-resistant C10 cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#[Hisat2 (version 2.1.0)] Used to map reads to human genome GRCh37[bedtools] Used to assemble transcripts[edgeR] Used to identify differenentially expressed genes[filtering] Genes with zero expression in all samples were excludedGenome_build: GRCH37/hg19Supplementary_files_format_and_content: tab-delimited text files include normalized expression values *#*#*#RNA-Seq*#*#*#C10Olaparib resistant cells cultured in 2uM olaparib *#*#*#GPL20301*#*#*#2019-08-15*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PEO1 *#*#*#[char](phenotype)Olaparib-resistant 	31219654	PEO1	Homo sapiens	null	high-throughput sequencing	PEO1 olaparib-resistant C10 cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-08-15	2018-07-28	NONE 	GPL20301	null	null	null	null	null	null	null	null	PEO1	MIM:606075;HGNC:1160;Ensembl:ENSG00000107815;BERN:324484902	HGNC:1160=>TWNK;Ensembl:ENSG00000107815=>TWNK;MIM:606075=>TWNK	TWNK	null	null	null	null	C10|PEO1	C10|PEO1	null	null
GSE117765	GSM3308404	{'cell line':'PEO1 ','phenotype':'Olaparib-resistant ','organism':'Homo sapiens','source name':'PEO1 olaparib-resistant C18 cells', 'title':'PEO1_Clone18', 'last update date':'2019-08-15', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308404*#*#*#PEO1_Clone18*#*#*#1*#*#*#PEO1 olaparib-resistant C18 cells*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#[Hisat2 (version 2.1.0)] Used to map reads to human genome GRCh37[bedtools] Used to assemble transcripts[edgeR] Used to identify differenentially expressed genes[filtering] Genes with zero expression in all samples were excludedGenome_build: GRCH37/hg19Supplementary_files_format_and_content: tab-delimited text files include normalized expression values *#*#*#RNA-Seq*#*#*#C18Olaparib resistant cells cultured in 2uM olaparib *#*#*#GPL20301*#*#*#2019-08-15*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)PEO1 *#*#*#[char](phenotype)Olaparib-resistant 	31219654	PEO1	Homo sapiens	null	high-throughput sequencing	PEO1 olaparib-resistant C18 cells	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-08-15	2018-07-28	NONE 	GPL20301	null	null	null	null	null	null	null	null	PEO1	MIM:606075;HGNC:1160;Ensembl:ENSG00000107815;BERN:324484902	HGNC:1160=>TWNK;Ensembl:ENSG00000107815=>TWNK;MIM:606075=>TWNK	TWNK	null	null	null	null	PEO1	PEO1	null	null
GSE117769	GSM3308425	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C137 ','gender':'M ','age':'66 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C137_C6K5PANXX_ACTGAT_L004: Donor C137 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308425*#*#*#C137_C6K5PANXX_ACTGAT_L004: Donor C137 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C137 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C137 *#*#*#[char](gender)M *#*#*#[char](age)66 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308425/suppl/GSM3308425_C137_C6K5PANXX_ACTGAT_L004.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308426	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C141 ','gender':'M ','age':'72 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C141_C6K5PANXX_CGTACG_L007: Donor C141 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308426*#*#*#C141_C6K5PANXX_CGTACG_L007: Donor C141 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C141 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C141 *#*#*#[char](gender)M *#*#*#[char](age)72 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308426/suppl/GSM3308426_C141_C6K5PANXX_CGTACG_L007.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308427	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C148 ','gender':'F ','age':'72 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C148_C6K5PANXX_AGTCAA_L007: Donor C148 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308427*#*#*#C148_C6K5PANXX_AGTCAA_L007: Donor C148 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C148 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C148 *#*#*#[char](gender)F *#*#*#[char](age)72 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308427/suppl/GSM3308427_C148_C6K5PANXX_AGTCAA_L007.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308428	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C383 ','gender':'M ','age':'61 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C383_C6K5PANXX_ACAGTG_L001: Donor C383 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308428*#*#*#C383_C6K5PANXX_ACAGTG_L001: Donor C383 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C383 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C383 *#*#*#[char](gender)M *#*#*#[char](age)61 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308428/suppl/GSM3308428_C383_C6K5PANXX_ACAGTG_L001.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308429	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C391 ','gender':'F ','age':'50 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C391_C6K5PANXX_GGCTAC_L003: Donor C391 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308429*#*#*#C391_C6K5PANXX_GGCTAC_L003: Donor C391 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C391 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C391 *#*#*#[char](gender)F *#*#*#[char](age)50 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308429/suppl/GSM3308429_C391_C6K5PANXX_GGCTAC_L003.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308430	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C392 ','gender':'F ','age':'59 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C392_C6K5PANXX_TGACCA_L008: Donor C392 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308430*#*#*#C392_C6K5PANXX_TGACCA_L008: Donor C392 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C392 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C392 *#*#*#[char](gender)F *#*#*#[char](age)59 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308430/suppl/GSM3308430_C392_C6K5PANXX_TGACCA_L008.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308431	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C396 ','gender':'F ','age':'62 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C396_C6K5PANXX_ACTTGA_L004: Donor C396 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308431*#*#*#C396_C6K5PANXX_ACTTGA_L004: Donor C396 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C396 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C396 *#*#*#[char](gender)F *#*#*#[char](age)62 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308431/suppl/GSM3308431_C396_C6K5PANXX_ACTTGA_L004.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308432	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C39 ','gender':'F ','age':'71 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C39_C6K5PANXX_GTCCGC_L006: Donor C39 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308432*#*#*#C39_C6K5PANXX_GTCCGC_L006: Donor C39 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C39 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C39 *#*#*#[char](gender)F *#*#*#[char](age)71 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308432/suppl/GSM3308432_C39_C6K5PANXX_GTCCGC_L006.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308433	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C43 ','gender':'F ','age':'68 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C43_C6K5PANXX_GGCTAC_L007: Donor C43 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308433*#*#*#C43_C6K5PANXX_GGCTAC_L007: Donor C43 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C43 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C43 *#*#*#[char](gender)F *#*#*#[char](age)68 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308433/suppl/GSM3308433_C43_C6K5PANXX_GGCTAC_L007.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308434	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C450 ','gender':'M ','age':'65 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C450_C6K5PANXX_GTTTCG_L003: Donor C450 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308434*#*#*#C450_C6K5PANXX_GTTTCG_L003: Donor C450 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C450 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C450 *#*#*#[char](gender)M *#*#*#[char](age)65 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308434/suppl/GSM3308434_C450_C6K5PANXX_GTTTCG_L003.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308435	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C451 ','gender':'F ','age':'65 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C451_C6K5PANXX_GCCAAT_L008: Donor C451 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308435*#*#*#C451_C6K5PANXX_GCCAAT_L008: Donor C451 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C451 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C451 *#*#*#[char](gender)F *#*#*#[char](age)65 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308435/suppl/GSM3308435_C451_C6K5PANXX_GCCAAT_L008.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308436	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C454 ','gender':'M ','age':'63 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C454_C6K5PANXX_GTTTCG_L002: Donor C454 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308436*#*#*#C454_C6K5PANXX_GTTTCG_L002: Donor C454 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C454 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C454 *#*#*#[char](gender)M *#*#*#[char](age)63 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308436/suppl/GSM3308436_C454_C6K5PANXX_GTTTCG_L002.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308437	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C455 ','gender':'M ','age':'73 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C455_C6K5PANXX_ATGTCA_L007: Donor C455 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308437*#*#*#C455_C6K5PANXX_ATGTCA_L007: Donor C455 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C455 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C455 *#*#*#[char](gender)M *#*#*#[char](age)73 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308437/suppl/GSM3308437_C455_C6K5PANXX_ATGTCA_L007.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308438	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C468 ','gender':'M ','age':'76 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C468_C6K5PANXX_ACAGTG_L008: Donor C468 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308438*#*#*#C468_C6K5PANXX_ACAGTG_L008: Donor C468 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C468 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C468 *#*#*#[char](gender)M *#*#*#[char](age)76 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308438/suppl/GSM3308438_C468_C6K5PANXX_ACAGTG_L008.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308439	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C470 ','gender':'F ','age':'56 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C470_C6K5PANXX_GATCAG_L007: Donor C470 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308439*#*#*#C470_C6K5PANXX_GATCAG_L007: Donor C470 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C470 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C470 *#*#*#[char](gender)F *#*#*#[char](age)56 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308439/suppl/GSM3308439_C470_C6K5PANXX_GATCAG_L007.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308440	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C473 ','gender':'F ','age':'55 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C473_C6K5PANXX_CGTACG_L003: Donor C473 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308440*#*#*#C473_C6K5PANXX_CGTACG_L003: Donor C473 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C473 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C473 *#*#*#[char](gender)F *#*#*#[char](age)55 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308440/suppl/GSM3308440_C473_C6K5PANXX_CGTACG_L003.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308441	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C473 ','gender':'F ','age':'55 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C473_C6K5PANXX_TGACCA_L006: Donor C473 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308441*#*#*#C473_C6K5PANXX_TGACCA_L006: Donor C473 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C473 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C473 *#*#*#[char](gender)F *#*#*#[char](age)55 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308441/suppl/GSM3308441_C473_C6K5PANXX_TGACCA_L006.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308442	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C478 ','gender':'M ','age':'55 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C478_C6K5PANXX_GGCTAC_L006: Donor C478 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308442*#*#*#C478_C6K5PANXX_GGCTAC_L006: Donor C478 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C478 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C478 *#*#*#[char](gender)M *#*#*#[char](age)55 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308442/suppl/GSM3308442_C478_C6K5PANXX_GGCTAC_L006.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308443	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C480 ','gender':'F ','age':'69 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C480_C6K5PANXX_ATTCCT_L004: Donor C480 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308443*#*#*#C480_C6K5PANXX_ATTCCT_L004: Donor C480 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C480 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C480 *#*#*#[char](gender)F *#*#*#[char](age)69 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308443/suppl/GSM3308443_C480_C6K5PANXX_ATTCCT_L004.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308444	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C56 ','gender':'F ','age':'58 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C56_C6K5PANXX_GTCCGC_L003: Donor C56 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308444*#*#*#C56_C6K5PANXX_GTCCGC_L003: Donor C56 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C56 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C56 *#*#*#[char](gender)F *#*#*#[char](age)58 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308444/suppl/GSM3308444_C56_C6K5PANXX_GTCCGC_L003.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308445	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C72 ','gender':'F ','age':'68 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C72_C6K5PANXX_ATGTCA_L006: Donor C72 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308445*#*#*#C72_C6K5PANXX_ATGTCA_L006: Donor C72 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C72 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C72 *#*#*#[char](gender)F *#*#*#[char](age)68 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308445/suppl/GSM3308445_C72_C6K5PANXX_ATGTCA_L006.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308446	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C82 ','gender':'M ','age':'57 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C82_C6K5PANXX_CAGATC_L001: Donor C82 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308446*#*#*#C82_C6K5PANXX_CAGATC_L001: Donor C82 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C82 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C82 *#*#*#[char](gender)M *#*#*#[char](age)57 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308446/suppl/GSM3308446_C82_C6K5PANXX_CAGATC_L001.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308447	{'tissue':'Blood ','cell type':'White blood cells ','donor':'C84 ','gender':'F ','age':'47 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'C84_C6K5PANXX_CGTACG_L002: Donor C84 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308447*#*#*#C84_C6K5PANXX_CGTACG_L002: Donor C84 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor C84 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)C84 *#*#*#[char](gender)F *#*#*#[char](age)47 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308447/suppl/GSM3308447_C84_C6K5PANXX_CGTACG_L002.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	C84	C84	null	null
GSE117769	GSM3308448	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN258 ','gender':'M ','age':'33 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.3 ','disease activity':'Moderate ','arthropathymeds':'Methotrexate 25mg/wk ','nsaids':'-- ','steroids':'Prednisolone 15mg/day ','biologics':'Tocilizumab ','plaquenil':'Plaquenil 400mg/day ','leflumide':'Leflumide 20mg/day ','sulfasalazine':'Sulfasalazine 20mg/day ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN258_C6K5PANXX_CTTGTA_L006: Donor SN258 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308448*#*#*#SN258_C6K5PANXX_CTTGTA_L006: Donor SN258 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN258 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN258 *#*#*#[char](gender)M *#*#*#[char](age)33 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.3 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)Methotrexate 25mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 15mg/day *#*#*#[char](biologics)Tocilizumab *#*#*#[char](plaquenil)Plaquenil 400mg/day *#*#*#[char](leflumide)Leflumide 20mg/day *#*#*#[char](sulfasalazine)Sulfasalazine 20mg/day *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308448/suppl/GSM3308448_SN258_C6K5PANXX_CTTGTA_L006.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308449	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN293 ','gender':'F ','age':'53 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.45 ','disease activity':'Moderate ','arthropathymeds':'-- ','nsaids':'Meloxicam ','steroids':'Prednisolone ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN293_C6K5PANXX_ACAGTG_L006: Donor SN293 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308449*#*#*#SN293_C6K5PANXX_ACAGTG_L006: Donor SN293 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN293 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN293 *#*#*#[char](gender)F *#*#*#[char](age)53 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.45 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)Meloxicam *#*#*#[char](steroids)Prednisolone *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308449/suppl/GSM3308449_SN293_C6K5PANXX_ACAGTG_L006.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308450	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN392 ','gender':'F ','age':'63 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.29 ','disease activity':'remission ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'prosyn ','steroids':'Prednisolone 3mg/day ','biologics':'Adalimumab ','plaquenil':'Plaquenil 400mg/day ','leflumide':'-- ','sulfasalazine':'Sulfasalazine 20mg/day ','rituximab':'-- ','othermeds':'Ca Vit D irbesartan ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN392_C6K5PANXX_ACAGTG_L002: Donor SN392 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308450*#*#*#SN392_C6K5PANXX_ACAGTG_L002: Donor SN392 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN392 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN392 *#*#*#[char](gender)F *#*#*#[char](age)63 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.29 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)prosyn *#*#*#[char](steroids)Prednisolone 3mg/day *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)Plaquenil 400mg/day *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)Sulfasalazine 20mg/day *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Ca Vit D irbesartan 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308450/suppl/GSM3308450_SN392_C6K5PANXX_ACAGTG_L002.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	SN392|Methotrexate|Prednisolone|Sulfasalazine|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:C483494;BERN:315491303|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:C483494=>10-amino-7-ethylcamptothecin|CHEBI:64755=>EDTA(2-);MESH:C483494=>10-amino-7-ethylcamptothecin	10-amino-7-ethylcamptothecin|EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308451	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN393 ','gender':'F ','age':'67 ','ancestry':'-- ','phenotype':'Rheumatoid arthritis ','das score':'2.5 ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN393_C6K5PANXX_GAGTGG_L008: Donor SN393 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308451*#*#*#SN393_C6K5PANXX_GAGTGG_L008: Donor SN393 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN393 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN393 *#*#*#[char](gender)F *#*#*#[char](age)67 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.5 *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308451/suppl/GSM3308451_SN393_C6K5PANXX_GAGTGG_L008.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308452	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN399 ','gender':'F ','age':'52 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.45 ','disease activity':'remission ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'Prednisolone 7.5mg/day ','biologics':'Etanercept ','plaquenil':'Plaquenil 400mg/day ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN399_C6K5PANXX_ACTTGA_L003: Donor SN399 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308452*#*#*#SN399_C6K5PANXX_ACTTGA_L003: Donor SN399 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN399 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN399 *#*#*#[char](gender)F *#*#*#[char](age)52 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.45 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 7.5mg/day *#*#*#[char](biologics)Etanercept *#*#*#[char](plaquenil)Plaquenil 400mg/day *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308452/suppl/GSM3308452_SN399_C6K5PANXX_ACTTGA_L003.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308453	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN401 ','gender':'F ','age':'31 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.16 ','disease activity':'remission ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Adalimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN401_C6K5PANXX_CCGTCC_L006: Donor SN401 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308453*#*#*#SN401_C6K5PANXX_CCGTCC_L006: Donor SN401 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN401 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN401 *#*#*#[char](gender)F *#*#*#[char](age)31 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.16 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308453/suppl/GSM3308453_SN401_C6K5PANXX_CCGTCC_L006.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308454	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN419 ','gender':'M ','age':'66 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.96 ','disease activity':'Moderate ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'-- ','biologics':'Adalimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN419_C6K5PANXX_GTGAAA_L005: Donor SN419 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308454*#*#*#SN419_C6K5PANXX_GTGAAA_L005: Donor SN419 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN419 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN419 *#*#*#[char](gender)M *#*#*#[char](age)66 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.96 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308454/suppl/GSM3308454_SN419_C6K5PANXX_GTGAAA_L005.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308455	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN420 ','gender':'F ','age':'73 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'7.42 ','disease activity':'High ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'Plaquenil 400mg/day ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Propranolol ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN420_C6K5PANXX_AGTCAA_L005: Donor SN420 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308455*#*#*#SN420_C6K5PANXX_AGTCAA_L005: Donor SN420 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN420 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN420 *#*#*#[char](gender)F *#*#*#[char](age)73 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)7.42 *#*#*#[char](disease activity)High *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)Plaquenil 400mg/day *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Propranolol 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308455/suppl/GSM3308455_SN420_C6K5PANXX_AGTCAA_L005.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Propranolol|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D011433;BERN:4133203|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D011433=>Propranolol|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Propranolol|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308456	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN421 ','gender':'F ','age':'72 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'4.43 ','disease activity':'Moderate ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'Plaquenil 400mg/day ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN421_C6K5PANXX_AGTTCC_L003: Donor SN421 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308456*#*#*#SN421_C6K5PANXX_AGTTCC_L003: Donor SN421 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN421 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN421 *#*#*#[char](gender)F *#*#*#[char](age)72 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)4.43 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)Plaquenil 400mg/day *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308456/suppl/GSM3308456_SN421_C6K5PANXX_AGTTCC_L003.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308457	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN422 ','gender':'F ','age':'71 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'6.23 ','disease activity':'High ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'Prednisolone 15mg/day for 1 week ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN422_C6K5PANXX_GAGTGG_L002: Donor SN422 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308457*#*#*#SN422_C6K5PANXX_GAGTGG_L002: Donor SN422 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN422 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN422 *#*#*#[char](gender)F *#*#*#[char](age)71 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)6.23 *#*#*#[char](disease activity)High *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 15mg/day for 1 week *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308457/suppl/GSM3308457_SN422_C6K5PANXX_GAGTGG_L002.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308458	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN423 ','gender':'F ','age':'67 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.68 ','disease activity':'remission ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'-- ','biologics':'Etanercept ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN423_C6K5PANXX_CCGTCC_L005: Donor SN423 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308458*#*#*#SN423_C6K5PANXX_CCGTCC_L005: Donor SN423 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN423 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN423 *#*#*#[char](gender)F *#*#*#[char](age)67 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.68 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Etanercept *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308458/suppl/GSM3308458_SN423_C6K5PANXX_CCGTCC_L005.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308459	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN424 ','gender':'F ','age':'30 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.21 ','disease activity':'Moderate ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'Prednisolone ','biologics':'Adalimumab ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'Sulfasalazine ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN424_C6K5PANXX_GTGAAA_L003: Donor SN424 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308459*#*#*#SN424_C6K5PANXX_GTGAAA_L003: Donor SN424 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN424 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN424 *#*#*#[char](gender)F *#*#*#[char](age)30 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.21 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)Sulfasalazine *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308459/suppl/GSM3308459_SN424_C6K5PANXX_GTGAAA_L003.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|Sulfasalazine|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308460	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN425 ','gender':'M ','age':'70 ','ancestry':'-- ','phenotype':'Rheumatoid arthritis ','das score':'1.8 ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN425_C6K5PANXX_CGATGT_L004: Donor SN425 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308460*#*#*#SN425_C6K5PANXX_CGATGT_L004: Donor SN425 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN425 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN425 *#*#*#[char](gender)M *#*#*#[char](age)70 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.8 *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308460/suppl/GSM3308460_SN425_C6K5PANXX_CGATGT_L004.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308461	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN426 ','gender':'F ','age':'49 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.57 ','disease activity':'Moderate ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN426_C6K5PANXX_GGCTAC_L001: Donor SN426 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308461*#*#*#SN426_C6K5PANXX_GGCTAC_L001: Donor SN426 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN426 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN426 *#*#*#[char](gender)F *#*#*#[char](age)49 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.57 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308461/suppl/GSM3308461_SN426_C6K5PANXX_GGCTAC_L001.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308462	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN431 ','gender':'M ','age':'29 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'4.47 ','disease activity':'Moderate ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN431_C6K5PANXX_GATCAG_L001: Donor SN431 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308462*#*#*#SN431_C6K5PANXX_GATCAG_L001: Donor SN431 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN431 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN431 *#*#*#[char](gender)M *#*#*#[char](age)29 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)4.47 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308462/suppl/GSM3308462_SN431_C6K5PANXX_GATCAG_L001.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308463	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN433 ','gender':'F ','age':'59 ','ancestry':'Chinese ','phenotype':'Rheumatoid arthritis ','das score':'6.48 ','disease activity':'High ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN433_C6K5PANXX_AGTCAA_L006: Donor SN433 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308463*#*#*#SN433_C6K5PANXX_AGTCAA_L006: Donor SN433 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN433 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN433 *#*#*#[char](gender)F *#*#*#[char](age)59 *#*#*#[char](ancestry)Chinese *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)6.48 *#*#*#[char](disease activity)High *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308463/suppl/GSM3308463_SN433_C6K5PANXX_AGTCAA_L006.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308464	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN435 ','gender':'F ','age':'27 ','ancestry':'Indian ','phenotype':'Rheumatoid arthritis ','das score':'4.3 ','disease activity':'Moderate ','arthropathymeds':'-- ','nsaids':'Celebrex ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN435_C6K5PANXX_AGTTCC_L006: Donor SN435 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308464*#*#*#SN435_C6K5PANXX_AGTTCC_L006: Donor SN435 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN435 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN435 *#*#*#[char](gender)F *#*#*#[char](age)27 *#*#*#[char](ancestry)Indian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)4.3 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)Celebrex *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308464/suppl/GSM3308464_SN435_C6K5PANXX_AGTTCC_L006.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308465	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN437 ','gender':'F ','age':'31 ','ancestry':'Pakistani ','phenotype':'Rheumatoid arthritis ','das score':'4.97 ','disease activity':'Moderate ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN437_C6K5PANXX_GTCCGC_L008: Donor SN437 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308465*#*#*#SN437_C6K5PANXX_GTCCGC_L008: Donor SN437 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN437 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN437 *#*#*#[char](gender)F *#*#*#[char](age)31 *#*#*#[char](ancestry)Pakistani *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)4.97 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308465/suppl/GSM3308465_SN437_C6K5PANXX_GTCCGC_L008.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308466	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN443 ','gender':'M ','age':'78 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.4 ','disease activity':'remission ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'Prednisolone 4mg/day ','biologics':'Etanercept ','plaquenil':'Plaquenil 200mg/day ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN443_C6K5PANXX_CTTGTA_L001: Donor SN443 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308466*#*#*#SN443_C6K5PANXX_CTTGTA_L001: Donor SN443 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN443 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN443 *#*#*#[char](gender)M *#*#*#[char](age)78 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.4 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 4mg/day *#*#*#[char](biologics)Etanercept *#*#*#[char](plaquenil)Plaquenil 200mg/day *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308466/suppl/GSM3308466_SN443_C6K5PANXX_CTTGTA_L001.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308467	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN444 ','gender':'F ','age':'71 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'5.79 ','disease activity':'High ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'Prednisolone ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN444_C6K5PANXX_GCCAAT_L001: Donor SN444 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308467*#*#*#SN444_C6K5PANXX_GCCAAT_L001: Donor SN444 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN444 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN444 *#*#*#[char](gender)F *#*#*#[char](age)71 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)5.79 *#*#*#[char](disease activity)High *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308467/suppl/GSM3308467_SN444_C6K5PANXX_GCCAAT_L001.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308468	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN445 ','gender':'F ','age':'45 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.97 ','disease activity':'Moderate ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'Prednisolone 5mg/day ','biologics':'Adalimumab ','plaquenil':'Plaquenil 200mg/day ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN445_C6K5PANXX_CGTACG_L008: Donor SN445 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308468*#*#*#SN445_C6K5PANXX_CGTACG_L008: Donor SN445 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN445 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN445 *#*#*#[char](gender)F *#*#*#[char](age)45 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.97 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 5mg/day *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)Plaquenil 200mg/day *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308468/suppl/GSM3308468_SN445_C6K5PANXX_CGTACG_L008.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308469	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN446 ','gender':'M ','age':'67 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.42 ','disease activity':'remission ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'Prednisolone 6mg/day ','biologics':'Etanercept ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN446_C6K5PANXX_CGATGT_L002: Donor SN446 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308469*#*#*#SN446_C6K5PANXX_CGATGT_L002: Donor SN446 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN446 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN446 *#*#*#[char](gender)M *#*#*#[char](age)67 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.42 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 6mg/day *#*#*#[char](biologics)Etanercept *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308469/suppl/GSM3308469_SN446_C6K5PANXX_CGATGT_L002.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308470	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN448 ','gender':'M ','age':'74 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'5.58 ','disease activity':'High ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'Prednisolone ','biologics':'-- ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Digoxin Warfarin ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN448_C6K5PANXX_CAGATC_L004: Donor SN448 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308470*#*#*#SN448_C6K5PANXX_CAGATC_L004: Donor SN448 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN448 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN448 *#*#*#[char](gender)M *#*#*#[char](age)74 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)5.58 *#*#*#[char](disease activity)High *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Digoxin Warfarin 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308470/suppl/GSM3308470_SN448_C6K5PANXX_CAGATC_L004.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Prednisolone|Warfarin|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids|Digoxin	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D004077;BERN:4703103|MESH:D014859;BERN:4109903|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D004077=>Digoxin|CHEBI:8378=>prednisolone;MESH:D014859=>Warfarin|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Steroids|Digoxin|Warfarin|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308471	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN451 ','gender':'M ','age':'71 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.09 ','disease activity':'remission ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'-- ','biologics':'Etanercept ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Telmisartan atenolol. Atorvastatin alendronic acid ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN451_C6K5PANXX_TTAGGC_L008: Donor SN451 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308471*#*#*#SN451_C6K5PANXX_TTAGGC_L008: Donor SN451 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN451 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN451 *#*#*#[char](gender)M *#*#*#[char](age)71 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.09 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Etanercept *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Telmisartan atenolol. Atorvastatin alendronic acid 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308471/suppl/GSM3308471_SN451_C6K5PANXX_TTAGGC_L008.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308472	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN454 ','gender':'F ','age':'59 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.66 ','disease activity':'Low ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN454_C6K5PANXX_TAGCTT_L006: Donor SN454 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308472*#*#*#SN454_C6K5PANXX_TAGCTT_L006: Donor SN454 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN454 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN454 *#*#*#[char](gender)F *#*#*#[char](age)59 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.66 *#*#*#[char](disease activity)Low *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308472/suppl/GSM3308472_SN454_C6K5PANXX_TAGCTT_L006.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308473	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN461 ','gender':'F ','age':'56 ','ancestry':'Chinese ','phenotype':'Rheumatoid arthritis ','das score':'2.5 ','disease activity':'remission ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN461_C6K5PANXX_GTGGCC_L002: Donor SN461 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308473*#*#*#SN461_C6K5PANXX_GTGGCC_L002: Donor SN461 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN461 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN461 *#*#*#[char](gender)F *#*#*#[char](age)56 *#*#*#[char](ancestry)Chinese *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.5 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308473/suppl/GSM3308473_SN461_C6K5PANXX_GTGGCC_L002.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308474	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN479 ','gender':'F ','age':'32 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.72 ','disease activity':'Moderate ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'Prednisolone 7.5mg/day ','biologics':'Infliximab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN479_C6K5PANXX_ACTGAT_L008: Donor SN479 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308474*#*#*#SN479_C6K5PANXX_ACTGAT_L008: Donor SN479 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN479 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN479 *#*#*#[char](gender)F *#*#*#[char](age)32 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.72 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 7.5mg/day *#*#*#[char](biologics)Infliximab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308474/suppl/GSM3308474_SN479_C6K5PANXX_ACTGAT_L008.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308475	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN481 ','gender':'F ','age':'33 ','ancestry':'Caucasian ','phenotype':'Ankylosing spondylitis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'Celebrex ','steroids':'Prednisolone ','biologics':'Golimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'Sulfasalazine ','rituximab':'-- ','othermeds':'Escitalopram ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN481_C6K5PANXX_ATTCCT_L005: Donor SN481 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308475*#*#*#SN481_C6K5PANXX_ATTCCT_L005: Donor SN481 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN481 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN481 *#*#*#[char](gender)F *#*#*#[char](age)33 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Ankylosing spondylitis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)Celebrex *#*#*#[char](steroids)Prednisolone *#*#*#[char](biologics)Golimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)Sulfasalazine *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Escitalopram 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308475/suppl/GSM3308475_SN481_C6K5PANXX_ATTCCT_L005.txt.gz 	GPL16791	Ankylosing spondylitis	OMIM:106300;MESH:D013167;BERN:107423401	OMIM:106300=>SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1;MESH:D013167=>Spondylitis, Ankylosing	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1|Spondylitis, Ankylosing	Prednisolone|Sulfasalazine|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308476	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN483 ','gender':'M ','age':'59 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.46 ','disease activity':'remission ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'-- ','biologics':'Etanercept ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'Sulfasalazine ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN483_C6K5PANXX_AGTCAA_L003: Donor SN483 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308476*#*#*#SN483_C6K5PANXX_AGTCAA_L003: Donor SN483 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN483 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN483 *#*#*#[char](gender)M *#*#*#[char](age)59 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.46 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Etanercept *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)Sulfasalazine *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308476/suppl/GSM3308476_SN483_C6K5PANXX_AGTCAA_L003.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Sulfasalazine|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308477	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN484 ','gender':'M ','age':'66 ','ancestry':'Caucasian ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Infliximab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN484_C6K5PANXX_ACAGTG_L004: Donor SN484 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308477*#*#*#SN484_C6K5PANXX_ACAGTG_L004: Donor SN484 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN484 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN484 *#*#*#[char](gender)M *#*#*#[char](age)66 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Infliximab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308477/suppl/GSM3308477_SN484_C6K5PANXX_ACAGTG_L004.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308478	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN486 ','gender':'M ','age':'64 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.45 ','disease activity':'Moderate ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'Prednisolone ','biologics':'Abatacept ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Maybe Metformin metoprolol perinopril lecanidipine ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN486_C6K5PANXX_CTTGTA_L004: Donor SN486 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308478*#*#*#SN486_C6K5PANXX_CTTGTA_L004: Donor SN486 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN486 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN486 *#*#*#[char](gender)M *#*#*#[char](age)64 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.45 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone *#*#*#[char](biologics)Abatacept *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Maybe Metformin metoprolol perinopril lecanidipine 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308478/suppl/GSM3308478_SN486_C6K5PANXX_CTTGTA_L004.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|Metformin|EDTA|ammonium chloride|metoprolol|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D008790;BERN:103602203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D008687;BERN:4118403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D008790=>Metoprolol|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D008687=>Metformin|CHEBI:64755=>EDTA(2-);MESH:D008687=>Metformin	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Metformin|Metoprolol|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308479	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN487 ','gender':'F ','age':'59 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'5.77 ','disease activity':'High ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'Prednisolone ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN487_C6K5PANXX_ACTGAT_L005: Donor SN487 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308479*#*#*#SN487_C6K5PANXX_ACTGAT_L005: Donor SN487 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN487 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN487 *#*#*#[char](gender)F *#*#*#[char](age)59 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)5.77 *#*#*#[char](disease activity)High *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308479/suppl/GSM3308479_SN487_C6K5PANXX_ACTGAT_L005.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308480	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN490 ','gender':'M ','age':'74 ','ancestry':'Caucasian ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'Prednisolone 5mg/day ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'aspirin atenolol amlodipine perindopril atorvastatin fosamax ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN490_C6K5PANXX_CGTACG_L005: Donor SN490 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308480*#*#*#SN490_C6K5PANXX_CGTACG_L005: Donor SN490 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN490 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN490 *#*#*#[char](gender)M *#*#*#[char](age)74 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 5mg/day *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)aspirin atenolol amlodipine perindopril atorvastatin fosamax 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308480/suppl/GSM3308480_SN490_C6K5PANXX_CGTACG_L005.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	Prednisolone|EDTA|perindopril|ammonium chloride|plaquenil|aspirin|sulfasalazine|steroids|atorvastatin	CHEBI:64755;BERN:293514603|MESH:D020913;BERN:4579203|MESH:D012460;BERN:4858703|MESH:D001241;BERN:4129703|CHEBI:39548;BERN:4281503|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D020913=>Perindopril|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D001241=>Aspirin|CHEBI:39548=>atorvastatin;MESH:D001241=>Aspirin|CHEBI:39548=>atorvastatin;MESH:D013256=>Steroids|CHEBI:39548=>atorvastatin;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Perindopril|Ammonium Chloride|prednisolone|Sulfasalazine|Aspirin|Steroids|Hydroxychloroquine|atorvastatin	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308481	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN498 ','gender':'F ','age':'63 ','ancestry':'Caucasian ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'-- ','biologics':'Infliximab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Calcium Vit D HRT ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN498_C6K5PANXX_ATCACG_L002: Donor SN498 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308481*#*#*#SN498_C6K5PANXX_ATCACG_L002: Donor SN498 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN498 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN498 *#*#*#[char](gender)F *#*#*#[char](age)63 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Infliximab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Calcium Vit D HRT 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308481/suppl/GSM3308481_SN498_C6K5PANXX_ATCACG_L002.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308482	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN506 ','gender':'F ','age':'64 ','ancestry':'Filipino ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'Leflumide ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Alendronic acid atorvastatin ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN506_C6K5PANXX_CCGTCC_L002: Donor SN506 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308482*#*#*#SN506_C6K5PANXX_CCGTCC_L002: Donor SN506 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN506 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN506 *#*#*#[char](gender)F *#*#*#[char](age)64 *#*#*#[char](ancestry)Filipino *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)Leflumide *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Alendronic acid atorvastatin 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308482/suppl/GSM3308482_SN506_C6K5PANXX_CCGTCC_L002.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308483	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN507 ','gender':'F ','age':'41 ','ancestry':'Caucasian ','phenotype':'Ankylosing spondylitis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Golimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Esomeprazole ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN507_C6K5PANXX_TTAGGC_L004: Donor SN507 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308483*#*#*#SN507_C6K5PANXX_TTAGGC_L004: Donor SN507 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN507 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN507 *#*#*#[char](gender)F *#*#*#[char](age)41 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Ankylosing spondylitis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Golimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Esomeprazole 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308483/suppl/GSM3308483_SN507_C6K5PANXX_TTAGGC_L004.txt.gz 	GPL16791	Ankylosing spondylitis	OMIM:106300;MESH:D013167;BERN:107423401	OMIM:106300=>SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1;MESH:D013167=>Spondylitis, Ankylosing	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1|Spondylitis, Ankylosing	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308484	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN509 ','gender':'F ','age':'33 ','ancestry':'Caucasian ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'Methotrexate ','nsaids':'prosyn ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Gabapentin ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN509_C6K5PANXX_ATCACG_L004: Donor SN509 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308484*#*#*#SN509_C6K5PANXX_ATCACG_L004: Donor SN509 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN509 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN509 *#*#*#[char](gender)F *#*#*#[char](age)33 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)prosyn *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Gabapentin 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308484/suppl/GSM3308484_SN509_C6K5PANXX_ATCACG_L004.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	Methotrexate|EDTA|ammonium chloride|Gabapentin|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:42797;BERN:4213903|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:42797=>gabapentin;MESH:D000643=>Ammonium Chloride|CHEBI:42797=>gabapentin;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|gabapentin|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308485	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN511 ','gender':'F ','age':'28 ','ancestry':'Caucasian ','phenotype':'Ankylosing spondylitis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'-- ','biologics':'Etanercept ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'OCP ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN511_C6K5PANXX_TAGCTT_L003: Donor SN511 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308485*#*#*#SN511_C6K5PANXX_TAGCTT_L003: Donor SN511 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN511 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN511 *#*#*#[char](gender)F *#*#*#[char](age)28 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Ankylosing spondylitis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Etanercept *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)OCP 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308485/suppl/GSM3308485_SN511_C6K5PANXX_TAGCTT_L003.txt.gz 	GPL16791	Ankylosing spondylitis	OMIM:106300;MESH:D013167;BERN:107423401	OMIM:106300=>SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1;MESH:D013167=>Spondylitis, Ankylosing	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1|Spondylitis, Ankylosing	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308486	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN512 ','gender':'F ','age':'47 ','ancestry':'Caucasian ','phenotype':'Ankylosing spondylitis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Etanercept ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Padol fexofedine ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN512_C6K5PANXX_TTAGGC_L005: Donor SN512 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308486*#*#*#SN512_C6K5PANXX_TTAGGC_L005: Donor SN512 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN512 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN512 *#*#*#[char](gender)F *#*#*#[char](age)47 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Ankylosing spondylitis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Etanercept *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Padol fexofedine 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308486/suppl/GSM3308486_SN512_C6K5PANXX_TTAGGC_L005.txt.gz 	GPL16791	Ankylosing spondylitis	OMIM:106300;MESH:D013167;BERN:107423401	OMIM:106300=>SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1;MESH:D013167=>Spondylitis, Ankylosing	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1|Spondylitis, Ankylosing	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308487	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN514 ','gender':'M ','age':'61 ','ancestry':'Caucasian ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'Methotrexate 15mg/wk ','nsaids':'-- ','steroids':'-- ','biologics':'Adalimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Targin paracetamol ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN514_C6K5PANXX_GATCAG_L006: Donor SN514 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308487*#*#*#SN514_C6K5PANXX_GATCAG_L006: Donor SN514 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN514 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN514 *#*#*#[char](gender)M *#*#*#[char](age)61 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)Methotrexate 15mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Targin paracetamol 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308487/suppl/GSM3308487_SN514_C6K5PANXX_GATCAG_L006.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308488	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN517 ','gender':'M ','age':'45 ','ancestry':'Caucasian ','phenotype':'Ankylosing spondylitis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'MethotrexateMaybe ','nsaids':'-- ','steroids':'-- ','biologics':'Infliximab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN517_C6K5PANXX_AGTTCC_L001: Donor SN517 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308488*#*#*#SN517_C6K5PANXX_AGTTCC_L001: Donor SN517 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN517 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN517 *#*#*#[char](gender)M *#*#*#[char](age)45 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Ankylosing spondylitis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)MethotrexateMaybe *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Infliximab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308488/suppl/GSM3308488_SN517_C6K5PANXX_AGTTCC_L001.txt.gz 	GPL16791	Ankylosing spondylitis	OMIM:106300;MESH:D013167;BERN:107423401	OMIM:106300=>SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1;MESH:D013167=>Spondylitis, Ankylosing	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1|Spondylitis, Ankylosing	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>null|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|null|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308489	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN518 ','gender':'M ','age':'35 ','ancestry':'Caucasian ','phenotype':'Ankylosing spondylitis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Infliximab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN518_C6K5PANXX_ATCACG_L001: Donor SN518 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308489*#*#*#SN518_C6K5PANXX_ATCACG_L001: Donor SN518 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN518 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN518 *#*#*#[char](gender)M *#*#*#[char](age)35 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Ankylosing spondylitis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Infliximab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308489/suppl/GSM3308489_SN518_C6K5PANXX_ATCACG_L001.txt.gz 	GPL16791	Ankylosing spondylitis	OMIM:106300;MESH:D013167;BERN:107423401	OMIM:106300=>SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1;MESH:D013167=>Spondylitis, Ankylosing	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1|Spondylitis, Ankylosing	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308490	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN519 ','gender':'F ','age':'44 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.68 ','disease activity':'Moderate ','arthropathymeds':'-- ','nsaids':'Meloxicam ','steroids':'Kecort 40mg x2 on day of bloods ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN519_C6K5PANXX_GATCAG_L004: Donor SN519 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308490*#*#*#SN519_C6K5PANXX_GATCAG_L004: Donor SN519 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN519 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN519 *#*#*#[char](gender)F *#*#*#[char](age)44 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.68 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)Meloxicam *#*#*#[char](steroids)Kecort 40mg x2 on day of bloods *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308490/suppl/GSM3308490_SN519_C6K5PANXX_GATCAG_L004.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308491	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN520 ','gender':'F ','age':'20 ','ancestry':'-- ','phenotype':'Rheumatoid arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN520_C6K5PANXX_TGACCA_L001: Donor SN520 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308491*#*#*#SN520_C6K5PANXX_TGACCA_L001: Donor SN520 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN520 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN520 *#*#*#[char](gender)F *#*#*#[char](age)20 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308491/suppl/GSM3308491_SN520_C6K5PANXX_TGACCA_L001.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308492	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN522 ','gender':'F ','age':'69 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.45 ','disease activity':'remission ','arthropathymeds':'Methotrexate 10mg/wk ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'Leflumide 10mg/day ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN522_C6K5PANXX_GTGAAA_L006: Donor SN522 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308492*#*#*#SN522_C6K5PANXX_GTGAAA_L006: Donor SN522 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN522 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN522 *#*#*#[char](gender)F *#*#*#[char](age)69 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.45 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 10mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)Leflumide 10mg/day *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308492/suppl/GSM3308492_SN522_C6K5PANXX_GTGAAA_L006.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308493	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN523 ','gender':'M ','age':'55 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.62 ','disease activity':'remission ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'-- ','biologics':'Adalimumab ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN523_C6K5PANXX_GTGGCC_L003: Donor SN523 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308493*#*#*#SN523_C6K5PANXX_GTGGCC_L003: Donor SN523 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN523 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN523 *#*#*#[char](gender)M *#*#*#[char](age)55 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.62 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308493/suppl/GSM3308493_SN523_C6K5PANXX_GTGGCC_L003.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308494	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN525 ','gender':'M ','age':'29 ','ancestry':'Caucasian ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN525_C6K5PANXX_ATGTCA_L005: Donor SN525 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308494*#*#*#SN525_C6K5PANXX_ATGTCA_L005: Donor SN525 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN525 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN525 *#*#*#[char](gender)M *#*#*#[char](age)29 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308494/suppl/GSM3308494_SN525_C6K5PANXX_ATGTCA_L005.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308495	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN552 ','gender':'M ','age':'54 ','ancestry':'Caucasian ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Adalimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN552_C6K5PANXX_ATCACG_L005: Donor SN552 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308495*#*#*#SN552_C6K5PANXX_ATCACG_L005: Donor SN552 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN552 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN552 *#*#*#[char](gender)M *#*#*#[char](age)54 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308495/suppl/GSM3308495_SN552_C6K5PANXX_ATCACG_L005.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308496	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN568 ','gender':'F ','age':'70 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.88 ','disease activity':'remission ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'-- ','biologics':'Adalimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN568_C6K5PANXX_CCGTCC_L008: Donor SN568 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308496*#*#*#SN568_C6K5PANXX_CCGTCC_L008: Donor SN568 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN568 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN568 *#*#*#[char](gender)F *#*#*#[char](age)70 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.88 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308496/suppl/GSM3308496_SN568_C6K5PANXX_CCGTCC_L008.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308497	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN569 ','gender':'F ','age':'61 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1 ','disease activity':'remission ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'-- ','biologics':'Tocilizumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN569_C6K5PANXX_GCCAAT_L004: Donor SN569 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308497*#*#*#SN569_C6K5PANXX_GCCAAT_L004: Donor SN569 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN569 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN569 *#*#*#[char](gender)F *#*#*#[char](age)61 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Tocilizumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308497/suppl/GSM3308497_SN569_C6K5PANXX_GCCAAT_L004.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308498	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN570 ','gender':'F ','age':'37 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.82 ','disease activity':'remission ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'Maybe Celebrex ','steroids':'Prednisolone 5mg/day ','biologics':'Tocilizumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Maybe Epilim nortriptylline oxycodone panedein forte ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN570_C6K5PANXX_CTTGTA_L007: Donor SN570 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308498*#*#*#SN570_C6K5PANXX_CTTGTA_L007: Donor SN570 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN570 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN570 *#*#*#[char](gender)F *#*#*#[char](age)37 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.82 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)Maybe Celebrex *#*#*#[char](steroids)Prednisolone 5mg/day *#*#*#[char](biologics)Tocilizumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Maybe Epilim nortriptylline oxycodone panedein forte 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308498/suppl/GSM3308498_SN570_C6K5PANXX_CTTGTA_L007.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Celebrex|Methotrexate|Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:41423;BERN:4195803|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:41423=>celecoxib|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|celecoxib|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308499	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN575 ','gender':'F ','age':'63 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.77 ','disease activity':'remission ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN575_C6K5PANXX_CAGATC_L007: Donor SN575 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308499*#*#*#SN575_C6K5PANXX_CAGATC_L007: Donor SN575 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN575 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN575 *#*#*#[char](gender)F *#*#*#[char](age)63 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.77 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308499/suppl/GSM3308499_SN575_C6K5PANXX_CAGATC_L007.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308500	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN581 ','gender':'F ','age':'49 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.74 ','disease activity':'remission ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Tocilizumab ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'Sulfasalazine ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN581_C6K5PANXX_GATCAG_L003: Donor SN581 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308500*#*#*#SN581_C6K5PANXX_GATCAG_L003: Donor SN581 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN581 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN581 *#*#*#[char](gender)F *#*#*#[char](age)49 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.74 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Tocilizumab *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)Sulfasalazine *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308500/suppl/GSM3308500_SN581_C6K5PANXX_GATCAG_L003.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Sulfasalazine|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308501	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN583 ','gender':'F ','age':'53 ','ancestry':'Somalian ','phenotype':'Rheumatoid arthritis ','das score':'2.4 ','disease activity':'remission ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'Plaquenil ','leflumide':'Leflumide 20mg/day ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Insulin ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN583_C6K5PANXX_ACTTGA_L006: Donor SN583 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308501*#*#*#SN583_C6K5PANXX_ACTTGA_L006: Donor SN583 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN583 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN583 *#*#*#[char](gender)F *#*#*#[char](age)53 *#*#*#[char](ancestry)Somalian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.4 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)Leflumide 20mg/day *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Insulin 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308501/suppl/GSM3308501_SN583_C6K5PANXX_ACTTGA_L006.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	Insulin	MIM:176730;HGNC:6081;Ensembl:ENSG00000254647;BERN:323759402	HGNC:6081=>INS;Ensembl:ENSG00000254647=>INS;MIM:176730=>INS	INS	null	null	null	null	null	null	null	null
GSE117769	GSM3308502	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN586 ','gender':'M ','age':'67 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.62 ','disease activity':'remission ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Golimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Candesartan ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN586_C6K5PANXX_ATTCCT_L002: Donor SN586 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308502*#*#*#SN586_C6K5PANXX_ATTCCT_L002: Donor SN586 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN586 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN586 *#*#*#[char](gender)M *#*#*#[char](age)67 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.62 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Golimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Candesartan 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308502/suppl/GSM3308502_SN586_C6K5PANXX_ATTCCT_L002.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308503	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN588 ','gender':'F ','age':'29 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.95 ','disease activity':'remission ','arthropathymeds':'Methotrexate ','nsaids':'prosyn ','steroids':'-- ','biologics':'Tocilizumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN588_C6K5PANXX_ATTCCT_L007: Donor SN588 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308503*#*#*#SN588_C6K5PANXX_ATTCCT_L007: Donor SN588 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN588 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN588 *#*#*#[char](gender)F *#*#*#[char](age)29 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.95 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)prosyn *#*#*#[char](steroids)-- *#*#*#[char](biologics)Tocilizumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308503/suppl/GSM3308503_SN588_C6K5PANXX_ATTCCT_L007.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308504	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN589 ','gender':'M ','age':'59 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.2 ','disease activity':'remission ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'Rituximab ','othermeds':'Allopurinol ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN589_C6K5PANXX_CGATGT_L001: Donor SN589 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308504*#*#*#SN589_C6K5PANXX_CGATGT_L001: Donor SN589 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN589 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN589 *#*#*#[char](gender)M *#*#*#[char](age)59 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.2 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)Rituximab *#*#*#[char](othermeds)Allopurinol 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308504/suppl/GSM3308504_SN589_C6K5PANXX_CGATGT_L001.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|EDTA|Allopurinol|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203|MESH:D000493;BERN:4769203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000493=>Allopurinol	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Allopurinol|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308505	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN591 ','gender':'M ','age':'63 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.08 ','disease activity':'Low ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'-- ','steroids':'Prednisolone 5mg/day ','biologics':'-- ','plaquenil':'Plaquenil ','leflumide':'Leflumide 20mg/day ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Quetiapine Venlafaxine ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN591_C6K5PANXX_TAGCTT_L004: Donor SN591 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308505*#*#*#SN591_C6K5PANXX_TAGCTT_L004: Donor SN591 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN591 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN591 *#*#*#[char](gender)M *#*#*#[char](age)63 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.08 *#*#*#[char](disease activity)Low *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 5mg/day *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)Leflumide 20mg/day *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Quetiapine Venlafaxine 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308505/suppl/GSM3308505_SN591_C6K5PANXX_TAGCTT_L004.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids|Quetiapine	CHEBI:8707;BERN:4749703|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:8707=>quetiapine|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|quetiapine|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308506	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN596 ','gender':'F ','age':'55 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.5 ','disease activity':'remission ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'Meloxicam ','steroids':'Prednisolone 1mg/day ','biologics':'-- ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'Sulfasalazine ','rituximab':'-- ','othermeds':'Esomeprazole padol osteo ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN596_C6K5PANXX_GTGGCC_L008: Donor SN596 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308506*#*#*#SN596_C6K5PANXX_GTGGCC_L008: Donor SN596 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN596 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN596 *#*#*#[char](gender)F *#*#*#[char](age)55 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.5 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)Meloxicam *#*#*#[char](steroids)Prednisolone 1mg/day *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)Sulfasalazine *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Esomeprazole padol osteo 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308506/suppl/GSM3308506_SN596_C6K5PANXX_GTGGCC_L008.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|Sulfasalazine|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308507	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN597 ','gender':'F ','age':'57 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'1.8 ','disease activity':'remission ','arthropathymeds':'Methotrexate 20mg/wk ','nsaids':'Meloxicam ','steroids':'Prednisolone 5mg/day ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN597_C6K5PANXX_GAGTGG_L007: Donor SN597 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308507*#*#*#SN597_C6K5PANXX_GAGTGG_L007: Donor SN597 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN597 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN597 *#*#*#[char](gender)F *#*#*#[char](age)57 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)1.8 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate 20mg/wk *#*#*#[char](nsaids)Meloxicam *#*#*#[char](steroids)Prednisolone 5mg/day *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308507/suppl/GSM3308507_SN597_C6K5PANXX_GAGTGG_L007.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308508	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN599 ','gender':'F ','age':'46 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.5 ','disease activity':'remission ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'Prednisolone 3mg/day ','biologics':'Infliximab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Irbesartan ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN599_C6K5PANXX_AGTTCC_L007: Donor SN599 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308508*#*#*#SN599_C6K5PANXX_AGTTCC_L007: Donor SN599 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN599 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN599 *#*#*#[char](gender)F *#*#*#[char](age)46 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.5 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 3mg/day *#*#*#[char](biologics)Infliximab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Irbesartan 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308508/suppl/GSM3308508_SN599_C6K5PANXX_AGTTCC_L007.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Methotrexate|Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D006886;BERN:4707203|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|CHEBI:64755;BERN:293514603	CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308509	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN602 ','gender':'F ','age':'58 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.5 ','disease activity':'Moderate ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'Prednisolone 5mg/day ','biologics':'-- ','plaquenil':'Plaquenil ','leflumide':'Leflumide ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Metformin ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN602_C6K5PANXX_CTTGTA_L003: Donor SN602 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308509*#*#*#SN602_C6K5PANXX_CTTGTA_L003: Donor SN602 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN602 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN602 *#*#*#[char](gender)F *#*#*#[char](age)58 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.5 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 5mg/day *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)Leflumide *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Metformin 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308509/suppl/GSM3308509_SN602_C6K5PANXX_CTTGTA_L003.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Prednisolone|Metformin|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D008687;BERN:4118403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D008687=>Metformin|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Metformin|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308510	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN605 ','gender':'F ','age':'54 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'2.7 ','disease activity':'Low ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'Prednisolone 10mg/day ','biologics':'Adalimumab ','plaquenil':'-- ','leflumide':'Leflumide 20mg/day ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN605_C6K5PANXX_CAGATC_L003: Donor SN605 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308510*#*#*#SN605_C6K5PANXX_CAGATC_L003: Donor SN605 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN605 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN605 *#*#*#[char](gender)F *#*#*#[char](age)54 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)2.7 *#*#*#[char](disease activity)Low *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 10mg/day *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)Leflumide 20mg/day *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308510/suppl/GSM3308510_SN605_C6K5PANXX_CAGATC_L003.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Prednisolone|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308511	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN606 ','gender':'F ','age':'34 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'3.3 ','disease activity':'Moderate ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'Prednisolone 10mg/day ','biologics':'Tocilizumab ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'Sulfasalazine ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN606_C6K5PANXX_GTCCGC_L002: Donor SN606 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308511*#*#*#SN606_C6K5PANXX_GTCCGC_L002: Donor SN606 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN606 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN606 *#*#*#[char](gender)F *#*#*#[char](age)34 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)3.3 *#*#*#[char](disease activity)Moderate *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)Prednisolone 10mg/day *#*#*#[char](biologics)Tocilizumab *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)Sulfasalazine *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308511/suppl/GSM3308511_SN606_C6K5PANXX_GTCCGC_L002.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	Prednisolone|Sulfasalazine|EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|CHEBI:8378;BERN:4097403|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D000643=>Ammonium Chloride|CHEBI:8378=>prednisolone;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|prednisolone|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308512	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN612 ','gender':'F ','age':'40 ','ancestry':'Caucasian ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Adalimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN612_C6K5PANXX_ATTCCT_L008: Donor SN612 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308512*#*#*#SN612_C6K5PANXX_ATTCCT_L008: Donor SN612 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN612 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN612 *#*#*#[char](gender)F *#*#*#[char](age)40 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308512/suppl/GSM3308512_SN612_C6K5PANXX_ATTCCT_L008.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308513	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN615 ','gender':'M ','age':'52 ','ancestry':'Caucasian ','phenotype':'Rheumatoid arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'Rituximab ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN615_C6K5PANXX_GAGTGG_L004: Donor SN615 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308513*#*#*#SN615_C6K5PANXX_GAGTGG_L004: Donor SN615 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN615 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN615 *#*#*#[char](gender)M *#*#*#[char](age)52 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)Rituximab *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308513/suppl/GSM3308513_SN615_C6K5PANXX_GAGTGG_L004.txt.gz 	GPL16791	Rheumatoid arthritis	MESH:D001172;OMIM:180300;BERN:107539501	OMIM:180300=>RHEUMATOID ARTHRITIS: RA;MESH:D001172=>Arthritis, Rheumatoid	Arthritis, Rheumatoid|RHEUMATOID ARTHRITIS: RA	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308514	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN618 ','gender':'M ','age':'54 ','ancestry':'Caucasian ','phenotype':'Rheumatoid or Psoriatic arthritis ','das score':'1.37 ','disease activity':'remission ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Etanercept ','plaquenil':'Plaquenil ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN618_C6K5PANXX_TAGCTT_L001: Donor SN618 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308514*#*#*#SN618_C6K5PANXX_TAGCTT_L001: Donor SN618 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN618 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN618 *#*#*#[char](gender)M *#*#*#[char](age)54 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Rheumatoid or Psoriatic arthritis *#*#*#[char](das score)1.37 *#*#*#[char](disease activity)remission *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Etanercept *#*#*#[char](plaquenil)Plaquenil *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308514/suppl/GSM3308514_SN618_C6K5PANXX_TAGCTT_L001.txt.gz 	GPL16791	Rheumatoid or Psoriatic arthritis	MESH:D001172;OMIM:180300;OMIM:607507;MESH:D015535;BERN:107539501;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	EDTA|Plaquenil|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308515	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN619 ','gender':'M ','age':'32 ','ancestry':'Caucasian ','phenotype':'Ankylosing spondylitis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Adalimumab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'Maybe Celebrex ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN619_C6K5PANXX_GCCAAT_L002: Donor SN619 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308515*#*#*#SN619_C6K5PANXX_GCCAAT_L002: Donor SN619 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN619 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN619 *#*#*#[char](gender)M *#*#*#[char](age)32 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Ankylosing spondylitis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Adalimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Maybe Celebrex 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308515/suppl/GSM3308515_SN619_C6K5PANXX_GCCAAT_L002.txt.gz 	GPL16791	Ankylosing spondylitis	OMIM:106300;MESH:D013167;BERN:107423401	OMIM:106300=>SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1;MESH:D013167=>Spondylitis, Ankylosing	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1|Spondylitis, Ankylosing	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308516	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN620 ','gender':'M ','age':'48 ','ancestry':'Caucasian ','phenotype':'Ankylosing spondylitis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'Infliximab ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'Sulfasalazine ','rituximab':'-- ','othermeds':'Ibuprofen digesic PPI Anti-hypertensive zolendronic acid ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN620_C6K5PANXX_ACTGAT_L007: Donor SN620 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308516*#*#*#SN620_C6K5PANXX_ACTGAT_L007: Donor SN620 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN620 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN620 *#*#*#[char](gender)M *#*#*#[char](age)48 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Ankylosing spondylitis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Infliximab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)Sulfasalazine *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)Ibuprofen digesic PPI Anti-hypertensive zolendronic acid 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308516/suppl/GSM3308516_SN620_C6K5PANXX_ACTGAT_L007.txt.gz 	GPL16791	Ankylosing spondylitis	OMIM:106300;MESH:D013167;BERN:107423401	OMIM:106300=>SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1;MESH:D013167=>Spondylitis, Ankylosing	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1: SPDA1|Spondylitis, Ankylosing	Sulfasalazine|Ibuprofen|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|CHEBI:43415;BERN:5880103|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:43415=>dexibuprofen;MESH:D013256=>Steroids|CHEBI:43415=>dexibuprofen;MESH:D000643=>Ammonium Chloride|CHEBI:43415=>dexibuprofen;MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|dexibuprofen|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308517	{'tissue':'Blood ','cell type':'White blood cells ','donor':'SN628 ','gender':'F ','age':'55 ','ancestry':'Caucasian ','phenotype':'Psoriatic arthritis ','das score':'-- ','disease activity':'-- ','arthropathymeds':'Methotrexate ','nsaids':'-- ','steroids':'-- ','biologics':'Golimumab ','plaquenil':'-- ','leflumide':'Leflumide ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'SN628_C6K5PANXX_ACTTGA_L001: Donor SN628 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308517*#*#*#SN628_C6K5PANXX_ACTTGA_L001: Donor SN628 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor SN628 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)SN628 *#*#*#[char](gender)F *#*#*#[char](age)55 *#*#*#[char](ancestry)Caucasian *#*#*#[char](phenotype)Psoriatic arthritis *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)Methotrexate *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)Golimumab *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)Leflumide *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308517/suppl/GSM3308517_SN628_C6K5PANXX_ACTTGA_L001.txt.gz 	GPL16791	Psoriatic arthritis	OMIM:607507;MESH:D015535;BERN:107460201	OMIM:607507=>PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO;MESH:D015535=>Arthritis, Psoriatic	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO|Arthritis, Psoriatic	Methotrexate|EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|CHEBI:50681;BERN:273827803|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:50681=>methotrexate(2-)|CHEBI:50681=>methotrexate(2-);MESH:D012460=>Sulfasalazine|CHEBI:50681=>methotrexate(2-);MESH:D013256=>Steroids|CHEBI:50681=>methotrexate(2-);MESH:D000643=>Ammonium Chloride|CHEBI:50681=>methotrexate(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|methotrexate(2-)|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308518	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V141 ','gender':'F ','age':'41 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V141_C6K5PANXX_TTAGGC_L001: Donor V141 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308518*#*#*#V141_C6K5PANXX_TTAGGC_L001: Donor V141 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V141 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V141 *#*#*#[char](gender)F *#*#*#[char](age)41 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308518/suppl/GSM3308518_V141_C6K5PANXX_TTAGGC_L001.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308519	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V157 ','gender':'M ','age':'38 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V157_C6K5PANXX_AGTCAA_L001: Donor V157 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308519*#*#*#V157_C6K5PANXX_AGTCAA_L001: Donor V157 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V157 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V157 *#*#*#[char](gender)M *#*#*#[char](age)38 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308519/suppl/GSM3308519_V157_C6K5PANXX_AGTCAA_L001.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308520	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V160 ','gender':'F ','age':'29 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V160_C6K5PANXX_TTAGGC_L002: Donor V160 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308520*#*#*#V160_C6K5PANXX_TTAGGC_L002: Donor V160 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V160 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V160 *#*#*#[char](gender)F *#*#*#[char](age)29 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308520/suppl/GSM3308520_V160_C6K5PANXX_TTAGGC_L002.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308521	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V182 ','gender':'F ','age':'49 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V182_C6K5PANXX_CAGATC_L006: Donor V182 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308521*#*#*#V182_C6K5PANXX_CAGATC_L006: Donor V182 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V182 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V182 *#*#*#[char](gender)F *#*#*#[char](age)49 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308521/suppl/GSM3308521_V182_C6K5PANXX_CAGATC_L006.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308522	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V183 ','gender':'F ','age':'32 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V183_C6K5PANXX_ATCACG_L008: Donor V183 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308522*#*#*#V183_C6K5PANXX_ATCACG_L008: Donor V183 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V183 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V183 *#*#*#[char](gender)F *#*#*#[char](age)32 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308522/suppl/GSM3308522_V183_C6K5PANXX_ATCACG_L008.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308523	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V250 ','gender':'F ','age':'46 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V250_C6K5PANXX_GAGTGG_L005: Donor V250 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308523*#*#*#V250_C6K5PANXX_GAGTGG_L005: Donor V250 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V250 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V250 *#*#*#[char](gender)F *#*#*#[char](age)46 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308523/suppl/GSM3308523_V250_C6K5PANXX_GAGTGG_L005.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308524	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V264 ','gender':'F ','age':'32 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V264_C6K5PANXX_ATGTCA_L001: Donor V264 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308524*#*#*#V264_C6K5PANXX_ATGTCA_L001: Donor V264 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V264 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V264 *#*#*#[char](gender)F *#*#*#[char](age)32 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308524/suppl/GSM3308524_V264_C6K5PANXX_ATGTCA_L001.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308525	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V268 ','gender':'M ','age':'60 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V268_C6K5PANXX_GCCAAT_L006: Donor V268 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308525*#*#*#V268_C6K5PANXX_GCCAAT_L006: Donor V268 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V268 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V268 *#*#*#[char](gender)M *#*#*#[char](age)60 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308525/suppl/GSM3308525_V268_C6K5PANXX_GCCAAT_L006.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308526	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V269 ','gender':'F ','age':'68 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V269_C6K5PANXX_CGATGT_L008: Donor V269 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308526*#*#*#V269_C6K5PANXX_CGATGT_L008: Donor V269 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V269 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V269 *#*#*#[char](gender)F *#*#*#[char](age)68 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308526/suppl/GSM3308526_V269_C6K5PANXX_CGATGT_L008.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308527	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V279 ','gender':'F ','age':'26 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V279_C6K5PANXX_GTCCGC_L005: Donor V279 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308527*#*#*#V279_C6K5PANXX_GTCCGC_L005: Donor V279 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V279 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V279 *#*#*#[char](gender)F *#*#*#[char](age)26 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308527/suppl/GSM3308527_V279_C6K5PANXX_GTCCGC_L005.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308528	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V303 ','gender':'F ','age':'52 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V303_C6K5PANXX_GTGAAA_L008: Donor V303 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308528*#*#*#V303_C6K5PANXX_GTGAAA_L008: Donor V303 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V303 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V303 *#*#*#[char](gender)F *#*#*#[char](age)52 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308528/suppl/GSM3308528_V303_C6K5PANXX_GTGAAA_L008.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308529	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V305 ','gender':'F ','age':'53 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V305_C6K5PANXX_TGACCA_L004: Donor V305 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308529*#*#*#V305_C6K5PANXX_TGACCA_L004: Donor V305 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V305 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V305 *#*#*#[char](gender)F *#*#*#[char](age)53 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308529/suppl/GSM3308529_V305_C6K5PANXX_TGACCA_L004.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308530	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V311 ','gender':'M ','age':'57 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V311_C6K5PANXX_TAGCTT_L007: Donor V311 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308530*#*#*#V311_C6K5PANXX_TAGCTT_L007: Donor V311 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V311 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V311 *#*#*#[char](gender)M *#*#*#[char](age)57 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308530/suppl/GSM3308530_V311_C6K5PANXX_TAGCTT_L007.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308531	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V382 ','gender':'F ','age':'33 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V382_C6K5PANXX_ACTGAT_L002: Donor V382 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308531*#*#*#V382_C6K5PANXX_ACTGAT_L002: Donor V382 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V382 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V382 *#*#*#[char](gender)F *#*#*#[char](age)33 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308531/suppl/GSM3308531_V382_C6K5PANXX_ACTGAT_L002.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308532	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V391 ','gender':'F ','age':'30 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V391_C6K5PANXX_GTGAAA_L002: Donor V391 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308532*#*#*#V391_C6K5PANXX_GTGAAA_L002: Donor V391 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V391 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V391 *#*#*#[char](gender)F *#*#*#[char](age)30 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308532/suppl/GSM3308532_V391_C6K5PANXX_GTGAAA_L002.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308533	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V3 ','gender':'F ','age':'63 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V3_C6K5PANXX_GTTTCG_L005: Donor V3 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308533*#*#*#V3_C6K5PANXX_GTTTCG_L005: Donor V3 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V3 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V3 *#*#*#[char](gender)F *#*#*#[char](age)63 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308533/suppl/GSM3308533_V3_C6K5PANXX_GTTTCG_L005.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308534	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V400 ','gender':'F ','age':'50 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V400_C6K5PANXX_GTTTCG_L007: Donor V400 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308534*#*#*#V400_C6K5PANXX_GTTTCG_L007: Donor V400 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V400 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V400 *#*#*#[char](gender)F *#*#*#[char](age)50 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308534/suppl/GSM3308534_V400_C6K5PANXX_GTTTCG_L007.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308535	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V405 ','gender':'F ','age':'48 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V405_C6K5PANXX_GTTTCG_L008: Donor V405 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308535*#*#*#V405_C6K5PANXX_GTTTCG_L008: Donor V405 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V405 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V405 *#*#*#[char](gender)F *#*#*#[char](age)48 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308535/suppl/GSM3308535_V405_C6K5PANXX_GTTTCG_L008.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308536	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V418 ','gender':'F ','age':'55 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V418_C6K5PANXX_ACTTGA_L007: Donor V418 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308536*#*#*#V418_C6K5PANXX_ACTTGA_L007: Donor V418 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V418 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V418 *#*#*#[char](gender)F *#*#*#[char](age)55 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308536/suppl/GSM3308536_V418_C6K5PANXX_ACTTGA_L007.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308537	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V433 ','gender':'M ','age':'31 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V433_C6K5PANXX_CGATGT_L005: Donor V433 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308537*#*#*#V433_C6K5PANXX_CGATGT_L005: Donor V433 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V433 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V433 *#*#*#[char](gender)M *#*#*#[char](age)31 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308537/suppl/GSM3308537_V433_C6K5PANXX_CGATGT_L005.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308538	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V436 ','gender':'F ','age':'33 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V436_C6K5PANXX_CCGTCC_L003: Donor V436 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308538*#*#*#V436_C6K5PANXX_CCGTCC_L003: Donor V436 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V436 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V436 *#*#*#[char](gender)F *#*#*#[char](age)33 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308538/suppl/GSM3308538_V436_C6K5PANXX_CCGTCC_L003.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308539	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V444 ','gender':'F ','age':'53 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V444_C6K5PANXX_ATGTCA_L003: Donor V444 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308539*#*#*#V444_C6K5PANXX_ATGTCA_L003: Donor V444 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V444 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V444 *#*#*#[char](gender)F *#*#*#[char](age)53 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308539/suppl/GSM3308539_V444_C6K5PANXX_ATGTCA_L003.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308540	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V447 ','gender':'M ','age':'62 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V447_C6K5PANXX_AGTTCC_L005: Donor V447 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308540*#*#*#V447_C6K5PANXX_AGTTCC_L005: Donor V447 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V447 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V447 *#*#*#[char](gender)M *#*#*#[char](age)62 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308540/suppl/GSM3308540_V447_C6K5PANXX_AGTTCC_L005.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308541	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V448 ','gender':'M ','age':'59 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V448_C6K5PANXX_TGACCA_L002: Donor V448 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308541*#*#*#V448_C6K5PANXX_TGACCA_L002: Donor V448 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V448 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V448 *#*#*#[char](gender)M *#*#*#[char](age)59 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308541/suppl/GSM3308541_V448_C6K5PANXX_TGACCA_L002.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308542	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V467 ','gender':'F ','age':'45 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V467_C6K5PANXX_GTGGCC_L007: Donor V467 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308542*#*#*#V467_C6K5PANXX_GTGGCC_L007: Donor V467 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V467 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V467 *#*#*#[char](gender)F *#*#*#[char](age)45 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308542/suppl/GSM3308542_V467_C6K5PANXX_GTGGCC_L007.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308543	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V58 ','gender':'F ','age':'52 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V58_C6K5PANXX_GGCTAC_L004: Donor V58 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308543*#*#*#V58_C6K5PANXX_GGCTAC_L004: Donor V58 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V58 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V58 *#*#*#[char](gender)F *#*#*#[char](age)52 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308543/suppl/GSM3308543_V58_C6K5PANXX_GGCTAC_L004.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117769	GSM3308544	{'tissue':'Blood ','cell type':'White blood cells ','donor':'V76 ','gender':'F ','age':'44 ','ancestry':'-- ','phenotype':'Healthy ','das score':'-- ','disease activity':'-- ','arthropathymeds':'-- ','nsaids':'-- ','steroids':'-- ','biologics':'-- ','plaquenil':'-- ','leflumide':'-- ','sulfasalazine':'-- ','rituximab':'-- ','othermeds':'-- ','organism':'Homo sapiens','source name':'RNA from white blood cells', 'title':'V76_C6K5PANXX_GTGGCC_L005: Donor V76 white blood cells', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3308544*#*#*#V76_C6K5PANXX_GTGGCC_L005: Donor V76 white blood cells*#*#*#1*#*#*#RNA from white blood cells*#*#*#Homo sapiens*#*#*#Peripheral blood was collected in EDTA vacutainers and red blood cells (RBC) lysed in ammonium chloride lysing solution. The remaining white blood cells (WBC) were stored in RNAprotect (QIAGEN, Germany) for later use *#*#*#polyA RNA*#*#*#null*#*#*#Reads were mapped to Homo sapiens GRCh37.p10 genome, using TopHat (TopHat v2.1.0, bowtie v2.2.5; Trapnell et al.,2009).Mapped reads were summaried on a gene level using Ensembl ID gene annotation (Ensembl Release 70 based on GRCh37.p10 genome build) and featureCounts (Rsubread package v1.23.2; Yang et al., 2014) software.Summarised read counts in this submission were NOT normalised nor filtered. We recommend using Bioconductor edgeR package functions: i) calcNormFactors (TMM method) to normalise between samples based on library sizes, and ii) rpkm function to normalise between genes within a sample based on gene lengths.Genome_build: GRCh37.p10Supplementary_files_format_and_content: All processed data files are in a tab delimited file format. They contain raw read counts summarised on a gene level according to Ensembl Release 70 annotation. *#*#*#RNA-Seq*#*#*#Donor V76 white blood cells *#*#*#GPL16791*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Blood *#*#*#[char](cell type)White blood cells *#*#*#[char](donor)V76 *#*#*#[char](gender)F *#*#*#[char](age)44 *#*#*#[char](ancestry)-- *#*#*#[char](phenotype)Healthy *#*#*#[char](das score)-- *#*#*#[char](disease activity)-- *#*#*#[char](arthropathymeds)-- *#*#*#[char](nsaids)-- *#*#*#[char](steroids)-- *#*#*#[char](biologics)-- *#*#*#[char](plaquenil)-- *#*#*#[char](leflumide)-- *#*#*#[char](sulfasalazine)-- *#*#*#[char](rituximab)-- *#*#*#[char](othermeds)-- 	null	null	Homo sapiens	White blood cells	high-throughput sequencing	RNA from white blood cells	Blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3308nnn/GSM3308544/suppl/GSM3308544_V76_C6K5PANXX_GTGGCC_L005.txt.gz 	GPL16791	null	null	null	null	EDTA|ammonium chloride|plaquenil|sulfasalazine|steroids	CHEBI:64755;BERN:293514603|MESH:D012460;BERN:4858703|MESH:D013256;BERN:283878503|MESH:D000643;BERN:282920803|MESH:D006886;BERN:4707203	CHEBI:64755=>EDTA(2-)|CHEBI:64755=>EDTA(2-);MESH:D012460=>Sulfasalazine|CHEBI:64755=>EDTA(2-);MESH:D013256=>Steroids|CHEBI:64755=>EDTA(2-);MESH:D000643=>Ammonium Chloride|CHEBI:64755=>EDTA(2-);MESH:D006886=>Hydroxychloroquine	EDTA(2-)|Ammonium Chloride|Sulfasalazine|Steroids|Hydroxychloroquine	null	null	null	null	null	null	null	null	null	null	null	null
GSE117773	GSM3308591	{'cell type':'Immortalized ','tissue':'Bone osteosarcoma ','passage':'12 ','treatment':'shRNA silencing ','organism':'Homo sapiens','source name':'143B cells (CRL-8303)', 'title':'WS-D1 (KD #1)', 'last update date':'2020-06-10', 'release date': '2020-06-10', 'method': 'high-throughput sequencing'}	GSM3308591*#*#*#WS-D1 (KD #1)*#*#*#1*#*#*#143B cells (CRL-8303)*#*#*#Homo sapiens*#*#*#Cells were lifted and plated at 4 x 10^5 cells per 100mm dishes, and cultured overnight. Media was changed to complete media containing hexadimethrine bromide and infected with lentiviral shJAB1 particles at MOI = 5. The following day media was changed to complete media, and after 24hrs cells were selected after 72hrs in complete media containing 0.5µg/mL puromycin. *#*#*#total RNA*#*#*#null*#*#*#TrimGalore for qc and adapter trimmingSTAR Aligner for read alignmentCufflinks for differential expression analysis.Genome_build: GRCh38Supplementary_files_format_and_content: Results from Cuffdiff *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2020-06-10*#*#*#2020-06-10*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized *#*#*#[char](tissue)Bone osteosarcoma *#*#*#[char](passage)12 *#*#*#[char](treatment)shRNA silencing 	32390003	null	Homo sapiens	Immortalized	high-throughput sequencing	143B cells (CRL-8303)	Bone osteosarcoma	null	shRNA silencing	RNA-Seq	null	transcriptomic	total RNA	SRA	2020-06-10	2020-06-10	NONE 	GPL16791	Bone osteosarcoma	BERN:260946601			puromycin|hexadimethrine bromide	CHEBI:60255;BERN:299059903|MESH:D006583;BERN:5010603	CHEBI:60255=>puromycin(1+)|CHEBI:60255=>puromycin(1+);MESH:D006583=>Hexadimethrine Bromide	puromycin(1+)|Hexadimethrine Bromide	null	null	null	null	null	null	null	null	143B	143B	null	null
GSE117773	GSM3308592	{'cell type':'Immortalized ','tissue':'Bone osteosarcoma ','passage':'12 ','treatment':'shRNA silencing ','organism':'Homo sapiens','source name':'143B cells (CRL-8303)', 'title':'WS-D2 (KD #2)', 'last update date':'2020-06-10', 'release date': '2020-06-10', 'method': 'high-throughput sequencing'}	GSM3308592*#*#*#WS-D2 (KD #2)*#*#*#1*#*#*#143B cells (CRL-8303)*#*#*#Homo sapiens*#*#*#Cells were lifted and plated at 4 x 10^5 cells per 100mm dishes, and cultured overnight. Media was changed to complete media containing hexadimethrine bromide and infected with lentiviral shJAB1 particles at MOI = 5. The following day media was changed to complete media, and after 24hrs cells were selected after 72hrs in complete media containing 0.5µg/mL puromycin. *#*#*#total RNA*#*#*#null*#*#*#TrimGalore for qc and adapter trimmingSTAR Aligner for read alignmentCufflinks for differential expression analysis.Genome_build: GRCh38Supplementary_files_format_and_content: Results from Cuffdiff *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2020-06-10*#*#*#2020-06-10*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized *#*#*#[char](tissue)Bone osteosarcoma *#*#*#[char](passage)12 *#*#*#[char](treatment)shRNA silencing 	32390003	null	Homo sapiens	Immortalized	high-throughput sequencing	143B cells (CRL-8303)	Bone osteosarcoma	null	shRNA silencing	RNA-Seq	null	transcriptomic	total RNA	SRA	2020-06-10	2020-06-10	NONE 	GPL16791	Bone osteosarcoma	BERN:260946601			puromycin|hexadimethrine bromide	CHEBI:60255;BERN:299059903|MESH:D006583;BERN:5010603	CHEBI:60255=>puromycin(1+)|CHEBI:60255=>puromycin(1+);MESH:D006583=>Hexadimethrine Bromide	puromycin(1+)|Hexadimethrine Bromide	null	null	null	null	null	null	null	null	143B	143B	null	null
GSE117773	GSM3308593	{'cell type':'Immortalized ','tissue':'Bone osteosarcoma ','passage':'12 ','treatment':'shRNA silencing ','organism':'Homo sapiens','source name':'143B cells (CRL-8303)', 'title':'WS-E1 (KD #3)', 'last update date':'2020-06-10', 'release date': '2020-06-10', 'method': 'high-throughput sequencing'}	GSM3308593*#*#*#WS-E1 (KD #3)*#*#*#1*#*#*#143B cells (CRL-8303)*#*#*#Homo sapiens*#*#*#Cells were lifted and plated at 4 x 10^5 cells per 100mm dishes, and cultured overnight. Media was changed to complete media containing hexadimethrine bromide and infected with lentiviral shJAB1 particles at MOI = 5. The following day media was changed to complete media, and after 24hrs cells were selected after 72hrs in complete media containing 0.5µg/mL puromycin. *#*#*#total RNA*#*#*#null*#*#*#TrimGalore for qc and adapter trimmingSTAR Aligner for read alignmentCufflinks for differential expression analysis.Genome_build: GRCh38Supplementary_files_format_and_content: Results from Cuffdiff *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2020-06-10*#*#*#2020-06-10*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized *#*#*#[char](tissue)Bone osteosarcoma *#*#*#[char](passage)12 *#*#*#[char](treatment)shRNA silencing 	32390003	null	Homo sapiens	Immortalized	high-throughput sequencing	143B cells (CRL-8303)	Bone osteosarcoma	null	shRNA silencing	RNA-Seq	null	transcriptomic	total RNA	SRA	2020-06-10	2020-06-10	NONE 	GPL16791	Bone osteosarcoma	BERN:260946601			puromycin|hexadimethrine bromide	CHEBI:60255;BERN:299059903|MESH:D006583;BERN:5010603	CHEBI:60255=>puromycin(1+)|CHEBI:60255=>puromycin(1+);MESH:D006583=>Hexadimethrine Bromide	puromycin(1+)|Hexadimethrine Bromide	null	null	null	null	null	null	null	null	143B	143B	null	null
GSE117773	GSM3308594	{'cell type':'Immortalized ','tissue':'Bone osteosarcoma ','passage':'12 ','treatment':'shRNA scrambled control ','organism':'Homo sapiens','source name':'143B cells (CRL-8303)', 'title':'WS-N1A (scrambled #1)', 'last update date':'2020-06-10', 'release date': '2020-06-10', 'method': 'high-throughput sequencing'}	GSM3308594*#*#*#WS-N1A (scrambled #1)*#*#*#1*#*#*#143B cells (CRL-8303)*#*#*#Homo sapiens*#*#*#Cells were lifted and plated at 4 x 10^5 cells per 100mm dishes, and cultured overnight. Media was changed to complete media containing hexadimethrine bromide and infected with lentiviral shJAB1 particles at MOI = 5. The following day media was changed to complete media, and after 24hrs cells were selected after 72hrs in complete media containing 0.5µg/mL puromycin. *#*#*#total RNA*#*#*#null*#*#*#TrimGalore for qc and adapter trimmingSTAR Aligner for read alignmentCufflinks for differential expression analysis.Genome_build: GRCh38Supplementary_files_format_and_content: Results from Cuffdiff *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2020-06-10*#*#*#2020-06-10*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized *#*#*#[char](tissue)Bone osteosarcoma *#*#*#[char](passage)12 *#*#*#[char](treatment)shRNA scrambled control 	32390003	null	Homo sapiens	Immortalized	high-throughput sequencing	143B cells (CRL-8303)	Bone osteosarcoma	null	shRNA scrambled control	RNA-Seq	null	transcriptomic	total RNA	SRA	2020-06-10	2020-06-10	NONE 	GPL16791	Bone osteosarcoma	BERN:260946601			puromycin|hexadimethrine bromide	CHEBI:60255;BERN:299059903|MESH:D006583;BERN:5010603	CHEBI:60255=>puromycin(1+)|CHEBI:60255=>puromycin(1+);MESH:D006583=>Hexadimethrine Bromide	puromycin(1+)|Hexadimethrine Bromide	null	null	null	null	null	null	null	null	143B	143B	null	null
GSE117773	GSM3308595	{'cell type':'Immortalized ','tissue':'Bone osteosarcoma ','passage':'12 ','treatment':'shRNA scrambled control ','organism':'Homo sapiens','source name':'143B cells (CRL-8303)', 'title':'WS-N1B (scrambled #2)', 'last update date':'2020-06-10', 'release date': '2020-06-10', 'method': 'high-throughput sequencing'}	GSM3308595*#*#*#WS-N1B (scrambled #2)*#*#*#1*#*#*#143B cells (CRL-8303)*#*#*#Homo sapiens*#*#*#Cells were lifted and plated at 4 x 10^5 cells per 100mm dishes, and cultured overnight. Media was changed to complete media containing hexadimethrine bromide and infected with lentiviral shJAB1 particles at MOI = 5. The following day media was changed to complete media, and after 24hrs cells were selected after 72hrs in complete media containing 0.5µg/mL puromycin. *#*#*#total RNA*#*#*#null*#*#*#TrimGalore for qc and adapter trimmingSTAR Aligner for read alignmentCufflinks for differential expression analysis.Genome_build: GRCh38Supplementary_files_format_and_content: Results from Cuffdiff *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2020-06-10*#*#*#2020-06-10*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized *#*#*#[char](tissue)Bone osteosarcoma *#*#*#[char](passage)12 *#*#*#[char](treatment)shRNA scrambled control 	32390003	null	Homo sapiens	Immortalized	high-throughput sequencing	143B cells (CRL-8303)	Bone osteosarcoma	null	shRNA scrambled control	RNA-Seq	null	transcriptomic	total RNA	SRA	2020-06-10	2020-06-10	NONE 	GPL16791	Bone osteosarcoma	BERN:260946601			puromycin|hexadimethrine bromide	CHEBI:60255;BERN:299059903|MESH:D006583;BERN:5010603	CHEBI:60255=>puromycin(1+)|CHEBI:60255=>puromycin(1+);MESH:D006583=>Hexadimethrine Bromide	puromycin(1+)|Hexadimethrine Bromide	null	null	null	null	null	null	null	null	143B	143B	null	null
GSE117773	GSM3308596	{'cell type':'Immortalized ','tissue':'Bone osteosarcoma ','passage':'12 ','treatment':'shRNA scrambled control ','organism':'Homo sapiens','source name':'143B cells (CRL-8303)', 'title':'WS-N2A (scrambled #3)', 'last update date':'2020-06-10', 'release date': '2020-06-10', 'method': 'high-throughput sequencing'}	GSM3308596*#*#*#WS-N2A (scrambled #3)*#*#*#1*#*#*#143B cells (CRL-8303)*#*#*#Homo sapiens*#*#*#Cells were lifted and plated at 4 x 10^5 cells per 100mm dishes, and cultured overnight. Media was changed to complete media containing hexadimethrine bromide and infected with lentiviral shJAB1 particles at MOI = 5. The following day media was changed to complete media, and after 24hrs cells were selected after 72hrs in complete media containing 0.5µg/mL puromycin. *#*#*#total RNA*#*#*#null*#*#*#TrimGalore for qc and adapter trimmingSTAR Aligner for read alignmentCufflinks for differential expression analysis.Genome_build: GRCh38Supplementary_files_format_and_content: Results from Cuffdiff *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2020-06-10*#*#*#2020-06-10*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)Immortalized *#*#*#[char](tissue)Bone osteosarcoma *#*#*#[char](passage)12 *#*#*#[char](treatment)shRNA scrambled control 	32390003	null	Homo sapiens	Immortalized	high-throughput sequencing	143B cells (CRL-8303)	Bone osteosarcoma	null	shRNA scrambled control	RNA-Seq	null	transcriptomic	total RNA	SRA	2020-06-10	2020-06-10	NONE 	GPL16791	Bone osteosarcoma	BERN:260946601			puromycin|hexadimethrine bromide	CHEBI:60255;BERN:299059903|MESH:D006583;BERN:5010603	CHEBI:60255=>puromycin(1+)|CHEBI:60255=>puromycin(1+);MESH:D006583=>Hexadimethrine Bromide	puromycin(1+)|Hexadimethrine Bromide	null	null	null	null	null	null	null	null	143B	143B	null	null
GSE117776	GSM3308621	{'tissue':'Brain ','organism':'Homo sapiens','source name':'human frontal cortex', 'title':'fragileX_sample_103108GP', 'last update date':'2018-12-14', 'release date': '2018-12-14', 'method': 'high-throughput sequencing'}	GSM3308621*#*#*#fragileX_sample_103108GP*#*#*#1*#*#*#human frontal cortex*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Map fastq reads with HISAT2 hisat2 -q --phred64 -x grch37_tran/genome_tran --no-unal --reorder --no-mixedExtract uniquely mapped reads from SAM filesRemap unmapped reads with hyperediting pipeline. In brief, convert all adenosines to guanosines and align to modified hg19 genome where adenosines are also substituted by guanosines.Obtain uniquely mapped reads pairs from hyperediting pipeline and combine with uniquely mapped reads from first round of read mappingIdentify RNA-DNA differences between mapped reads and hg19 reference genome.Apply log-likelihood test to determine whether RDD is likely resulted from sequencing error (Bahn et. al. PMID: 21960545)Apply posterior filters to remove RDD sites that are likely caused by technical artifats (Bahn et. al. PMID: 21960545 and Lee et. al. PMID: 23598527)Retain only highly prevalent editing sites. In particular, filter for editing sites where both pooled fragile X and pooled controls have at least 10 reads each and where pooled fragile X or pooled controls have editing ratio at least 0.1Also quantify gene expression as RPKM values over the exon union of ENSEMBL transcripts in hg19.Genome_build: hg19Supplementary_files_format_and_content: gene expression (RPKM) *#*#*#RNA-Seq*#*#*#polyA-selectedfragileX definition: sample derived from patient diagnosed with Fragile X Syndrome *#*#*#GPL11154*#*#*#2018-12-14*#*#*#2018-12-14*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Brain 	30559470	null	Homo sapiens	null	high-throughput sequencing	human frontal cortex	Brain	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-12-14	2018-12-14	NONE 	GPL11154	fragile X|Fragile X Syndrome	OMIM:300624;MESH:D005600;BERN:106912101	OMIM:300624=>FRAGILE X SYNDROME: FXS;MESH:D005600=>Fragile X Syndrome	FRAGILE X SYNDROME: FXS|Fragile X Syndrome	guanosines|adenosines	CHEBI:24458;BERN:296324403|CHEBI:22260;BERN:281587603	null|null	CHEBI:24458=>null|CHEBI:22260=>null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117776	GSM3308622	{'tissue':'Brain ','organism':'Homo sapiens','source name':'human frontal cortex', 'title':'fragileX_sample_JS03', 'last update date':'2018-12-14', 'release date': '2018-12-14', 'method': 'high-throughput sequencing'}	GSM3308622*#*#*#fragileX_sample_JS03*#*#*#1*#*#*#human frontal cortex*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Map fastq reads with HISAT2 hisat2 -q --phred64 -x grch37_tran/genome_tran --no-unal --reorder --no-mixedExtract uniquely mapped reads from SAM filesRemap unmapped reads with hyperediting pipeline. In brief, convert all adenosines to guanosines and align to modified hg19 genome where adenosines are also substituted by guanosines.Obtain uniquely mapped reads pairs from hyperediting pipeline and combine with uniquely mapped reads from first round of read mappingIdentify RNA-DNA differences between mapped reads and hg19 reference genome.Apply log-likelihood test to determine whether RDD is likely resulted from sequencing error (Bahn et. al. PMID: 21960545)Apply posterior filters to remove RDD sites that are likely caused by technical artifats (Bahn et. al. PMID: 21960545 and Lee et. al. PMID: 23598527)Retain only highly prevalent editing sites. In particular, filter for editing sites where both pooled fragile X and pooled controls have at least 10 reads each and where pooled fragile X or pooled controls have editing ratio at least 0.1Also quantify gene expression as RPKM values over the exon union of ENSEMBL transcripts in hg19.Genome_build: hg19Supplementary_files_format_and_content: gene expression (RPKM) *#*#*#RNA-Seq*#*#*#polyA-selectedfragileX definition: sample derived from patient diagnosed with Fragile X Syndrome *#*#*#GPL11154*#*#*#2018-12-14*#*#*#2018-12-14*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Brain 	30559470	null	Homo sapiens	null	high-throughput sequencing	human frontal cortex	Brain	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-12-14	2018-12-14	NONE 	GPL11154	fragile X|Fragile X Syndrome	OMIM:300624;MESH:D005600;BERN:106912101	OMIM:300624=>FRAGILE X SYNDROME: FXS;MESH:D005600=>Fragile X Syndrome	FRAGILE X SYNDROME: FXS|Fragile X Syndrome	guanosines|adenosines	CHEBI:24458;BERN:296324403|CHEBI:22260;BERN:281587603	null|null	CHEBI:24458=>null|CHEBI:22260=>null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117776	GSM3308623	{'tissue':'Brain ','organism':'Homo sapiens','source name':'human frontal cortex', 'title':'control_sample_UCD1407', 'last update date':'2018-12-14', 'release date': '2018-12-14', 'method': 'high-throughput sequencing'}	GSM3308623*#*#*#control_sample_UCD1407*#*#*#1*#*#*#human frontal cortex*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Map fastq reads with HISAT2 hisat2 -q --phred64 -x grch37_tran/genome_tran --no-unal --reorder --no-mixedExtract uniquely mapped reads from SAM filesRemap unmapped reads with hyperediting pipeline. In brief, convert all adenosines to guanosines and align to modified hg19 genome where adenosines are also substituted by guanosines.Obtain uniquely mapped reads pairs from hyperediting pipeline and combine with uniquely mapped reads from first round of read mappingIdentify RNA-DNA differences between mapped reads and hg19 reference genome.Apply log-likelihood test to determine whether RDD is likely resulted from sequencing error (Bahn et. al. PMID: 21960545)Apply posterior filters to remove RDD sites that are likely caused by technical artifats (Bahn et. al. PMID: 21960545 and Lee et. al. PMID: 23598527)Retain only highly prevalent editing sites. In particular, filter for editing sites where both pooled fragile X and pooled controls have at least 10 reads each and where pooled fragile X or pooled controls have editing ratio at least 0.1Also quantify gene expression as RPKM values over the exon union of ENSEMBL transcripts in hg19.Genome_build: hg19Supplementary_files_format_and_content: gene expression (RPKM) *#*#*#RNA-Seq*#*#*#polyA-selectedcontrol definition: sample derived from control individual *#*#*#GPL11154*#*#*#2018-12-14*#*#*#2018-12-14*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Brain 	30559470	null	Homo sapiens	null	high-throughput sequencing	human frontal cortex	Brain	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-12-14	2018-12-14	NONE 	GPL11154	fragile X	OMIM:300624;MESH:D005600;BERN:106912101	OMIM:300624=>FRAGILE X SYNDROME: FXS;MESH:D005600=>Fragile X Syndrome	FRAGILE X SYNDROME: FXS|Fragile X Syndrome	guanosines|adenosines	CHEBI:24458;BERN:296324403|CHEBI:22260;BERN:281587603	null|null	CHEBI:24458=>null|CHEBI:22260=>null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117776	GSM3308624	{'tissue':'Brain ','organism':'Homo sapiens','source name':'human frontal cortex', 'title':'control_sample_103710XX', 'last update date':'2018-12-14', 'release date': '2018-12-14', 'method': 'high-throughput sequencing'}	GSM3308624*#*#*#control_sample_103710XX*#*#*#1*#*#*#human frontal cortex*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Map fastq reads with HISAT2 hisat2 -q --phred64 -x grch37_tran/genome_tran --no-unal --reorder --no-mixedExtract uniquely mapped reads from SAM filesRemap unmapped reads with hyperediting pipeline. In brief, convert all adenosines to guanosines and align to modified hg19 genome where adenosines are also substituted by guanosines.Obtain uniquely mapped reads pairs from hyperediting pipeline and combine with uniquely mapped reads from first round of read mappingIdentify RNA-DNA differences between mapped reads and hg19 reference genome.Apply log-likelihood test to determine whether RDD is likely resulted from sequencing error (Bahn et. al. PMID: 21960545)Apply posterior filters to remove RDD sites that are likely caused by technical artifats (Bahn et. al. PMID: 21960545 and Lee et. al. PMID: 23598527)Retain only highly prevalent editing sites. In particular, filter for editing sites where both pooled fragile X and pooled controls have at least 10 reads each and where pooled fragile X or pooled controls have editing ratio at least 0.1Also quantify gene expression as RPKM values over the exon union of ENSEMBL transcripts in hg19.Genome_build: hg19Supplementary_files_format_and_content: gene expression (RPKM) *#*#*#RNA-Seq*#*#*#polyA-selectedcontrol definition: sample derived from control individual *#*#*#GPL11154*#*#*#2018-12-14*#*#*#2018-12-14*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)Brain 	30559470	null	Homo sapiens	null	high-throughput sequencing	human frontal cortex	Brain	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-12-14	2018-12-14	NONE 	GPL11154	fragile X	OMIM:300624;MESH:D005600;BERN:106912101	OMIM:300624=>FRAGILE X SYNDROME: FXS;MESH:D005600=>Fragile X Syndrome	FRAGILE X SYNDROME: FXS|Fragile X Syndrome	guanosines|adenosines	CHEBI:24458;BERN:296324403|CHEBI:22260;BERN:281587603	null|null	CHEBI:24458=>null|CHEBI:22260=>null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117796	GSM3308820	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C01: shNS etoh replicate 1', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308820*#*#*#Nalm6_RNAseq_C01: shNS etoh replicate 1*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a|shNS	MIM:606977;HGNC:18621;Ensembl:ENSG00000133103;BERN:324542402|MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:18621=>COG6;Ensembl:ENSG00000133103=>COG6;MIM:606977=>COG6|HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	COG6|EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308821	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C02: shNS dex replicate 1', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308821*#*#*#Nalm6_RNAseq_C02: shNS dex replicate 1*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a|shNS	MIM:606977;HGNC:18621;Ensembl:ENSG00000133103;BERN:324542402|MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:18621=>COG6;Ensembl:ENSG00000133103=>COG6;MIM:606977=>COG6|HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	COG6|EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308822	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C03: shG9a etoh replicate 1', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308822*#*#*#Nalm6_RNAseq_C03: shG9a etoh replicate 1*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308823	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C04: shG9a dex replicate 1', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308823*#*#*#Nalm6_RNAseq_C04: shG9a dex replicate 1*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308824	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C05: shGLP etoh replicate 1', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308824*#*#*#Nalm6_RNAseq_C05: shGLP etoh replicate 1*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308825	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C06: shGLP dex replicate 1', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308825*#*#*#Nalm6_RNAseq_C06: shGLP dex replicate 1*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308826	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C07: shHP1g etoh replicate 1', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308826*#*#*#Nalm6_RNAseq_C07: shHP1g etoh replicate 1*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308827	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C08: shHP1g dex replicate 1', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308827*#*#*#Nalm6_RNAseq_C08: shHP1g dex replicate 1*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308828	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C09: shNS etoh replicate 2', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308828*#*#*#Nalm6_RNAseq_C09: shNS etoh replicate 2*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a|shNS	MIM:606977;HGNC:18621;Ensembl:ENSG00000133103;BERN:324542402|MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:18621=>COG6;Ensembl:ENSG00000133103=>COG6;MIM:606977=>COG6|HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	COG6|EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308829	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C10: shNS dex replicate 2', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308829*#*#*#Nalm6_RNAseq_C10: shNS dex replicate 2*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308830	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C11: shG9a etoh replicate 2', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308830*#*#*#Nalm6_RNAseq_C11: shG9a etoh replicate 2*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308831	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C12: shG9a dex replicate 2', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308831*#*#*#Nalm6_RNAseq_C12: shG9a dex replicate 2*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308832	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C13: shGLP etoh replicate 2', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308832*#*#*#Nalm6_RNAseq_C13: shGLP etoh replicate 2*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308833	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C14: shGLP dex replicate 2', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308833*#*#*#Nalm6_RNAseq_C14: shGLP dex replicate 2*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308834	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C15: shHP1g etoh replicate 2', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308834*#*#*#Nalm6_RNAseq_C15: shHP1g etoh replicate 2*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308835	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C16: shHP1g dex replicate 2', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308835*#*#*#Nalm6_RNAseq_C16: shHP1g dex replicate 2*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308836	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C17: shNS etoh replicate 3', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308836*#*#*#Nalm6_RNAseq_C17: shNS etoh replicate 3*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a|shNS	MIM:606977;HGNC:18621;Ensembl:ENSG00000133103;BERN:324542402|MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:18621=>COG6;Ensembl:ENSG00000133103=>COG6;MIM:606977=>COG6|HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	COG6|EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308837	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C18: shNS dex replicate 3', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308837*#*#*#Nalm6_RNAseq_C18: shNS dex replicate 3*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308838	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C19: shG9a etoh replicate 3', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308838*#*#*#Nalm6_RNAseq_C19: shG9a etoh replicate 3*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308839	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C20: shG9a dex replicate 3', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308839*#*#*#Nalm6_RNAseq_C20: shG9a dex replicate 3*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308840	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C21: shGLP etoh replicate 3', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308840*#*#*#Nalm6_RNAseq_C21: shGLP etoh replicate 3*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308841	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C22: shGLP dex replicate 3', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308841*#*#*#Nalm6_RNAseq_C22: shGLP dex replicate 3*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308842	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C23: shHP1g etoh replicate 3', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308842*#*#*#Nalm6_RNAseq_C23: shHP1g etoh replicate 3*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117796	GSM3308843	{'tissue':'acute lymphoblastic leukemia cell line ','cell line':'Nalm6 ','organism':'Homo sapiens','source name':'Nalm6 cells', 'title':'Nalm6_RNAseq_C24: shHP1g dex replicate 3', 'last update date':'2018-10-18', 'release date': '2018-10-18', 'method': 'high-throughput sequencing'}	GSM3308843*#*#*#Nalm6_RNAseq_C24: shHP1g dex replicate 3*#*#*#1*#*#*#Nalm6 cells*#*#*#Homo sapiens*#*#*#Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h. *#*#*#total RNA*#*#*#null*#*#*#NextSeq Control Software (NCS) v1.4 was used for base callingAfter trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genomeMapped reads were quantified to known UCSC genes using the GenomicAlignments R packageGene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzedWe implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.Genome_build: hg19Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene *#*#*#RNA-Seq*#*#*#null*#*#*#GPL18573*#*#*#2018-10-18*#*#*#2018-10-18*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)acute lymphoblastic leukemia cell line *#*#*#[char](cell line)Nalm6 	30305606	Nalm6	Homo sapiens	null	high-throughput sequencing	Nalm6 cells	acute lymphoblastic leukemia cell line	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-10-18	2018-10-18	NONE 	GPL18573	lymphoblastic leukemia	OMIM:613065;MESH:D054198;BERN:107405101	OMIM:613065=>LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL;MESH:D054198=>Precursor Cell Lymphoblastic Leukemia-Lymphoma	LEUKEMIA, ACUTE LYMPHOBLASTIC: ALL|Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dex|ethanol|Dexamethasone	CHEBI:16236;BERN:4168403|MESH:D003907;BERN:4134303	CHEBI:16236=>ethanol|CHEBI:16236=>ethanol;MESH:D003907=>Dexamethasone	Dexamethasone|ethanol	GLP|G9a	MIM:610288;HGNC:13567;Ensembl:ENSG00000159289;BERN:323683802|MIM:604599;HGNC:14129;Ensembl:ENSG00000204371;BERN:322686402	HGNC:13567=>GOLGA6A;Ensembl:ENSG00000159289=>GOLGA6A;MIM:610288=>GOLGA6A|HGNC:14129=>EHMT2;Ensembl:ENSG00000204371=>EHMT2;MIM:604599=>EHMT2	EHMT2|GOLGA6A	null	null	null	null	null	null	null	null
GSE117798	GSM3309421	{'tissue/cell type':'post-transplant lymphoproliferative disease (PTLD) ','ebv status with eber':'EBER staining negative ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'tissue', 'title':'Sample 1_PTLD4', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309421*#*#*#Sample 1_PTLD4*#*#*#1*#*#*#tissue*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#PLTD4_R1232 *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue/cell type)post-transplant lymphoproliferative disease (PTLD) *#*#*#[char](ebv status with eber)EBER staining negative *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	null	Homo sapiens	null	high-throughput sequencing	tissue	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309421/suppl/GSM3309421_PTLD4-R1232vsHg19.txt.gz 	GPL20795	PTLD|lymphoproliferative disease	BERN:258473301|MESH:D008232;OMIM:308240;BERN:106984501	OMIM:308240=>LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1: XLP1;MESH:D008232=>Lymphoproliferative Disorders	Lymphoproliferative Disorders|LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1: XLP1	DMSO|TPA	CHEBI:53394;BERN:311737603|MESH:D004121;BERN:4277403	null|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	null	null	null	null	null	null	null	null	null	BCBL1	null	null
GSE117798	GSM3309422	{'tissue/cell type':'post-transplant lymphoproliferative disease (PTLD) ','ebv status with eber':'EBER staining negative ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'tissue', 'title':'Sample 2_PTLD5', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309422*#*#*#Sample 2_PTLD5*#*#*#1*#*#*#tissue*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#PLTD5_R1233 *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue/cell type)post-transplant lymphoproliferative disease (PTLD) *#*#*#[char](ebv status with eber)EBER staining negative *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	null	Homo sapiens	null	high-throughput sequencing	tissue	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309422/suppl/GSM3309422_PTLD5-R1233vsHg19.txt.gz 	GPL20795	PTLD|lymphoproliferative disease	BERN:258473301|MESH:D008232;OMIM:308240;BERN:106984501	OMIM:308240=>LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1: XLP1;MESH:D008232=>Lymphoproliferative Disorders	Lymphoproliferative Disorders|LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1: XLP1	DMSO|TPA	CHEBI:53394;BERN:311737603|MESH:D004121;BERN:4277403	null|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	null	null	null	null	null	null	null	null	null	BCBL1	null	null
GSE117798	GSM3309423	{'tissue/cell type':'post-transplant lymphoproliferative disease (PTLD) ','ebv status with eber':'EBER staining positive ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'tissue', 'title':'Sample 3_PTLD6', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309423*#*#*#Sample 3_PTLD6*#*#*#1*#*#*#tissue*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#PLTD6_R1235 *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue/cell type)post-transplant lymphoproliferative disease (PTLD) *#*#*#[char](ebv status with eber)EBER staining positive *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	null	Homo sapiens	null	high-throughput sequencing	tissue	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309423/suppl/GSM3309423_PTLD6-R1235vsEBV.txt.gz 	GPL20795	PTLD|lymphoproliferative disease	BERN:258473301|MESH:D008232;OMIM:308240;BERN:106984501	OMIM:308240=>LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1: XLP1;MESH:D008232=>Lymphoproliferative Disorders	Lymphoproliferative Disorders|LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1: XLP1	DMSO|TPA	CHEBI:53394;BERN:311737603|MESH:D004121;BERN:4277403	null|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	null	null	null	null	null	null	null	null	null	BCBL1	null	null
GSE117798	GSM3309424	{'tissue/cell type':'post-transplant lymphoproliferative disease (PTLD) ','ebv status with eber':'EBER staining positive ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'tissue', 'title':'Sample 4_PTLD9', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309424*#*#*#Sample 4_PTLD9*#*#*#1*#*#*#tissue*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#PLTD9_R1243 *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue/cell type)post-transplant lymphoproliferative disease (PTLD) *#*#*#[char](ebv status with eber)EBER staining positive *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	null	Homo sapiens	null	high-throughput sequencing	tissue	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309424/suppl/GSM3309424_PTLD9-R1243vsEBV.txt.gz 	GPL20795	PTLD|lymphoproliferative disease	BERN:258473301|MESH:D008232;OMIM:308240;BERN:106984501	OMIM:308240=>LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1: XLP1;MESH:D008232=>Lymphoproliferative Disorders	Lymphoproliferative Disorders|LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1: XLP1	DMSO|TPA	CHEBI:53394;BERN:311737603|MESH:D004121;BERN:4277403	null|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	null	null	null	null	null	null	null	null	null	BCBL1	null	null
GSE117798	GSM3309425	{'cell line':'BC1 ','tissue/cell type':'lymphoma cell line ','dmso vs nab/tpa':'DMSO treated ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'cell line', 'title':'Sample 5_BC1_UNT', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309425*#*#*#Sample 5_BC1_UNT*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#BC1_UNT *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)BC1 *#*#*#[char](tissue/cell type)lymphoma cell line *#*#*#[char](dmso vs nab/tpa)DMSO treated *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	BC1	Homo sapiens	null	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309425/suppl/GSM3309425_BC1_UNTvsEBVtxt.txt.gz 	GPL20795	lymphoma	MESH:D008223;BERN:106966001	MESH:D008223=>Lymphoma	Lymphoma	DMSO|TPA	CHEBI:53394;BERN:311737603|MESH:D004121;BERN:4277403	null|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	tpa	MIM:173370;HGNC:9051;Ensembl:ENSG00000104368;BERN:324298802	HGNC:9051=>PLAT;Ensembl:ENSG00000104368=>PLAT;MIM:173370=>PLAT	PLAT	null	null	null	null	BC1	BC1|BCBL1	null	null
GSE117798	GSM3309426	{'cell line':'BC1 ','tissue/cell type':'lymphoma cell line ','dmso vs nab/tpa':'NaB/TPA treated for 48h ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'cell line', 'title':'Sample 6_BC1_NaB/TPA', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309426*#*#*#Sample 6_BC1_NaB/TPA*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#BC1_NaB-TPA *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)BC1 *#*#*#[char](tissue/cell type)lymphoma cell line *#*#*#[char](dmso vs nab/tpa)NaB/TPA treated for 48h *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	BC1	Homo sapiens	null	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309426/suppl/GSM3309426_BC1_NaB-TPAvsEBV.txt.gz 	GPL20795	null	null	null	null	DMSO|TPA	MESH:D004121;BERN:4277403|CHEBI:53394;BERN:311737603	MESH:D004121=>Dimethyl Sulfoxide|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	tpa	MIM:173370;HGNC:9051;Ensembl:ENSG00000104368;BERN:324298802	HGNC:9051=>PLAT;Ensembl:ENSG00000104368=>PLAT;MIM:173370=>PLAT	PLAT	null	null	null	null	BC1	BC1|BCBL1	null	null
GSE117798	GSM3309427	{'cell line':'BCBL1 ','tissue/cell type':'B cell lymphoma cell line ','dmso vs nab/tpa':'DMSO treated ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'cell line', 'title':'Sample 7_BCBL1_UNT', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309427*#*#*#Sample 7_BCBL1_UNT*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#BCBL1_UNT *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)BCBL1 *#*#*#[char](tissue/cell type)B cell lymphoma cell line *#*#*#[char](dmso vs nab/tpa)DMSO treated *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	BCBL1	Homo sapiens	null	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309427/suppl/GSM3309427_BCBL1_UNTvsHg19.txt.gz 	GPL20795	B cell lymphoma	MESH:D016393;BERN:107548501	MESH:D016393=>Lymphoma, B-Cell	Lymphoma, B-Cell	DMSO|TPA	CHEBI:53394;BERN:311737603|MESH:D004121;BERN:4277403	null|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	tpa	MIM:173370;HGNC:9051;Ensembl:ENSG00000104368;BERN:324298802	HGNC:9051=>PLAT;Ensembl:ENSG00000104368=>PLAT;MIM:173370=>PLAT	PLAT	null	null	null	null	BCBL1	BCBL1	null	null
GSE117798	GSM3309428	{'cell line':'BCBL1 ','tissue/cell type':'B cell lymphoma cell line ','dmso vs nab/tpa':'NaB/TPA treated for 48h ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'cell line', 'title':'Sample 8_BCBL1_NaB/TPA', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309428*#*#*#Sample 8_BCBL1_NaB/TPA*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#BCBL1_NaB-TPA *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)BCBL1 *#*#*#[char](tissue/cell type)B cell lymphoma cell line *#*#*#[char](dmso vs nab/tpa)NaB/TPA treated for 48h *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	BCBL1	Homo sapiens	null	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309428/suppl/GSM3309428_BCBL1_NaB-TPAvsHg19.txt.gz 	GPL20795	cell lymphoma	MESH:D008228;OMIM:605027;BERN:107530201	OMIM:605027=>LYMPHOMA, NON-HODGKIN, FAMILIAL;MESH:D008228=>Lymphoma, Non-Hodgkin	Lymphoma, Non-Hodgkin|LYMPHOMA, NON-HODGKIN, FAMILIAL	DMSO|TPA	CHEBI:53394;BERN:311737603|MESH:D004121;BERN:4277403	null|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	tpa	MIM:173370;HGNC:9051;Ensembl:ENSG00000104368;BERN:324298802	HGNC:9051=>PLAT;Ensembl:ENSG00000104368=>PLAT;MIM:173370=>PLAT	PLAT	null	null	null	null	BCBL1	BCBL1	null	null
GSE117798	GSM3309429	{'cell line':'BJAB ','tissue/cell type':'Burkitt-like lymphoma cell line ','dmso vs nab/tpa':'DMSO treated ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'cell line', 'title':'Sample 9_BJAB_UNT', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309429*#*#*#Sample 9_BJAB_UNT*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#BJAB_UNT *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)BJAB *#*#*#[char](tissue/cell type)Burkitt-like lymphoma cell line *#*#*#[char](dmso vs nab/tpa)DMSO treated *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	BJAB	Homo sapiens	null	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309429/suppl/GSM3309429_BJAB_UNTvsHg19.txt.gz 	GPL20795	lymphoma	MESH:D008223;BERN:106966001	MESH:D008223=>Lymphoma	Lymphoma	DMSO|TPA	CHEBI:53394;BERN:311737603|MESH:D004121;BERN:4277403	null|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	tpa	MIM:173370;HGNC:9051;Ensembl:ENSG00000104368;BERN:324298802	HGNC:9051=>PLAT;Ensembl:ENSG00000104368=>PLAT;MIM:173370=>PLAT	PLAT	null	null	null	null	BJAB	BCBL1|BJAB	null	null
GSE117798	GSM3309430	{'cell line':'BJAB ','tissue/cell type':'Burkitt-like lymphoma cell line ','dmso vs nab/tpa':'NaB/TPA treated for 48h ','molecule subtype':'RnaseR+, ribosome depleted RNA ','organism':'Homo sapiens','source name':'cell line', 'title':'Sample 10_BJAB_NaB/TPA', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309430*#*#*#Sample 10_BJAB_NaB/TPA*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#Samples 5, 7, and 9 were treated with DMSO for 48 hours and harvested for RNA extraction. Samples 6, 8, and 10 were treated with 20ng/ml TPA and 3mM NaB for 48 hours and harvested for RNA extraction. *#*#*#total RNA*#*#*#null*#*#*#Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence with trim galore, then mapped to Hg19 or KSHV/EBV genomesFASTA formatted reference sequence and a SAM alignment generated by the BWA-MEM algorithmBackspliced splice junctions were identified and mapped using CIRI2 prediction algorithmGenome_build: Hg19 and EBV (Mutu strain KC207814), KSHV (BCBL1 strain HQ404500.1) reference genome filesSupplementary_files_format_and_content: ciri2 outfile (txt) *#*#*#RNA-Seq*#*#*#BJAB_NaB-TPA *#*#*#GPL20795*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell line)BJAB *#*#*#[char](tissue/cell type)Burkitt-like lymphoma cell line *#*#*#[char](dmso vs nab/tpa)NaB/TPA treated for 48h *#*#*#[char](molecule subtype)RnaseR+, ribosome depleted RNA 	30150410	BJAB	Homo sapiens	null	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309430/suppl/GSM3309430_BJAB_NaB-TPAvsHg19.txt.gz 	GPL20795	null	null	null	null	DMSO|TPA	CHEBI:53394;BERN:311737603|MESH:D004121;BERN:4277403	null|null;MESH:D004121=>Dimethyl Sulfoxide	Dimethyl Sulfoxide|CHEBI:53394=>null	tpa	MIM:173370;HGNC:9051;Ensembl:ENSG00000104368;BERN:324298802	HGNC:9051=>PLAT;Ensembl:ENSG00000104368=>PLAT;MIM:173370=>PLAT	PLAT	null	null	null	null	BJAB	BCBL1|BJAB	null	null
GSE117803	GSM3309466	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'001_SCT80_AIT_015_Bcells_Control_A1', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309466*#*#*#001_SCT80_AIT_015_Bcells_Control_A1*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#001_SCT80_AIT_015_Bcells_Control_A1_S1 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	ige	MIM:147180;HGNC:5522;IMGT/GENE-DB:IGHE;BERN:323723302	HGNC:5522=>IGHE;MIM:147180=>IGHE	IGHE	null	null	null	null	null	null	null	null
GSE117803	GSM3309467	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'002_SCT80_AIT_015_Bcells_B1', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309467*#*#*#002_SCT80_AIT_015_Bcells_B1*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#002_SCT80_AIT_015_Bcells_B1_S2 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309468	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'003_SCT80_AIT_015_Bcells_C1', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309468*#*#*#003_SCT80_AIT_015_Bcells_C1*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#003_SCT80_AIT_015_Bcells_C1_S3 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309469	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'004_SCT80_AIT_015_Bcells_D1', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309469*#*#*#004_SCT80_AIT_015_Bcells_D1*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#004_SCT80_AIT_015_Bcells_D1_S4 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309470	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'005_SCT80_AIT_015_Bcells_E1', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309470*#*#*#005_SCT80_AIT_015_Bcells_E1*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#005_SCT80_AIT_015_Bcells_E1_S5 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	E1	BERN:324581902			null	null	null	null	null	null	null	null
GSE117803	GSM3309471	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'006_SCT80_AIT_015_Bcells_F1', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309471*#*#*#006_SCT80_AIT_015_Bcells_F1*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#006_SCT80_AIT_015_Bcells_F1_S6 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309472	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'007_SCT80_AIT_015_Bcells_G1', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309472*#*#*#007_SCT80_AIT_015_Bcells_G1*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#007_SCT80_AIT_015_Bcells_G1_S7 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309473	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'008_SCT80_AIT_015_Bcells_H1', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309473*#*#*#008_SCT80_AIT_015_Bcells_H1*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#008_SCT80_AIT_015_Bcells_H1_S8 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309474	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'009_SCT80_AIT_015_Bcells_A2', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309474*#*#*#009_SCT80_AIT_015_Bcells_A2*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#009_SCT80_AIT_015_Bcells_A2_S9 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309475	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'010_SCT80_AIT_015_Bcells_B2', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309475*#*#*#010_SCT80_AIT_015_Bcells_B2*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#010_SCT80_AIT_015_Bcells_B2_S10 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309476	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'011_SCT80_AIT_015_Bcells_C2', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309476*#*#*#011_SCT80_AIT_015_Bcells_C2*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#011_SCT80_AIT_015_Bcells_C2_S11 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309477	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'012_SCT80_AIT_015_Bcells_D2', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309477*#*#*#012_SCT80_AIT_015_Bcells_D2*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#012_SCT80_AIT_015_Bcells_D2_S12 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309478	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'013_SCT80_AIT_015_Bcells_E2', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309478*#*#*#013_SCT80_AIT_015_Bcells_E2*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#013_SCT80_AIT_015_Bcells_E2_S13 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	E2	BERN:323039202			null	null	null	null	null	null	null	null
GSE117803	GSM3309479	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'014_SCT80_AIT_015_Bcells_F2', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309479*#*#*#014_SCT80_AIT_015_Bcells_F2*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#014_SCT80_AIT_015_Bcells_F2_S14 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309480	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'015_SCT80_AIT_015_Bcells_G2', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309480*#*#*#015_SCT80_AIT_015_Bcells_G2*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#015_SCT80_AIT_015_Bcells_G2_S15 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309481	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'016_SCT80_AIT_015_Bcells_H2', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309481*#*#*#016_SCT80_AIT_015_Bcells_H2*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#016_SCT80_AIT_015_Bcells_H2_S16 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309482	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'yes ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'017_SCT80_AIT_015_Bcells_A3', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309482*#*#*#017_SCT80_AIT_015_Bcells_A3*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#017_SCT80_AIT_015_Bcells_A3_S17 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)yes 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309483	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'018_SCT80_AIT_015_Bcells_B3', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309483*#*#*#018_SCT80_AIT_015_Bcells_B3*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#018_SCT80_AIT_015_Bcells_B3_S18 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309484	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'019_SCT80_AIT_015_Bcells_C3', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309484*#*#*#019_SCT80_AIT_015_Bcells_C3*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#019_SCT80_AIT_015_Bcells_C3_S19 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309485	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'021_SCT80_AIT_015_Bcells_E3', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309485*#*#*#021_SCT80_AIT_015_Bcells_E3*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#021_SCT80_AIT_015_Bcells_E3_S20 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309486	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'022_SCT80_AIT_015_Bcells_F3', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309486*#*#*#022_SCT80_AIT_015_Bcells_F3*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#022_SCT80_AIT_015_Bcells_F3_S21 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309487	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'023_SCT80_AIT_015_Bcells_G3', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309487*#*#*#023_SCT80_AIT_015_Bcells_G3*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#023_SCT80_AIT_015_Bcells_G3_S22 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309488	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'024_SCT80_AIT_015_Bcells_H3', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309488*#*#*#024_SCT80_AIT_015_Bcells_H3*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#024_SCT80_AIT_015_Bcells_H3_S23 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309489	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'025_SCT80_AIT_015_Bcells_A4', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309489*#*#*#025_SCT80_AIT_015_Bcells_A4*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#025_SCT80_AIT_015_Bcells_A4_S24 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309490	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'026_SCT80_AIT_015_Bcells_B4', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309490*#*#*#026_SCT80_AIT_015_Bcells_B4*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#026_SCT80_AIT_015_Bcells_B4_S25 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309491	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'027_SCT80_AIT_015_Bcells_C4', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309491*#*#*#027_SCT80_AIT_015_Bcells_C4*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#027_SCT80_AIT_015_Bcells_C4_S26 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309492	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'028_SCT80_AIT_015_Bcells_D4', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309492*#*#*#028_SCT80_AIT_015_Bcells_D4*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#028_SCT80_AIT_015_Bcells_D4_S27 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309493	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'029_SCT80_AIT_015_Bcells_E4', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309493*#*#*#029_SCT80_AIT_015_Bcells_E4*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#029_SCT80_AIT_015_Bcells_E4_S28 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309494	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'030_SCT80_AIT_015_Bcells_F4', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309494*#*#*#030_SCT80_AIT_015_Bcells_F4*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#030_SCT80_AIT_015_Bcells_F4_S29 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309495	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'031_SCT80_AIT_015_Bcells_G4', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309495*#*#*#031_SCT80_AIT_015_Bcells_G4*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#031_SCT80_AIT_015_Bcells_G4_S30 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309496	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'032_SCT80_AIT_015_Bcells_H4', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309496*#*#*#032_SCT80_AIT_015_Bcells_H4*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#032_SCT80_AIT_015_Bcells_H4_S31 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309497	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'033_SCT80_AIT_015_Bcells_A5', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309497*#*#*#033_SCT80_AIT_015_Bcells_A5*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#033_SCT80_AIT_015_Bcells_A5_S32 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309498	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'034_SCT80_AIT_015_Bcells_B5', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309498*#*#*#034_SCT80_AIT_015_Bcells_B5*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#034_SCT80_AIT_015_Bcells_B5_S33 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309499	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'035_SCT80_AIT_015_Bcells_C5', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309499*#*#*#035_SCT80_AIT_015_Bcells_C5*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#035_SCT80_AIT_015_Bcells_C5_S34 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309500	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'036_SCT80_AIT_015_Bcells_D5', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309500*#*#*#036_SCT80_AIT_015_Bcells_D5*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#036_SCT80_AIT_015_Bcells_D5_S35 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309501	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'037_SCT80_AIT_015_Bcells_E5', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309501*#*#*#037_SCT80_AIT_015_Bcells_E5*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#037_SCT80_AIT_015_Bcells_E5_S36 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309502	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'038_SCT80_AIT_015_Bcells_F5', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309502*#*#*#038_SCT80_AIT_015_Bcells_F5*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#038_SCT80_AIT_015_Bcells_F5_S37 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309503	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'039_SCT80_AIT_015_Bcells_G5', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309503*#*#*#039_SCT80_AIT_015_Bcells_G5*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#039_SCT80_AIT_015_Bcells_G5_S38 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309504	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'040_SCT80_AIT_015_Bcells_H5', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309504*#*#*#040_SCT80_AIT_015_Bcells_H5*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#040_SCT80_AIT_015_Bcells_H5_S39 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309505	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'041_SCT80_AIT_015_Bcells_A6', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309505*#*#*#041_SCT80_AIT_015_Bcells_A6*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#041_SCT80_AIT_015_Bcells_A6_S40 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309506	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'042_SCT80_AIT_015_Bcells_B6', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309506*#*#*#042_SCT80_AIT_015_Bcells_B6*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#042_SCT80_AIT_015_Bcells_B6_S41 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309507	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'043_SCT80_AIT_015_Bcells_C6', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309507*#*#*#043_SCT80_AIT_015_Bcells_C6*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#043_SCT80_AIT_015_Bcells_C6_S42 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309508	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'044_SCT80_AIT_015_Bcells_D6', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309508*#*#*#044_SCT80_AIT_015_Bcells_D6*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#044_SCT80_AIT_015_Bcells_D6_S43 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309509	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'045_SCT80_AIT_015_Bcells_E6', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309509*#*#*#045_SCT80_AIT_015_Bcells_E6*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#045_SCT80_AIT_015_Bcells_E6_S44 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	E6	BERN:326427402			null	null	null	null	null	null	null	null
GSE117803	GSM3309510	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'046_SCT80_AIT_015_Bcells_F6', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309510*#*#*#046_SCT80_AIT_015_Bcells_F6*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#046_SCT80_AIT_015_Bcells_F6_S45 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309511	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'047_SCT80_AIT_015_Bcells_G6', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309511*#*#*#047_SCT80_AIT_015_Bcells_G6*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#047_SCT80_AIT_015_Bcells_G6_S46 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309512	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'048_SCT80_AIT_015_Bcells_H6', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309512*#*#*#048_SCT80_AIT_015_Bcells_H6*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#048_SCT80_AIT_015_Bcells_H6_S47 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309513	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'049_SCT80_AIT_015_Bcells_A7', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309513*#*#*#049_SCT80_AIT_015_Bcells_A7*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#049_SCT80_AIT_015_Bcells_A7_S48 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309514	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'050_SCT80_AIT_015_Bcells_B7', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309514*#*#*#050_SCT80_AIT_015_Bcells_B7*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#050_SCT80_AIT_015_Bcells_B7_S49 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309515	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'051_SCT80_AIT_015_Bcells_C7', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309515*#*#*#051_SCT80_AIT_015_Bcells_C7*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#051_SCT80_AIT_015_Bcells_C7_S50 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309516	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'052_SCT80_AIT_015_Bcells_D7', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309516*#*#*#052_SCT80_AIT_015_Bcells_D7*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#052_SCT80_AIT_015_Bcells_D7_S51 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309517	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'054_SCT80_AIT_015_Bcells_F7', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309517*#*#*#054_SCT80_AIT_015_Bcells_F7*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#054_SCT80_AIT_015_Bcells_F7_S52 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309518	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'055_SCT80_AIT_015_Bcells_G7', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309518*#*#*#055_SCT80_AIT_015_Bcells_G7*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#055_SCT80_AIT_015_Bcells_G7_S53 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	S53	MIM:605485;HGNC:12713;Ensembl:ENSG00000006715;BERN:323374802	HGNC:12713=>VPS41;Ensembl:ENSG00000006715=>VPS41;MIM:605485=>VPS41	VPS41	null	null	null	null	null	null	null	null
GSE117803	GSM3309519	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'056_SCT80_AIT_015_Bcells_H7', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309519*#*#*#056_SCT80_AIT_015_Bcells_H7*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#056_SCT80_AIT_015_Bcells_H7_S54 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309520	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'057_SCT80_AIT_015_Bcells_A8', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309520*#*#*#057_SCT80_AIT_015_Bcells_A8*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#057_SCT80_AIT_015_Bcells_A8_S55 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309521	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'058_SCT80_AIT_015_Bcells_B8', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309521*#*#*#058_SCT80_AIT_015_Bcells_B8*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#058_SCT80_AIT_015_Bcells_B8_S56 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309522	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'059_SCT80_AIT_015_Bcells_C8', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309522*#*#*#059_SCT80_AIT_015_Bcells_C8*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#059_SCT80_AIT_015_Bcells_C8_S57 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309523	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'060_SCT80_AIT_015_Bcells_D8', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309523*#*#*#060_SCT80_AIT_015_Bcells_D8*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#060_SCT80_AIT_015_Bcells_D8_S58 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309524	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'061_SCT80_AIT_015_Bcells_E8', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309524*#*#*#061_SCT80_AIT_015_Bcells_E8*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#061_SCT80_AIT_015_Bcells_E8_S59 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309525	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'062_SCT80_AIT_015_Bcells_F8', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309525*#*#*#062_SCT80_AIT_015_Bcells_F8*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#062_SCT80_AIT_015_Bcells_F8_S60 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309526	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'063_SCT80_AIT_015_Bcells_G8', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309526*#*#*#063_SCT80_AIT_015_Bcells_G8*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#063_SCT80_AIT_015_Bcells_G8_S61 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309527	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'064_SCT80_AIT_015_Bcells_H8', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309527*#*#*#064_SCT80_AIT_015_Bcells_H8*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#064_SCT80_AIT_015_Bcells_H8_S62 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309528	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'065_SCT80_AIT_015_Bcells_A9', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309528*#*#*#065_SCT80_AIT_015_Bcells_A9*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#065_SCT80_AIT_015_Bcells_A9_S63 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309529	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'066_SCT80_AIT_015_Bcells_B9', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309529*#*#*#066_SCT80_AIT_015_Bcells_B9*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#066_SCT80_AIT_015_Bcells_B9_S64 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309530	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'067_SCT80_AIT_015_Bcells_C9', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309530*#*#*#067_SCT80_AIT_015_Bcells_C9*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#067_SCT80_AIT_015_Bcells_C9_S65 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309531	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'068_SCT80_AIT_015_Bcells_D9', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309531*#*#*#068_SCT80_AIT_015_Bcells_D9*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#068_SCT80_AIT_015_Bcells_D9_S66 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309532	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'069_SCT80_AIT_015_Bcells_E9', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309532*#*#*#069_SCT80_AIT_015_Bcells_E9*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#069_SCT80_AIT_015_Bcells_E9_S67 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309533	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'070_SCT80_AIT_015_Bcells_F9', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309533*#*#*#070_SCT80_AIT_015_Bcells_F9*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#070_SCT80_AIT_015_Bcells_F9_S68 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309534	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'071_SCT80_AIT_015_Bcells_G9', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309534*#*#*#071_SCT80_AIT_015_Bcells_G9*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#071_SCT80_AIT_015_Bcells_G9_S69 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309535	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'072_SCT80_AIT_015_Bcells_H9', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309535*#*#*#072_SCT80_AIT_015_Bcells_H9*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#072_SCT80_AIT_015_Bcells_H9_S70 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309536	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'073_SCT80_AIT_015_Bcells_A10', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309536*#*#*#073_SCT80_AIT_015_Bcells_A10*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#073_SCT80_AIT_015_Bcells_A10_S71 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309537	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'074_SCT80_AIT_015_Bcells_B10', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309537*#*#*#074_SCT80_AIT_015_Bcells_B10*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#074_SCT80_AIT_015_Bcells_B10_S72 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309538	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'075_SCT80_AIT_015_Bcells_C10', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309538*#*#*#075_SCT80_AIT_015_Bcells_C10*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#075_SCT80_AIT_015_Bcells_C10_S73 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309539	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'076_SCT80_AIT_015_Bcells_D10', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309539*#*#*#076_SCT80_AIT_015_Bcells_D10*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#076_SCT80_AIT_015_Bcells_D10_S74 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309540	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'077_SCT80_AIT_015_Bcells_E10', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309540*#*#*#077_SCT80_AIT_015_Bcells_E10*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#077_SCT80_AIT_015_Bcells_E10_S75 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309541	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'078_SCT80_AIT_015_Bcells_F10', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309541*#*#*#078_SCT80_AIT_015_Bcells_F10*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#078_SCT80_AIT_015_Bcells_F10_S76 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309542	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'079_SCT80_AIT_015_Bcells_G10', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309542*#*#*#079_SCT80_AIT_015_Bcells_G10*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#079_SCT80_AIT_015_Bcells_G10_S77 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309543	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'080_SCT80_AIT_015_Bcells_H10', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309543*#*#*#080_SCT80_AIT_015_Bcells_H10*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#080_SCT80_AIT_015_Bcells_H10_S78 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309544	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'081_SCT80_AIT_015_Bcells_A11', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309544*#*#*#081_SCT80_AIT_015_Bcells_A11*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#081_SCT80_AIT_015_Bcells_A11_S79 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309545	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'yes ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'083_SCT80_AIT_015_Bcells_C11', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309545*#*#*#083_SCT80_AIT_015_Bcells_C11*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#083_SCT80_AIT_015_Bcells_C11_S80 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)yes 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309546	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'084_SCT80_AIT_015_Bcells_D11', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309546*#*#*#084_SCT80_AIT_015_Bcells_D11*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#084_SCT80_AIT_015_Bcells_D11_S81 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309547	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'085_SCT80_AIT_015_Bcells_E11', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309547*#*#*#085_SCT80_AIT_015_Bcells_E11*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#085_SCT80_AIT_015_Bcells_E11_S82 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309548	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'086_SCT80_AIT_015_Bcells_F11', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309548*#*#*#086_SCT80_AIT_015_Bcells_F11*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#086_SCT80_AIT_015_Bcells_F11_S83 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309549	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'087_SCT80_AIT_015_Bcells_G11', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309549*#*#*#087_SCT80_AIT_015_Bcells_G11*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#087_SCT80_AIT_015_Bcells_G11_S84 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309550	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'088_SCT80_AIT_015_Bcells_H11', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309550*#*#*#088_SCT80_AIT_015_Bcells_H11*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#088_SCT80_AIT_015_Bcells_H11_S85 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309551	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'089_SCT80_AIT_015_Bcells_A12', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309551*#*#*#089_SCT80_AIT_015_Bcells_A12*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#089_SCT80_AIT_015_Bcells_A12_S86 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309552	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'090_SCT80_AIT_015_Bcells_B12', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309552*#*#*#090_SCT80_AIT_015_Bcells_B12*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#090_SCT80_AIT_015_Bcells_B12_S87 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309553	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'091_SCT80_AIT_015_Bcells_C12', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309553*#*#*#091_SCT80_AIT_015_Bcells_C12*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#091_SCT80_AIT_015_Bcells_C12_S88 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309554	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'092_SCT80_AIT_015_Bcells_D12', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309554*#*#*#092_SCT80_AIT_015_Bcells_D12*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#092_SCT80_AIT_015_Bcells_D12_S89 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309555	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'093_SCT80_AIT_015_Bcells_E12', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309555*#*#*#093_SCT80_AIT_015_Bcells_E12*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#093_SCT80_AIT_015_Bcells_E12_S90 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309556	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'094_SCT80_AIT_015_Bcells_F12', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309556*#*#*#094_SCT80_AIT_015_Bcells_F12*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#094_SCT80_AIT_015_Bcells_F12_S91 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309557	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'095_SCT80_AIT_015_Bcells_G12', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309557*#*#*#095_SCT80_AIT_015_Bcells_G12*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#095_SCT80_AIT_015_Bcells_G12_S92 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117803	GSM3309558	{'tissue':'blood ','cell type':'peripheral blood mononuclear cells ','cell subtype':'B cell ','true ige producing memory b cells':'no ','organism':'Homo sapiens','source name':'B cell single cell seq', 'title':'096_SCT80_AIT_015_Bcells_H12', 'last update date':'2019-07-31', 'release date': '2019-07-31', 'method': 'high-throughput sequencing'}	GSM3309558*#*#*#096_SCT80_AIT_015_Bcells_H12*#*#*#1*#*#*#B cell single cell seq*#*#*#Homo sapiens*#*#*#ex vivo staining and FACS sorted *#*#*#polyA RNA*#*#*#null*#*#*#Reads passing Illumina filters were further filtered for those mapping to tRNA, rRNA, adapters, and spike-in controls using Bowtie v1.0.0 (-S --fr)Filtered reads were mapped against the mm9 reference using Tophat v1.4.1 (--library-type fr-firststrand)Reads mapping to the reference genome are further filtered to remove low-complexity reads with PRINSEQ v0.20.3 (-lc_method "dust" -lc_threshold 4)Sequencing read coverage per gene was counted using HTSeq-count v0.7.1 (-m union -s yes -t exon -i gene_id) and features with 0 counts across all samples were removedSamples were then processed in R using the Seurat packageGenome_build: hg19Supplementary_files_format_and_content: read count matrix with rows as genes and columns as cells *#*#*#RNA-Seq*#*#*#096_SCT80_AIT_015_Bcells_H12_S93 *#*#*#GPL16791*#*#*#2019-07-31*#*#*#2019-07-31*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](tissue)blood *#*#*#[char](cell type)peripheral blood mononuclear cells *#*#*#[char](cell subtype)B cell *#*#*#[char](true ige producing memory b cells)no 	null	null	Homo sapiens	peripheral blood mononuclear cells	high-throughput sequencing	B cell single cell seq	blood	null	null	RNA-Seq	null	transcriptomic	polyA RNA	SRA	2019-07-31	2019-07-31	NONE 	GPL16791	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117805	GSM3309559	{'mimics':'Negative control ','rna type':'total RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with negative control mimic, total RNA, repeat III', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309559*#*#*#Cells with negative control mimic, total RNA, repeat III*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)Negative control *#*#*#[char](rna type)total RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|Myc	MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	MYC|MIR489	null	null	null	null	null	HEK293	null	null
GSE117805	GSM3309560	{'mimics':'Negative control ','rna type':'total RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with negative control mimic, total RNA, repeat II', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309560*#*#*#Cells with negative control mimic, total RNA, repeat II*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)Negative control *#*#*#[char](rna type)total RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|Myc	MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	MYC|MIR489	null	null	null	null	null	HEK293	null	null
GSE117805	GSM3309561	{'mimics':'Negative control ','rna type':'total RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with negative control mimic, total RNA, repeat I', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309561*#*#*#Cells with negative control mimic, total RNA, repeat I*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)Negative control *#*#*#[char](rna type)total RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|Myc	MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	MYC|MIR489	null	null	null	null	null	HEK293	null	null
GSE117805	GSM3309562	{'mimics':'Negative control ','rna type':'RISC RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with negative control mimic, RNA from RISC, repeat III', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309562*#*#*#Cells with negative control mimic, RNA from RISC, repeat III*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)Negative control *#*#*#[char](rna type)RISC RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|RISC|Myc	HGNC:29507;Ensembl:ENSG00000121064;BERN:324587902|MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:29507=>SCPEP1;Ensembl:ENSG00000121064=>null|HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	SCPEP1|MYC|MIR489|null	null	null	null	null	null	HEK293	null	null
GSE117805	GSM3309563	{'mimics':'Negative control ','rna type':'RISC RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with negative control mimics, RNA from RISC, repeat II', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309563*#*#*#Cells with negative control mimics, RNA from RISC, repeat II*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)Negative control *#*#*#[char](rna type)RISC RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|RISC|Myc	HGNC:29507;Ensembl:ENSG00000121064;BERN:324587902|MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:29507=>SCPEP1;Ensembl:ENSG00000121064=>null|HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	SCPEP1|MYC|MIR489|null	null	null	null	null	null	HEK293	null	null
GSE117805	GSM3309564	{'mimics':'Negative control ','rna type':'RISC RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with negative control mimics, RNA from RISC, repeat I', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309564*#*#*#Cells with negative control mimics, RNA from RISC, repeat I*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)Negative control *#*#*#[char](rna type)RISC RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|RISC|Myc	HGNC:29507;Ensembl:ENSG00000121064;BERN:324587902|MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:29507=>SCPEP1;Ensembl:ENSG00000121064=>null|HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	SCPEP1|MYC|MIR489|null	null	null	null	null	null	HEK293	null	null
GSE117805	GSM3309565	{'mimics':'microRNA-668 ','rna type':'total RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-668 overexpression, total RNA, repeat III', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309565*#*#*#Cells with microRNA-668 overexpression, total RNA, repeat III*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-668 *#*#*#[char](rna type)total RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|Myc|microRNA-668	MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202|HGNC:33135;Ensembl:ENSG00000276352;miRBase:MI0003761;BERN:325099602	HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC|HGNC:33135=>MIR668;Ensembl:ENSG00000276352=>null;MIM:190080=>MYC	MYC|MIR489|null|MIR668	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309566	{'mimics':'microRNA-668 ','rna type':'total RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-668 overexpression, total RNA, repeat II', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309566*#*#*#Cells with microRNA-668 overexpression, total RNA, repeat II*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-668 *#*#*#[char](rna type)total RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|Myc|microRNA-668	MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202|HGNC:33135;Ensembl:ENSG00000276352;miRBase:MI0003761;BERN:325099602	HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC|HGNC:33135=>MIR668;Ensembl:ENSG00000276352=>null;MIM:190080=>MYC	MYC|MIR489|null|MIR668	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309567	{'mimics':'microRNA-668 ','rna type':'total RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-668 overexpression, total RNA, repeat I', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309567*#*#*#Cells with microRNA-668 overexpression, total RNA, repeat I*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-668 *#*#*#[char](rna type)total RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|Myc|microRNA-668	MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202|HGNC:33135;Ensembl:ENSG00000276352;miRBase:MI0003761;BERN:325099602	HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC|HGNC:33135=>MIR668;Ensembl:ENSG00000276352=>null;MIM:190080=>MYC	MYC|MIR489|null|MIR668	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309568	{'mimics':'microRNA-668 ','rna type':'RISC RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-668 overexpression, RNA from RISC, repeats III', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309568*#*#*#Cells with microRNA-668 overexpression, RNA from RISC, repeats III*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-668 *#*#*#[char](rna type)RISC RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|RISC|Myc|microRNA-668	HGNC:29507;Ensembl:ENSG00000121064;BERN:324587902|MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202|HGNC:33135;Ensembl:ENSG00000276352;miRBase:MI0003761;BERN:325099602	HGNC:29507=>SCPEP1;Ensembl:ENSG00000121064=>null|HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC|HGNC:33135=>MIR668;Ensembl:ENSG00000276352=>null;MIM:190080=>MYC	SCPEP1|MIR489|null|MIR668|MYC	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309569	{'mimics':'microRNA-668 ','rna type':'RISC RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-668 overexpression, RNA from RISC, repeats II', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309569*#*#*#Cells with microRNA-668 overexpression, RNA from RISC, repeats II*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-668 *#*#*#[char](rna type)RISC RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|RISC|Myc|microRNA-668	HGNC:29507;Ensembl:ENSG00000121064;BERN:324587902|MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202|HGNC:33135;Ensembl:ENSG00000276352;miRBase:MI0003761;BERN:325099602	HGNC:29507=>SCPEP1;Ensembl:ENSG00000121064=>null|HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC|HGNC:33135=>MIR668;Ensembl:ENSG00000276352=>null;MIM:190080=>MYC	SCPEP1|MIR489|null|MIR668|MYC	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309570	{'mimics':'microRNA-668 ','rna type':'RISC RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-668 overexpression, RNA from RISC, repeats I', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309570*#*#*#Cells with microRNA-668 overexpression, RNA from RISC, repeats I*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-668 *#*#*#[char](rna type)RISC RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|RISC|Myc|microRNA-668	HGNC:29507;Ensembl:ENSG00000121064;BERN:324587902|MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202|HGNC:33135;Ensembl:ENSG00000276352;miRBase:MI0003761;BERN:325099602	HGNC:29507=>SCPEP1;Ensembl:ENSG00000121064=>null|HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC|HGNC:33135=>MIR668;Ensembl:ENSG00000276352=>null;MIM:190080=>MYC	SCPEP1|MIR489|null|MIR668|MYC	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309571	{'mimics':'microRNA-489 ','rna type':'total RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-489 overexpression, total RNA, repeat III', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309571*#*#*#Cells with microRNA-489 overexpression, total RNA, repeat III*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-489 *#*#*#[char](rna type)total RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|Myc|microRNA-489	MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	MYC|MIR489	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309572	{'mimics':'microRNA-489 ','rna type':'total RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-489 overexpression, total RNA, repeat II', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309572*#*#*#Cells with microRNA-489 overexpression, total RNA, repeat II*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-489 *#*#*#[char](rna type)total RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|Myc|microRNA-489	MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	MYC|MIR489	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309573	{'mimics':'microRNA-489 ','rna type':'total RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-489 overexpression, total RNA, repeat I', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309573*#*#*#Cells with microRNA-489 overexpression, total RNA, repeat I*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-489 *#*#*#[char](rna type)total RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|Myc|microRNA-489	MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	MYC|MIR489	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309574	{'mimics':'microRNA-489 ','rna type':'RISC RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-489 overexpression, RNA from RISC, repeats III', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309574*#*#*#Cells with microRNA-489 overexpression, RNA from RISC, repeats III*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-489 *#*#*#[char](rna type)RISC RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|RISC|Myc|microRNA-489	HGNC:29507;Ensembl:ENSG00000121064;BERN:324587902|MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:29507=>SCPEP1;Ensembl:ENSG00000121064=>null|HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	SCPEP1|MYC|MIR489|null	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309575	{'mimics':'microRNA-489 ','rna type':'RISC RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-489 overexpression, RNA from RISC, repeats II', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309575*#*#*#Cells with microRNA-489 overexpression, RNA from RISC, repeats II*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-489 *#*#*#[char](rna type)RISC RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|RISC|Myc|microRNA-489	HGNC:29507;Ensembl:ENSG00000121064;BERN:324587902|MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:29507=>SCPEP1;Ensembl:ENSG00000121064=>null|HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	SCPEP1|MYC|MIR489|null	null	null	null	y	null	HEK293	null	null
GSE117805	GSM3309576	{'mimics':'microRNA-489 ','rna type':'RISC RNA ','treatment':'microRNA mimic transfection ','organism':'Homo sapiens','source name':'HEK 293 cells', 'title':'Cells with microRNA-489 overexpression, RNA from RISC, repeats I', 'last update date':'2019-07-27', 'release date': '2019-07-27', 'method': 'high-throughput sequencing'}	GSM3309576*#*#*#Cells with microRNA-489 overexpression, RNA from RISC, repeats I*#*#*#1*#*#*#HEK 293 cells*#*#*#Homo sapiens*#*#*#HEK293 cells were co-transfected with FLAG-Ago-2 plasmid (Addgene, Cambridge, MA) or control plasmid (p3xFLAG-Myc-CMV™-24 Expression Vector, Sigma, St. Louis, MO) and 100nM negative control RNA oligos, or hsa-mir-668 mimics, or hsa-mir-489 mimics (Dharmacon Research, Inc., Pittsburgh PA). *#*#*#total RNA*#*#*#null*#*#*#Data QC and trim with FastQ_V0.10.0 and DynamicTrim_v.1.10Read alignment with TopHap version 2.0.5Transcript quantification and normalization with cufflinks version 2.0.2Differential expression analysis with cufflinks version 2.0.2Genome_build: hg19/Homo_sapiens.GRCh37.64Supplementary_files_format_and_content: transcript/gene abundance *#*#*#RNA-Seq*#*#*#null*#*#*#GPL11154*#*#*#2019-07-27*#*#*#2019-07-27*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](mimics)microRNA-489 *#*#*#[char](rna type)RISC RNA *#*#*#[char](treatment)microRNA mimic transfection 	null	null	Homo sapiens	null	high-throughput sequencing	HEK 293 cells	null	null	microRNA mimic transfection	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-07-27	2019-07-27	NONE 	GPL11154	null	null	null	null	null	null	null	null	hsa-mir-489|RISC|Myc|microRNA-489	HGNC:29507;Ensembl:ENSG00000121064;BERN:324587902|MIM:614523;HGNC:32074;Ensembl:ENSG00000207656;miRBase:MI0003124;BERN:324528502|MIM:190080;HGNC:7553;Ensembl:ENSG00000136997;BERN:324142202	HGNC:29507=>SCPEP1;Ensembl:ENSG00000121064=>null|HGNC:32074=>MIR489;Ensembl:ENSG00000207656=>MIR489;MIM:614523=>MIR489|HGNC:7553=>MYC;Ensembl:ENSG00000136997=>MYC;MIM:190080=>MYC	SCPEP1|MYC|MIR489|null	null	null	null	y	null	HEK293	null	null
GSE117821	GSM3309794	{'cell type':'293T ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S1 293T native with added control duplex', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309794*#*#*#S1 293T native with added control duplex*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#native with added control duplex *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)293T *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	293T	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309794/suppl/GSM3309794_S1_293T_native_with_added_control_duplex_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117821	GSM3309795	{'cell type':'293T ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S2 293T native', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309795*#*#*#S2 293T native*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#native *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)293T *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	293T	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309795/suppl/GSM3309795_S2_293T_native_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117821	GSM3309796	{'cell type':'293T ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S3 293T protein removed', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309796*#*#*#S3 293T protein removed*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#protein removed *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)293T *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	293T	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309796/suppl/GSM3309796_S3_293T_protein_removed_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117821	GSM3309797	{'cell type':'HeLa ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S4 HeLa native', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309797*#*#*#S4 HeLa native*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#native *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)HeLa *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	HeLa	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309797/suppl/GSM3309797_S4_HeLa_native_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	HeLa	HeLa	null	null
GSE117821	GSM3309798	{'cell type':'HeLa ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S5 HeLa-protein removed', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309798*#*#*#S5 HeLa-protein removed*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#protein removed *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)HeLa *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	HeLa	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309798/suppl/GSM3309798_S5_HeLa-protein_removed_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	HeLa	HeLa	null	null
GSE117821	GSM3309799	{'cell type':'293T ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S6 293T native', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309799*#*#*#S6 293T native*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#native *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)293T *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	293T	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309799/suppl/GSM3309799_S6_293T_native_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117821	GSM3309800	{'cell type':'293T ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S7 293T ribo removed', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309800*#*#*#S7 293T ribo removed*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#ribo removed *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)293T *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	293T	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309800/suppl/GSM3309800_S7_293T_ribo_removed_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117821	GSM3309801	{'cell type':'HeLa ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S8 HeLa native', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309801*#*#*#S8 HeLa native*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#native *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)HeLa *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	HeLa	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309801/suppl/GSM3309801_S8_HeLa_native_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	HeLa	HeLa	null	null
GSE117821	GSM3309802	{'cell type':'HeLa ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S9 HeLa ribo removed', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309802*#*#*#S9 HeLa ribo removed*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#ribo removed *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)HeLa *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	HeLa	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309802/suppl/GSM3309802_S9_HeLa_ribo_removed_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	HeLa	HeLa	null	null
GSE117821	GSM3309803	{'cell type':'MCF7 ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S10 MCF7 native', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309803*#*#*#S10 MCF7 native*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#native *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	MCF7	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309803/suppl/GSM3309803_S10_MCF7_native_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	MCF7	MCF7	null	null
GSE117821	GSM3309804	{'cell type':'MCF7 ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S11 MCF7 ribo removed', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309804*#*#*#S11 MCF7 ribo removed*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#ribo removed *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	MCF7	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309804/suppl/GSM3309804_S11_MCF7_ribo_removed_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	MCF7	MCF7	null	null
GSE117821	GSM3309805	{'cell type':'U2OS ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S12 U2OS native', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309805*#*#*#S12 U2OS native*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#native *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)U2OS *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	U2OS	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309805/suppl/GSM3309805_S12_U2OS_native_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	U2OS	U2OS	null	null
GSE117821	GSM3309806	{'cell type':'U2OS ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S13 U2OS ribo removed', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309806*#*#*#S13 U2OS ribo removed*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#ribo removed *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)U2OS *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	U2OS	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309806/suppl/GSM3309806_S13_U2OS_ribo_removed_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	U2OS	U2OS	null	null
GSE117821	GSM3309807	{'cell type':'293T ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S14 293T rRNA band', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309807*#*#*#S14 293T rRNA band*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#rRNA band *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)293T *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	293T	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309807/suppl/GSM3309807_S14_293T_rRNA_band_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117821	GSM3309808	{'cell type':'HeLa ','passage':'15-18 ','organism':'Homo sapiens','source name':'cell line', 'title':'S15 HeLa rRNA band', 'last update date':'2018-07-29', 'release date': '2018-07-28', 'method': 'high-throughput sequencing'}	GSM3309808*#*#*#S15 HeLa rRNA band*#*#*#1*#*#*#cell line*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#Illumina Casava1.7 software used for basecalling.Sequenced reads were trimmed for adaptor sequence, and de-multiplexing reads for artificial PCR amplificationReads were quality-filtered using the program sickle (version 1.33)Reads were mapped to transcriptome using program salmon (version 0.9.1). Options: salmon quant -i INDEXFILE -l SF -r FASTQFILE -p 1 -o OUTPUTFILETranscripts listed in the quantification files generated by the salmon program were annotated with an RNA type classification.Genome_build: hg38Supplementary_files_format_and_content: transcript quantification files are in comma-separated-value (csv) format. Columns are: Name: Name of transcript; Length: Length of transcript; EffectiveLength: effective length; TPM: relative expression (transcripts per million); NumReads: number of mapped reads; RelNumReads: relative number of reads; Type: annotated type of RNA *#*#*#RNA-Seq*#*#*#rRNA band *#*#*#GPL15520*#*#*#2018-07-29*#*#*#2018-07-28*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)HeLa *#*#*#[char](passage)15-18 	30558267	null	Homo sapiens	HeLa	high-throughput sequencing	cell line	null	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2018-07-29	2018-07-28	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309808/suppl/GSM3309808_S15_HeLa_rRNA_band_salmon.csv.gz 	GPL15520	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	HeLa	HeLa	null	null
GSE117822	GSM3309809	{'cell type':'hepatoma cells ','tissue':'liver ','adenovirus':'adenovirus with GFP control ','organism':'Homo sapiens','source name':'Huh 7 cells', 'title':'Huh7 AdGFP rep1', 'last update date':'2019-01-02', 'release date': '2019-01-02', 'method': 'high-throughput sequencing'}	GSM3309809*#*#*#Huh7 AdGFP rep1*#*#*#1*#*#*#Huh 7 cells*#*#*#Homo sapiens*#*#*#Adenoviral recombinant AdGSTZ1 or AdPCK1 were generated using the AdEasy system, and green fluorescent protein-expressing analogous adenovirus (AdGFP) was used as a control. *#*#*#total RNA*#*#*#null*#*#*#Reads filtering under criteria removing reads with 20% of the base quality lower than 13MapSplice mapping to reference genomecount countingGenome_build: GRCh37Supplementary_files_format_and_content: TXT file contain counts for each sample *#*#*#RNA-Seq*#*#*#All_Counts.txt *#*#*#GPL17303*#*#*#2019-01-02*#*#*#2019-01-02*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)hepatoma cells *#*#*#[char](tissue)liver *#*#*#[char](adenovirus)adenovirus with GFP control 	30717766	null	Homo sapiens	hepatoma cells	high-throughput sequencing	Huh 7 cells	liver	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-01-02	2019-01-02	NONE 	GPL17303	hepatoma	OMIM:114550;MESH:D006528;BERN:107524301	OMIM:114550=>HEPATOCELLULAR CARCINOMA;MESH:D006528=>Carcinoma, Hepatocellular	Carcinoma, Hepatocellular|HEPATOCELLULAR CARCINOMA	null	null	null	null	green fluorescent protein|GFP	BERN:326405102|BERN:326411302			null	null	null	null	Huh7	TXT|Huh7	null	null
GSE117822	GSM3309810	{'cell type':'hepatoma cells ','tissue':'liver ','adenovirus':'adenovirus with GFP control ','organism':'Homo sapiens','source name':'Huh 7 cells', 'title':'Huh7 AdGFP rep2', 'last update date':'2019-01-02', 'release date': '2019-01-02', 'method': 'high-throughput sequencing'}	GSM3309810*#*#*#Huh7 AdGFP rep2*#*#*#1*#*#*#Huh 7 cells*#*#*#Homo sapiens*#*#*#Adenoviral recombinant AdGSTZ1 or AdPCK1 were generated using the AdEasy system, and green fluorescent protein-expressing analogous adenovirus (AdGFP) was used as a control. *#*#*#total RNA*#*#*#null*#*#*#Reads filtering under criteria removing reads with 20% of the base quality lower than 13MapSplice mapping to reference genomecount countingGenome_build: GRCh37Supplementary_files_format_and_content: TXT file contain counts for each sample *#*#*#RNA-Seq*#*#*#All_Counts.txt *#*#*#GPL17303*#*#*#2019-01-02*#*#*#2019-01-02*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)hepatoma cells *#*#*#[char](tissue)liver *#*#*#[char](adenovirus)adenovirus with GFP control 	30717766	null	Homo sapiens	hepatoma cells	high-throughput sequencing	Huh 7 cells	liver	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-01-02	2019-01-02	NONE 	GPL17303	hepatoma	OMIM:114550;MESH:D006528;BERN:107524301	OMIM:114550=>HEPATOCELLULAR CARCINOMA;MESH:D006528=>Carcinoma, Hepatocellular	Carcinoma, Hepatocellular|HEPATOCELLULAR CARCINOMA	null	null	null	null	green fluorescent protein|GFP	BERN:326405102|BERN:326411302			null	null	null	null	Huh7	TXT|Huh7	null	null
GSE117822	GSM3309811	{'cell type':'hepatoma cells ','tissue':'liver ','adenovirus':'adenovirus with GFP control ','organism':'Homo sapiens','source name':'Huh 7 cells', 'title':'Huh7 AdGFP rep3', 'last update date':'2019-01-02', 'release date': '2019-01-02', 'method': 'high-throughput sequencing'}	GSM3309811*#*#*#Huh7 AdGFP rep3*#*#*#1*#*#*#Huh 7 cells*#*#*#Homo sapiens*#*#*#Adenoviral recombinant AdGSTZ1 or AdPCK1 were generated using the AdEasy system, and green fluorescent protein-expressing analogous adenovirus (AdGFP) was used as a control. *#*#*#total RNA*#*#*#null*#*#*#Reads filtering under criteria removing reads with 20% of the base quality lower than 13MapSplice mapping to reference genomecount countingGenome_build: GRCh37Supplementary_files_format_and_content: TXT file contain counts for each sample *#*#*#RNA-Seq*#*#*#All_Counts.txt *#*#*#GPL17303*#*#*#2019-01-02*#*#*#2019-01-02*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)hepatoma cells *#*#*#[char](tissue)liver *#*#*#[char](adenovirus)adenovirus with GFP control 	30717766	null	Homo sapiens	hepatoma cells	high-throughput sequencing	Huh 7 cells	liver	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-01-02	2019-01-02	NONE 	GPL17303	hepatoma	OMIM:114550;MESH:D006528;BERN:107524301	OMIM:114550=>HEPATOCELLULAR CARCINOMA;MESH:D006528=>Carcinoma, Hepatocellular	Carcinoma, Hepatocellular|HEPATOCELLULAR CARCINOMA	null	null	null	null	green fluorescent protein|GFP	BERN:326405102|BERN:326411302			null	null	null	null	Huh7	TXT|Huh7	null	null
GSE117822	GSM3309812	{'cell type':'hepatoma cells ','tissue':'liver ','adenovirus':'adenovirus overexpression GSTZ1 ','organism':'Homo sapiens','source name':'Huh 7 cells', 'title':'Huh7 AdGSTZ1 rep2', 'last update date':'2019-01-02', 'release date': '2019-01-02', 'method': 'high-throughput sequencing'}	GSM3309812*#*#*#Huh7 AdGSTZ1 rep2*#*#*#1*#*#*#Huh 7 cells*#*#*#Homo sapiens*#*#*#Adenoviral recombinant AdGSTZ1 or AdPCK1 were generated using the AdEasy system, and green fluorescent protein-expressing analogous adenovirus (AdGFP) was used as a control. *#*#*#total RNA*#*#*#null*#*#*#Reads filtering under criteria removing reads with 20% of the base quality lower than 13MapSplice mapping to reference genomecount countingGenome_build: GRCh37Supplementary_files_format_and_content: TXT file contain counts for each sample *#*#*#RNA-Seq*#*#*#All_Counts.txt *#*#*#GPL17303*#*#*#2019-01-02*#*#*#2019-01-02*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)hepatoma cells *#*#*#[char](tissue)liver *#*#*#[char](adenovirus)adenovirus overexpression GSTZ1 	30717766	null	Homo sapiens	hepatoma cells	high-throughput sequencing	Huh 7 cells	liver	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-01-02	2019-01-02	NONE 	GPL17303	hepatoma	OMIM:114550;MESH:D006528;BERN:107524301	OMIM:114550=>HEPATOCELLULAR CARCINOMA;MESH:D006528=>Carcinoma, Hepatocellular	Carcinoma, Hepatocellular|HEPATOCELLULAR CARCINOMA	null	null	null	null	green fluorescent protein|GSTZ1|rep2	MIM:603758;HGNC:4643;Ensembl:ENSG00000100577;BERN:323568402|BERN:326411302|MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602	HGNC:4643=>GSTZ1;Ensembl:ENSG00000100577=>GSTZ1;MIM:603758=>GSTZ1|HGNC:4643=>GSTZ1;Ensembl:ENSG00000100577=>GSTZ1;MIM:603758=>GSTZ1|HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML	GSTZ1|CHML	null	null	null	y	Huh7	TXT|Huh7	null	null
GSE117822	GSM3309813	{'cell type':'hepatoma cells ','tissue':'liver ','adenovirus':'adenovirus overexpression GSTZ1 ','organism':'Homo sapiens','source name':'Huh 7 cells', 'title':'Huh7 AdGSTZ1 rep3', 'last update date':'2019-01-02', 'release date': '2019-01-02', 'method': 'high-throughput sequencing'}	GSM3309813*#*#*#Huh7 AdGSTZ1 rep3*#*#*#1*#*#*#Huh 7 cells*#*#*#Homo sapiens*#*#*#Adenoviral recombinant AdGSTZ1 or AdPCK1 were generated using the AdEasy system, and green fluorescent protein-expressing analogous adenovirus (AdGFP) was used as a control. *#*#*#total RNA*#*#*#null*#*#*#Reads filtering under criteria removing reads with 20% of the base quality lower than 13MapSplice mapping to reference genomecount countingGenome_build: GRCh37Supplementary_files_format_and_content: TXT file contain counts for each sample *#*#*#RNA-Seq*#*#*#All_Counts.txt *#*#*#GPL17303*#*#*#2019-01-02*#*#*#2019-01-02*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)hepatoma cells *#*#*#[char](tissue)liver *#*#*#[char](adenovirus)adenovirus overexpression GSTZ1 	30717766	null	Homo sapiens	hepatoma cells	high-throughput sequencing	Huh 7 cells	liver	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-01-02	2019-01-02	NONE 	GPL17303	hepatoma	OMIM:114550;MESH:D006528;BERN:107524301	OMIM:114550=>HEPATOCELLULAR CARCINOMA;MESH:D006528=>Carcinoma, Hepatocellular	Carcinoma, Hepatocellular|HEPATOCELLULAR CARCINOMA	null	null	null	null	green fluorescent protein|GSTZ1	BERN:326411302|MIM:603758;HGNC:4643;Ensembl:ENSG00000100577;BERN:323568402	HGNC:4643=>GSTZ1;Ensembl:ENSG00000100577=>GSTZ1;MIM:603758=>GSTZ1	GSTZ1	null	null	null	y	Huh7	TXT|Huh7	null	null
GSE117822	GSM3309814	{'cell type':'hepatoma cells ','tissue':'liver ','adenovirus':'adenovirus overexpression GSTZ1 ','organism':'Homo sapiens','source name':'Huh 7 cells', 'title':'Huh7 AdGSTZ1 rep4', 'last update date':'2019-01-02', 'release date': '2019-01-02', 'method': 'high-throughput sequencing'}	GSM3309814*#*#*#Huh7 AdGSTZ1 rep4*#*#*#1*#*#*#Huh 7 cells*#*#*#Homo sapiens*#*#*#Adenoviral recombinant AdGSTZ1 or AdPCK1 were generated using the AdEasy system, and green fluorescent protein-expressing analogous adenovirus (AdGFP) was used as a control. *#*#*#total RNA*#*#*#null*#*#*#Reads filtering under criteria removing reads with 20% of the base quality lower than 13MapSplice mapping to reference genomecount countingGenome_build: GRCh37Supplementary_files_format_and_content: TXT file contain counts for each sample *#*#*#RNA-Seq*#*#*#All_Counts.txt *#*#*#GPL17303*#*#*#2019-01-02*#*#*#2019-01-02*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)hepatoma cells *#*#*#[char](tissue)liver *#*#*#[char](adenovirus)adenovirus overexpression GSTZ1 	30717766	null	Homo sapiens	hepatoma cells	high-throughput sequencing	Huh 7 cells	liver	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-01-02	2019-01-02	NONE 	GPL17303	hepatoma	OMIM:114550;MESH:D006528;BERN:107524301	OMIM:114550=>HEPATOCELLULAR CARCINOMA;MESH:D006528=>Carcinoma, Hepatocellular	Carcinoma, Hepatocellular|HEPATOCELLULAR CARCINOMA	null	null	null	null	green fluorescent protein|GSTZ1	BERN:326411302|MIM:603758;HGNC:4643;Ensembl:ENSG00000100577;BERN:323568402	HGNC:4643=>GSTZ1;Ensembl:ENSG00000100577=>GSTZ1;MIM:603758=>GSTZ1	GSTZ1	null	null	null	y	Huh7	TXT|Huh7	null	null
GSE117822	GSM3309815	{'cell type':'hepatoma cells ','tissue':'liver ','adenovirus':'adenovirus overexpression PCK1 ','organism':'Homo sapiens','source name':'Huh 7 cells', 'title':'Huh7 AdPCK1 rep1', 'last update date':'2019-01-02', 'release date': '2019-01-02', 'method': 'high-throughput sequencing'}	GSM3309815*#*#*#Huh7 AdPCK1 rep1*#*#*#1*#*#*#Huh 7 cells*#*#*#Homo sapiens*#*#*#Adenoviral recombinant AdGSTZ1 or AdPCK1 were generated using the AdEasy system, and green fluorescent protein-expressing analogous adenovirus (AdGFP) was used as a control. *#*#*#total RNA*#*#*#null*#*#*#Reads filtering under criteria removing reads with 20% of the base quality lower than 13MapSplice mapping to reference genomecount countingGenome_build: GRCh37Supplementary_files_format_and_content: TXT file contain counts for each sample *#*#*#RNA-Seq*#*#*#All_Counts.txt *#*#*#GPL17303*#*#*#2019-01-02*#*#*#2019-01-02*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)hepatoma cells *#*#*#[char](tissue)liver *#*#*#[char](adenovirus)adenovirus overexpression PCK1 	30717766	null	Homo sapiens	hepatoma cells	high-throughput sequencing	Huh 7 cells	liver	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-01-02	2019-01-02	NONE 	GPL17303	hepatoma	OMIM:114550;MESH:D006528;BERN:107524301	OMIM:114550=>HEPATOCELLULAR CARCINOMA;MESH:D006528=>Carcinoma, Hepatocellular	Carcinoma, Hepatocellular|HEPATOCELLULAR CARCINOMA	null	null	null	null	green fluorescent protein|PCK1	MIM:614168;HGNC:8724;Ensembl:ENSG00000124253;BERN:324229502|BERN:326411302	HGNC:8724=>PCK1;Ensembl:ENSG00000124253=>PCK1;MIM:614168=>PCK1|HGNC:8724=>PCK1;Ensembl:ENSG00000124253=>PCK1;MIM:614168=>PCK1	PCK1	null	null	null	y	Huh7	TXT|Huh7	null	null
GSE117822	GSM3309816	{'cell type':'hepatoma cells ','tissue':'liver ','adenovirus':'adenovirus overexpression PCK1 ','organism':'Homo sapiens','source name':'Huh 7 cells', 'title':'Huh7 AdPCK1 rep2', 'last update date':'2019-01-02', 'release date': '2019-01-02', 'method': 'high-throughput sequencing'}	GSM3309816*#*#*#Huh7 AdPCK1 rep2*#*#*#1*#*#*#Huh 7 cells*#*#*#Homo sapiens*#*#*#Adenoviral recombinant AdGSTZ1 or AdPCK1 were generated using the AdEasy system, and green fluorescent protein-expressing analogous adenovirus (AdGFP) was used as a control. *#*#*#total RNA*#*#*#null*#*#*#Reads filtering under criteria removing reads with 20% of the base quality lower than 13MapSplice mapping to reference genomecount countingGenome_build: GRCh37Supplementary_files_format_and_content: TXT file contain counts for each sample *#*#*#RNA-Seq*#*#*#All_Counts.txt *#*#*#GPL17303*#*#*#2019-01-02*#*#*#2019-01-02*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)hepatoma cells *#*#*#[char](tissue)liver *#*#*#[char](adenovirus)adenovirus overexpression PCK1 	30717766	null	Homo sapiens	hepatoma cells	high-throughput sequencing	Huh 7 cells	liver	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-01-02	2019-01-02	NONE 	GPL17303	hepatoma	OMIM:114550;MESH:D006528;BERN:107524301	OMIM:114550=>HEPATOCELLULAR CARCINOMA;MESH:D006528=>Carcinoma, Hepatocellular	Carcinoma, Hepatocellular|HEPATOCELLULAR CARCINOMA	null	null	null	null	green fluorescent protein|PCK1|rep2	MIM:614168;HGNC:8724;Ensembl:ENSG00000124253;BERN:324229502|BERN:326411302|MIM:118825;HGNC:1941;Ensembl:ENSG00000203668;BERN:322714602	HGNC:8724=>PCK1;Ensembl:ENSG00000124253=>PCK1;MIM:614168=>PCK1|HGNC:8724=>PCK1;Ensembl:ENSG00000124253=>PCK1;MIM:614168=>PCK1|HGNC:1941=>CHML;Ensembl:ENSG00000203668=>CHML;MIM:118825=>CHML	PCK1|CHML	null	null	null	y	Huh7	TXT|Huh7	null	null
GSE117822	GSM3309817	{'cell type':'hepatoma cells ','tissue':'liver ','adenovirus':'adenovirus overexpression PCK1 ','organism':'Homo sapiens','source name':'Huh 7 cells', 'title':'Huh7 AdPCK1 rep3', 'last update date':'2019-01-02', 'release date': '2019-01-02', 'method': 'high-throughput sequencing'}	GSM3309817*#*#*#Huh7 AdPCK1 rep3*#*#*#1*#*#*#Huh 7 cells*#*#*#Homo sapiens*#*#*#Adenoviral recombinant AdGSTZ1 or AdPCK1 were generated using the AdEasy system, and green fluorescent protein-expressing analogous adenovirus (AdGFP) was used as a control. *#*#*#total RNA*#*#*#null*#*#*#Reads filtering under criteria removing reads with 20% of the base quality lower than 13MapSplice mapping to reference genomecount countingGenome_build: GRCh37Supplementary_files_format_and_content: TXT file contain counts for each sample *#*#*#RNA-Seq*#*#*#All_Counts.txt *#*#*#GPL17303*#*#*#2019-01-02*#*#*#2019-01-02*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)hepatoma cells *#*#*#[char](tissue)liver *#*#*#[char](adenovirus)adenovirus overexpression PCK1 	30717766	null	Homo sapiens	hepatoma cells	high-throughput sequencing	Huh 7 cells	liver	null	null	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-01-02	2019-01-02	NONE 	GPL17303	hepatoma	OMIM:114550;MESH:D006528;BERN:107524301	OMIM:114550=>HEPATOCELLULAR CARCINOMA;MESH:D006528=>Carcinoma, Hepatocellular	Carcinoma, Hepatocellular|HEPATOCELLULAR CARCINOMA	null	null	null	null	green fluorescent protein|PCK1	MIM:614168;HGNC:8724;Ensembl:ENSG00000124253;BERN:324229502|BERN:326411302	HGNC:8724=>PCK1;Ensembl:ENSG00000124253=>PCK1;MIM:614168=>PCK1|HGNC:8724=>PCK1;Ensembl:ENSG00000124253=>PCK1;MIM:614168=>PCK1	PCK1	null	null	null	y	Huh7	TXT|Huh7	null	null
GSE117824	GSM3309832	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'15% (source: CD34+ cells) ','Sex':'Female ','age':'69 ','diagnosis':'ET ','wbc(k/mcl)':'6.5 ','hg(g/dl)':'12.6 ','platelets(k/mcl)':'519 ','pb blast count':'0 ','bm blast count':'0.03 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin; previously hydroxyurea ','organism':'Homo sapiens','source name':'ET01, scRNA-seq', 'title':'10x.ET01', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309832*#*#*#10x.ET01*#*#*#1*#*#*#ET01, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))15% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)69 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.5 *#*#*#[char](hg(g/dl))12.6 *#*#*#[char](platelets(k/mcl))519 *#*#*#[char](pb blast count)0 *#*#*#[char](bm blast count)0.03 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin; previously hydroxyurea 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET01	null	null	Aspirin; previously hydroxyurea	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309832/suppl/GSM3309832_ET01.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	CD34+|mcl	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117824	GSM3309833	{'source':'BMMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'26% (source: CD34- cells) ','Sex':'Male ','age':'29 ','diagnosis':'ET ','wbc(k/mcl)':'6.5 ','hg(g/dl)':'13.9 ','platelets(k/mcl)':'1060 ','pb blast count':'0 ','bm blast count':'0.03 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET02, scRNA-seq', 'title':'10x.ET02', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309833*#*#*#10x.ET02*#*#*#1*#*#*#ET02, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))26% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)29 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.5 *#*#*#[char](hg(g/dl))13.9 *#*#*#[char](platelets(k/mcl))1060 *#*#*#[char](pb blast count)0 *#*#*#[char](bm blast count)0.03 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET02	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309833/suppl/GSM3309833_ET02.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117824	GSM3309834	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'29% (source: CD34- cells) ','Sex':'Male ','age':'40 ','diagnosis':'ET ','wbc(k/mcl)':'7.7 ','hg(g/dl)':'12.4 ','platelets(k/mcl)':'1252 ','pb blast count':'0 ','bm blast count':'0.02 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET03, scRNA-seq', 'title':'10x.ET03', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309834*#*#*#10x.ET03*#*#*#1*#*#*#ET03, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))29% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)40 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))7.7 *#*#*#[char](hg(g/dl))12.4 *#*#*#[char](platelets(k/mcl))1252 *#*#*#[char](pb blast count)0 *#*#*#[char](bm blast count)0.02 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET03	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309834/suppl/GSM3309834_ET03.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117824	GSM3309835	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'45% (source: unfractionated PBMCs) ','Sex':'Female ','age':'54 ','diagnosis':'Post-ET myelofibrosis ','wbc(k/mcl)':'9.8 ','hg(g/dl)':'9.7 ','platelets(k/mcl)':'318 ','pb blast count':'0 ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'None; previously anagrelide ','organism':'Homo sapiens','source name':'MF01, scRNA-seq', 'title':'10x.MF01', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309835*#*#*#10x.MF01*#*#*#1*#*#*#MF01, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))45% (source: unfractionated PBMCs) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Post-ET myelofibrosis *#*#*#[char](wbc(k/mcl))9.8 *#*#*#[char](hg(g/dl))9.7 *#*#*#[char](platelets(k/mcl))318 *#*#*#[char](pb blast count)0 *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)None; previously anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF01	null	null	None; previously anagrelide	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309835/suppl/GSM3309835_MF01.barcodes.tsv.gz 	GPL16791	myelofibrosis	OMIM:254450;MESH:D055728;BERN:106922101	OMIM:254450=>MYELOFIBROSIS;MESH:D055728=>Primary Myelofibrosis	MYELOFIBROSIS|Primary Myelofibrosis	null	null	null	null	mcl	MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D	null	null	null	null	null	null	null	null
GSE117824	GSM3309836	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'47.5% (source: CD34+ cells) ','Sex':'Female ','age':'54 ','diagnosis':'Myelofibrotic myeloid neoplasm ','wbc(k/mcl)':'5.8 ','hg(g/dl)':'8.1 ','platelets(k/mcl)':'291 ','pb blast count':'0.01 ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'Procrit; previously hydroxyurea and anagrelide ','organism':'Homo sapiens','source name':'MF05, scRNA-seq', 'title':'10x.MF05', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309836*#*#*#10x.MF05*#*#*#1*#*#*#MF05, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))47.5% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Myelofibrotic myeloid neoplasm *#*#*#[char](wbc(k/mcl))5.8 *#*#*#[char](hg(g/dl))8.1 *#*#*#[char](platelets(k/mcl))291 *#*#*#[char](pb blast count)0.01 *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Procrit; previously hydroxyurea and anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF05	null	null	Procrit; previously hydroxyurea and anagrelide	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309836/suppl/GSM3309836_MF05.barcodes.tsv.gz 	GPL16791	myeloid neoplasm	MESH:D009196;BERN:106920001	MESH:D009196=>Myeloproliferative Disorders	Myeloproliferative Disorders	hydroxyurea|anagrelide	MESH:C021139;BERN:4904003|CHEBI:44423;BERN:4763303	MESH:C021139=>anagrelide|CHEBI:44423=>hydroxyurea;MESH:C021139=>anagrelide	hydroxyurea|anagrelide	CD34+	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34	CD34	null	null	null	null	null	null	null	null
GSE117824	GSM3309837	{'source':'mixing study ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'. ','Sex':'missing ','age':'. ','diagnosis':'. ','wbc(k/mcl)':'. ','hg(g/dl)':'. ','platelets(k/mcl)':'. ','pb blast count':'. ','bm blast count':'. ','bm fibrosis':'. ','treatment':'. ','organism':'Homo sapiens','source name':'mixing UT7 & Ba/F3, scRNA-seq', 'title':'10x.species_mix', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309837*#*#*#10x.species_mix*#*#*#1*#*#*#mixing UT7 & Ba/F3, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL22245*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)mixing study *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing)). *#*#*#[char](Sex)missing *#*#*#[char](age). *#*#*#[char](diagnosis). *#*#*#[char](wbc(k/mcl)). *#*#*#[char](hg(g/dl)). *#*#*#[char](platelets(k/mcl)). *#*#*#[char](pb blast count). *#*#*#[char](bm blast count). *#*#*#[char](bm fibrosis). *#*#*#[char](treatment). 	31270458	null	Homo sapiens	null	high-throughput sequencing	mixing UT7 & Ba/F3	null	null	.	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309837/suppl/GSM3309837_species_mix.barcodes.hg38.tsv.gz 	GPL22245	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	UT7	UT7	null	null
GSE117824	GSM3739217	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'16.7% (source: CD34- cells) ','Sex':'Female ','age':'57 ','diagnosis':'ET ','wbc(k/mcl)':'7.6 ','hg(g/dl)':'14.8 ','platelets(k/mcl)':'650 ','pb blast count':'0% ','bm blast count':'1% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET04, scRNA-seq', 'title':'10x.ET04', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739217*#*#*#10x.ET04*#*#*#1*#*#*#ET04, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))16.7% (source: CD34- cells) *#*#*#[char](Sex)Female *#*#*#[char](age)57 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))7.6 *#*#*#[char](hg(g/dl))14.8 *#*#*#[char](platelets(k/mcl))650 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)1% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET04	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739217/suppl/GSM3739217_ET04.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR|CD34	null	null	null	null	null	null	null	null
GSE117824	GSM3739218	{'source':'BMMC ','targeted mutation':'CALR exon9 A382Rfs*58 (c.1144_1215delins67) ','vaf (targeted exon sequencing)':'18% (source: unfractionated BM) ','Sex':'Male ','age':'17 ','diagnosis':'ET ','wbc(k/mcl)':'6.3 ','hg(g/dl)':'12.4 ','platelets(k/mcl)':'1421 ','pb blast count':'0% ','bm blast count':'1% ','bm fibrosis':'MF-0/3 ','treatment':'None ','organism':'Homo sapiens','source name':'ET05, scRNA-seq', 'title':'10x.ET05', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739218*#*#*#10x.ET05*#*#*#1*#*#*#ET05, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 A382Rfs*58 (c.1144_1215delins67) *#*#*#[char](vaf (targeted exon sequencing))18% (source: unfractionated BM) *#*#*#[char](Sex)Male *#*#*#[char](age)17 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.3 *#*#*#[char](hg(g/dl))12.4 *#*#*#[char](platelets(k/mcl))1421 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)1% *#*#*#[char](bm fibrosis)MF-0/3 *#*#*#[char](treatment)None 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET05	null	null	None	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739218/suppl/GSM3739218_ET05.barcodes.tsv.gz 	GPL16791	null	null	null	null	null	null	null	null	CALR	MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CALR	null	null	null	null	null	null	null	null
GSE117824	GSM3739219	{'source':'PBMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'25% (source: unfractionated PB) ','Sex':'Male ','age':'62 ','diagnosis':'MF ','wbc(k/mcl)':'4.3 ','hg(g/dl)':'10.2 ','platelets(k/mcl)':'191 ','pb blast count':'0% ','bm blast count':'2% ','bm fibrosis':'MF-2/3 ','treatment':'None ','organism':'Homo sapiens','source name':'MF02, scRNA-seq', 'title':'10x.MF02', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739219*#*#*#10x.MF02*#*#*#1*#*#*#MF02, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))25% (source: unfractionated PB) *#*#*#[char](Sex)Male *#*#*#[char](age)62 *#*#*#[char](diagnosis)MF *#*#*#[char](wbc(k/mcl))4.3 *#*#*#[char](hg(g/dl))10.2 *#*#*#[char](platelets(k/mcl))191 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)2% *#*#*#[char](bm fibrosis)MF-2/3 *#*#*#[char](treatment)None 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF02	null	null	None	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739219/suppl/GSM3739219_MF02.barcodes.tsv.gz 	GPL16791	MF	MESH:D009182;BERN:106909301	MESH:D009182=>Mycosis Fungoides	Mycosis Fungoides	null	null	null	null	CALR	MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CALR	null	null	null	null	null	null	null	null
GSE117824	GSM3739220	{'source':'PBMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'20.6% (source: CD34- cells) ','Sex':'Male ','age':'59 ','diagnosis':'MF ','wbc(k/mcl)':'12.8 ','hg(g/dl)':'12.7 ','platelets(k/mcl)':'464 ','pb blast count':'0% ','bm blast count':'<5% ','bm fibrosis':'MF-3/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'MF03, scRNA-seq', 'title':'10x.MF03', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739220*#*#*#10x.MF03*#*#*#1*#*#*#MF03, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))20.6% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)59 *#*#*#[char](diagnosis)MF *#*#*#[char](wbc(k/mcl))12.8 *#*#*#[char](hg(g/dl))12.7 *#*#*#[char](platelets(k/mcl))464 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)<5% *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF03	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739220/suppl/GSM3739220_MF03.barcodes.tsv.gz 	GPL16791	MF|fibrosis	MESH:D005355;BERN:256366601|MESH:D009182;BERN:106909301	MESH:D005355=>Fibrosis|MESH:D009182=>Mycosis Fungoides	Fibrosis|Mycosis Fungoides	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR|CD34	null	null	null	null	null	null	null	null
GSE117824	GSM3739221	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'17.3% (source: CD34- cells) ','Sex':'Male ','age':'59 ','diagnosis':'Post-ET MF ','wbc(k/mcl)':'7.9 ','hg(g/dl)':'12.6 ','platelets(k/mcl)':'309 ','pb blast count':'0% ','bm blast count':'0.01 ','bm fibrosis':'MF-2/3 ','treatment':'None; previously IFN ','organism':'Homo sapiens','source name':'MF04, scRNA-seq', 'title':'10x.MF04', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739221*#*#*#10x.MF04*#*#*#1*#*#*#MF04, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))17.3% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)59 *#*#*#[char](diagnosis)Post-ET MF *#*#*#[char](wbc(k/mcl))7.9 *#*#*#[char](hg(g/dl))12.6 *#*#*#[char](platelets(k/mcl))309 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)0.01 *#*#*#[char](bm fibrosis)MF-2/3 *#*#*#[char](treatment)None; previously IFN 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF04	null	null	None; previously IFN	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739221/suppl/GSM3739221_MF04.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	IFN|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502|MIM:147660;HGNC:5417;Ensembl:ENSG00000197919;BERN:323693802	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR|HGNC:5417=>IFNA1;Ensembl:ENSG00000197919=>IFNA1;MIM:147660=>IFNA1	IFNA1|CALR|CD34	null	null	null	null	null	null	null	null
GSE117824	GSM3739222	{'source':'BMMC ','targeted mutation':'JAK2 V617F (c.1849G>T) ','vaf (targeted exon sequencing)':'16.4% (source: unfractionated PB) ','Sex':'Female ','age':'17 ','diagnosis':'ET ','wbc(k/mcl)':'11.3 ','hg(g/dl)':'13.3 ','platelets(k/mcl)':'711 ','pb blast count':'0% ','bm blast count':'0.04 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'Mixing UT7 & Ba/F3, scRNA-seq', 'title':'10x.ET09', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739222*#*#*#10x.ET09*#*#*#1*#*#*#Mixing UT7 & Ba/F3, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)JAK2 V617F (c.1849G>T) *#*#*#[char](vaf (targeted exon sequencing))16.4% (source: unfractionated PB) *#*#*#[char](Sex)Female *#*#*#[char](age)17 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))11.3 *#*#*#[char](hg(g/dl))13.3 *#*#*#[char](platelets(k/mcl))711 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)0.04 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	Mixing UT7 & Ba/F3	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739222/suppl/GSM3739222_ET09.barcodes.tsv.gz 	GPL16791	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	JAK2	MIM:147796;HGNC:6192;Ensembl:ENSG00000096968;BERN:323767202	HGNC:6192=>JAK2;Ensembl:ENSG00000096968=>JAK2;MIM:147796=>JAK2	JAK2	null	null	null	null	UT7	UT7	null	null
GSE117825	GSM3309838	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'15% (source: CD34+ cells) ','Sex':'Female ','age':'69 ','diagnosis':'ET ','wbc(k/mcl)':'6.5 ','hg(g/dl)':'12.6 ','platelets(k/mcl)':'519 ','pb blast count':'0% ','bm blast count':'3% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin; previously hydroxyurea ','organism':'Homo sapiens','source name':'ET01, amplicon, straight', 'title':'amplicon.ET01.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309838*#*#*#amplicon.ET01.CALR*#*#*#1*#*#*#ET01, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL15520*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))15% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)69 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.5 *#*#*#[char](hg(g/dl))12.6 *#*#*#[char](platelets(k/mcl))519 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)3% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin; previously hydroxyurea 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET01	null	null	Aspirin; previously hydroxyurea	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309838/suppl/GSM3309838_ET01.CALR.txt.gz 	GPL15520	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	CD34+|mcl|CALR	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR|CD34	null	null	null	null	null	null	null	null
GSE117825	GSM3309839	{'source':'BMMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'26% (source: CD34- cells) ','Sex':'Male ','age':'29 ','diagnosis':'ET ','wbc(k/mcl)':'6.5 ','hg(g/dl)':'13.9 ','platelets(k/mcl)':'1060 ','pb blast count':'0% ','bm blast count':'3% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET02, amplicon, straight', 'title':'amplicon.ET02.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309839*#*#*#amplicon.ET02.CALR*#*#*#1*#*#*#ET02, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL15520*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))26% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)29 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.5 *#*#*#[char](hg(g/dl))13.9 *#*#*#[char](platelets(k/mcl))1060 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)3% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET02	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309839/suppl/GSM3309839_ET02.CALR.txt.gz 	GPL15520	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117825	GSM3309840	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'29% (source: CD34- cells) ','Sex':'Male ','age':'40 ','diagnosis':'ET ','wbc(k/mcl)':'7.7 ','hg(g/dl)':'12.4 ','platelets(k/mcl)':'1252 ','pb blast count':'0% ','bm blast count':'2% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET03, amplicon, straight', 'title':'amplicon.ET03.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309840*#*#*#amplicon.ET03.CALR*#*#*#1*#*#*#ET03, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))29% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)40 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))7.7 *#*#*#[char](hg(g/dl))12.4 *#*#*#[char](platelets(k/mcl))1252 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)2% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET03	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309840/suppl/GSM3309840_ET03.CALR.txt.gz 	GPL16791	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR|CD34	null	null	null	null	null	null	null	null
GSE117825	GSM3309841	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'45% (source: unfractionated PBMCs) ','Sex':'Female ','age':'54 ','diagnosis':'Post-ET myelofibrosis ','wbc(k/mcl)':'9.8 ','hg(g/dl)':'9.7 ','platelets(k/mcl)':'318 ','pb blast count':'0% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'None; previously anagrelide ','organism':'Homo sapiens','source name':'MF01, amplicon, straight', 'title':'amplicon.MF01.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309841*#*#*#amplicon.MF01.CALR*#*#*#1*#*#*#MF01, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))45% (source: unfractionated PBMCs) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Post-ET myelofibrosis *#*#*#[char](wbc(k/mcl))9.8 *#*#*#[char](hg(g/dl))9.7 *#*#*#[char](platelets(k/mcl))318 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)None; previously anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF01	null	null	None; previously anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309841/suppl/GSM3309841_MF01.CALR.txt.gz 	GPL16791	myelofibrosis	OMIM:254450;MESH:D055728;BERN:106922101	OMIM:254450=>null;MESH:D055728=>Primary Myelofibrosis	Primary Myelofibrosis|null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117825	GSM3309842	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'47.5% (source: CD34+ cells) ','Sex':'Female ','age':'54 ','diagnosis':'Myelofibrotic myeloid neoplasm ','wbc(k/mcl)':'5.8 ','hg(g/dl)':'8.1 ','platelets(k/mcl)':'291 ','pb blast count':'1% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'Procrit; previously hydroxyurea and anagrelide ','organism':'Homo sapiens','source name':'MF05, amplicon, straight', 'title':'amplicon.MF05.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309842*#*#*#amplicon.MF05.CALR*#*#*#1*#*#*#MF05, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))47.5% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Myelofibrotic myeloid neoplasm *#*#*#[char](wbc(k/mcl))5.8 *#*#*#[char](hg(g/dl))8.1 *#*#*#[char](platelets(k/mcl))291 *#*#*#[char](pb blast count)1% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Procrit; previously hydroxyurea and anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF05	null	null	Procrit; previously hydroxyurea and anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309842/suppl/GSM3309842_MF05.CALR.txt.gz 	GPL16791	Myelofibrotic myeloid neoplasm|fibrosis	MESH:D005355;BERN:256366601|MESH:D009196;BERN:106920001	MESH:D005355=>Fibrosis|MESH:D009196=>Myeloproliferative Disorders	Fibrosis|Myeloproliferative Disorders	hydroxyurea	CHEBI:44423;BERN:4763303	CHEBI:44423=>hydroxyurea	hydroxyurea	CD34+|mcl	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117825	GSM3309843	{'source':'PBMC ','targeted mutation':'NFE2 exon3 p.Glu261fs (c.782_785delAGAG) ','vaf (targeted exon sequencing)':'33% (source: CD34+ cells) ','Sex':'Female ','age':'54 ','diagnosis':'Myelofibrotic myeloid neoplasm ','wbc(k/mcl)':'5.8 ','hg(g/dl)':'8.1 ','platelets(k/mcl)':'291 ','pb blast count':'1% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'Procrit; previously hydroxyurea and anagrelide ','organism':'Homo sapiens','source name':'MF05, amplicon, straight', 'title':'amplicon.MF05.NFE2', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309843*#*#*#amplicon.MF05.NFE2*#*#*#1*#*#*#MF05, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL15520*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)NFE2 exon3 p.Glu261fs (c.782_785delAGAG) *#*#*#[char](vaf (targeted exon sequencing))33% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Myelofibrotic myeloid neoplasm *#*#*#[char](wbc(k/mcl))5.8 *#*#*#[char](hg(g/dl))8.1 *#*#*#[char](platelets(k/mcl))291 *#*#*#[char](pb blast count)1% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Procrit; previously hydroxyurea and anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF05	null	null	Procrit; previously hydroxyurea and anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309843/suppl/GSM3309843_MF05.NFE2.txt.gz 	GPL15520	Myelofibrotic myeloid neoplasm	MESH:D009196;BERN:106920001	MESH:D009196=>Myeloproliferative Disorders	Myeloproliferative Disorders	hydroxyurea|anagrelide	MESH:C021139;BERN:4904003|CHEBI:44423;BERN:4763303	MESH:C021139=>anagrelide|CHEBI:44423=>hydroxyurea;MESH:C021139=>anagrelide	hydroxyurea|anagrelide	CD34+|NFE2|mcl	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:601490;HGNC:7780;Ensembl:ENSG00000123405;BERN:324173202	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:7780=>NFE2;Ensembl:ENSG00000123405=>NFE2;MIM:601490=>NFE2	CLEC4D|NFE2|CD34	null	null	null	null	null	null	null	null
GSE117825	GSM3309844	{'source':'PBMC ','targeted mutation':'SF3B1 exon14 p.H662D(c.1984C>G) ','vaf (targeted exon sequencing)':'43.5% (source: CD34+ cells) ','Sex':'Female ','age':'54 ','diagnosis':'Myelofibrotic myeloid neoplasm ','wbc(k/mcl)':'5.8 ','hg(g/dl)':'8.1 ','platelets(k/mcl)':'291 ','pb blast count':'1% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'Procrit; previously hydroxyurea and anagrelide ','organism':'Homo sapiens','source name':'MF05, amplicon, straight', 'title':'amplicon.MF05.SF3B1', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309844*#*#*#amplicon.MF05.SF3B1*#*#*#1*#*#*#MF05, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)SF3B1 exon14 p.H662D(c.1984C>G) *#*#*#[char](vaf (targeted exon sequencing))43.5% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Myelofibrotic myeloid neoplasm *#*#*#[char](wbc(k/mcl))5.8 *#*#*#[char](hg(g/dl))8.1 *#*#*#[char](platelets(k/mcl))291 *#*#*#[char](pb blast count)1% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Procrit; previously hydroxyurea and anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF05	null	null	Procrit; previously hydroxyurea and anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309844/suppl/GSM3309844_MF05.SF3B1.txt.gz 	GPL16791	Myelofibrotic myeloid neoplasm	MESH:D009196;BERN:106920001	MESH:D009196=>Myeloproliferative Disorders	Myeloproliferative Disorders	hydroxyurea|anagrelide	MESH:C021139;BERN:4904003|CHEBI:44423;BERN:4763303	MESH:C021139=>anagrelide|CHEBI:44423=>hydroxyurea;MESH:C021139=>anagrelide	hydroxyurea|anagrelide	CD34+|SF3B1	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:605590;HGNC:10768;Ensembl:ENSG00000115524;BERN:323204302	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:10768=>SF3B1;Ensembl:ENSG00000115524=>SF3B1;MIM:605590=>SF3B1	SF3B1|CD34	null	null	null	null	null	null	null	null
GSE117825	GSM3309845	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'45% (source: unfractionated PBMCs) ','Sex':'Female ','age':'54 ','diagnosis':'Post-ET myelofibrosis ','wbc(k/mcl)':'9.8 ','hg(g/dl)':'9.7 ','platelets(k/mcl)':'318 ','pb blast count':'0% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'None; previously anagrelide ','organism':'Homo sapiens','source name':'MF01, amplicon, circularization', 'title':'amplicon.MF01.circCALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309845*#*#*#amplicon.MF01.circCALR*#*#*#1*#*#*#MF01, amplicon, circularization*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))45% (source: unfractionated PBMCs) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Post-ET myelofibrosis *#*#*#[char](wbc(k/mcl))9.8 *#*#*#[char](hg(g/dl))9.7 *#*#*#[char](platelets(k/mcl))318 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)None; previously anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF01	null	null	None; previously anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309845/suppl/GSM3309845_MF01.CALR.circ.txt.gz 	GPL16791	myelofibrosis	OMIM:254450;MESH:D055728;BERN:106922101	OMIM:254450=>MYELOFIBROSIS;MESH:D055728=>Primary Myelofibrosis	MYELOFIBROSIS|Primary Myelofibrosis	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117825	GSM3309846	{'source':'mixing study ','targeted mutation':'JAK2 exon12 p.V617F (c.1849G>T) ','vaf (targeted exon sequencing)':'. ','Sex':'missing ','age':'. ','diagnosis':'. ','wbc(k/mcl)':'. ','hg(g/dl)':'. ','platelets(k/mcl)':'. ','pb blast count':'. ','bm blast count':'. ','bm fibrosis':'. ','treatment':'. ','organism':'Homo sapiens','source name':'mixing TF1 & HEL, amplicon, circularization', 'title':'amplicon.TF1_HEL.circJAK2', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309846*#*#*#amplicon.TF1_HEL.circJAK2*#*#*#1*#*#*#mixing TF1 & HEL, amplicon, circularization*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)mixing study *#*#*#[char](targeted mutation)JAK2 exon12 p.V617F (c.1849G>T) *#*#*#[char](vaf (targeted exon sequencing)). *#*#*#[char](Sex)missing *#*#*#[char](age). *#*#*#[char](diagnosis). *#*#*#[char](wbc(k/mcl)). *#*#*#[char](hg(g/dl)). *#*#*#[char](platelets(k/mcl)). *#*#*#[char](pb blast count). *#*#*#[char](bm blast count). *#*#*#[char](bm fibrosis). *#*#*#[char](treatment). 	31270458	null	Homo sapiens	null	high-throughput sequencing	mixing TF1 & HEL	null	null	.	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309846/suppl/GSM3309846_TF1_HEL.JAK2.circ.txt.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	mcl)	MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D	null	null	null	null	HEL|TF1	HEL|TF1	null	null
GSE117825	GSM3309847	{'source':'mixing study ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'. ','Sex':'missing ','age':'. ','diagnosis':'. ','wbc(k/mcl)':'. ','hg(g/dl)':'. ','platelets(k/mcl)':'. ','pb blast count':'. ','bm blast count':'. ','bm fibrosis':'. ','treatment':'. ','organism':'Homo sapiens','source name':'mixing UT7 & Ba/F3, amplicon, straight', 'title':'amplicon.species_mix.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309847*#*#*#amplicon.species_mix.CALR*#*#*#1*#*#*#mixing UT7 & Ba/F3, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL22245*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)mixing study *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing)). *#*#*#[char](Sex)missing *#*#*#[char](age). *#*#*#[char](diagnosis). *#*#*#[char](wbc(k/mcl)). *#*#*#[char](hg(g/dl)). *#*#*#[char](platelets(k/mcl)). *#*#*#[char](pb blast count). *#*#*#[char](bm blast count). *#*#*#[char](bm fibrosis). *#*#*#[char](treatment). 	31270458	null	Homo sapiens	null	high-throughput sequencing	mixing UT7 & Ba/F3	null	null	.	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309847/suppl/GSM3309847_species_mix.CALR.txt.gz 	GPL22245	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	mcl)|CALR	MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR	null	null	null	null	UT7	UT7	null	null
GSE117825	GSM3739223	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'16.7% (source: CD34- cells) ','Sex':'Female ','age':'57 ','diagnosis':'ET ','wbc(k/mcl)':'7.6 ','hg(g/dl)':'14.8 ','platelets(k/mcl)':'650 ','pb blast count':'0% ','bm blast count':'1% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET04, amplicon, straight', 'title':'amplicon.ET04.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739223*#*#*#amplicon.ET04.CALR*#*#*#1*#*#*#ET04, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))16.7% (source: CD34- cells) *#*#*#[char](Sex)Female *#*#*#[char](age)57 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))7.6 *#*#*#[char](hg(g/dl))14.8 *#*#*#[char](platelets(k/mcl))650 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)1% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET04	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739223/suppl/GSM3739223_ET04.CALR.txt.gz 	GPL16791	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CALR|CD34	null	null	null	null	null	null	null	null
GSE117825	GSM3739224	{'source':'BMMC ','targeted mutation':'CALR exon9 A382Rfs*58 (c.1144_1215delins67) ','vaf (targeted exon sequencing)':'18% (source: unfractionated BM) ','Sex':'Male ','age':'17 ','diagnosis':'ET ','wbc(k/mcl)':'6.3 ','hg(g/dl)':'12.4 ','platelets(k/mcl)':'1421 ','pb blast count':'0% ','bm blast count':'1% ','bm fibrosis':'MF-0/3 ','treatment':'None ','organism':'Homo sapiens','source name':'ET05, amplicon, straight', 'title':'amplicon.ET05.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739224*#*#*#amplicon.ET05.CALR*#*#*#1*#*#*#ET05, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 A382Rfs*58 (c.1144_1215delins67) *#*#*#[char](vaf (targeted exon sequencing))18% (source: unfractionated BM) *#*#*#[char](Sex)Male *#*#*#[char](age)17 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.3 *#*#*#[char](hg(g/dl))12.4 *#*#*#[char](platelets(k/mcl))1421 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)1% *#*#*#[char](bm fibrosis)MF-0/3 *#*#*#[char](treatment)None 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET05	null	null	None	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739224/suppl/GSM3739224_ET05.CALR.txt.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117825	GSM3739225	{'source':'PBMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'25% (source: unfractionated PB) ','Sex':'Male ','age':'62 ','diagnosis':'MF ','wbc(k/mcl)':'4.3 ','hg(g/dl)':'10.2 ','platelets(k/mcl)':'191 ','pb blast count':'0% ','bm blast count':'2% ','bm fibrosis':'MF-2/3 ','treatment':'None ','organism':'Homo sapiens','source name':'MF02, amplicon, straight', 'title':'amplicon.MF02.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739225*#*#*#amplicon.MF02.CALR*#*#*#1*#*#*#MF02, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))25% (source: unfractionated PB) *#*#*#[char](Sex)Male *#*#*#[char](age)62 *#*#*#[char](diagnosis)MF *#*#*#[char](wbc(k/mcl))4.3 *#*#*#[char](hg(g/dl))10.2 *#*#*#[char](platelets(k/mcl))191 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)2% *#*#*#[char](bm fibrosis)MF-2/3 *#*#*#[char](treatment)None 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF02	null	null	None	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739225/suppl/GSM3739225_MF02.CALR.txt.gz 	GPL16791	MF	MESH:D009182;BERN:106909301	MESH:D009182=>Mycosis Fungoides	Mycosis Fungoides	null	null	null	null	mcl|CALR	MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR	null	null	null	null	null	null	null	null
GSE117825	GSM3739226	{'source':'PBMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'20.6% (source: CD34- cells) ','Sex':'Male ','age':'59 ','diagnosis':'MF ','wbc(k/mcl)':'12.8 ','hg(g/dl)':'12.7 ','platelets(k/mcl)':'464 ','pb blast count':'0% ','bm blast count':'<5% ','bm fibrosis':'MF-3/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'MF03, amplicon, straight', 'title':'amplicon.MF03.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739226*#*#*#amplicon.MF03.CALR*#*#*#1*#*#*#MF03, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))20.6% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)59 *#*#*#[char](diagnosis)MF *#*#*#[char](wbc(k/mcl))12.8 *#*#*#[char](hg(g/dl))12.7 *#*#*#[char](platelets(k/mcl))464 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)<5% *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF03	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739226/suppl/GSM3739226_MF03.CALR.txt.gz 	GPL16791	MF	MESH:D009182;BERN:106909301	MESH:D009182=>Mycosis Fungoides	Mycosis Fungoides	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CALR|CD34	null	null	null	null	null	null	null	null
GSE117825	GSM3739227	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'17.3% (source: CD34- cells) ','Sex':'Male ','age':'59 ','diagnosis':'Post-ET MF ','wbc(k/mcl)':'7.9 ','hg(g/dl)':'12.6 ','platelets(k/mcl)':'309 ','pb blast count':'0% ','bm blast count':'0.01 ','bm fibrosis':'MF-2/3 ','treatment':'None; previously IFN ','organism':'Homo sapiens','source name':'MF04, amplicon, straight', 'title':'amplicon.MF04.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739227*#*#*#amplicon.MF04.CALR*#*#*#1*#*#*#MF04, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))17.3% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)59 *#*#*#[char](diagnosis)Post-ET MF *#*#*#[char](wbc(k/mcl))7.9 *#*#*#[char](hg(g/dl))12.6 *#*#*#[char](platelets(k/mcl))309 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)0.01 *#*#*#[char](bm fibrosis)MF-2/3 *#*#*#[char](treatment)None; previously IFN 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF04	null	null	None; previously IFN	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739227/suppl/GSM3739227_MF04.CALR.txt.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	IFN|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502|MIM:147660;HGNC:5417;Ensembl:ENSG00000197919;BERN:323693802	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR|HGNC:5417=>IFNA1;Ensembl:ENSG00000197919=>IFNA1;MIM:147660=>IFNA1	IFNA1|CALR|CD34	null	null	null	null	null	null	null	null
GSE117825	GSM3739228	{'source':'BMMC ','targeted mutation':'JAK2 V617F (c.1849G>T) ','vaf (targeted exon sequencing)':'16.4% (source: unfractionated PB) ','Sex':'Female ','age':'17 ','diagnosis':'ET ','wbc(k/mcl)':'11.3 ','hg(g/dl)':'13.3 ','platelets(k/mcl)':'711 ','pb blast count':'0% ','bm blast count':'0.04 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET09, amplicon, circularization', 'title':'amplicon.ET09.circJAK2', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739228*#*#*#amplicon.ET09.circJAK2*#*#*#1*#*#*#ET09, amplicon, circularization*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)JAK2 V617F (c.1849G>T) *#*#*#[char](vaf (targeted exon sequencing))16.4% (source: unfractionated PB) *#*#*#[char](Sex)Female *#*#*#[char](age)17 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))11.3 *#*#*#[char](hg(g/dl))13.3 *#*#*#[char](platelets(k/mcl))711 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)0.04 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET09	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739228/suppl/GSM3739228_ET09.JAK2.circ.txt.gz 	GPL16791	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	JAK2	MIM:147796;HGNC:6192;Ensembl:ENSG00000096968;BERN:323767202	HGNC:6192=>JAK2;Ensembl:ENSG00000096968=>JAK2;MIM:147796=>JAK2	JAK2	null	null	null	null	null	null	null	null
GSE117826	GSM3309832	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'15% (source: CD34+ cells) ','Sex':'Female ','age':'69 ','diagnosis':'ET ','wbc(k/mcl)':'6.5 ','hg(g/dl)':'12.6 ','platelets(k/mcl)':'519 ','pb blast count':'0 ','bm blast count':'0.03 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin; previously hydroxyurea ','organism':'Homo sapiens','source name':'ET01, scRNA-seq', 'title':'10x.ET01', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309832*#*#*#10x.ET01*#*#*#1*#*#*#ET01, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))15% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)69 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.5 *#*#*#[char](hg(g/dl))12.6 *#*#*#[char](platelets(k/mcl))519 *#*#*#[char](pb blast count)0 *#*#*#[char](bm blast count)0.03 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin; previously hydroxyurea 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET01	null	null	Aspirin; previously hydroxyurea	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309832/suppl/GSM3309832_ET01.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	CD34+|mcl	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309833	{'source':'BMMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'26% (source: CD34- cells) ','Sex':'Male ','age':'29 ','diagnosis':'ET ','wbc(k/mcl)':'6.5 ','hg(g/dl)':'13.9 ','platelets(k/mcl)':'1060 ','pb blast count':'0 ','bm blast count':'0.03 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET02, scRNA-seq', 'title':'10x.ET02', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309833*#*#*#10x.ET02*#*#*#1*#*#*#ET02, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))26% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)29 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.5 *#*#*#[char](hg(g/dl))13.9 *#*#*#[char](platelets(k/mcl))1060 *#*#*#[char](pb blast count)0 *#*#*#[char](bm blast count)0.03 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET02	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309833/suppl/GSM3309833_ET02.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309834	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'29% (source: CD34- cells) ','Sex':'Male ','age':'40 ','diagnosis':'ET ','wbc(k/mcl)':'7.7 ','hg(g/dl)':'12.4 ','platelets(k/mcl)':'1252 ','pb blast count':'0 ','bm blast count':'0.02 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET03, scRNA-seq', 'title':'10x.ET03', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309834*#*#*#10x.ET03*#*#*#1*#*#*#ET03, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))29% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)40 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))7.7 *#*#*#[char](hg(g/dl))12.4 *#*#*#[char](platelets(k/mcl))1252 *#*#*#[char](pb blast count)0 *#*#*#[char](bm blast count)0.02 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET03	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309834/suppl/GSM3309834_ET03.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309835	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'45% (source: unfractionated PBMCs) ','Sex':'Female ','age':'54 ','diagnosis':'Post-ET myelofibrosis ','wbc(k/mcl)':'9.8 ','hg(g/dl)':'9.7 ','platelets(k/mcl)':'318 ','pb blast count':'0 ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'None; previously anagrelide ','organism':'Homo sapiens','source name':'MF01, scRNA-seq', 'title':'10x.MF01', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309835*#*#*#10x.MF01*#*#*#1*#*#*#MF01, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))45% (source: unfractionated PBMCs) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Post-ET myelofibrosis *#*#*#[char](wbc(k/mcl))9.8 *#*#*#[char](hg(g/dl))9.7 *#*#*#[char](platelets(k/mcl))318 *#*#*#[char](pb blast count)0 *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)None; previously anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF01	null	null	None; previously anagrelide	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309835/suppl/GSM3309835_MF01.barcodes.tsv.gz 	GPL16791	myelofibrosis	OMIM:254450;MESH:D055728;BERN:106922101	OMIM:254450=>null;MESH:D055728=>Primary Myelofibrosis	Primary Myelofibrosis|null	null	null	null	null	mcl	MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D	null	null	null	null	null	null	null	null
GSE117826	GSM3309836	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'47.5% (source: CD34+ cells) ','Sex':'Female ','age':'54 ','diagnosis':'Myelofibrotic myeloid neoplasm ','wbc(k/mcl)':'5.8 ','hg(g/dl)':'8.1 ','platelets(k/mcl)':'291 ','pb blast count':'0.01 ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'Procrit; previously hydroxyurea and anagrelide ','organism':'Homo sapiens','source name':'MF05, scRNA-seq', 'title':'10x.MF05', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309836*#*#*#10x.MF05*#*#*#1*#*#*#MF05, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))47.5% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Myelofibrotic myeloid neoplasm *#*#*#[char](wbc(k/mcl))5.8 *#*#*#[char](hg(g/dl))8.1 *#*#*#[char](platelets(k/mcl))291 *#*#*#[char](pb blast count)0.01 *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Procrit; previously hydroxyurea and anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF05	null	null	Procrit; previously hydroxyurea and anagrelide	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309836/suppl/GSM3309836_MF05.barcodes.tsv.gz 	GPL16791	myeloid neoplasm	MESH:D009196;BERN:106920001	MESH:D009196=>Myeloproliferative Disorders	Myeloproliferative Disorders	hydroxyurea|anagrelide	MESH:C021139;BERN:4904003|CHEBI:44423;BERN:4763303	MESH:C021139=>anagrelide|CHEBI:44423=>hydroxyurea;MESH:C021139=>anagrelide	hydroxyurea|anagrelide	CD34+	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34	CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309837	{'source':'mixing study ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'. ','Sex':'missing ','age':'. ','diagnosis':'. ','wbc(k/mcl)':'. ','hg(g/dl)':'. ','platelets(k/mcl)':'. ','pb blast count':'. ','bm blast count':'. ','bm fibrosis':'. ','treatment':'. ','organism':'Homo sapiens','source name':'mixing UT7 & Ba/F3, scRNA-seq', 'title':'10x.species_mix', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309837*#*#*#10x.species_mix*#*#*#1*#*#*#mixing UT7 & Ba/F3, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19/mm10Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL22245*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)mixing study *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing)). *#*#*#[char](Sex)missing *#*#*#[char](age). *#*#*#[char](diagnosis). *#*#*#[char](wbc(k/mcl)). *#*#*#[char](hg(g/dl)). *#*#*#[char](platelets(k/mcl)). *#*#*#[char](pb blast count). *#*#*#[char](bm blast count). *#*#*#[char](bm fibrosis). *#*#*#[char](treatment). 	31270458	null	Homo sapiens	null	high-throughput sequencing	mixing UT7 & Ba/F3	null	null	.	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309837/suppl/GSM3309837_species_mix.barcodes.hg38.tsv.gz 	GPL22245	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	UT7	UT7	null	null
GSE117826	GSM3309838	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'15% (source: CD34+ cells) ','Sex':'Female ','age':'69 ','diagnosis':'ET ','wbc(k/mcl)':'6.5 ','hg(g/dl)':'12.6 ','platelets(k/mcl)':'519 ','pb blast count':'0% ','bm blast count':'3% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin; previously hydroxyurea ','organism':'Homo sapiens','source name':'ET01, amplicon, straight', 'title':'amplicon.ET01.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309838*#*#*#amplicon.ET01.CALR*#*#*#1*#*#*#ET01, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL15520*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))15% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)69 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.5 *#*#*#[char](hg(g/dl))12.6 *#*#*#[char](platelets(k/mcl))519 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)3% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin; previously hydroxyurea 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET01	null	null	Aspirin; previously hydroxyurea	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309838/suppl/GSM3309838_ET01.CALR.txt.gz 	GPL15520	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	CD34+|mcl|CALR	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309839	{'source':'BMMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'26% (source: CD34- cells) ','Sex':'Male ','age':'29 ','diagnosis':'ET ','wbc(k/mcl)':'6.5 ','hg(g/dl)':'13.9 ','platelets(k/mcl)':'1060 ','pb blast count':'0% ','bm blast count':'3% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET02, amplicon, straight', 'title':'amplicon.ET02.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309839*#*#*#amplicon.ET02.CALR*#*#*#1*#*#*#ET02, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL15520*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))26% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)29 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.5 *#*#*#[char](hg(g/dl))13.9 *#*#*#[char](platelets(k/mcl))1060 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)3% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET02	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309839/suppl/GSM3309839_ET02.CALR.txt.gz 	GPL15520	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309840	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'29% (source: CD34- cells) ','Sex':'Male ','age':'40 ','diagnosis':'ET ','wbc(k/mcl)':'7.7 ','hg(g/dl)':'12.4 ','platelets(k/mcl)':'1252 ','pb blast count':'0% ','bm blast count':'2% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET03, amplicon, straight', 'title':'amplicon.ET03.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309840*#*#*#amplicon.ET03.CALR*#*#*#1*#*#*#ET03, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))29% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)40 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))7.7 *#*#*#[char](hg(g/dl))12.4 *#*#*#[char](platelets(k/mcl))1252 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)2% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET03	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309840/suppl/GSM3309840_ET03.CALR.txt.gz 	GPL16791	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309841	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'45% (source: unfractionated PBMCs) ','Sex':'Female ','age':'54 ','diagnosis':'Post-ET myelofibrosis ','wbc(k/mcl)':'9.8 ','hg(g/dl)':'9.7 ','platelets(k/mcl)':'318 ','pb blast count':'0% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'None; previously anagrelide ','organism':'Homo sapiens','source name':'MF01, amplicon, straight', 'title':'amplicon.MF01.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309841*#*#*#amplicon.MF01.CALR*#*#*#1*#*#*#MF01, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))45% (source: unfractionated PBMCs) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Post-ET myelofibrosis *#*#*#[char](wbc(k/mcl))9.8 *#*#*#[char](hg(g/dl))9.7 *#*#*#[char](platelets(k/mcl))318 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)None; previously anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF01	null	null	None; previously anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309841/suppl/GSM3309841_MF01.CALR.txt.gz 	GPL16791	myelofibrosis	OMIM:254450;MESH:D055728;BERN:106922101	OMIM:254450=>MYELOFIBROSIS;MESH:D055728=>Primary Myelofibrosis	MYELOFIBROSIS|Primary Myelofibrosis	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117826	GSM3309842	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'47.5% (source: CD34+ cells) ','Sex':'Female ','age':'54 ','diagnosis':'Myelofibrotic myeloid neoplasm ','wbc(k/mcl)':'5.8 ','hg(g/dl)':'8.1 ','platelets(k/mcl)':'291 ','pb blast count':'1% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'Procrit; previously hydroxyurea and anagrelide ','organism':'Homo sapiens','source name':'MF05, amplicon, straight', 'title':'amplicon.MF05.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309842*#*#*#amplicon.MF05.CALR*#*#*#1*#*#*#MF05, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))47.5% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Myelofibrotic myeloid neoplasm *#*#*#[char](wbc(k/mcl))5.8 *#*#*#[char](hg(g/dl))8.1 *#*#*#[char](platelets(k/mcl))291 *#*#*#[char](pb blast count)1% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Procrit; previously hydroxyurea and anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF05	null	null	Procrit; previously hydroxyurea and anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309842/suppl/GSM3309842_MF05.CALR.txt.gz 	GPL16791	Myelofibrotic myeloid neoplasm|fibrosis	MESH:D005355;BERN:256366601|MESH:D009196;BERN:106920001	MESH:D005355=>Fibrosis|MESH:D009196=>Myeloproliferative Disorders	Fibrosis|Myeloproliferative Disorders	hydroxyurea	CHEBI:44423;BERN:4763303	CHEBI:44423=>hydroxyurea	hydroxyurea	CD34+|mcl	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309843	{'source':'PBMC ','targeted mutation':'NFE2 exon3 p.Glu261fs (c.782_785delAGAG) ','vaf (targeted exon sequencing)':'33% (source: CD34+ cells) ','Sex':'Female ','age':'54 ','diagnosis':'Myelofibrotic myeloid neoplasm ','wbc(k/mcl)':'5.8 ','hg(g/dl)':'8.1 ','platelets(k/mcl)':'291 ','pb blast count':'1% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'Procrit; previously hydroxyurea and anagrelide ','organism':'Homo sapiens','source name':'MF05, amplicon, straight', 'title':'amplicon.MF05.NFE2', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309843*#*#*#amplicon.MF05.NFE2*#*#*#1*#*#*#MF05, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL15520*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)NFE2 exon3 p.Glu261fs (c.782_785delAGAG) *#*#*#[char](vaf (targeted exon sequencing))33% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Myelofibrotic myeloid neoplasm *#*#*#[char](wbc(k/mcl))5.8 *#*#*#[char](hg(g/dl))8.1 *#*#*#[char](platelets(k/mcl))291 *#*#*#[char](pb blast count)1% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Procrit; previously hydroxyurea and anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF05	null	null	Procrit; previously hydroxyurea and anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309843/suppl/GSM3309843_MF05.NFE2.txt.gz 	GPL15520	Myelofibrotic myeloid neoplasm	MESH:D009196;BERN:106920001	MESH:D009196=>Myeloproliferative Disorders	Myeloproliferative Disorders	hydroxyurea|anagrelide	MESH:C021139;BERN:4904003|CHEBI:44423;BERN:4763303	MESH:C021139=>anagrelide|CHEBI:44423=>hydroxyurea;MESH:C021139=>anagrelide	hydroxyurea|anagrelide	CD34+|NFE2|mcl	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:601490;HGNC:7780;Ensembl:ENSG00000123405;BERN:324173202	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:7780=>NFE2;Ensembl:ENSG00000123405=>NFE2;MIM:601490=>NFE2	CLEC4D|NFE2|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309844	{'source':'PBMC ','targeted mutation':'SF3B1 exon14 p.H662D(c.1984C>G) ','vaf (targeted exon sequencing)':'43.5% (source: CD34+ cells) ','Sex':'Female ','age':'54 ','diagnosis':'Myelofibrotic myeloid neoplasm ','wbc(k/mcl)':'5.8 ','hg(g/dl)':'8.1 ','platelets(k/mcl)':'291 ','pb blast count':'1% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'Procrit; previously hydroxyurea and anagrelide ','organism':'Homo sapiens','source name':'MF05, amplicon, straight', 'title':'amplicon.MF05.SF3B1', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309844*#*#*#amplicon.MF05.SF3B1*#*#*#1*#*#*#MF05, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)SF3B1 exon14 p.H662D(c.1984C>G) *#*#*#[char](vaf (targeted exon sequencing))43.5% (source: CD34+ cells) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Myelofibrotic myeloid neoplasm *#*#*#[char](wbc(k/mcl))5.8 *#*#*#[char](hg(g/dl))8.1 *#*#*#[char](platelets(k/mcl))291 *#*#*#[char](pb blast count)1% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Procrit; previously hydroxyurea and anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF05	null	null	Procrit; previously hydroxyurea and anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309844/suppl/GSM3309844_MF05.SF3B1.txt.gz 	GPL16791	Myelofibrotic myeloid neoplasm	MESH:D009196;BERN:106920001	MESH:D009196=>Myeloproliferative Disorders	Myeloproliferative Disorders	hydroxyurea|anagrelide	MESH:C021139;BERN:4904003|CHEBI:44423;BERN:4763303	MESH:C021139=>anagrelide|CHEBI:44423=>hydroxyurea;MESH:C021139=>anagrelide	hydroxyurea|anagrelide	CD34+|SF3B1	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:605590;HGNC:10768;Ensembl:ENSG00000115524;BERN:323204302	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:10768=>SF3B1;Ensembl:ENSG00000115524=>SF3B1;MIM:605590=>SF3B1	SF3B1|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3309845	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'45% (source: unfractionated PBMCs) ','Sex':'Female ','age':'54 ','diagnosis':'Post-ET myelofibrosis ','wbc(k/mcl)':'9.8 ','hg(g/dl)':'9.7 ','platelets(k/mcl)':'318 ','pb blast count':'0% ','bm blast count':'Indeterminate ','bm fibrosis':'MF-3/3 ','treatment':'None; previously anagrelide ','organism':'Homo sapiens','source name':'MF01, amplicon, circularization', 'title':'amplicon.MF01.circCALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309845*#*#*#amplicon.MF01.circCALR*#*#*#1*#*#*#MF01, amplicon, circularization*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))45% (source: unfractionated PBMCs) *#*#*#[char](Sex)Female *#*#*#[char](age)54 *#*#*#[char](diagnosis)Post-ET myelofibrosis *#*#*#[char](wbc(k/mcl))9.8 *#*#*#[char](hg(g/dl))9.7 *#*#*#[char](platelets(k/mcl))318 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)Indeterminate *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)None; previously anagrelide 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF01	null	null	None; previously anagrelide	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309845/suppl/GSM3309845_MF01.CALR.circ.txt.gz 	GPL16791	myelofibrosis	OMIM:254450;MESH:D055728;BERN:106922101	OMIM:254450=>MYELOFIBROSIS;MESH:D055728=>Primary Myelofibrosis	MYELOFIBROSIS|Primary Myelofibrosis	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117826	GSM3309846	{'source':'mixing study ','targeted mutation':'JAK2 exon12 p.V617F (c.1849G>T) ','vaf (targeted exon sequencing)':'. ','Sex':'missing ','age':'. ','diagnosis':'. ','wbc(k/mcl)':'. ','hg(g/dl)':'. ','platelets(k/mcl)':'. ','pb blast count':'. ','bm blast count':'. ','bm fibrosis':'. ','treatment':'. ','organism':'Homo sapiens','source name':'mixing TF1 & HEL, amplicon, circularization', 'title':'amplicon.TF1_HEL.circJAK2', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309846*#*#*#amplicon.TF1_HEL.circJAK2*#*#*#1*#*#*#mixing TF1 & HEL, amplicon, circularization*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)mixing study *#*#*#[char](targeted mutation)JAK2 exon12 p.V617F (c.1849G>T) *#*#*#[char](vaf (targeted exon sequencing)). *#*#*#[char](Sex)missing *#*#*#[char](age). *#*#*#[char](diagnosis). *#*#*#[char](wbc(k/mcl)). *#*#*#[char](hg(g/dl)). *#*#*#[char](platelets(k/mcl)). *#*#*#[char](pb blast count). *#*#*#[char](bm blast count). *#*#*#[char](bm fibrosis). *#*#*#[char](treatment). 	31270458	null	Homo sapiens	null	high-throughput sequencing	mixing TF1 & HEL	null	null	.	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309846/suppl/GSM3309846_TF1_HEL.JAK2.circ.txt.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	mcl)	MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102	HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D	CLEC4D	null	null	null	null	HEL|TF1	HEL|TF1	null	null
GSE117826	GSM3309847	{'source':'mixing study ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'. ','Sex':'missing ','age':'. ','diagnosis':'. ','wbc(k/mcl)':'. ','hg(g/dl)':'. ','platelets(k/mcl)':'. ','pb blast count':'. ','bm blast count':'. ','bm fibrosis':'. ','treatment':'. ','organism':'Homo sapiens','source name':'mixing UT7 & Ba/F3, amplicon, straight', 'title':'amplicon.species_mix.CALR', 'last update date':'2019-06-01', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3309847*#*#*#amplicon.species_mix.CALR*#*#*#1*#*#*#mixing UT7 & Ba/F3, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger 2.1.0 using default parameters. RNA reads were aligned to the human or mouse referece genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Genome_build: GRCh38 or hg19/mm10 *#*#*#OTHER*#*#*#null*#*#*#GPL22245*#*#*#2019-06-01*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)mixing study *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing)). *#*#*#[char](Sex)missing *#*#*#[char](age). *#*#*#[char](diagnosis). *#*#*#[char](wbc(k/mcl)). *#*#*#[char](hg(g/dl)). *#*#*#[char](platelets(k/mcl)). *#*#*#[char](pb blast count). *#*#*#[char](bm blast count). *#*#*#[char](bm fibrosis). *#*#*#[char](treatment). 	31270458	null	Homo sapiens	null	high-throughput sequencing	mixing UT7 & Ba/F3	null	null	.	OTHER	null	transcriptomic	total RNA	SRA	2019-06-01	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309847/suppl/GSM3309847_species_mix.CALR.txt.gz 	GPL22245	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	mcl)|CALR	MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR	null	null	null	null	UT7	UT7	null	null
GSE117826	GSM3739217	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'16.7% (source: CD34- cells) ','Sex':'Female ','age':'57 ','diagnosis':'ET ','wbc(k/mcl)':'7.6 ','hg(g/dl)':'14.8 ','platelets(k/mcl)':'650 ','pb blast count':'0% ','bm blast count':'1% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET04, scRNA-seq', 'title':'10x.ET04', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739217*#*#*#10x.ET04*#*#*#1*#*#*#ET04, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))16.7% (source: CD34- cells) *#*#*#[char](Sex)Female *#*#*#[char](age)57 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))7.6 *#*#*#[char](hg(g/dl))14.8 *#*#*#[char](platelets(k/mcl))650 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)1% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET04	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739217/suppl/GSM3739217_ET04.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3739218	{'source':'BMMC ','targeted mutation':'CALR exon9 A382Rfs*58 (c.1144_1215delins67) ','vaf (targeted exon sequencing)':'18% (source: unfractionated BM) ','Sex':'Male ','age':'17 ','diagnosis':'ET ','wbc(k/mcl)':'6.3 ','hg(g/dl)':'12.4 ','platelets(k/mcl)':'1421 ','pb blast count':'0% ','bm blast count':'1% ','bm fibrosis':'MF-0/3 ','treatment':'None ','organism':'Homo sapiens','source name':'ET05, scRNA-seq', 'title':'10x.ET05', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739218*#*#*#10x.ET05*#*#*#1*#*#*#ET05, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 A382Rfs*58 (c.1144_1215delins67) *#*#*#[char](vaf (targeted exon sequencing))18% (source: unfractionated BM) *#*#*#[char](Sex)Male *#*#*#[char](age)17 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.3 *#*#*#[char](hg(g/dl))12.4 *#*#*#[char](platelets(k/mcl))1421 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)1% *#*#*#[char](bm fibrosis)MF-0/3 *#*#*#[char](treatment)None 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET05	null	null	None	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739218/suppl/GSM3739218_ET05.barcodes.tsv.gz 	GPL16791	null	null	null	null	null	null	null	null	CALR	MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CALR	null	null	null	null	null	null	null	null
GSE117826	GSM3739219	{'source':'PBMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'25% (source: unfractionated PB) ','Sex':'Male ','age':'62 ','diagnosis':'MF ','wbc(k/mcl)':'4.3 ','hg(g/dl)':'10.2 ','platelets(k/mcl)':'191 ','pb blast count':'0% ','bm blast count':'2% ','bm fibrosis':'MF-2/3 ','treatment':'None ','organism':'Homo sapiens','source name':'MF02, scRNA-seq', 'title':'10x.MF02', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739219*#*#*#10x.MF02*#*#*#1*#*#*#MF02, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))25% (source: unfractionated PB) *#*#*#[char](Sex)Male *#*#*#[char](age)62 *#*#*#[char](diagnosis)MF *#*#*#[char](wbc(k/mcl))4.3 *#*#*#[char](hg(g/dl))10.2 *#*#*#[char](platelets(k/mcl))191 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)2% *#*#*#[char](bm fibrosis)MF-2/3 *#*#*#[char](treatment)None 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF02	null	null	None	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739219/suppl/GSM3739219_MF02.barcodes.tsv.gz 	GPL16791	MF	MESH:D009182;BERN:106909301	MESH:D009182=>Mycosis Fungoides	Mycosis Fungoides	null	null	null	null	CALR	MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CALR	null	null	null	null	null	null	null	null
GSE117826	GSM3739220	{'source':'PBMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'20.6% (source: CD34- cells) ','Sex':'Male ','age':'59 ','diagnosis':'MF ','wbc(k/mcl)':'12.8 ','hg(g/dl)':'12.7 ','platelets(k/mcl)':'464 ','pb blast count':'0% ','bm blast count':'<5% ','bm fibrosis':'MF-3/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'MF03, scRNA-seq', 'title':'10x.MF03', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739220*#*#*#10x.MF03*#*#*#1*#*#*#MF03, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))20.6% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)59 *#*#*#[char](diagnosis)MF *#*#*#[char](wbc(k/mcl))12.8 *#*#*#[char](hg(g/dl))12.7 *#*#*#[char](platelets(k/mcl))464 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)<5% *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF03	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739220/suppl/GSM3739220_MF03.barcodes.tsv.gz 	GPL16791	MF|fibrosis	MESH:D005355;BERN:256366601|MESH:D009182;BERN:106909301	MESH:D005355=>Fibrosis|MESH:D009182=>Mycosis Fungoides	Fibrosis|Mycosis Fungoides	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	mcl|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3739221	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'17.3% (source: CD34- cells) ','Sex':'Male ','age':'59 ','diagnosis':'Post-ET MF ','wbc(k/mcl)':'7.9 ','hg(g/dl)':'12.6 ','platelets(k/mcl)':'309 ','pb blast count':'0% ','bm blast count':'0.01 ','bm fibrosis':'MF-2/3 ','treatment':'None; previously IFN ','organism':'Homo sapiens','source name':'MF04, scRNA-seq', 'title':'10x.MF04', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739221*#*#*#10x.MF04*#*#*#1*#*#*#MF04, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))17.3% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)59 *#*#*#[char](diagnosis)Post-ET MF *#*#*#[char](wbc(k/mcl))7.9 *#*#*#[char](hg(g/dl))12.6 *#*#*#[char](platelets(k/mcl))309 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)0.01 *#*#*#[char](bm fibrosis)MF-2/3 *#*#*#[char](treatment)None; previously IFN 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF04	null	null	None; previously IFN	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739221/suppl/GSM3739221_MF04.barcodes.tsv.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	IFN|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502|MIM:147660;HGNC:5417;Ensembl:ENSG00000197919;BERN:323693802	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR|HGNC:5417=>IFNA1;Ensembl:ENSG00000197919=>IFNA1;MIM:147660=>IFNA1	IFNA1|CALR|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3739222	{'source':'BMMC ','targeted mutation':'JAK2 V617F (c.1849G>T) ','vaf (targeted exon sequencing)':'16.4% (source: unfractionated PB) ','Sex':'Female ','age':'17 ','diagnosis':'ET ','wbc(k/mcl)':'11.3 ','hg(g/dl)':'13.3 ','platelets(k/mcl)':'711 ','pb blast count':'0% ','bm blast count':'0.04 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'Mixing UT7 & Ba/F3, scRNA-seq', 'title':'10x.ET09', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739222*#*#*#10x.ET09*#*#*#1*#*#*#Mixing UT7 & Ba/F3, scRNA-seq*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human reference genome, or human reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Genome_build: GRCh38 or hg19Supplementary_files_format_and_content: counts *#*#*#RNA-Seq*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)JAK2 V617F (c.1849G>T) *#*#*#[char](vaf (targeted exon sequencing))16.4% (source: unfractionated PB) *#*#*#[char](Sex)Female *#*#*#[char](age)17 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))11.3 *#*#*#[char](hg(g/dl))13.3 *#*#*#[char](platelets(k/mcl))711 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)0.04 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	Mixing UT7 & Ba/F3	null	null	Aspirin	RNA-Seq	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739222/suppl/GSM3739222_ET09.barcodes.tsv.gz 	GPL16791	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	JAK2	MIM:147796;HGNC:6192;Ensembl:ENSG00000096968;BERN:323767202	HGNC:6192=>JAK2;Ensembl:ENSG00000096968=>JAK2;MIM:147796=>JAK2	JAK2	null	null	null	null	UT7	UT7	null	null
GSE117826	GSM3739223	{'source':'BMMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'16.7% (source: CD34- cells) ','Sex':'Female ','age':'57 ','diagnosis':'ET ','wbc(k/mcl)':'7.6 ','hg(g/dl)':'14.8 ','platelets(k/mcl)':'650 ','pb blast count':'0% ','bm blast count':'1% ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET04, amplicon, straight', 'title':'amplicon.ET04.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739223*#*#*#amplicon.ET04.CALR*#*#*#1*#*#*#ET04, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))16.7% (source: CD34- cells) *#*#*#[char](Sex)Female *#*#*#[char](age)57 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))7.6 *#*#*#[char](hg(g/dl))14.8 *#*#*#[char](platelets(k/mcl))650 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)1% *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET04	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739223/suppl/GSM3739223_ET04.CALR.txt.gz 	GPL16791	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CALR|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3739224	{'source':'BMMC ','targeted mutation':'CALR exon9 A382Rfs*58 (c.1144_1215delins67) ','vaf (targeted exon sequencing)':'18% (source: unfractionated BM) ','Sex':'Male ','age':'17 ','diagnosis':'ET ','wbc(k/mcl)':'6.3 ','hg(g/dl)':'12.4 ','platelets(k/mcl)':'1421 ','pb blast count':'0% ','bm blast count':'1% ','bm fibrosis':'MF-0/3 ','treatment':'None ','organism':'Homo sapiens','source name':'ET05, amplicon, straight', 'title':'amplicon.ET05.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739224*#*#*#amplicon.ET05.CALR*#*#*#1*#*#*#ET05, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)CALR exon9 A382Rfs*58 (c.1144_1215delins67) *#*#*#[char](vaf (targeted exon sequencing))18% (source: unfractionated BM) *#*#*#[char](Sex)Male *#*#*#[char](age)17 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))6.3 *#*#*#[char](hg(g/dl))12.4 *#*#*#[char](platelets(k/mcl))1421 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)1% *#*#*#[char](bm fibrosis)MF-0/3 *#*#*#[char](treatment)None 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET05	null	null	None	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739224/suppl/GSM3739224_ET05.CALR.txt.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117826	GSM3739225	{'source':'PBMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'25% (source: unfractionated PB) ','Sex':'Male ','age':'62 ','diagnosis':'MF ','wbc(k/mcl)':'4.3 ','hg(g/dl)':'10.2 ','platelets(k/mcl)':'191 ','pb blast count':'0% ','bm blast count':'2% ','bm fibrosis':'MF-2/3 ','treatment':'None ','organism':'Homo sapiens','source name':'MF02, amplicon, straight', 'title':'amplicon.MF02.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739225*#*#*#amplicon.MF02.CALR*#*#*#1*#*#*#MF02, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))25% (source: unfractionated PB) *#*#*#[char](Sex)Male *#*#*#[char](age)62 *#*#*#[char](diagnosis)MF *#*#*#[char](wbc(k/mcl))4.3 *#*#*#[char](hg(g/dl))10.2 *#*#*#[char](platelets(k/mcl))191 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)2% *#*#*#[char](bm fibrosis)MF-2/3 *#*#*#[char](treatment)None 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF02	null	null	None	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739225/suppl/GSM3739225_MF02.CALR.txt.gz 	GPL16791	MF	MESH:D009182;BERN:106909301	MESH:D009182=>Mycosis Fungoides	Mycosis Fungoides	null	null	null	null	mcl|CALR	MIM:609964;HGNC:14554;Ensembl:ENSG00000166527;BERN:323647102|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:14554=>CLEC4D;Ensembl:ENSG00000166527=>CLEC4D;MIM:609964=>CLEC4D|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CLEC4D|CALR	null	null	null	null	null	null	null	null
GSE117826	GSM3739226	{'source':'PBMC ','targeted mutation':'CALR exon9 L367Rfs*46 (c.1099_1150del) ','vaf (targeted exon sequencing)':'20.6% (source: CD34- cells) ','Sex':'Male ','age':'59 ','diagnosis':'MF ','wbc(k/mcl)':'12.8 ','hg(g/dl)':'12.7 ','platelets(k/mcl)':'464 ','pb blast count':'0% ','bm blast count':'<5% ','bm fibrosis':'MF-3/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'MF03, amplicon, straight', 'title':'amplicon.MF03.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739226*#*#*#amplicon.MF03.CALR*#*#*#1*#*#*#MF03, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 L367Rfs*46 (c.1099_1150del) *#*#*#[char](vaf (targeted exon sequencing))20.6% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)59 *#*#*#[char](diagnosis)MF *#*#*#[char](wbc(k/mcl))12.8 *#*#*#[char](hg(g/dl))12.7 *#*#*#[char](platelets(k/mcl))464 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)<5% *#*#*#[char](bm fibrosis)MF-3/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF03	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739226/suppl/GSM3739226_MF03.CALR.txt.gz 	GPL16791	MF	MESH:D009182;BERN:106909301	MESH:D009182=>Mycosis Fungoides	Mycosis Fungoides	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR	CALR|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3739227	{'source':'PBMC ','targeted mutation':'CALR exon9 K385fs*47 (c.1154_1155insTTGTC) ','vaf (targeted exon sequencing)':'17.3% (source: CD34- cells) ','Sex':'Male ','age':'59 ','diagnosis':'Post-ET MF ','wbc(k/mcl)':'7.9 ','hg(g/dl)':'12.6 ','platelets(k/mcl)':'309 ','pb blast count':'0% ','bm blast count':'0.01 ','bm fibrosis':'MF-2/3 ','treatment':'None; previously IFN ','organism':'Homo sapiens','source name':'MF04, amplicon, straight', 'title':'amplicon.MF04.CALR', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739227*#*#*#amplicon.MF04.CALR*#*#*#1*#*#*#MF04, amplicon, straight*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)PBMC *#*#*#[char](targeted mutation)CALR exon9 K385fs*47 (c.1154_1155insTTGTC) *#*#*#[char](vaf (targeted exon sequencing))17.3% (source: CD34- cells) *#*#*#[char](Sex)Male *#*#*#[char](age)59 *#*#*#[char](diagnosis)Post-ET MF *#*#*#[char](wbc(k/mcl))7.9 *#*#*#[char](hg(g/dl))12.6 *#*#*#[char](platelets(k/mcl))309 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)0.01 *#*#*#[char](bm fibrosis)MF-2/3 *#*#*#[char](treatment)None; previously IFN 	31270458	null	Homo sapiens	null	high-throughput sequencing	MF04	null	null	None; previously IFN	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739227/suppl/GSM3739227_MF04.CALR.txt.gz 	GPL16791	fibrosis	MESH:D005355;BERN:256366601	MESH:D005355=>Fibrosis	Fibrosis	null	null	null	null	IFN|CALR|CD34	MIM:142230;HGNC:1662;Ensembl:ENSG00000174059;BERN:325502202|MIM:109091;HGNC:1455;Ensembl:ENSG00000179218;BERN:325222502|MIM:147660;HGNC:5417;Ensembl:ENSG00000197919;BERN:323693802	HGNC:1662=>CD34;Ensembl:ENSG00000174059=>CD34;MIM:142230=>CD34|HGNC:1455=>CALR;Ensembl:ENSG00000179218=>CALR;MIM:109091=>CALR|HGNC:5417=>IFNA1;Ensembl:ENSG00000197919=>IFNA1;MIM:147660=>IFNA1	IFNA1|CALR|CD34	null	null	null	null	null	null	null	null
GSE117826	GSM3739228	{'source':'BMMC ','targeted mutation':'JAK2 V617F (c.1849G>T) ','vaf (targeted exon sequencing)':'16.4% (source: unfractionated PB) ','Sex':'Female ','age':'17 ','diagnosis':'ET ','wbc(k/mcl)':'11.3 ','hg(g/dl)':'13.3 ','platelets(k/mcl)':'711 ','pb blast count':'0% ','bm blast count':'0.04 ','bm fibrosis':'MF-1/3 ','treatment':'Aspirin ','organism':'Homo sapiens','source name':'ET09, amplicon, circularization', 'title':'amplicon.ET09.circJAK2', 'last update date':'2019-06-02', 'release date': '2019-06-01', 'method': 'high-throughput sequencing'}	GSM3739228*#*#*#amplicon.ET09.circJAK2*#*#*#1*#*#*#ET09, amplicon, circularization*#*#*#Homo sapiens*#*#*#null*#*#*#total RNA*#*#*#null*#*#*#10x data was processed using Cell Ranger (version 2.1.0 or 3.0.0 according to used chemistry version) using default parameters. RNA reads were aligned to the human or mouse reference genome, or human and mouse reference concatenation for species mixing experiment.Amplicon reads was processed following steps: 1) Identification of reads with proper priming, 2) Identification of cell barcodes (CB) that match with the whitelisted CB, 3) Replacement of CB that are not perfectly matched with the whitelist CB, 4) Deduplication of reads, and 5) Analyze reads with CB that are also observed in the 10x scRNA-seq data.Output matrices processed from amplicon data have three columns: barcodes (BC), number of wildtype calls (num.WT.call), and number of mutant calls (num.MUT.call).Supplementary_files_format_and_content: mutation call *#*#*#OTHER*#*#*#null*#*#*#GPL16791*#*#*#2019-06-02*#*#*#2019-06-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](source)BMMC *#*#*#[char](targeted mutation)JAK2 V617F (c.1849G>T) *#*#*#[char](vaf (targeted exon sequencing))16.4% (source: unfractionated PB) *#*#*#[char](Sex)Female *#*#*#[char](age)17 *#*#*#[char](diagnosis)ET *#*#*#[char](wbc(k/mcl))11.3 *#*#*#[char](hg(g/dl))13.3 *#*#*#[char](platelets(k/mcl))711 *#*#*#[char](pb blast count)0% *#*#*#[char](bm blast count)0.04 *#*#*#[char](bm fibrosis)MF-1/3 *#*#*#[char](treatment)Aspirin 	31270458	null	Homo sapiens	null	high-throughput sequencing	ET09	null	null	Aspirin	OTHER	null	transcriptomic	total RNA	SRA	2019-06-02	2019-06-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739228/suppl/GSM3739228_ET09.JAK2.circ.txt.gz 	GPL16791	null	null	null	null	Aspirin	MESH:D001241;BERN:4129703	MESH:D001241=>Aspirin	Aspirin	JAK2	MIM:147796;HGNC:6192;Ensembl:ENSG00000096968;BERN:323767202	HGNC:6192=>JAK2;Ensembl:ENSG00000096968=>JAK2;MIM:147796=>JAK2	JAK2	null	null	null	null	null	null	null	null
GSE117827	GSM3309848	{'gender':'M ','age (months)':'6 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N003_RNA', 'title':'N003_ROC10006', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309848*#*#*#N003_ROC10006*#*#*#1*#*#*#blood_N003_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))6 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N003_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309848/suppl/GSM3309848_27966.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309849	{'gender':'M ','age (months)':'65 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N008_RNA', 'title':'N008_ROC10014', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309849*#*#*#N008_ROC10014*#*#*#1*#*#*#blood_N008_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))65 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N008_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309849/suppl/GSM3309849_27968.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309850	{'gender':'M ','age (months)':'15 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N009_RNA', 'title':'N009_ROC10016', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309850*#*#*#N009_ROC10016*#*#*#1*#*#*#blood_N009_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))15 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N009_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309850/suppl/GSM3309850_27089.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309851	{'gender':'M ','age (months)':'131 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N011_RNA', 'title':'N011_ROC10020', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309851*#*#*#N011_ROC10020*#*#*#1*#*#*#blood_N011_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))131 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N011_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309851/suppl/GSM3309851_27970.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309852	{'gender':'F ','age (months)':'19 ','infection':'picornavirus (cosxackievirus A2) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N012_RNA', 'title':'N012_ROC10022', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309852*#*#*#N012_ROC10022*#*#*#1*#*#*#blood_N012_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))19 *#*#*#[char](infection)picornavirus (cosxackievirus A2) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N012_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309852/suppl/GSM3309852_27090.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309853	{'gender':'M ','age (months)':'17 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N016_RNA', 'title':'N016_ROC10032', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309853*#*#*#N016_ROC10032*#*#*#1*#*#*#blood_N016_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))17 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N016_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309853/suppl/GSM3309853_27996.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309854	{'gender':'M ','age (months)':'9 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N019_RNA', 'title':'N019_ROC10040', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309854*#*#*#N019_ROC10040*#*#*#1*#*#*#blood_N019_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))9 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N019_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309854/suppl/GSM3309854_27997.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309855	{'gender':'M ','age (months)':'11 ','infection':'picornavirus (enterovirus D68) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N024_RNA', 'title':'N024_ROC10054', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309855*#*#*#N024_ROC10054*#*#*#1*#*#*#blood_N024_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))11 *#*#*#[char](infection)picornavirus (enterovirus D68) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N024_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309855/suppl/GSM3309855_27979.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309856	{'gender':'F ','age (months)':'14 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N028_RNA', 'title':'N028_ROC10065', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309856*#*#*#N028_ROC10065*#*#*#1*#*#*#blood_N028_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))14 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N028_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309856/suppl/GSM3309856_27982.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309857	{'gender':'F ','age (months)':'112 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N017_RNA', 'title':'N017_ROC10035', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309857*#*#*#N017_ROC10035*#*#*#1*#*#*#blood_N017_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))112 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N017_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309857/suppl/GSM3309857_27974.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309858	{'gender':'F ','age (months)':'107 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N020_RNA', 'title':'N020_ROC10043', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309858*#*#*#N020_ROC10043*#*#*#1*#*#*#blood_N020_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))107 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N020_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309858/suppl/GSM3309858_27977.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309859	{'gender':'M ','age (months)':'29 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N023_RNA', 'title':'N023_ROC10052', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309859*#*#*#N023_ROC10052*#*#*#1*#*#*#blood_N023_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))29 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N023_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309859/suppl/GSM3309859_27978.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309860	{'gender':'F ','age (months)':'4 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N025_RNA', 'title':'N025_ROC10057', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309860*#*#*#N025_ROC10057*#*#*#1*#*#*#blood_N025_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))4 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N025_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309860/suppl/GSM3309860_27980.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309861	{'gender':'M ','age (months)':'11 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N033_RNA', 'title':'N033_ROC10077', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309861*#*#*#N033_ROC10077*#*#*#1*#*#*#blood_N033_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))11 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N033_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309861/suppl/GSM3309861_27984.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309862	{'gender':'M ','age (months)':'34 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N015_RNA', 'title':'N015_ROC10030', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309862*#*#*#N015_ROC10030*#*#*#1*#*#*#blood_N015_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))34 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N015_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309862/suppl/GSM3309862_27972.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309863	{'gender':'M ','age (months)':'93 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N018_RNA', 'title':'N018_ROC10038', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309863*#*#*#N018_ROC10038*#*#*#1*#*#*#blood_N018_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))93 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N018_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309863/suppl/GSM3309863_27975.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309864	{'gender':'M ','age (months)':'15 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N026_RNA', 'title':'N026_ROC10060', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309864*#*#*#N026_ROC10060*#*#*#1*#*#*#blood_N026_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))15 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N026_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309864/suppl/GSM3309864_27981.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309865	{'gender':'M ','age (months)':'9 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N040_RNA', 'title':'N040_ROC10098', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309865*#*#*#N040_ROC10098*#*#*#1*#*#*#blood_N040_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))9 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N040_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309865/suppl/GSM3309865_27985.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309866	{'gender':'M ','age (months)':'17 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N041_RNA', 'title':'N041_ROC10101', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309866*#*#*#N041_ROC10101*#*#*#1*#*#*#blood_N041_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))17 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N041_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309866/suppl/GSM3309866_27986.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309867	{'gender':'M ','age (months)':'26 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'blood_N045_RNA', 'title':'N045_ROC10114', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309867*#*#*#N045_ROC10114*#*#*#1*#*#*#blood_N045_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))26 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N045_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309867/suppl/GSM3309867_27991.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309868	{'gender':'F ','age (months)':'8 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N030_RNA', 'title':'N030_ROC10070', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309868*#*#*#N030_ROC10070*#*#*#1*#*#*#blood_N030_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))8 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N030_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309868/suppl/GSM3309868_27983.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309869	{'gender':'F ','age (months)':'4 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N043_RNA', 'title':'N043_ROC10105', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309869*#*#*#N043_ROC10105*#*#*#1*#*#*#blood_N043_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))4 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N043_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309869/suppl/GSM3309869_27987.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309870	{'gender':'F ','age (months)':'5 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N044_RNA', 'title':'N044_ROC10111', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309870*#*#*#N044_ROC10111*#*#*#1*#*#*#blood_N044_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))5 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N044_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309870/suppl/GSM3309870_27989.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309871	{'gender':'M ','age (months)':'7 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'blood_N046_RNA', 'title':'N046_ROC10116', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309871*#*#*#N046_ROC10116*#*#*#1*#*#*#blood_N046_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#whole blood *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))7 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	blood_N046_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309871/suppl/GSM3309871_27993.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309872	{'gender':'M ','age (months)':'6 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N003_RNA', 'title':'N003_ROC10005', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309872*#*#*#N003_ROC10005*#*#*#1*#*#*#nasal_N003_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))6 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N003_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309872/suppl/GSM3309872_27965.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309873	{'gender':'M ','age (months)':'65 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N008_RNA', 'title':'N008_ROC10013', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309873*#*#*#N008_ROC10013*#*#*#1*#*#*#nasal_N008_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))65 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N008_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309873/suppl/GSM3309873_27967.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309874	{'gender':'M ','age (months)':'15 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N009_RNA', 'title':'N009_ROC10015', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309874*#*#*#N009_ROC10015*#*#*#1*#*#*#nasal_N009_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))15 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N009_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309874/suppl/GSM3309874_27087.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309875	{'gender':'M ','age (months)':'131 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N011_RNA', 'title':'N011_ROC10019', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309875*#*#*#N011_ROC10019*#*#*#1*#*#*#nasal_N011_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))131 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N011_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309875/suppl/GSM3309875_27969.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309876	{'gender':'F ','age (months)':'19 ','infection':'picornavirus (cosxackievirus A2) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N012_RNA', 'title':'N012_ROC10021', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309876*#*#*#N012_ROC10021*#*#*#1*#*#*#nasal_N012_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))19 *#*#*#[char](infection)picornavirus (cosxackievirus A2) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N012_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309876/suppl/GSM3309876_27088.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309877	{'gender':'M ','age (months)':'17 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N016_RNA', 'title':'N016_ROC10031', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309877*#*#*#N016_ROC10031*#*#*#1*#*#*#nasal_N016_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))17 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N016_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309877/suppl/GSM3309877_27953.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309878	{'gender':'M ','age (months)':'9 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N019_RNA', 'title':'N019_ROC10039', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309878*#*#*#N019_ROC10039*#*#*#1*#*#*#nasal_N019_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))9 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N019_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309878/suppl/GSM3309878_27950.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309879	{'gender':'M ','age (months)':'11 ','infection':'picornavirus (enterovirus D68) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N024_RNA', 'title':'N024_ROC10053', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309879*#*#*#N024_ROC10053*#*#*#1*#*#*#nasal_N024_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))11 *#*#*#[char](infection)picornavirus (enterovirus D68) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N024_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309879/suppl/GSM3309879_27956.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309880	{'gender':'F ','age (months)':'14 ','infection':'picornavirus (rhinovirus) ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N028_RNA', 'title':'N028_ROC10064', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309880*#*#*#N028_ROC10064*#*#*#1*#*#*#nasal_N028_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))14 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N028_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309880/suppl/GSM3309880_27959.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309881	{'gender':'F ','age (months)':'112 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N017_RNA', 'title':'N017_ROC10033', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309881*#*#*#N017_ROC10033*#*#*#1*#*#*#nasal_N017_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))112 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N017_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309881/suppl/GSM3309881_27954.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309882	{'gender':'F ','age (months)':'107 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N020_RNA', 'title':'N020_ROC10041', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309882*#*#*#N020_ROC10041*#*#*#1*#*#*#nasal_N020_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))107 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N020_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309882/suppl/GSM3309882_27951.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309883	{'gender':'M ','age (months)':'29 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N023_RNA', 'title':'N023_ROC10050', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309883*#*#*#N023_ROC10050*#*#*#1*#*#*#nasal_N023_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))29 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N023_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309883/suppl/GSM3309883_27952.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309884	{'gender':'F ','age (months)':'4 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N025_RNA', 'title':'N025_ROC10055', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309884*#*#*#N025_ROC10055*#*#*#1*#*#*#nasal_N025_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))4 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N025_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309884/suppl/GSM3309884_27957.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309885	{'gender':'M ','age (months)':'11 ','infection':'picornavirus (rhinovirus) ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N033_RNA', 'title':'N033_ROC10075', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309885*#*#*#N033_ROC10075*#*#*#1*#*#*#nasal_N033_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))11 *#*#*#[char](infection)picornavirus (rhinovirus) *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N033_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309885/suppl/GSM3309885_27961.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309886	{'gender':'M ','age (months)':'34 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N015_RNA', 'title':'N015_ROC10028', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309886*#*#*#N015_ROC10028*#*#*#1*#*#*#nasal_N015_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))34 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N015_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309886/suppl/GSM3309886_27971.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309887	{'gender':'M ','age (months)':'93 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N018_RNA', 'title':'N018_ROC10036', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309887*#*#*#N018_ROC10036*#*#*#1*#*#*#nasal_N018_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))93 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N018_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309887/suppl/GSM3309887_27955.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309888	{'gender':'M ','age (months)':'15 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N026_RNA', 'title':'N026_ROC10058', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309888*#*#*#N026_ROC10058*#*#*#1*#*#*#nasal_N026_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))15 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N026_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309888/suppl/GSM3309888_27958.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309889	{'gender':'M ','age (months)':'9 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N040_RNA', 'title':'N040_ROC10096', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309889*#*#*#N040_ROC10096*#*#*#1*#*#*#nasal_N040_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))9 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N040_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309889/suppl/GSM3309889_27962.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309890	{'gender':'M ','age (months)':'17 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N041_RNA', 'title':'N041_ROC10099', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309890*#*#*#N041_ROC10099*#*#*#1*#*#*#nasal_N041_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))17 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N041_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309890/suppl/GSM3309890_27963.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309891	{'gender':'M ','age (months)':'26 ','infection':'none ','symptomatic':'No ','organism':'Homo sapiens','source name':'nasal_N045_RNA', 'title':'N045_ROC10112', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309891*#*#*#N045_ROC10112*#*#*#1*#*#*#nasal_N045_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))26 *#*#*#[char](infection)none *#*#*#[char](symptomatic)No 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N045_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309891/suppl/GSM3309891_27990.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309892	{'gender':'M ','age (months)':'4 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N005_RNA', 'title':'N005_ROC10009', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309892*#*#*#N005_ROC10009*#*#*#1*#*#*#nasal_N005_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))4 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N005_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309892/suppl/GSM3309892_27994.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309893	{'gender':'F ','age (months)':'4 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N006_RNA', 'title':'N006_ROC10010', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309893*#*#*#N006_ROC10010*#*#*#1*#*#*#nasal_N006_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))4 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N006_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309893/suppl/GSM3309893_27995.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309894	{'gender':'F ','age (months)':'8 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N030_RNA', 'title':'N030_ROC10069', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309894*#*#*#N030_ROC10069*#*#*#1*#*#*#nasal_N030_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))8 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N030_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309894/suppl/GSM3309894_27960.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309895	{'gender':'F ','age (months)':'4 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N043_RNA', 'title':'N043_ROC10104', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309895*#*#*#N043_ROC10104*#*#*#1*#*#*#nasal_N043_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))4 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N043_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309895/suppl/GSM3309895_27964.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309896	{'gender':'F ','age (months)':'5 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N044_RNA', 'title':'N044_ROC10110', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309896*#*#*#N044_ROC10110*#*#*#1*#*#*#nasal_N044_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)F *#*#*#[char](age (months))5 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N044_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309896/suppl/GSM3309896_27988.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE117827	GSM3309897	{'gender':'M ','age (months)':'7 ','infection':'respiratory syncytial virus ','symptomatic':'Yes ','organism':'Homo sapiens','source name':'nasal_N046_RNA', 'title':'N046_ROC10115', 'last update date':'2019-01-01', 'release date': '2019-01-01', 'method': 'in situ oligonucleotide'}	GSM3309897*#*#*#N046_ROC10115*#*#*#1*#*#*#nasal_N046_RNA*#*#*#Homo sapiens*#*#*#The blood samples obtained by venipuncture were drawn into a Tempus tube (Applied Biosystems, Foster City, CA). The nasopharynx was washed with normal saline by a trained study coordinator and a nasal swab was obtained using a mid-turbinate flocked swab (Copan Diagnostics, Inc., Murrieta, CA). The nasal swab was immediately placed in RNAprotect (Qiagen, Valencia, CA). The nasal swab in RNAprotect was stored for 1-5 days at 4°C, after which cells were pelleted, suspended in lysis buffer containing BME, and homogenized by passing the lysate 10-12 times through a 28- gauge needle. *#*#*#total RNA*#*#*#biotin*#*#*#The raw chip data files (.CEL) were processed through Affymetrix standard analysis pipeline for RMA background correction, median-polish summarization and quantile normalization. The .CHP files were generated at gene-level. *#*#*#null*#*#*#nasal swab *#*#*#GPL23126*#*#*#2019-01-01*#*#*#2019-01-01*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)RNA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](gender)M *#*#*#[char](age (months))7 *#*#*#[char](infection)respiratory syncytial virus *#*#*#[char](symptomatic)Yes 	30339221	null	Homo sapiens	null	in situ oligonucleotide	nasal_N046_RNA	null	null	null	null	null	null	total RNA	RNA	2019-01-01	2019-01-01	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3309nnn/GSM3309897/suppl/GSM3309897_27992.CEL.gz 	GPL23126	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
GSE81851	GSM2176714	{'cell type':'MCF7 breast cancer cells ','drug treatment':'24 hour vehicle (ethanol) treatment ','exogenous treatment':'N/A ','organism':'Homo sapiens','source name':'MCF7', 'title':'Mock S 9.6 DRIP Seq', 'last update date':'2020-01-14', 'release date': '2016-08-23', 'method': 'high-throughput sequencing'}	GSM2176714*#*#*#Mock S 9.6 DRIP Seq*#*#*#1*#*#*#MCF7*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Base calling CASAVA v1.8.2Reads were aligned to genome with bowtie2 -p 10 --qc-filter --no-unal -q -x hg19Reads aligned over restriction digest intervals with bedtools coverageDESEq2 (R package) was used to call enriched intervals over inputDESeq2 (R package) was again used to call regions with differential enrichmentGenome_build: hg19Supplementary_files_format_and_content: Tab delimited files include raw read counts over the intervals. For DESeq_differential_calls.tsv the file also includes the output from DESEq runs. "T0_DRIP_over_Input", "T2_DRIP_over_Input" and "T24 DRIP over input" refer to the enrichemnt of the mock, 2 hour and 24 hour samples over input respectively. "T0_T24_DRIP", "T0_T2_DRIP" and "T2_T24_DRIP" refer to the DESeq enrichment of 24 hour samples over mock, 2 hour samples over mock, and 2 hour over 24 hour respectively. *#*#*#OTHER*#*#*#count_data.tsv, DESeq_differential_calls.tsvlibrary strategy: DRIP-seq *#*#*#GPL16791*#*#*#2020-01-14*#*#*#2016-08-23*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 breast cancer cells *#*#*#[char](drug treatment)24 hour vehicle (ethanol) treatment *#*#*#[char](exogenous treatment)N/A 	27552054	null	Homo sapiens	MCF7 breast cancer cells	high-throughput sequencing	MCF7	null	null	null	OTHER	DRIP-seq	genomic	genomic DNA	SRA	2020-01-14	2016-08-23	NONE 	GPL16791	breast cancer	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	ethanol	CHEBI:16236;BERN:4168403	CHEBI:16236=>ethanol	ethanol	null	null	null	null	null	null	null	null	MCF7	T24|MCF7	null	null
GSE81851	GSM2176715	{'cell type':'MCF7 breast cancer cells ','drug treatment':'24 hour vehicle (ethanol) treatment ','exogenous treatment':'N/A ','organism':'Homo sapiens','source name':'MCF7', 'title':'Mock input S 9.6 DRIP Seq', 'last update date':'2020-01-14', 'release date': '2016-08-23', 'method': 'high-throughput sequencing'}	GSM2176715*#*#*#Mock input S 9.6 DRIP Seq*#*#*#1*#*#*#MCF7*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Base calling CASAVA v1.8.2Reads were aligned to genome with bowtie2 -p 10 --qc-filter --no-unal -q -x hg19Reads aligned over restriction digest intervals with bedtools coverageDESEq2 (R package) was used to call enriched intervals over inputDESeq2 (R package) was again used to call regions with differential enrichmentGenome_build: hg19Supplementary_files_format_and_content: Tab delimited files include raw read counts over the intervals. For DESeq_differential_calls.tsv the file also includes the output from DESEq runs. "T0_DRIP_over_Input", "T2_DRIP_over_Input" and "T24 DRIP over input" refer to the enrichemnt of the mock, 2 hour and 24 hour samples over input respectively. "T0_T24_DRIP", "T0_T2_DRIP" and "T2_T24_DRIP" refer to the DESeq enrichment of 24 hour samples over mock, 2 hour samples over mock, and 2 hour over 24 hour respectively. *#*#*#OTHER*#*#*#count_data.tsv, DESeq_differential_calls.tsvlibrary strategy: DRIP-seq *#*#*#GPL16791*#*#*#2020-01-14*#*#*#2016-08-23*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 breast cancer cells *#*#*#[char](drug treatment)24 hour vehicle (ethanol) treatment *#*#*#[char](exogenous treatment)N/A 	27552054	null	Homo sapiens	MCF7 breast cancer cells	high-throughput sequencing	MCF7	null	null	null	OTHER	DRIP-seq	genomic	genomic DNA	SRA	2020-01-14	2016-08-23	NONE 	GPL16791	breast cancer	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	ethanol	CHEBI:16236;BERN:4168403	CHEBI:16236=>ethanol	ethanol	null	null	null	null	null	null	null	null	MCF7	T24|MCF7	null	null
GSE81851	GSM2176716	{'cell type':'MCF7 breast cancer cells ','drug treatment':'24 hour vehicle (ethanol) treatment ','exogenous treatment':'RNaseH ','organism':'Homo sapiens','source name':'MCF7', 'title':'Mock RNaseH S 9.6 DRIP Seq', 'last update date':'2020-01-14', 'release date': '2016-08-23', 'method': 'high-throughput sequencing'}	GSM2176716*#*#*#Mock RNaseH S 9.6 DRIP Seq*#*#*#1*#*#*#MCF7*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Base calling CASAVA v1.8.2Reads were aligned to genome with bowtie2 -p 10 --qc-filter --no-unal -q -x hg19Reads aligned over restriction digest intervals with bedtools coverageDESEq2 (R package) was used to call enriched intervals over inputDESeq2 (R package) was again used to call regions with differential enrichmentGenome_build: hg19Supplementary_files_format_and_content: Tab delimited files include raw read counts over the intervals. For DESeq_differential_calls.tsv the file also includes the output from DESEq runs. "T0_DRIP_over_Input", "T2_DRIP_over_Input" and "T24 DRIP over input" refer to the enrichemnt of the mock, 2 hour and 24 hour samples over input respectively. "T0_T24_DRIP", "T0_T2_DRIP" and "T2_T24_DRIP" refer to the DESeq enrichment of 24 hour samples over mock, 2 hour samples over mock, and 2 hour over 24 hour respectively. *#*#*#OTHER*#*#*#DESeq_differential_calls.tsvlibrary strategy: DRIP-seq *#*#*#GPL16791*#*#*#2020-01-14*#*#*#2016-08-23*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 breast cancer cells *#*#*#[char](drug treatment)24 hour vehicle (ethanol) treatment *#*#*#[char](exogenous treatment)RNaseH 	27552054	null	Homo sapiens	MCF7 breast cancer cells	high-throughput sequencing	MCF7	null	null	null	OTHER	DRIP-seq	genomic	genomic DNA	SRA	2020-01-14	2016-08-23	NONE 	GPL16791	breast cancer	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	ethanol	CHEBI:16236;BERN:4168403	CHEBI:16236=>ethanol	ethanol	null	null	null	null	null	null	null	null	MCF7	T24|MCF7	null	null
GSE81851	GSM2176717	{'cell type':'MCF7 breast cancer cells ','drug treatment':'2 hour treatment with 100 nM estradiol ','exogenous treatment':'N/A ','organism':'Homo sapiens','source name':'MCF7', 'title':'2hr S 9.6 DRIP Seq', 'last update date':'2020-01-14', 'release date': '2016-08-23', 'method': 'high-throughput sequencing'}	GSM2176717*#*#*#2hr S 9.6 DRIP Seq*#*#*#1*#*#*#MCF7*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Base calling CASAVA v1.8.2Reads were aligned to genome with bowtie2 -p 10 --qc-filter --no-unal -q -x hg19Reads aligned over restriction digest intervals with bedtools coverageDESEq2 (R package) was used to call enriched intervals over inputDESeq2 (R package) was again used to call regions with differential enrichmentGenome_build: hg19Supplementary_files_format_and_content: Tab delimited files include raw read counts over the intervals. For DESeq_differential_calls.tsv the file also includes the output from DESEq runs. "T0_DRIP_over_Input", "T2_DRIP_over_Input" and "T24 DRIP over input" refer to the enrichemnt of the mock, 2 hour and 24 hour samples over input respectively. "T0_T24_DRIP", "T0_T2_DRIP" and "T2_T24_DRIP" refer to the DESeq enrichment of 24 hour samples over mock, 2 hour samples over mock, and 2 hour over 24 hour respectively. *#*#*#OTHER*#*#*#count_data.tsv, DESeq_differential_calls.tsvlibrary strategy: DRIP-seq *#*#*#GPL16791*#*#*#2020-01-14*#*#*#2016-08-23*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 breast cancer cells *#*#*#[char](drug treatment)2 hour treatment with 100 nM estradiol *#*#*#[char](exogenous treatment)N/A 	27552054	null	Homo sapiens	MCF7 breast cancer cells	high-throughput sequencing	MCF7	null	null	null	OTHER	DRIP-seq	genomic	genomic DNA	SRA	2020-01-14	2016-08-23	NONE 	GPL16791	breast cancer	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	estradiol	CHEBI:16469;BERN:269208503	CHEBI:16469=>17beta-estradiol	17beta-estradiol	null	null	null	null	null	null	null	null	MCF7	T24|MCF7	null	null
GSE81851	GSM2176718	{'cell type':'MCF7 breast cancer cells ','drug treatment':'2 hour treatment with 100 nM estradiol ','exogenous treatment':'N/A ','organism':'Homo sapiens','source name':'MCF7', 'title':'2hr input S 9.6 DRIP Seq', 'last update date':'2020-01-14', 'release date': '2016-08-23', 'method': 'high-throughput sequencing'}	GSM2176718*#*#*#2hr input S 9.6 DRIP Seq*#*#*#1*#*#*#MCF7*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Base calling CASAVA v1.8.2Reads were aligned to genome with bowtie2 -p 10 --qc-filter --no-unal -q -x hg19Reads aligned over restriction digest intervals with bedtools coverageDESEq2 (R package) was used to call enriched intervals over inputDESeq2 (R package) was again used to call regions with differential enrichmentGenome_build: hg19Supplementary_files_format_and_content: Tab delimited files include raw read counts over the intervals. For DESeq_differential_calls.tsv the file also includes the output from DESEq runs. "T0_DRIP_over_Input", "T2_DRIP_over_Input" and "T24 DRIP over input" refer to the enrichemnt of the mock, 2 hour and 24 hour samples over input respectively. "T0_T24_DRIP", "T0_T2_DRIP" and "T2_T24_DRIP" refer to the DESeq enrichment of 24 hour samples over mock, 2 hour samples over mock, and 2 hour over 24 hour respectively. *#*#*#OTHER*#*#*#count_data.tsv, DESeq_differential_calls.tsvlibrary strategy: DRIP-seq *#*#*#GPL16791*#*#*#2020-01-14*#*#*#2016-08-23*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 breast cancer cells *#*#*#[char](drug treatment)2 hour treatment with 100 nM estradiol *#*#*#[char](exogenous treatment)N/A 	27552054	null	Homo sapiens	MCF7 breast cancer cells	high-throughput sequencing	MCF7	null	null	null	OTHER	DRIP-seq	genomic	genomic DNA	SRA	2020-01-14	2016-08-23	NONE 	GPL16791	breast cancer	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	estradiol	CHEBI:16469;BERN:269208503	CHEBI:16469=>17beta-estradiol	17beta-estradiol	null	null	null	null	null	null	null	null	MCF7	T24|MCF7	null	null
GSE81851	GSM2176719	{'cell type':'MCF7 breast cancer cells ','drug treatment':'24 hour treatment with 100 nM estradiol ','exogenous treatment':'N/A ','organism':'Homo sapiens','source name':'MCF7', 'title':'24hr S 9.6 DRIP Seq', 'last update date':'2020-01-14', 'release date': '2016-08-23', 'method': 'high-throughput sequencing'}	GSM2176719*#*#*#24hr S 9.6 DRIP Seq*#*#*#1*#*#*#MCF7*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Base calling CASAVA v1.8.2Reads were aligned to genome with bowtie2 -p 10 --qc-filter --no-unal -q -x hg19Reads aligned over restriction digest intervals with bedtools coverageDESEq2 (R package) was used to call enriched intervals over inputDESeq2 (R package) was again used to call regions with differential enrichmentGenome_build: hg19Supplementary_files_format_and_content: Tab delimited files include raw read counts over the intervals. For DESeq_differential_calls.tsv the file also includes the output from DESEq runs. "T0_DRIP_over_Input", "T2_DRIP_over_Input" and "T24 DRIP over input" refer to the enrichemnt of the mock, 2 hour and 24 hour samples over input respectively. "T0_T24_DRIP", "T0_T2_DRIP" and "T2_T24_DRIP" refer to the DESeq enrichment of 24 hour samples over mock, 2 hour samples over mock, and 2 hour over 24 hour respectively. *#*#*#OTHER*#*#*#count_data.tsv, DESeq_differential_calls.tsvlibrary strategy: DRIP-seq *#*#*#GPL16791*#*#*#2020-01-14*#*#*#2016-08-23*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 breast cancer cells *#*#*#[char](drug treatment)24 hour treatment with 100 nM estradiol *#*#*#[char](exogenous treatment)N/A 	27552054	null	Homo sapiens	MCF7 breast cancer cells	high-throughput sequencing	MCF7	null	null	null	OTHER	DRIP-seq	genomic	genomic DNA	SRA	2020-01-14	2016-08-23	NONE 	GPL16791	breast cancer	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	estradiol	CHEBI:16469;BERN:269208503	CHEBI:16469=>17beta-estradiol	17beta-estradiol	null	null	null	null	null	null	null	null	MCF7	T24|MCF7	null	null
GSE81851	GSM2176720	{'cell type':'MCF7 breast cancer cells ','drug treatment':'24 hour treatment with 100 nM estradiol ','exogenous treatment':'RNAseH ','organism':'Homo sapiens','source name':'MCF7', 'title':'24hr RNAseH S 9.6 DRIP Seq', 'last update date':'2020-01-14', 'release date': '2016-08-23', 'method': 'high-throughput sequencing'}	GSM2176720*#*#*#24hr RNAseH S 9.6 DRIP Seq*#*#*#1*#*#*#MCF7*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Base calling CASAVA v1.8.2Reads were aligned to genome with bowtie2 -p 10 --qc-filter --no-unal -q -x hg19Reads aligned over restriction digest intervals with bedtools coverageDESEq2 (R package) was used to call enriched intervals over inputDESeq2 (R package) was again used to call regions with differential enrichmentGenome_build: hg19Supplementary_files_format_and_content: Tab delimited files include raw read counts over the intervals. For DESeq_differential_calls.tsv the file also includes the output from DESEq runs. "T0_DRIP_over_Input", "T2_DRIP_over_Input" and "T24 DRIP over input" refer to the enrichemnt of the mock, 2 hour and 24 hour samples over input respectively. "T0_T24_DRIP", "T0_T2_DRIP" and "T2_T24_DRIP" refer to the DESeq enrichment of 24 hour samples over mock, 2 hour samples over mock, and 2 hour over 24 hour respectively. *#*#*#OTHER*#*#*#DESeq_differential_calls.tsvlibrary strategy: DRIP-seq *#*#*#GPL16791*#*#*#2020-01-14*#*#*#2016-08-23*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 breast cancer cells *#*#*#[char](drug treatment)24 hour treatment with 100 nM estradiol *#*#*#[char](exogenous treatment)RNAseH 	27552054	null	Homo sapiens	MCF7 breast cancer cells	high-throughput sequencing	MCF7	null	null	null	OTHER	DRIP-seq	genomic	genomic DNA	SRA	2020-01-14	2016-08-23	NONE 	GPL16791	breast cancer	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	estradiol	CHEBI:16469;BERN:269208503	CHEBI:16469=>17beta-estradiol	17beta-estradiol	null	null	null	null	null	null	null	null	MCF7	T24|MCF7	null	null
GSE81851	GSM2176721	{'cell type':'MCF7 breast cancer cells ','drug treatment':'24 hour treatment with 100 nM estradiol ','exogenous treatment':'N/A ','organism':'Homo sapiens','source name':'MCF7', 'title':'24hr input S 9.6 DRIP Seq', 'last update date':'2020-01-14', 'release date': '2016-08-23', 'method': 'high-throughput sequencing'}	GSM2176721*#*#*#24hr input S 9.6 DRIP Seq*#*#*#1*#*#*#MCF7*#*#*#Homo sapiens*#*#*#null*#*#*#genomic DNA*#*#*#null*#*#*#Base calling CASAVA v1.8.2Reads were aligned to genome with bowtie2 -p 10 --qc-filter --no-unal -q -x hg19Reads aligned over restriction digest intervals with bedtools coverageDESEq2 (R package) was used to call enriched intervals over inputDESeq2 (R package) was again used to call regions with differential enrichmentGenome_build: hg19Supplementary_files_format_and_content: Tab delimited files include raw read counts over the intervals. For DESeq_differential_calls.tsv the file also includes the output from DESEq runs. "T0_DRIP_over_Input", "T2_DRIP_over_Input" and "T24 DRIP over input" refer to the enrichemnt of the mock, 2 hour and 24 hour samples over input respectively. "T0_T24_DRIP", "T0_T2_DRIP" and "T2_T24_DRIP" refer to the DESeq enrichment of 24 hour samples over mock, 2 hour samples over mock, and 2 hour over 24 hour respectively. *#*#*#OTHER*#*#*#count_data.tsv, DESeq_differential_calls.tsvlibrary strategy: DRIP-seq *#*#*#GPL16791*#*#*#2020-01-14*#*#*#2016-08-23*#*#*#(SAGE_anchor)null*#*#*#(SAGE_type)SRA*#*#*#(SAGE_count)null*#*#*#(SAGE_len)null*#*#*#[char](cell type)MCF7 breast cancer cells *#*#*#[char](drug treatment)24 hour treatment with 100 nM estradiol *#*#*#[char](exogenous treatment)N/A 	27552054	null	Homo sapiens	MCF7 breast cancer cells	high-throughput sequencing	MCF7	null	null	null	OTHER	DRIP-seq	genomic	genomic DNA	SRA	2020-01-14	2016-08-23	NONE 	GPL16791	breast cancer	OMIM:114480;MESH:D001943;BERN:107480901	OMIM:114480=>BREAST CANCER;MESH:D001943=>Breast Neoplasms	Breast Neoplasms|BREAST CANCER	estradiol	CHEBI:16469;BERN:269208503	CHEBI:16469=>17beta-estradiol	17beta-estradiol	null	null	null	null	null	null	null	null	MCF7	T24|MCF7	null	null
